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Abstract 
 
Nicotinic acid adenine dinucleotide phosphate (NAADP) is a potent Ca2+ mobilising 
messenger in mammalian and non-mammalian cells.  Studies on a variety of cell 
types suggest that NAADP evokes Ca2+ release from a lysosome-related store and via 
activation of a receptor distinct from either ryanodine receptors (RyR) or inositol 
1,4,5-trisphosphate (IP3) receptors (IP3R).  However, the identity of the NAADP 
receptor has, until now, remained elusive.  In this thesis I have shown that NAADP-
evoked Ca2+ release from lysosomes is underpinned by two-pore channels (TPCs), of 
which there are 3 subtypes, TPC1, TPC2 and TPC3.  When stably over-expressed in 
HEK293 cells, TPC2 was found to be specifically targeted to lysosomes, while TPC1 
and TPC3 were targeted to endosomes.  Initial Ca2+ signals via TPC2, but not those 
via TPC1, were amplified into global Ca2+ waves by Ca2+-induced Ca2+ release 
(CICR) from the endoplasmic reticulum (ER) via IP3Rs.  I have shown that, consistent 
with a role for TPCs in NAADP-mediated Ca2+ release, TPC2 is expressed in 
pulmonary arterial smooth muscle cells (PASMCs), is likely targeted to lysosomal 
membranes, and that TPCs also underpin NAADP-evoked Ca2+ signalling in this cell 
type.  However, and in contrast to HEK293 cells, in PASMCs NAADP evokes 
spatially restricted Ca2+ bursts that are amplified into global Ca2+ waves by CICR 
from the sarcoplasmic reticulum (SR) via a subpopulation of RyRs, but not via IP3Rs.  
I have demonstrated that lysosomes preferentially co-localise with RyR subtype 3 
(RyR3) in the perinuclear region of PASMCs to comprise a “trigger zone” for Ca2+ 
signalling by NAADP, away from which a propagating Ca2+ wave may be carried by 
subsequent recruitment of RyR2.  The identification of TPCs as a family of NAADP 
receptors may further our understanding of the mechanisms that confer the versatility 
of Ca2+ signalling which is required to regulate such diverse cellular functions as gene 
expression, fertilization, cell growth, and ultimately cell death. 
 
 viii 
 ix 
Table of contents 
 
 
Title i 
Declaration iii 
Acknowledgements v 
Abstract vii 
Table of contents ix 
  
Chapter 1: Introduction 1 
1.1  Intracellular Ca2+ signalling 1 
1.2  Ca2+ signalling across the plasma membrane 2 
1.2.1  Voltage-gated Ca2+ channels 2 
1.2.2  Voltage-independent Ca2+ channels 4 
1.2.2.1  Receptor-operated Ca2+ entry 4 
1.2.2.2  Store-operated Ca2+ entry 6 
1.2.3  The role of voltage-gated Na+ channels 7 
1.2.4  K+ channels 8 
1.2.4.1  Ca2+-activated K+ channels 8 
1.2.4.2  Voltage-gated K+ channels 9 
1.2.4.3  Inward rectifier K+ channels 9 
1.2.5  Ca2+-activated Cl- channel 10 
1.2.6 Removal of Ca2+ across the plasma membrane 11 
1.2.6.1  Removal of Ca2+ by the plasma membrane Ca2+-ATPase 11 
1.2.6.2  Removal of Ca2+ by the Na+ / Ca2+ exchanger 12 
1.3 Ca2+ handling by mitochondria 13 
1.4 Mobilisable intracellular Ca2+ stores 15 
1.4.1 Endoplasmic / Sarcoplasmic reticulum 15 
1.4.1.1 Sequestration of Ca2+ by the sarcoplasmic / endoplasmic 
reticulum Ca2+ ATPase 
15 
1.4.1.2  Ca2+ buffering proteins of the sarcoplasmic / endoplasmic 
reticulum 
17 
1.4.2 Golgi apparatus 17 
1.4.3  Ca2+ mobilisation by IP3 19 
1.4.3.1  Synthesis and metabolism of IP3 19 
1.4.3.2  IP3R subtypes 19 
1.4.4 Ca2+ mobilisation by pyridine nucleotides 20 
1.4.4.1  Ca2+ mobilisation by cADPR 21 
1.4.4.2  Synthesis of cADPR 21 
1.4.4.3 cADPR-mediated Ca2+ mobilisation via ryanodine receptors 23 
1.5 NAADP-dependent Ca2+ signalling 25 
1.5.1 Synthesis and metabolism of NAADP 26 
1.5.2 NAADP mobilises Ca2+ from a separate store to that mobilised 
by IP3 and cADPR 
27 
1.5.3 NAADP mediates Ca2+ release via interaction with a 
pharmacologically discreet receptor 
28 
1.5.4 NAADP mediates Ca2+ release via a two-pool system in sea 
urchin eggs 
30 
1.5.5 NAADP mobilises Ca2+ from a lysosome-related acidic Ca2+ 
store 
30 
 x 
1.5.5.1 Acidic Ca2+ stores 30 
1.5.5.2 Acidic lysosome-related organelles function as NAADP-
sensitive Ca2+ stores 
33 
1.5.6 NAADP-mediated Ca2+ release in mammalian cells 34 
1.5.6.1 NAADP mobilises Ca2+ from lysosome-related organelles in 
mammalian cells 
35 
1.5.6.2 The NAADP “trigger zone” underpins NAADP-mediated Ca2+ 
release 
36 
1.5.7 The NAADP receptor 37 
1.6 Aims of this thesis 38 
   
Chapter 2: Materials and Methods 39 
2.1 Dissection and cell isolation 39 
2.1.1 Identification and dissection of 2nd order pulmonary arteries 39 
2.1.2 Isolation of pulmonary arterial smooth muscle cells 39 
2.2 Cell culture 40 
2.2.1 Maintenance of HEK293 cells 41 
2.2.2 Preparation of HEK293 cells for Ca2+ imaging and visualization 
of intracellular proteins using fluorescent labelling 
43 
2.2.3 Long-term storage of cells 43 
2.3 Immunocytochemistry 44 
2.3.1 Fixation and labelling of isolated pulmonary arterial smooth 
muscle cells and HEK293 cells 
44 
2.3.2 Preparation of control slides for immunocytochemical 
investigations 
46 
2.3.3 Labelling of lysosomes within isolated pulmonary arterial 
smooth muscle cells and HEK293 cells stably expressing HA-
hTPC2 / mCherry-hTPC2 
47 
2.4 Deconvolution microscopy 48 
2.4.1 Visualisation of fluorescently labelled intracellular proteins in 
isolated pulmonary arterial smooth muscle cells and HEK293 
cells 
48 
2.4.2 Analysis of fluorescent labelling of intracellular proteins within 
isolated pulmonary arterial smooth muscle cells and HEK293 
cells 
49 
2.5 Ca2+ imaging within isolated pulmonary arterial smooth muscle 
cells and HEK293 cells 
49 
2.5.1 Fluorescence as a biological tool 49 
2.5.2 Loading of HEK293 cells and isolated pulmonary arterial 
smooth muscle cells with the Ca2+ indicator dye Fura-2 
52 
2.5.3 Imaging of changes in Ca2+ within HEK293 cells and isolated 
pulmonary arterial smooth muscle cells 
53 
2.6 Whole-cell patch clamping 56 
2.6.1 Preparation and filling of patch pipettes 56 
2.6.2 Generation of a seal and delivery of pharmacological agents 57 
2.6.3 Extracellular application of pharmacological agents 59 
2.7 Radioligand binding assay 59 
2.7.1 Preparation of sea urchin egg homogenate for use in 
radioligand binding assay 
59 
   
 xi 
2.7.2 Preparation of mouse liver homogenate for use in radioligand 
binding assay 
60 
2.7.3 Preparation of wild-type HEK293 and HA-hTPC2 expressing 
cell homogenates for use in radioligand binding assay 
60 
2.7.4 BSA protein assay for the determination of protein 
concentration 
61 
2.7.5 Preparation of [32P]NAADP for use in radioligand binding 
assay 
62 
2.7.6 Radioligand competition binding assay 62 
2.7.7 Radioligand competition binding assay to determine whether 
Ned-19 inhibits [32P]NAADP binding to TPC2 
64 
2.8 Drugs and chemicals 65 
2.9 Statistical analysis 65 
   
Chapter 3: Lysosomes co-localise with ryanodine receptor subtype 3 to 
form a trigger zone for Ca2+ signalling by NAADP in rat 
pulmonary arterial smooth muscle 
66 
3.1 Introduction 66 
3.2 Methods 67 
3.3 Results 72 
3.3.1 Examination of the spatial distribution of lysosomal labeling in 
isolated pulmonary arterial smooth muscle cells 
72 
3.3.1.1 Lysosomes are predominantly localised to the perinuclear 
region of isolated pulmonary arterial smooth muscle cells 
72 
3.3.1.2 Lysosomes cluster preferentially in the perinuclear region of 
isolated pulmonary arterial smooth muscle cells 
74 
3.3.2 Ryanodine receptor subtypes 1, 2, and 3 are differentially 
distributed within isolated pulmonary arterial smooth muscle 
cells 
76 
3.3.2.1 Ryanodine receptor subtype 3 is predominantly targeted to the 
perinuclear region of isolated pulmonary arterial smooth 
muscle cells 
76 
3.3.2.2 Ryanodine receptor subtype 2 is predominantly targeted to the 
extra-perinuclear region of isolated pulmonary arterial smooth 
muscle cells 
78 
3.3.2.3 Ryanodine receptor subtype 1 is uniformly distributed within 
isolated pulmonary arterial smooth muscle cells 
78 
3.3.2.4 Each ryanodine receptor subtype exhibits a different 
distribution profile 
79 
3.3.2.5 Ryanodine receptor subtype 3 preferentially clusters in the 
perinuclear region of isolated pulmonary arterial smooth 
muscle cells 
80 
3.3.3 Examination of the co-localisation between lysosomes and each 
ryanodine receptor subtype in isolated pulmonary arterial 
smooth muscle cells 
82 
3.3.3.1 Lysosomes preferentially co-localise with ryanodine receptor 
subtype 3 in isolated pulmonary arterial smooth muscle cells 
82 
3.3.4 Examination of the regional distribution of co-localisation 
between lysosomes and each ryanodine receptor subtype in 
isolated pulmonary arterial smooth muscle cells 
86 
 xii 
3.3.4.1 Lysosomes preferentially co-localise with ryanodine receptor 
subtype 3 in the perinuclear region of isolated pulmonary 
arterial smooth muscle cells 
86 
3.3.4.2 Co-localisation of lysosomes with each ryanodine receptor 
subtype in the extra-perinuclear region of isolated pulmonary 
arterial smooth muscle cells 
87 
3.3.4.3 Co-localisation of lysosomes with each ryanodine receptor 
subtype in the sub-plasmalemmal region of isolated pulmonary 
arterial smooth muscle cells 
88 
3.3.4.4 Lysosomes preferentially cluster with ryanodine receptor 
subtype 3 in the parinuclear region of isolated pulmonary 
arterial smooth muscle cells 
89 
3.3.4.5 The density of ryanodine receptor subtype and lysosomal 
labelling was equal across all isolated pulmonary arterial 
smooth muscle cells studied 
90 
3.3.5 Inhibition of ryanodine receptor subtypes 1 and 3 by dantrolene 
abolishes global Ca2+ waves but not Ca2+ bursts in response to 
NAADP 
91 
3.3.5.1 Dantrolene is without effect on ionomycin-induced Ca2+ influx 
in pulmonary arterial smooth muscle cells 
93 
3.4 Discussion 94 
3.4.1 Lysosomes are predominantly localised in the perinuclear 
region of pulmonary arterial smooth muscle cells 
95 
3.4.2 Ryanodine receptor subtypes exhibit different spatial 
distributions 
96 
3.4.2.1 Ryanodine receptor subtype 3 is predominantly targeted to the 
perinuclear region of isolated pulmonary arterial smooth 
muscle cells 
96 
3.4.2.2 Ryanodine receptor subtype 2 is predominantly localised to the 
extra-perinuclear region of isolated pulmonary arterial smooth 
muscle cells 
96 
3.4.2.3 Ryanodine receptor subtype 1 is the predominant subtype in the 
sub-plasmalemmal region of isolated pulmonary arterial smooth 
muscle cells 
97 
3.4.3 Lysosomes preferentially co-localise with ryanodine receptor 
subtype 3 in the perinuclear region to comprise a trigger zone 
for Ca2+ signalling by NAADP 
98 
3.4.3.1 Lysosomes predominantly co-localise with ryanodine receptor 
subtype 3 in the perinuclear region of pulmonary arterial 
smooth muscle cells 
98 
3.4.3.2 Dantrolene inhibits NAADP-induced global Ca2+ waves but not 
Ca2+ bursts in isolated pulmonary arterial smooth muscle cells 
99 
3.4.4 Why might ryanodine receptor subtype 3 be specifically 
targeted to lysosome-SR junctions? 
99 
3.4.5 How may a propagating global Ca2+ wave be precipitated 
following amplification of Ca2+ bursts by ryanodine receptor 
subtype 3 within lysosome-SR junctions? 
 
 
 
101 
 xiii 
Chapter 4: Two-pore channels are targeted to endosomes and 
lysosomes and mobilise Ca2+ in response to NAADP 
103 
4.1 Introduction 103 
4.1.1 Transient receptor potential mucolipin 1 and NAADP-
dependent Ca2+ signalling 
103 
4.1.2 Two-pore channels 104 
4.1.2.1 Identification of two-pore channels as novel members of the 
voltage-gated cation channel superfamily 
104 
4.1.2.2 Two-pore channels are expressed in a broad range of species 
and exhibit an extensive mammalian tissue distribution 
108 
4.1.3 Are two-pore channels candidate NAADP receptors? 110 
4.2 Methods 110 
4.2.1 shRNA-mediated knockdown of two-pore channel subtype 2 in 
HEK293 cells 
111 
4.2.1.1 shRNA transfection of HEK293 cells 113 
4.2.2 Determination of shRNA-mediated knockdown of two-pore 
channel subtype 2 in HEK293 cells by use of Western blot 
114 
4.2.2.1 Lysis of cells and preparation of protein samples 114 
4.2.2.2 Determination of protein concentration by Bradford assay 115 
4.2.2.3 SDS-polyacrylamide gel electrophoresis 116 
4.2.2.4 Immunoblotting 117 
4.2.2.5 Immunodetection (by ECL) 118 
4.2.3 Flash photolysis of caged NAADP 119 
4.3 Results 120 
4.3.1 Two-pore channels are targeted to endosomes and lysosomes 120 
4.3.1.1 Two-pore channel subtype 2 is specifically targeted to 
lysosomes 
120 
4.3.1.2 Two-pore channel subtypes 1 and 3 are targeted to endosomes 
and other unidentified organelles 
125 
4.3.2 [32P]NAADP binds to two-pore channel subtype 2 with two 
binding affinities 
128 
4.3.3 NAADP mobilises Ca2+ in HEK293 cells that stably over-
express two-pore channel subtype 2 
131 
4.3.4 NAADP-dependent Ca2+ release exhibits a bell-shaped 
concentration-response curve in HEK293 cells over-expressing 
two-pore channel subtype 2 
135 
4.3.5 The concentration delay kinetics for intracellular dialysis of 
NAADP 
138 
4.3.6 NAADP mobilises Ca2+ from lysosome-related acidic 
organelles via two-pore channel subtype 2 
140 
4.3.7 Knockdown of two-pore channel subtype 2 expression by 
shRNA blocks NAADP-dependent Ca2+ signalling 
145 
4.3.8 NAADP evokes Ca2+ bursts but not global Ca2+ transients in 
HEK293 cells that stably over-express two-pore channel  
subtype 1 
150 
4.4 Discussion 151 
4.4.1 Two-pore channel subtype 2 is specifically targeted to 
lysosomes in HEK293 cells. 
152 
4.4.2 NAADP binds to two-pore channel subtype 2 with two 
affinities 
152 
 xiv 
4.4.3 NAADP-mediated Ca2+ mobilisation via two-pore channel 
subtype 2 exhibits a bell-shaped concentration-response curve 
154 
4.4.4 Two-pore channel subtype 2 expression is knocked down by 
shRNA in HEK293 cells stably over-expressing two-pore 
channel subtype 2 
155 
4.4.5 NAADP mobilises Ca2+ via two-pore channel subtype 2 from 
lysosome-related acidic organelles 
155 
4.4.6 NAADP evokes Ca2+ bursts via two-pore channel subtype 1 157 
4.4.7 Two-pore channel subtype 2 is a molecular target of NAADP 157 
   
Chapter 5: NAADP elicits Ca2+ release via two-pore channels in rat 
pulmonary arterial smooth muscle cells 
159 
5.1 Introduction 159 
5.2 Methods 160 
5.2.1 RNA extraction for the analysis of two-pore channel subtype 2 
content in pulmonary arterial smooth muscle 
160 
5.2.2 Examination of two-pore channel subtype 2 expression in 
pulmonary arterial smooth muscle by RT-PCR 
161 
5.3 Results 162 
5.3.1 Two-pore channel subtype 2 is expressed in pulmonary arterial 
smooth muscle cells 
162 
5.3.2 Ned-19 displaces [32P]NAADP binding in sea urchin egg 
homogenates and HEK293 cells stably over-expressing two-
pore channel subtype 2 
163 
5.3.3 The NAADP antagonist Ned-19 specifically labels two-pore 
channel subtype 2 stably expressed in HEK293 cells 
165 
5.3.4 Ned-19 exhibits a high degree of concentration at the surface of 
LysoTracker labelled acidic organelles 
167 
5.3.5 Ned-19 labelling concentrates on LysoTracker labelled 
organelles in pulmonary arterial smooth muscle cells 
170 
5.3.6 Ned-19 blocks NAADP-mediated Ca2+ transients in HEK293 
cells stably over-expressing two-pore channel subtype 2 
171 
5.3.7 Ned-19 blocks NAADP-mediated Ca2+ transients in pulmonary 
arterial smooth muscle cells 
173 
5.4 Discussion 176 
5.4.1 Two-pore channel subtype 2 is present in pulmonary arterial 
smooth muscle cells and is targeted by the selective NAADP 
antagonist Ned-19 
176 
5.4.2 Ned-19 inhibits NAADP-mediated Ca2+ release in both 
HEK293 cells that stably over-express two-pore channel 
subtype 2 and pulmonary arterial smooth muscle cells 
178 
   
Chapter 6: General discussion 181 
6.1 Two-pore channels in relation to other cation channels 182 
6.2   NAADP mobilises Ca2+ via two-pore channels that are targeted 
to lysosome-related organelles 
183 
6.3   Functional significance of two-pore channels 185 
6.3.1   Two-pore channels and lysosomal function 185 
6.3.2   Two-pore channels and endosomal function 187 
6.3.3   Two-pore channels and recycling endosome function 187 
 xv 
6.3.4   Two-pore channels and the function of lysosome-related acidic 
organelles 
188 
6.3.5   Possible function of TPC desensitisation / inactivation 189 
6.3.6   Significance of two-pore channel-dependent Ca2+ signalling in 
disease 
190 
6.4   Junctional coupling of NAADP-mediated Ca2+ signalling via 
two-pore channels 
192 
6.4.1   Ca2+ release via two-pore channels generate elementary Ca2+ 
signals that may be amplified by coupling to the sarco / 
endoplasmic reticulum 
193 
6.4.2   Coupling efficiency may be determined by the receptor subtype 
present on the sarco / endoplasmic reticulum  
194 
6.4.3   Targeted coupling may determine agonist-specific signalling 195 
6.4.4   Two-pore channel subtype 2 and ryanodine receptor subtype 3 
comprise a trigger zone for Ca2+ signalling by NAADP in 
pulmonary arterial smooth muscle cells 
198 
   
Chapter 7:   Future directions 202 
7.1 Are all two-pore channel subtypes NAADP receptors? 202 
7.2 Are either of the three ryanodine receptor subtypes NAADP 
receptors?  
203 
7.3 Is the antagonism of NAADP-mediated Ca2+ signalling by Ned-
19 two-pore channel subtype-selective? 
203 
7.4 Do voltage-gated Ca2+ channel agonists and antagonists block 
NAADP-dependent Ca2+ signalling via two-pore channels? 
204 
7.5 Does two-pore channel subtype 2 tightly couple to inositol 
1,4,5-trisphosphate receptors in HEK293 cells? 
205 
7.6 Does two-pore channel subtype 2 and ryanodine receptor 
subtype 3 co-localise in pulmonary arterial smooth muscle 
cells? 
206 
7.7 Determination of a structural protein within the trigger zone 207 
7.8 Investigation into cooperative Ca2+ signalling between cADPR 
and NAADP 
208 
7.9 Investigation into the role of two-pore channels in vascular 
function 
209 
7.10 Investigation into the role of NAADP-mediated Ca2+ signalling 
in lysosomal storage diseases 
210 
7.10.1 Functional investigation into the role of two-pore channels in 
endosomal membrane fusion in Niemann-Pick disease type C1 
210 
7.10.2 Functional investigation into the role of NAADP-mediated Ca2+ 
release in Gaucher disease 
211 
   
Chapter 8: References 212 
   
Appendix 1: Results tables for Chapter 3 243 
Appendix 2: Results tables for Chapter 4  266 
Appendix 3: Results tables for Chapter 5 279 
Appendix 4: Publications associated with this thesis 287 
  
 1 
Chapter 1:  Introduction 
 
 
1.1  Intracellular Ca2+ signalling 
 
Ca2+ is a highly versatile signalling molecule capable of mediating a vast 
number of cellular processes including fertilization, gene expression, contraction, 
neurosecretion and cell death.  The fact that there is such an array of Ca2+-mediated 
cellular processes poses the following question: how can changes in the concentration 
of a simple divalent cation convey such information?  This is not a simple case of 
modulating the Ca2+ concentration of the cytoplasm within the cell.  It is now clear 
that Ca2+ signals are generated in segregated cellular compartments that determine 
both its site of action and the functional outcome.  For example, in pancreatic β-cells 
the response to carbamylcholine in individual cells produced characteristic Ca2+ 
oscillations of particular amplitude, frequency, and shape (Prentki et al., 1988).  This 
led to the proposal that the spatiotemporal pattern of a given Ca2+ signal could 
provide a “fingerprint” that conveys the necessary information by which Ca2+ can 
regulate a particular cell process (Prentki et al., 1988).  Thus by utilizing 
spatiotemporal patterns of Ca2+ to mediate cellular processes the cell can impart the 
necessary information whilst avoiding the detrimental effect of universal and 
prolonged rises in Ca2+.  For example, gene expression can be modulated by 
variations in the Ca2+ signal over time in T-lymphocytes, where Ca2+ oscillations 
activate the Ca2+-sensitive transcription factors NF-AT, Oct/OAP and NF-κB.  
However, low frequency Ca2+ oscillations only recruit NF-κB whereas higher 
frequencies recruit all 3 transcription factors, demonstrating that oscillations in Ca2+ 
mediate frequency-dependent gene expression (Dolmetsch et al., 1998).  
Over the last 20 years the complex mechanisms involved in Ca2+ signalling 
have begun to be unravelled.  These mechanisms involve the regulation of Ca2+ 
uptake/sequestration and release/influx across the plasma membrane and the 
membrane of defined and multiple intracellular stores.  Therefore an understanding of 
the mechanisms involved in the movement of Ca2+ across these various membranes is 
fundamental to resolving the means by which the cell can generate a variety of 
complex Ca2+ signals in order to regulate different Ca2+-sensitive processes. 
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1.2  Ca2+ signalling across the plasma membrane 
 
The plasma membrane is impermeable to Ca2+ and therefore Ca2+ must cross 
this barrier via a number of specialised protein channels and in response to a number 
of stimuli including depolarisation, receptor agonists and intracellular store depletion.  
Furthermore, in order to allow Ca2+ influx driven by its electrochemical gradient, the 
cytoplasmic Ca2+ is maintained at a low concentration relative to the extracellular 
environment and the lumen of intracellular Ca2+ stores.  Therefore, in addition to 
channels mediating Ca2+ influx, the cell membrane also contains a number of specific 
pumps and transporters that actively remove Ca2+ from the cytoplasm. 
 
1.2.1  Voltage-gated Ca2+ channels 
 
An important pathway by which ions enter the cytoplasm via the plasma 
membrane is that of voltage-gated ion channels which are regulated by changes in the 
potential difference across the plasma membrane. Voltage-gated Ca2+ channels 
(VGCCs) are members of the family of voltage-gated ion channels which represent a 
superfamily of signal transduction proteins that are grouped together based on shared 
structural motifs.  This superfamily consists of over 140 members including the 
voltage-gated Na+, Ca2+ and K+ channels, Ca2+-activated K+ channels and transient 
receptor potential (TRP) channels (Yu et al., 2005).  The features that determine the 
functionality of the members of this superfamily are ion-conductance, pore gating and 
pore regulation (Yu et al., 2005). 
VGCCs mediate Ca2+ influx across the plasma membrane in response to 
membrane depolarisation.  VGCCs are comprised of a principal pore-forming subunit 
(α1) and 3 auxiliary subunits (β, γ and the disulfide-linked complex α2δ; (Takahashi et 
al., 1987).  VGCCs are broadly characterised into subtypes according to their 
pharmacological and electrophysiological properties.  These subtypes include L-, T-, 
P/Q-, N- and R-type.  L-type channels were first identified as long-lasting high-
voltage-activated (HVA) channels which are sensitive to block by dihydropyridines 
and phenylalkylamines.  Moreover, the L-type VGCC agonist BayK8644 selectively 
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increases the mean open time of L-type channels (Hess et al., 1984).  The L-type 
channel was initially detected in neurons and skeletal, cardiac and smooth muscle 
(Hess et al 1984).  However, in neurons there remained an HVA component that was 
insensitive to dihydropyridines.  This was further divided into a ω-conotoxin sensitive 
component (N-type) and a slow inactivating Ca2+ current (P/Q-type) which was ω-
conotoxin and dihydropyridine-insensitive.  Furthermore, a low-voltage-activated 
Ca2+ channel was also detected, termed T-type (Fox et al., 1987a; Fox et al., 1987b).  
A current due to the R- (residual) type channel was also identified due to its resistance 
to dihydropyridines and the toxins used to identify the N and P/Q channels (Randall et 
al., 1995).  The pore-forming α1 subunit determines many of the VGCC 
characteristics, and currently there are 10 identified mammalian α1 subunits, for 
which a new classification system was required.  The new nomenclature is based 
upon the α1 subunit such that there are 4 genes encoding L-type channels (Cav1.1 – 
1.4), 3 genes encoding the remaining HVA channels (P/Q-, N- and R-type replaced 
with Cav2.1, 2.2 and 2.3 respectively) and 3 genes encoding the T-type channels 
(Cav3.1 – 3.3) (Ertel et al., 2000).   
The functional multiplicity of VGCCs is dependent on the α1 subunit as this is 
the pore-forming subunit and also contains the voltage sensor, gating apparatus and 
many sites involved in channel regulation (Catterall et al., 2003).  The α1 subunit 
comprises 4 homologous domains each consisting of 6 transmembrane (TM) 
α−helices (S1-S6).  The sequence also contains a membrane-reentrant loop (P-loop) 
which is situated between S5 and S6 of each domain repeat.  The function of the P-
loop is to determine the ion conductance and selectivity.  Such is the degree of 
selectivity that, for example, a 3 amino acid residue change in the P-loop of a voltage-
gated Na+ channel results in it displaying Ca2+ ion selectivity (Catterall et al., 2003).  
Negatively charged glutamate residues within the P-loops, which form the pore, are 
thought to determine the Ca2+ selectivity of the VGCCs (Yang et al., 1993).  The 
voltage sensing capability of the α-subunit is thought to be determined by the S4 
section of each domain and specifically positively charged lysine and arginine 
residues (Dolphin, 2006).  Depolarisation causes a conformational change within the 
protein which effectively ‘opens’ the pore allowing the passage of Ca2+ (Jones, 2003).  
In addition to voltage-dependent regulation, L-type Ca2+ channels are also 
subject to regulation by a number of other factors.  For example calmodulin (CaM) in 
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complex with Ca2+ (Ca2+:CaM) is important in both the Ca2+-dependent inactivation 
and facilitation of L-Type Ca2+ channel opening by binding to a motif within the C-
terminal tail of the α1 subunit (Zuhlke et al., 1999).  In addition to Ca2+:CaM, 
phosphorylation by a number of protein kinases also regulates L-Type Ca2+ channels 
including protein kinase A, C, G (PKA, PKC and PKG) Ca2+/calmodulin-dependent 
kinase II (CaMKII) and protein tyrosine kinases  (Bers, 2002; Hudmon et al., 2005; 
Kamp et al., 2000; Keef et al., 2001; McHugh et al., 2000; Schroder et al., 2003; 
Tewari et al., 1997; Yagi et al., 2002). 
 
 
1.2.2  Voltage-independent Ca2+ channels 
 
In addition to Ca2+ influx via VGCCs, there are a number of channels which can 
permit the flux of Ca2+ independent of a change in membrane potential.  These 
include receptor-operated Ca2+ entry (ROCE) and store-operated Ca2+ entry (SOCE). 
 
1.2.2.1  Receptor-operated Ca2+ entry 
 
Receptor operated channels were first described in the late 1970’s and are 
defined as plasma membrane channels that are gated by ligand binding and in a 
voltage-independent manner (Bolton, 1979; Van Breemen et al., 1978).  ROCE is 
mediated by an extracellular agonist either binding to a receptor in the plasma 
membrane (e.g. NMDA, P2X receptor) or by activating a secondary process such the 
G-protein coupled receptor whose heterotrimeric G-protein pathway mediates the 
opening of a Ca2+ permeable channel (e.g. α1-adrenoceptor).  One such example of 
ROCE was shown in arterial smooth muscle cells where ATP was shown to evoke a 
Ca2+ current via activation of P2X receptors (Benham et al., 1987).  The physiological 
importance of this ROCE mechanism has been demonstrated using P2X1 knockout 
mice.  Mesenteric arteries from these mice lost the rise in intracellular Ca2+ and 
contraction in response to neuronally released ATP (Lamont et al., 2006). 
ROCE is also mediated by members of the transient receptor potential (TRP) 
channel family of proteins.  TRP channels are a diverse family of non-voltage-gated 
cation channels exhibiting a range of functional properties.  TRPs are found in a broad 
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range of species and there are over 20 mammalian TRPs which are grouped into 6 
subfamilies; canonical (TRPC), vanilloid (TRPV), melastatin (TRPM), ankyrin 
(TRPA), mucolipin (TRPML), and polycystin (TRPP) (Clapham et al., 2005).  All 
members of the TRP family have a characteristic primary structure consisting of 6 
TM domains (S1-S6) and a re-entrant P-loop situated between S5 and S6.  This basic 
structure is reminiscent of one of the 4-repeat domains of the pore forming subunit of 
VGCCs.  Indeed, single domain channels such as TRPs form hetero- or 
homotetramers in order to form a functional pore (Amiri et al., 2003; Kedei et al., 
2001).  This suggests that predecessors of TRPs may have undergone 2 rounds of 
duplication in order to form the more complex VGCCs.  However, despite this 
similarity to VGCCs, TRPs lack the necessary set of positively charged amino acid 
residues, such as arginine, within S4 required to convey voltage sensitivity (Catterall, 
2000; Montell, 2005).  TRP channels are non-selective with respect to Na+ and Ca2+ 
permeability, with the exceptions of Ca2+-selective TRPV5/6 and the monovalent-
selective TRPM4/5 (Clapham et al., 2005).   
TRP channels have no unifying function, however a growing body of evidence 
suggests that TRPs play an important role as physiological sensors involved in vision, 
taste, smell, hearing, mechanosensation and thermosensation (Montell, 2005).  For 
example, TRPV1 is gated by capsaicin and by increases in temperature from 22 °C to 
~45 °C (Caterina et al., 1997).  Conversely, both TRPA1 and TRPM8 are activated by 
cold temperatures (~10 °C) and cooling compounds such as methanol and icilin (Peier 
et al., 2002; Story et al., 2003).  Moreover, TRPM5 is required for sweet, bitter and 
umami taste signalling pathways (Zhang et al., 2003).  Another example of the 
diverse physiological role of TRPs is TRPML1 which is thought to act as a H+ leak 
pathway in order to prevent over-acidification of lysosomes (Soyombo et al., 2006).  
Of particular importance with reference to ROCE, are the members of the TRPC 
subfamily which have been implicated in this Ca2+ influx mechanism.  For example, 
TRPC3, 6 and 7 have been shown to mediate ROCE via α1-adrenoceptor activation or 
in response to increased diacylglycerol (DAG) activity (Hofmann et al., 1999; 
Lievremont et al., 2004; Thebault et al., 2005). 
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1.2.2.2  Store-operated Ca2+ entry 
 
The mechanism of SOCE was first termed ‘capacitative Ca2+ entry’ upon its 
proposal in 1986 (Putney, 1986), although this process was first described by 
Ginsborg and co-workers between 1979 and 1980 working on the cockroach salivary 
gland (Blackman et al., 1979; Ginsborg et al., 1980a; Ginsborg et al., 1980b).  It 
describes the coupling of the sarcoplasmic / endoplasmic reticulum (S / ER) store 
with plasma membrane channels that mediate Ca2+ influx in response to store 
emptying, such that a low luminal Ca2+ concentration of the ER will initiate Ca2+ 
influx across the plasma membrane in order to replenish the intracellular Ca2+ stores 
(Putney, 1986).  Although much later than the observations of Ginsborg and co-
workers, an endogenous SOCE current in mast cells is generally acknowledged as 
being the first characterised (Hoth et al., 1992).  This current was termed the calcium 
release-activated current (ICRAC) and two proteins, the stromal interaction molecule 
(STIM1) and Orai1, have been identified as key components in SOCE.  STIM1 has a 
single TM region which spans the ER membrane.  The luminal part of STIM1 
contains an EF-hand motif which is able to bind Ca2+ and thus act as a Ca2+ sensor.  
Upon store depletion STIM1 redistributes to puncta in close proximity to the plasma 
membrane (Liou et al., 2005).  It is proposed that STIM1 is then able to directly 
interact with the plasma membrane bound protein Orai1 in order to mediate Ca2+ 
influx (Hewavitharana et al., 2007).  Indeed, Orai has been shown to restore ICRAC in 
SOCE deficient cells (Feske et al., 2006) and when co-expressed with STIM1 form 
large ICRAC currents (Peinelt et al., 2006; Zhang et al., 2006b).  Some studies have 
suggested that Orai1 interacts with TRPCs and that this STIM1:Orai:TRPC complex 
mediates SOCE (Liao et al., 2007).  However, this suggestion has been contested by 
the recent finding that either STIM1 or Orai knockdown is without effect on TRPC7-
mediated Ba2+ influx (DeHaven et al., 2009).  Furthermore, in HEK293 cells co-
expression of STIM1 did not increase the Ca2+ entry activity of TRPC1, TRPC3, 
TRPC5 or TRPC6.  Thus, Putney and colleagues concluded that STIM1 and Orai do 
not associate with TRPCs but rather that the agonists used in previous studies had 
indeed activated both ROCE and SOCE mechanisms (DeHaven et al., 2009).  
Recently, Penna et al. have proposed that STIM1 interaction causes the formation of 
Orai1 tetramers and thus Orai forms the SOCE-associated Ca2+ pore (Penna et al., 
2008).  This interaction would allow the influx of Ca2+ to be directed to regions of the 
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ER that have become depleted of Ca2+.  This mechanism would thus allow refilling of 
the depleted store in localised regions, whilst avoiding global Ca2+ influx.  It is 
therefore clear that organelles are able to form close associations that allow for the 
coordination of localised Ca2+ flux, and thus add further complexity to the tight 
regulation of Ca2+ signalling within the cell. 
 
1.2.3  The role of voltage-gated Na+ channels 
 
Voltage-gated Na+ channels (Navazio et al.) are members of the voltage-gated 
ion channel superfamily that also include Cav channels and voltage-gated potassium 
channels (Kv) (Yu et al., 2005).  Consistent with this, Nav channels are principally 
comprised of a pore-forming α-subunit which consists of 4 homologous domains of 6 
TM regions (S1-S6) with a reentrant P-loop between S5 and S6 of each domain.  
Thus, the 4 P-loops together form a Na+-selective pore (Yu et al., 2003).  There are 
currently 9 mammalian Nav channels identified (Nav1.1-Nav1.9) which share over 50 
% identity (Catterall et al., 2005).  Further to this Nav channels can associate with one 
or more of 4 auxilliary β-subunits (Navβ1-Navβ4) (Catterall et al., 2005) which 
modulate channel gating (Yu et al., 2003).  The established role of Nav channels in 
excitable cells such as neurones cardiomyocytes and skeletal muscle cells is the 
initiation and propagation of action potentials.  Upon membrane depolarisation, Nav 
channels activate and subsequently inactivate within milliseconds, permitting the 
influx of Na+ through the channel and into the cytoplasm resulting in further 
membrane depolarisation (Yu et al., 2003).  In contrast to excitable cells, Nav 
channels were not thought to play an important role in Ca2+ homeostasis in non-
excitable cells such as smooth muscle cells (SMCs).  However, Nav channels have 
been shown to enhance contractility in portal vein SMCs (Saleh et al., 2005).  This 
Nav-dependent increase in contractility is thought to be due to stimulation of the 
reverse reaction of Na+/Ca2+ exchanger (NCX) thus resulting in Ca2+ influx (Saleh et 
al., 2005).  Furthermore, in uterine SMCs, Nav channel activation has been shown to 
cause subsequent opening of Cav1 channels that mediate SMC contraction (Saleh et 
al., 2005). 
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1.2.4  K+ channels 
 
In addition to Ca2+-mediated ion influx/efflux, a number of other channels play 
an important role in cellular processes including the control of membrane potential 
and repolarisation following, for example, an action potential.  The K+ channel 
superfamily are key in this respect.  These represent a large family of ion channels 
that share selectivity for K+ over Na+.  Included in this family are the Ca2+-activated 
channels (KCa), inward rectifier K+ channel (Kir) and voltage-gated K+ channel (Kv).  
This selectivity for K+ is due to a conserved amino acid sequence motif (TXGYG) 
(Sansom et al., 2002; Wray, 2004).  
 
1.2.4.1  Ca2+-activated K+ channels 
 
The family of Ca2+-activated K+ channels are formed by 5 subfamilies (KCa1.1-
5.1) (Wei et al., 2005).  Of these subfamilies, there are 2 major groups that contain 
channels sensitive to Ca2+ activation.  One group contains the “large-conductance” 
KCa channel (KCa1.1) and the second group contains the “small-conductance” KCa 
channels (KCa2.1-2.3) and “intermediate-conductance” channel (KCa3.1).  Gating of 
these channels results in the efflux of K+ and an outward current.  Thus these channels 
can mediate hyperpolarisation or provide repolarisation in response to a prior 
depolarisation.  KCa1.1 is activated by both voltage and an increase in intracellular 
Ca2+ concentration (Tanaka et al., 1997).  The channel is comprised of a pore-forming 
α-subunit which contains both the voltage-sensor and Ca2+ binding sites, and an 
auxiliary β-subunit which increases the Ca2+-sensitivity of the channel (Cox et al., 
2000).  However, KCa1.1 can be voltage-activated in the absence of intracellular Ca2+ 
and thus Ca2+ binding is thought to affect various gating kinetics such as lowering the 
voltage at which the channel is activated (Horrigan et al., 2002).  Ca2+ modulation of 
KCa1.1 is mediated by Ca2+ binding directly to the α-subunit at 3 Ca2+ binding sites 
(Zeng et al., 2005).  In contrast to KCa1.1, KCa2.1-2.3 and KCa3.1 are gated 
exclusively by intracellular Ca2+ and independent of voltage (Schumacher et al., 
2001).  Furthermore, these channels do not bind Ca2+ directly but rather by a 
constitutively bound CaM molecule.  Upon binding Ca2+ ions in its 2 EF-hand motifs, 
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CaM undergoes a conformational change which in turn causes a shift in conformation 
of the pore region of the channel and thus opens the pore (Schumacher et al., 2001). 
 
1.2.4.2  Voltage-gated K+ channels 
 
Voltage-gated K+ channels (Kv) are structurally related to the pore-forming 
subunits of Cav. and are activated by depolarisation to allow the efflux of K+.  This 
results in a repolarisation of Vm.  Sustained depolarisation generates a slow 
inactivation of the channel, thus preventing sustained channel opening and subsequent 
hyperpolarisation.  There are currently over 30 genes that encode Kv channels (Kv1.1-
12.3) which are single domain units structurally composed of 6 TM regions (S1-S6) 
with the characteristic P-loop between S5 and S6 (Gutman et al., 2005; Korovkina et 
al., 2002).  In order to form a viable pore, Kv channels are thought to form homo- or 
heterotetramers with the P-loop of each subunit together forming the selectivity filter 
of the pore (Liman et al., 1992; MacKinnon, 1991).  Similar to other ion channels 
with the same architecture such as TRPs, this tetramer formation has led some to 
suggest that the 4 domain pore forming subunits of Cav are the product of 2 rounds of 
duplication of single pore domain channels such as Kv (Yu et al., 2005).  Similar to 
Cav channels, the tetrameric Kv channels are able to interact with ancillary β-subunits 
that confer various effects such as fast-inactivation (Bahring et al., 2001). 
 
1.2.4.3  Inward rectifier K + channels 
 
Another channel of importance to the regulation of membrane potential is the 
inward rectifier potassium channel (Kir).  These channels are defined by having a 
higher conductance for K+ moving into the cell than outwards (Sansom et al., 2002).  
Potassium channels that share this characteristic form the Kir family which is 
comprised of 7 subfamilies (Kir1.1-7.1) (Kubo et al., 2005).  The 2 main suggested 
functions of Kir are in responding to increased extracellular K+ concentrations (Park et 
al., 2007b) and contributing to resting Vm (Park et al., 2007a).  The inward flux of K+ 
or rectification via Kir occurs when Vm is more negative than the equilibrium potential 
for K+.  Therefore, as most cells resting Vm is more positive relative to the equilibrium 
potential of K+, Kir channels allow small outward currents (Xu et al., 1999).  However 
at more positive membrane potentials, K+ efflux via Kir is limited due to blockade of 
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the channel by cytoplasmic Mg2+ and polyamines such as spermine (Lopatin et al., 
1994; Matsuda et al., 1987).  Further modulation of Kir activity is mediated by a 
number of cytoplasmic factors including phosphatidylinositol 4,5-bisphosphate 
(PIP2), pH, ATP, phosphorylation, and heterotrimeric G proteins (Bichet et al., 2003). 
The structure of Kir channels represents the most basic structural motif in the 
ion channel superfamily.  They consist of 2 TM regions (M1-M2) which are 
homologous to the S5 and S6 regions of Kv, and therefore also incorporate the re-
enterant P-loop between the two TM regions (Yu et al., 2005).  These subunits are 
also able to form a functional pore via the formation of homo or heterotetramers, 
further exemplifying the requirement of this common motif consisting of a 4-repeat P-
loop anchored by TM regions. 
 
1.2.5  Ca2+-activated Cl- channel 
 
Ca2+ influx across the plasma membrane can have a direct depolarising effect on 
the cell membrane potential (Vm).  In addition to these direct effects, Ca2+ may also 
affect Vm by modulating other ion channels which are also present in the plasma 
membrane such as the Ca2+-activated Cl- channel (CaCC).  CaCCs are anion-selective 
channels present on the plasma membrane that are characteristically activated by 
increases in the intracellular Ca2+ concentration.  These channels are activated by Ca2+ 
in a voltage-dependent manner, such that at depolarising membrane potentials CaCCs 
are more sensitive to activation by Ca2+ (Kuruma et al., 2000).  Such activating 
increases in intracellular Ca2+ concentration can be as a result of both Ca2+ release 
from intracellular stores and by Ca2+ influx via L-type Ca2+ channels (Wray et al., 
2005).  Activation of CaCCs permits the efflux of Cl- which confers an inward current 
and concomitant depolarisation and thereby VGCC activation.  The molecular identity 
of CaCC has recently been identified as anoctamin 1 (ANO1; also referred to as 
TMEM16A) (Caputo et al., 2008; Yang et al., 2008).  There are 10 isoforms of ANO 
(ANO1-10) with each sequence containing 8 TM domains and a highly conserved re-
entrant pore-forming loop between TM domains 5 and 6 (Caputo et al., 2008; Yang et 
al., 2008).  This loop contains 3 conserved, positively charged amino acid residues 
which are responsible for the channels Cl- selectivity (Yang et al., 2008).  Indeed, 
substituting the negatively charged amino acid, glutamic acid, for the positively 
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charged residue arginine (Arg621) resulted in an increase in cation permeability of 
approximately 30-fold (Yang et al., 2008). 
 
1.2.6  Removal of Ca2+ across the plasma membrane 
 
In order to maintain cytoplasmic Ca2+ at a low (~100 nM) concentration the 
plasma membrane contains pumps and transporters that actively remove free Ca2+ 
ions from the cytoplasm.  The plasma membrane Ca2+-ATPase (PMCA) pump and the 
Na+/Ca2+ exchanger (NCX) are the two major routes by which Ca2+ is removed from 
the cytoplasm across the plasma membrane. 
 
1.2.6.1  Removal of Ca2+ by the plasma membrane Ca2+-ATPase 
 
The PMCA is a P-type ATPase which is ubiquitously expressed within 
eukaryotes and is considered to be the major Ca2+ transporter in the plasma membrane 
(Strehler et al., 2001).  There are 4 isoforms of PMCAs currently identified (PMCA1-
4) with each isoform containing at least 6 splice variants (Strehler et al., 2001).  The 
energy obtained from the hydrolysis of 1 ATP molecule is utilised to transport 1 Ca2+ 
ion whilst allowing H+ into the cell.  However, there is currently some debate as to the 
Ca2+:H+ ratio with either a ratio of 1:1 (Di Leva et al., 2008) or 1:2 (Thomas, 2009) 
reported.  This could be significant because a ratio of 1:2 could have a greater affect 
on the local intracellular environment as H+ movement causes changes in pH and thus 
can affect the modulation of a number of ion channels, while a ratio of 1:1 would 
impact on membrane potential as it would be electrogenic.  The PMCA contains 10 
TM domains and 4 cytoplasmic domains.  The C-terminal region contains a number 
of regulatory sites through which it interacts with PKA, PKC and CaM (Di Leva et 
al., 2008; Kuo et al., 1991; Preiano et al., 1996).  The CaM binding site is thought to 
interact with two sites on the main body of the pump and by doing so acts as an 
autoinhibitory sequence.  Upon binding Ca2+:CaM this domain dissociates from the 
main body of the pump thus alleviating its autoinhibitory effect (Di Leva et al., 2008).  
3 Ca2+ binding sites have also been identified on the C-terminal tail (Hofmann et al., 
1993).  Two of these are thought to be constitutive binding sites with the remaining, 
lower affinity binding site responsible for the sequestration of Ca2+. 
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1.2.6.2  Removal of Ca2+ by the Na+/ Ca2+ exchanger 
 
The other major mechanism of reversible Ca2+ extrusion by the plasma 
membrane is via the NCX.  In physiological conditions, mammalian cells maintain 
intracellular Na+ concentration at relatively low levels relative to the extracellular 
environment (~10 mM and ~140 mM respectively).  The NCX is therefore able to 
utilise the energy obtained from allowing Na+ ions into the cell in order to transport 
Ca2+ ions out in a ratio of 3 Na+:1 Ca2+ (Zhang et al., 2005).  The NCX consists of 9 
TM segments which are divided into 2 clusters of 5 and 4 TM segments.  Within each 
of these clusters there exists α-repeat motifs which are orientated in opposing 
directions (Iwamoto et al., 2000).  These α-repeat motifs form the ion-binding pocket 
on each side of the membrane (Lytton, 2007).  There are 3 mammalian isoforms of 
NCX (NCX1-3) which belong to the Ca2+/cation antiporter gene superfamily (Lytton, 
2007).  NCX1 is ubiquitously expressed whereas NCX2 expression is limited to the 
brain and NCX3 has high expression within skeletal muscle with little or no 
expression elsewhere (Quednau et al., 2004).  The cellular distribution of NCX is also 
of particular interest as it has been shown that NCX within the plasma membrane 
overlies regions of the S / ER (Blaustein et al., 1999; Juhaszova et al., 1997).  This 
tight association could serve to quickly remove Ca2+ from areas of focal release and 
thus contribute to the spatiotemporal pattern of Ca2+ signalling.  Alternatively, reverse 
mode NCX may contribute to Ca2+ influx in an agonist specific manner (Syyong et 
al., 2007). 
 
Ca2+ movement across the plasma membrane is vital for the appropriate 
functioning of the cell and involves an array of specialised proteins (Fig. 1.1).  
However, it is also clear that many of the protein channels, pumps and exchangers 
within the plasma membrane interact with intracellular Ca2+ stores.  These 
interactions can either be direct such as the coupling of the S / ER to the plasma 
membrane via STIM and Orai, or indirect via changes in the local Ca2+ concentration 
and/or pH.   
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Fig. 1.1.  Schematic representation of Ca2+ extrusion and influx mechanisms across the plasma 
membrane 
Depicted are some of the mechanisms by which Ca2+ crosses the plasma membrane together with some 
of the ion channels that are stimulated by localised increases in intracellular Ca2+.  Cav, voltage gated 
Ca2+ channel; ROC, receptor operated channel; PMCA, plasma membrane Ca2+ ATPase; NCX, 
Na+/Ca2+ exchanger; KCa, Ca2+-activated K+ channel; ClCa, Ca2+-activated Cl- channel; STIM, stromal 
interaction molecule. 
 
 
1.3  Ca2+ handling by Mitochondria  
 
The precise role of mitochondria in Ca2+ homeostasis is as yet unclear.  
However, mitochondria are not generally considered to provide a releasable Ca2+ 
store, although there is a degree of Ca2+ efflux that is mediated by two ion 
transporters.  This Ca2+ efflux is mediated by either a Na+-independent mechanism 
which is considered to be a H+/Ca2+ antiporter, or via a Na+-dependent mechanism 
which is considered to be a Na+/Ca2+ exchanger (Gunter et al., 2004). 
Despite not being recognised as a mobilisable Ca2+ store, mitochondria can have 
an important role as Ca2+ sinks because they are able to sequester Ca2+ from the 
cytoplasm via the mitochondrial Ca2+ uniporter.  This route of Ca2+ influx is 
dependent upon the electrochemical potential gradient which, due to the 
mitochondrial respiratory chain, maintains the mitochondrial membrane potential at 
approximately -150 to -200 mV relative to the cytoplasm (Duchen, 2000).  However, 
whether or not the mitochondrial Ca2+ uniporter is able to sequester significant Ca2+ in 
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response to agonist-mediated intracellular Ca2+ waves/pulses was questioned until 
1995.  Then a rapid mode (RaM) of calcium entry was identified by which 
mitochondria are able to rapidly sequester Ca2+ at the beginning of each Ca2+ pulse 
(Sparagna et al., 1995).  RaM Ca2+ conductivity can be up to 300-fold faster than the 
uniporter (Buntinas et al., 2001) and therefore provides mitochondria with a method 
by which they can operate as high capacity Ca2+ sinks.  For example, in the polarised 
pancreatic acinar cells mitochondria form a barrier around the secretory granule-rich 
apical pole.  These mitochondria are able to rapidly sequester Ca2+ and in doing so 
stop the propagation of an IP3-mediated Ca2+ wave from the apical pole to the luminal 
pole (Tinel et al., 1999).  The presence of a “mitochondrial firewall” has also been 
implicated in the functioning of cardiomyocytes and in motor neurones (David et al., 
1998; Mackenzie et al., 2004).  Thus the spatial organisation of mitochondria may 
regulate the shape of Ca2+ signals or compartmentalise them, and thereby determine 
the functional response to a given Ca2+ release event.  In addition, an important way 
in which Ca2+ can modulate mitochondria function comes from the observation that 
an agonist-induced rise in the intracellular Ca2+ concentration is able to stimulate ATP 
production (Jouaville et al., 1999; Robb-Gaspers et al., 1998).  Taken together with 
the observation that skeletal muscle mitochondria increase Ca2+ influx during 
contraction (Rudolf et al., 2004) this process would therefore allow the stimulated cell 
to increase its ATP production in order to meet the increased metabolic demand.  At 
greater concentrations Ca2+ is able to stimulate the mitochondrial permeability 
transition (MPT) and opening of the large non-selective MPT pore.  The opening of 
this pore can cause rapid mitochondrial depolarisation and the subsequent ATP 
depletion can lead to cell death.  Furthermore, opening of the MPT pore can also lead 
to the release of cytochrome C which can in turn activate the apoptotic cascade of 
proteolytic caspase enzymes also resulting in cell death (Bernardi, 1999).  Despite not 
being considered as a classical releasable Ca2+ store, it is evident that mitochondria 
play an important role in Ca2+ homeostasis, and in particular their localisation and 
ability to rapidly sequester Ca2+ could help to shape cell type-specific Ca2+ signals. 
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1.4  Mobilisable intracellular Ca2+ stores 
 
In order to achieve the array of specific spatiotemporal Ca2+ signals, influx of 
Ca2+ from outside the cell does not provide the sufficient level of complexity 
required.  As a result there are a number of defined intracellular stores within the cell 
that can provide rapid and spatially restricted Ca2+ release. 
 
1.4.1  Endoplasmic / Sarcoplasmic Reticulum 
 
The endoplasmic reticulum (ER) is an organelle that forms an interconnected 
network of membrane-bound tubules and cisternae.  The ER is involved in a number 
of functions including phospholipid synthesis and the translocation, integration, 
folding and modification of proteins (Voeltz et al., 2002).  The other important 
function of the ER, with respect to this thesis, is that it is considered to be the major 
intracellular Ca2+ store.  The ER can be divided into two main groups, smooth ER and 
rough ER.  Rough ER is studded with membrane bound ribosomes on its surface and 
is primarily involved in the synthesis of membrane and secretory proteins.  Smooth 
ER is characterised by the absence of ribosomes and is involved, for example, in 
steroid synthesis and Ca2+ release.  Within muscle cells their exists a specialized form 
of smooth ER known as the sarcoplasmic reticulum (SR) which is dedicated to the 
storage and release of Ca2+.  This specialised function is reflected by the fact that in 
longitudinal SR of striated muscle the major sequestration protein, the sarcoplasmic / 
endoplasmic reticulum ATPase (SERCA) pump, represents up to 90% of the total 
membrane protein compared to 1% with respect to the ER (Rizzuto et al., 2006).  As 
the S / ER is a releasable Ca2+ store, it also contains a number of proteins that are able 
to sequester and store Ca2+, and mediate its release into the cytoplasm.   
 
1.4.1.1  Sequestration of Ca2+ by the sarcoplasmic / endoplasmic reticulum 
Ca2+ATPase 
 
Sequestration of Ca2+ into the S / ER lumen is performed by the SERCA pumps.  
In mammals there are 3 SERCA (ATP2A1-3) genes which each encode for at least 
two SERCA isoforms (SERCA1a-b, SERCA2a-b, SERCA3a-f).  These isoforms are 
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the result of alternative splicing and have varying tissue distribution.  SERCA pumps 
are P-type ATPases characterised by the formation of an aspartyl-phosphorylated 
intermediate during the catalytic process.  These single-subunit enzymes utilize the 
energy obtained from ATP hydrolysis to transport 2 Ca2+ ions from the cytoplasm to 
the ER/SR lumen in exchange for 2 H+ ions (Yu et al., 1993).  The SERCA subtypes 
express functional variations, for example, SERCA1 and 2a have similar affinities for 
Ca2+ whereas the affinity of SERCA2b for Ca2+ is approximately 2-fold greater 
(Lytton et al., 1992; Verboomen et al., 1994).  SERCA3 on the other hand exhibits 3 
to 4-fold lower affinity for Ca2+ than the other subtypes (Lytton et al., 1992).  This 
functional variability between SERCA isoforms could play an important role in the 
regulation of Ca2+ signals, and the prevalence of one or other isoform could therefore 
contribute to cell-type specific functions. 
SERCA pumps are regulated by 2 endogenous proteins present in the SR 
membrane: phospholamban (PLN) and sarcolipin (SLN).  PLN is a membrane 
spanning protein that associates with SERCA pumps and inhibits their activity by 
lowering the affinity of the pump for Ca2+ (Traaseth et al., 2008).  This inhibition is 
relieved upon phosphorylation of PLN at Ser16 by PKA and/or Thr17 by CaMKII 
(Wegener et al., 1989).  Within the SR PLN is thought to exist as an inactive 
homopentamer which must first depolymerise into monomers prior to interaction with 
and subsequent inhibition of SERCA pumps (Kimura et al., 1997).  SLN is also a 
membrane spanning protein that is homologous to PLN (Traaseth et al., 2008) and, 
consistent with this similarity, the inhibitory effect of SLN on SERCA pump activity 
may be reversed via phosphorylation at Ser4 and Thr5 by serine threonine kinases 
(Gramolini et al., 2004).  Co-expression of PLN and SLN in HEK293 cells led to 
‘superinhibition’ of SERCA1a and SERCA2a.  Thus, co-expression of SLN with PLN 
has been proposed to cause depolymerisation of PLN into monomers, which form 
heterodimers with SLN resulting in subsequent superinhibition of SERCA pumps 
(Asahi et al., 2002; Asahi et al., 2003).  Superinhibition of SERCA pumps may occur 
endogenously given that, despite varied tissue expression for both PLN and SLN, 
mRNA expression for both proteins has been shown to be particularly high in mouse 
and rat atria (Vangheluwe et al., 2005). 
Of significance to experimental studies is the fact that SERCA pumps may also 
be blocked by two potent inhibitors: thapsigargin and cyclopiazonic acid (Lytton et 
al., 1991; Martinez-Azorin, 2004).  Blockade of SERCA pumps with these inhibitors 
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results in the depletion of the S / ER Ca2+ store.  Thus, these pharmacological tools 
can be very useful when investigating intracellular Ca2+ mobilising messengers and 
can be used to determine whether the Ca2+ released by these messengers is mobilised 
from the S / ER. 
 
1.4.1.2  Ca2+ buffering proteins of the sarcoplasmic / endoplasmic reticulum 
 
In order for the lumen to have a concentration that is not inhibitory to the 
SERCA pump, the S / ER contains Ca2+ buffering proteins (MacLennan et al., 2002).  
The key characteristic for such proteins is to bind multiple Ca2+ ions with low affinity 
and therefore allow the organelle to effectively store Ca2+ (Volpe et al., 1994).  One 
such protein is calsequestrin (CSQ) which has a low affinity for Ca2+ (Kd 0.8 mM) 
and, with 700-800 nmol of Ca2+ per mg of protein (40-50 Ca2+ ions per CSQ 
molecule), it has a high capacity for Ca2+ storage (MacLennan et al., 2002; Volpe et 
al., 1994).  In place of a Ca2+ binding site motif such as the EF-hand motif, CSQs 
posses a high negative charge and are thought to bind Ca2+ via pairs of acidic residues 
(Wang et al., 1998).  In addition to CSQ, another Ca2+ buffering protein, calreticulin 
was identified in the early 1970’s (Ostwald et al., 1974) and is expressed in the 
ER/SR of many cell types (Michalak et al., 1992).  Calreticulin has a low affinity (Kd 
2 mM) Ca2+ binding domain with high capacity for Ca2+ binding (18 mol of Ca2+/mol 
of protein) in the C-terminal domain.  This high Ca2+ binding capacity is determined 
by a region rich in acidic amino acid residues.  Calreticulin also has a high affinity 
(Kd 6 µM) low capacity (1.3 mol of Ca2+/mol of protein) Ca2+ binding site in the P-
domain (Baksh et al., 1991; Michalak et al., 1999).  Both of these Ca2+ binding 
proteins allow storage of high concentrations of Ca2+ and with their low affinity 
binding sites, allow the rapid release of Ca2+ upon activation of Ca2+ release channels 
within the ER/SR, inositol 1,4,5-trisphosphate receptors (IP3R) and ryanodine 
receptors (RyR).  
 
1.4.2  Golgi Apparatus 
 
The Golgi apparatus (GA) is an organelle consisting of a ribbon-like labyrinth 
of cisternal membranes.  The GA functions as the major pathway for protein and lipid 
transport from the ER to the plasma membrane and other organelles.  During this 
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process the transported proteins and lipids may undergo a number of modifications.  
The cis-Golgi is the entry face to the intermediate GA ribbon whilst the trans-Golgi 
serves as the exit surface of the GA.  Both intra-Golgi transport and modifications 
include a number of Ca2+-dependent processes (Carnell et al., 1994; Oda, 1992; Porat 
et al., 2000) and therefore the GA sequesters Ca2+ such that the GA cisternae Ca2+ 
content is maintained at a high concentration relative to the cytoplasm (Pezzati et al., 
1997).  Furthermore, Ca2+ gradients can be formed between the trans- and cis-Golgi.  
For example, in pancreatic acinar cells, IP3-mediated Ca2+ release via the application 
of acetylcholine resulted in a greater luminal Ca2+ concentration in the trans-Golgi 
than in the cis-Golgi (Dolman et al., 2005).  That steep Ca2+ gradients may be formed 
between trans- and cis-Golgi suggests that these different parts may have different 
affinities for ”released” Ca2+.  Due to this dependency on Ca2+ the GA therefore 
contains a number of Ca2+ sequestering proteins as well as Ca2+ release channels.  In 
order to sequester Ca2+, the cis- and intermediate-Golgi membrane contains SERCA 
pumps whereas the trans-Golgi membrane contains the secretory-pathway Ca2+-
ATPases (SPCAs) (Behne et al., 2003).  These Ca2+ pumps are encoded by two genes 
in humans (ATPC1 and ATPC2) and are similar to SERCAs as they are also P-type 
ATPases.  However there are distinct differences in that they can transport Ca2+ or 
Mn2+ equally well, and transport 1 ion of Ca2+/Mn2+ per ATP hydrolysis (Wei et al., 
2000).  It has also been shown that the GA contains IP3Rs making it a rapidly 
releasable Ca2+ store (Collado-Hilly et al., 2009; Lin et al., 1999) and consistent with 
this IP3 was found to mobilise Ca2+ from GA vesicles (Surroca et al., 2000).  
However, RyR agonists cADPR and caffeine failed to evoke Ca2+ release from GA 
vesicles suggesting that RyRs are absent from the membranes of this organelle 
(Surroca et al., 2000).  The presence of IP3Rs therefore allow the GA to act as either a 
Ca2+ sink or as a releasable store that cooperates with other organelles (Dolman et al., 
2005; Vanoevelen et al., 2004).  However, an important consideration when 
determining the involvement of the GA in IP3-mediated Ca2+ signalling, is that similar 
to SERCAs, the SPCAs are also inhibited by thapsigargin albeit with less sensitivity 
(Dode et al., 2006; Rojas et al., 2000).  Thus without SPCA-specific inhibitors, 
distinguishing the individual contribution of these organelles in Ca2+ signalling could 
be problematic.    
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1.4.3  Ca2+ mobilisation by IP3 
 
Ca2+ mobilisation by IP3 was first reported in the blowfly salivary gland 
(Berridge, 1982).  This was shortly followed by the observation that IP3 evoked Ca2+ 
release in pancreatic acinar cells (Streb et al., 1983).  IP3 has since been shown to 
mediate intracellular Ca2+ release in a wide range of mammalian and non-mammalian 
cells, and is now regarded as the major intracellular Ca2+ mobilising messenger. 
 
1.4.3.1  Synthesis and metabolism of IP3 
 
IP3 signalling occurs via the activation of the multi-domain enzyme 
phospholipase C (PLC).  Stimulation of cell-surface receptors leads to the activation 
of this enzyme which then catalyses the hydrolysis of the membrane phospholipid 
phosphatidylinositol 4,5-bisphosphate, generating 1,2-diacylglycerol (DAG) and IP3.  
Initially there were 3 identifiable mammalian subtypes of PLC (β, γ, and δ) which are 
activated by either Gαq subunits of G-protein coupled receptors (GPCRs) in the case 
of PLC-β and PLC-δ, or in the instance of PLC-γ by tyrosine-kinase receptors 
(Rebecchi et al., 2000).  In addition, PLC-δ is also regulated by changes in the 
intracellular Ca2+ concentration (Pawelczyk, 1999).  More recently, conserved regions 
of the PLC subtypes were used to identify 3 additional PLC subtypes: ε, η and ζ 
(Katan, 2005).  Following its formation, IP3 then diffuses through the cytoplasm and 
binds to IP3Rs on the S / ER membrane causing the channel to open and Ca2+ to be 
released.  IP3-mediated Ca2+ signalling is terminated by metabolism via the action of 
two different enzymes.  The PKC-regulated IP3 5-phosphatase cleaves the 5-
phosphate group (Majerus et al., 1988) whereas the CaM-sensitive IP3 3-kinase also 
terminates IP3 signalling by the addition of a phosphate to the 3 position (Hawkins et 
al., 1986; Takazawa et al., 1990). 
 
1.4.3.2  IP3R subtypes 
 
As previously mentioned, IP3 binds to IP3Rs on the S / ER which causes the 
channel moiety to open and thereby Ca2+ is released from the intracellular store into 
the cytoplasm (Berridge et al., 2000).  There are currently three characterised IP3R 
subtypes (IP3R-1, 2 and 3) (Blondel et al., 1993) which have a tetrameric structure 
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with each unit comprising of 6 TM regions present in the C-terminal and an IP3-
binding site in the N-terminal region (Michikawa et al., 1994; Mignery et al., 1990).  
It is suggested that each of the 4 subunits require one molecule of IP3 to be bound in 
order for the channel to open (Marchant et al., 1997).  The expression of the three 
IP3R subtypes is not ubiquitous, as the relative contribution of each subtype to the 
overall expression of IP3R varies in a tissue-dependent manner.  For example, in 
arterial smooth muscle IP3R-1 is the predominantly expressed subtype with little 
expression of IP3R-2 and IP3R-3 (Grayson et al., 2004).  Using a cell line expressing 
all 3 IP3R subtypes, it was determined that these subtypes exhibit different 
sensitivities to IP3 with an EC50 regarding Ca2+ release for IP3R-2, IP3R-1 and IP3R-3 
of 0.35, 4.7 and 18.6 µM respectively (Miyakawa et al., 1999).  However, in terms of 
IP3 binding, IP3R-3 bound IP3 with significantly less affinity (Kd ~40 nM) than either 
IP3R-1 or IP3R-2 (Kd ~1 and ~2 nM respectively) (Wojcikiewicz et al., 1998).  The 
difference between the 3 IP3R subtypes in both IP3 binding and sensitivity to 
activation by IP3 illustrates that, as with the SERCA isoforms, IP3R subtype 
expression may also allow the cell to match specific protein expression to cell-type 
specific function.  In addition to gating by IP3, IP3Rs are also biphasically regulated 
by changes in the intracellular Ca2+ concentration.  However, as with IP3 gating, their 
appears to be variation in the sensitivity of each IP3R subtype with respect to Ca2+-
dependent regulation of IP3Rs (Boehning et al., 2000; Missiaen et al., 1998; 
Miyakawa et al., 1999; Taylor et al., 2002).  Therefore, IP3Rs exhibit subtype-specific 
regulation and gating by both IP3 and Ca2+, allowing the cell and, in particular the S / 
ER, to tightly regulate both IP3-mediated Ca2+ signals and CICR amplification of Ca2+ 
signals via IP3Rs. 
 
1.4.4  Ca2+ mobilisation by pyridine nucleotides 
 
In addition to intracellular Ca2+ mobilisation by IP3, there is a substantial body 
of evidence supporting the role of two pyridine nucleotides in Ca2+ mobilisation, 
cyclic adenosine diphosphate-ribose (cADPR) and nicotinic acid adenine dinucleotide 
phosphate (NAADP).   
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1.4.4.1  Ca2+ mobilisation by cADPR 
 
In 1987 Lee and colleagues discovered that, in addition to IP3, 2 pyridine 
nucleotides were capable of mediating Ca2+ release in sea urchin egg homogenate.  
These nucleotides were identified as β-nicotinamide adenine dinucleotide (β-NAD+) 
and β-nicotinamide adenine dinucleotide phosphate (β-NADP+) (Clapper et al., 
1987).  Prior desensitisation of the homogenates with any of the 3 messengers did not 
inhibit further Ca2+ release by subsequent application of a different molecule.  This 
illustrated that the 2 pyridine nucleotides not only mobilised Ca2+ by a mechanism 
different to that of IP3 but also via mechanisms independent of each other (Clapper et 
al., 1987).  However, the authors also observed that β-NAD+ mobilised Ca2+ after a 
notable delay of approximately 1-2 minutes which was absent with both IP3 and β-
NADP+ mediated Ca2+ release (Clapper et al., 1987).  This delay was later 
demonstrated to be due to the enzymatic conversion of β-NAD+ into an active, Ca2+ 
mobilising metabolite identified as cADPR (Lee et al., 1989).  Following this 
discovery, enzymes capable of synthesising cADPR were identified in sea urchin eggs 
and a number of mammalian tissues, suggesting that cADPR is a ubiquitous 
intracellular Ca2+ mobilising messenger (Koshiyama et al., 1991; Lee et al., 1991; 
Rusinko et al., 1989; Walseth et al., 1991). 
 
1.4.4.2  Synthesis of cADPR 
 
The synthesis of cADPR may be stimulated by the activation of a number of 
GPCR signalling pathways (Higashida, 1997).  cADPR is synthesised from β-NAD+ 
and this reaction is thought to be mediated by ADP-ribosyl cyclases (ARCs) which 
are a family of multifunctional enzymes, that exhibit a number of activities such as 
base-exchange, glycohydrolase and cyclase activity (Lee, 1999; Lee, 2000).  The first 
ARC to be isolated was from the ovetestis of Aplysia californica (Hellmich et al., 
1991) and two mammalian homologues of the Aplysia ARC have also been identified: 
the type II membrane glycoprotein CD38 (Howard et al., 1993; States et al., 1992) 
and a GPI-anchored protein, CD157 (Hirata et al., 1994).  However investigations 
into the topology of the CD38 enzyme revealed that that the catalytic site is located on 
the extracellular face of the plasma membrane.  This poses a ‘topological paradox’ 
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whereby cADPR is potentially synthesised extracellularly, only to then mobilise Ca2+ 
via interaction with its intracellularly located receptor (De Flora et al., 2000).  A 
solution to this paradox was proposed by De Flora and colleagues, basing their 
suggestion on the finding that β-NAD+ can be transported outside the cell via 
connexin 43 hemichannels where it is then converted to cADPR, and transported back 
into the cell (Bruzzone et al., 2001).  However this process would appear to be energy 
inefficient and more suited to an autocrine / paracrine signalling mechanism rather 
than a rapid intracellular signalling system.  A more probable solution is that an as yet 
unidentified CD38 homologue could be found on the surface of intracellular 
organelles.  Consistent with this view, 3 ARC isoforms from the sea urchin egg, 
ARCα, ARCβ and ARCγ, have been cloned and characterised by Galione and co-
workers (Davis et al., 2008).  Though not closely related to CD38 the distribution of 
these isoforms revealed that ARCα was ectocellular, while ARCβ and ARCγ were 
located within the lumen of acidic organelles and in a pattern reminiscent of the 
distribution of cortical granules (Davis et al., 2008).  It is therefore clear, that in sea 
urchin eggs there exists a closer coupling between the site of cADPR synthesis and its 
target receptor, than would be indicative of an extracellularly orientated ARC.  
Furthermore, in mammalian cells subpopulations of CD38 appear to be localised on 
the ER and nuclear membranes (Sun et al., 2002; Yalcintepe et al., 2005).  Taken 
together these data suggest that future investigations may identify a mammalian 
equivalent of the intracellular ARCβ and ARCγ, yet with limited homology to the sea 
urchin isoforms.  Such an enzyme that is distinct from CD38 and CD157 would 
therefore be capable of cADPR synthesis intracellularly and thus resolve the paradox 
associated with CD38 and CD157. 
Some but not all ARCs are multifunctional, and it has been shown that 
metabolism of cADPR may be mediated by ARCs as, in addition to being able to 
catalyse the generation of cADPR from β-NAD+, both CD38 and CD157 have also 
been shown to catalyse the hydrolysis of cADPR to ADP-ribose (Hirata et al., 1994; 
Howard et al., 1993). 
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1.4.4.3  cADPR-mediated Ca2+ mobilisation via ryanodine receptors 
 
Ca2+ release by cADPR involves the regulation of RyRs present on the ER/SR.  
This was first demonstrated in sea urchin egg homogenates whereby caffeine and 
ryanodine desensitised sea urchin egg homogenate to Ca2+ release by cADPR but not 
IP3 (Galione et al., 1991; Lee et al., 1993).  Also, the RyR antagonist ruthenium red 
inhibited cADPR-mediated Ca2+ release (Galione et al., 1991).  Furthermore, it was 
later shown that lower, subthreshold concentrations of caffeine potentiated Ca2+ 
release by cADPR (Lee, 1993).  This suggested that cADPR not only released Ca2+ 
from the same store as caffeine but also acted on the same Ca2+ release channels, 
RyRs (Lee, 1993).  The role of RyRs in cADPR-mediated Ca2+ release has since been 
shown in a broad range of cell types from protozoa to mammals.  In the protozoan 
parasite, T. gondii ruthenium red inhibited cADPR-mediated Ca2+ release but not IP3-
mediated Ca2+ release (Chini et al., 2005).  Consistent with cADPR-mediated Ca2+ 
release via RyRs in the sea urchin egg, inhibitory concentrations of ryanodine and 
ruthenium red block cADPR-mediated Ca2+ release in a number of mammalian 
preparations including rat brain microsomes and mesangial cells (Meszaros et al., 
1993; White et al., 1993; Yusufi et al., 2001).  Furthermore, ryanodine also inhibits 
cADPR-mediated hyperpolarisation and dilation in rat pulmonary arterial smooth 
muscle cells (Boittin et al., 2003), and reduced expression of the RyR subtype 3 in 
Jurkat T-cells results in a significant reduction in Ca2+ release in response to cADPR 
without affecting Ca2+ release by IP3 (Schwarzmann et al., 2002). 
RyRs are large (~2000 kDa) homotetramers that regulate Ca2+ release from the 
S / ER.  There are currently 3 known mammalian subtypes of RyR (RyR1, RyR2 and 
RyR3) which have approximately 65% amino acid homology (Hamilton, 2005).  
RyRs may be activated by Ca2+ directly or Ca2+ may facilitate further Ca2+ release via 
RyRs in a process known as Ca2+-induced Ca2+ release (CICR) (Endo et al., 1970).  
This process of CICR allows the amplification of small, localised Ca2+ signals into 
global Ca2+ waves via the progressive recruitment of subpopulations of RyRs.  Ca2+ at 
millimolar concentrations may also inhibit RyRs and thus RyRs exhibit a bell-shaped 
concentration-response to cytoplasmic Ca2+ (Fill et al., 2002).  As previously 
mentioned, in addition to Ca2+ modulation of RyRs, cADPR is also an endogenous 
regulator that can either activate RyRs directly or facilitate CICR via RyRs by 
sensitising RyRs to Ca2+ (Galione et al., 1991; Meszaros et al., 1993).  Further 
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complexity is provided by the fact that Ca2+ can sensitise RyRs to activation by 
cADPR (Panfoli et al., 1999).  It is therefore important to consider these 
combinatorial effects of cADPR and Ca2+ on the regulation of RyRs when 
investigating Ca2+ signals involving RyR and / or CICR (Evans et al., 2005).   
Despite the fact that cADPR has been shown to regulate Ca2+ signalling via 
RyRs, investigations on the mechanism of binding / regulation of RyRs by cADPR 
have proved inconclusive. Initial experiments regarding cADPR binding used 
[32P]N3-cADPR as a photoaffinity probe for cADPR binding sites.  Photoaffinity 
labelling identified two putative cADPR binding proteins (Walseth et al., 1993).  
These proteins of approximately 100 and 140 kDa in size are smaller than RyRs 
(~2000 kDa) (Hamilton, 2005) and were therefore considered to be either RyR 
fragments or distinct cADPR binding/accessory proteins (Walseth et al., 1993).  
However, the former suggestion was deemed ‘unlikely’ by the authors as no larger 
labelled proteins, indicative of less fragmented sections, were detected.  Furthermore, 
binding of cADPR to the two detected proteins was inhibited by caffeine to a 
differing extent, suggesting that they are separate proteins rather than resultant 
fragments from proteolysis of a larger protein (Walseth, et al., 1993).  In recent years 
evidence has also been presented to suggest that FK506-binding protein 12.6 
(FKBP12.6) is involved in cADPR-mediated Ca2+ release via RyRs.  Based on studies 
involving microsomes from rat pancreatic islets it was proposed that FKBP12.6 
normally binds to RyRs and has an inhibitory effect.  Upon cADPR binding to 
FKBP12.6 it has been proposed that the FKBP12.6-cADPR complex dissociates from 
the RyR resulting in an increased open probability (Noguchi et al., 1997).  Similar 
results have also been demonstrated in other cell types including coronary arterial 
smooth muscle and tracheal smooth muscle (Tang et al., 2002; Wang et al., 2004) 
thus adding further support for FKBP12.6 acting as a cADPR binding protein.  
However, contrary to this proposal, it was observed that cADPR did not affect the 
binding of recombinant FKBPs to RyR3 in HEK293 cells (Bultynck et al., 2001).  
Furthermore, it has also been demonstrated that in the sea urchin egg, antagonists of 
FKBP, rapamycin and FK-506, failed to inhibit [32P]cADPR binding (Thomas et al., 
2001).  Taken together, these data would suggest that either the cADPR binding site is 
an as yet unidentified homologue of the FKBPs or that cADPR binding to FKBP12.6 
could be RyR subtype-specific. 
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Fig. 1.2.  Summary schematic representation of the mechanisms involved in Ca2+ extrusion/influx 
across the plasma membrane and sequestering/release of Ca2+ by intracellular Ca2+ stores 
Depicted are some of the mechanisms by which Ca2+ is able cross the plasma membrane and the 
membranes of some of the intracellular Ca2+ stores.  Cav, voltage gated Ca2+ channel; ROC, receptor 
operated channel; PMCA, plasma membrane Ca2+ ATPase; NCX, Na+/Ca2+ exchanger; KCa, Ca2+-
activated K+ channel; ClCa, Ca2+-activated Cl- channel; STIM, stromal interaction molecule; SERCA, 
Sarco/endoplasmic reticulum Ca2+ ATPase; RyR, Ryanodine receptor; IP3R, IP3 receptor; SPCA, 
secretory pathway ATPase; MCU, mitochondrial Ca2+ uniporter; RaM, rapid mode of mitochondrial 
Ca2+ uptake. 
 
 
1.5  NAADP-dependent Ca2+ signalling 
 
In 1987 Lee and colleagues first discovered that a nicotinic acid derivative of β-
nicotinamide adenine dinucleotide phosphate (β-NADP+) released Ca2+ in sea urchin 
egg, and that this mechanism was independent of the IP3- and β-NAD+/cADPR-
mediated Ca2+ release mechanisms (Clapper et al., 1987).  This Ca2+-mobilising 
derivative was later identified as NAADP (Chini et al., 1995a; Lee et al., 1995).  
Since its discovery NAADP has been found to mobilise Ca2+ in a wide variety of 
organisms including invertebrates (Albrieux et al., 1998; Chini et al., 1995a; Santella 
et al., 2000) vertebrates (Berg et al., 2000; Cancela et al., 1999; Chini et al., 1995b; 
Mojzisova et al., 2001; Zhang et al., 2006a) and plants (Navazio et al., 2000) and has 
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been described as the most potent Ca2+ mobilising agent known to date (Galione et 
al., 2005).   
 
1.5.1  Synthesis and metabolism of NAADP 
 
It is widely thought that, similar to the synthesis of cADPR, NAADP is 
synthesised by members of the ARC family.  As well as exhibiting cyclase activity 
necessary for cADPR synthesis, ARCs are also capable of catalysing the base-
exchange reaction needed to generate NAADP (Aarhus et al., 1995; Lee et al., 1991).  
The proposed mechanism for NAADP synthesis is a base-exchange reaction via 
substitution of the nicotinamide group for a nicotinc acid group on β-NADP+ (Aarhus 
et al., 1995).  However, this dual function of ARCs implies that NAADP synthesis is 
subject to the same topological paradox that is associtated with cADPR synthesis.  
NAADP is therefore likely to be synthesised by an as yet unidentified CD38 
homologue, as mentioned previously with regard to cADPR synthesis.  Recently 
however, work from Churchill and colleagues has shown that an enzyme present on 
the membrane of sea urchin sperm is capable of synthesising NAADP.  Indeed, this 
enzyme favours base-exchange over cyclase activity and therefore does not produce 
measurable cADPR.  This enzyme is unique from the ARC family and was termed 
NAADP-synthase (Vasudevan et al., 2008).  However, as NAADP-synthase was 
found to be present on the surface of the sea urchin sperm, the cellular location of this 
enzyme prompts similar questions regarding its functional relevance within other cell 
types.  Nevertheless, the finding of a unique enzyme capable of NAADP synthesis 
adds further support to the proposal that an as yet unidentified CD38-like enzyme 
with an intracellularly-orientated active site, is responsible for the synthesis of 
NAADP necessary to support a role in intracellular signalling.   
Unlike cADPR, the metabolism of NAADP is not catalysed by any of the 
known ARCs.  However a number of common hydrolytic enzymes are responsible for 
the break down of this potent Ca2+ mobilising messenger.  For example, NAADP has 
been shown to be metabolised to yield NAAD by cellular alkaline phosphatases 
(Kontani et al., 1993), and the action of nucleotide pyrophosphatase yields 2’-
phospho-AMP and nicotinic acid mononucleotide (De Flora et al., 2000). 
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1.5.2  NAADP mobilises Ca2+ from a separate store to that mobilised by IP3 and 
cADPR  
 
Since its discovery a number of studies have been carried out in order to 
characterise the precise mechanism underpinning NAADP-mediated Ca2+ release.  
Importantly, NAADP has been shown to mobilise Ca2+ in an IP3R- and RyR-
independent manner, and from a store separate to that mobilised by IP3 and cADPR.  
This was first indicated by Lee & Aarhus using Percoll density gradient centrifugation 
of sea urchin egg homogenate (Lee et al., 1995).  This technique is able to separate 
the homogenate into a number of fractions and their sensitivities to 
IP3/cADPR/NAADP can then be assayed.  Both IP3- and cADPR-sensitive fractions 
co-migrated to the same two fractions.  These two fractions also contained the ER 
marker, glucose-6-phophatase.  Conversely, NAADP-sensitive fractions had a much 
broader distribution suggesting that this was a separate Ca2+ store from that mobilised 
by either IP3 or cADPR (Lee et al., 1995).  Furthermore, cADPR antagonists (8-NH2-
cADPR, ruthenium red, and procaine) and IP3 antagonists (heparin) had no effect on 
NAADP-mediated Ca2+ release in either the whole sea urchin egg or mircrosomes 
derived from homogenates of the sea urchin egg, suggesting that NAADP acts on a 
receptor distinct from RyRs and IP3Rs (Chini et al., 1995a; Lee et al., 1995).  The 
view that NAADP mobilises Ca2+ from a separate store was further supported by the 
finding that in sea urchin egg homogenate, depletion of the ER Ca2+ stores using the 
SERCA pump inhibitor thapsigargin was without effect on NAADP-mediated Ca2+ 
release, whereas both IP3- and cADPR-mediated Ca2+ release was abolished 
(Genazzani et al., 1996b).  And this has now been confirmed in variety of mammalian 
cell types including PASMCs (Boittin et al., 2002; Kinnear et al., 2004). 
In addition to the pharmacological distinction, evidence in support of a separate 
NAADP-mediated Ca2+ release mechanism has been obtained in the stratified sea 
urchin egg (Lee et al., 2000).  The process of stratification elongates sea urchin eggs 
by centrifugation such that cellular components can be partially separated by density.  
Within the stratified cells, Ca2+ release triggered by flash-photolysis of caged IP3 and 
cADPR triggered Ca2+ release from the nuclear pole of the stratified egg.  In marked 
contrast, photo-release of NAADP triggered Ca2+ release from the opposing distal 
pole of the egg (Lee et al., 2000). 
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1.5.3  NAADP mediates Ca2+ release via interaction with a pharmacologically 
discreet receptor 
 
Experiments have not only shown that NAADP mobilises a non-ER store but 
there is also a growing body of evidence to suggest that NAADP mediates its effect 
via interaction with a discreet NAADP receptor.  As previously mentioned cADPR 
and IP3 antagonists were without effect on NAADP-meditated Ca2+ release in both 
homogenates of sea urchin eggs and whole sea urchin egg suggesting that NAADP 
does not release Ca2+ via IP3Rs or RyRs (Chini et al., 1995a; Lee et al., 1995).  For 
example, in the sea urchin egg, in contrast to IP3- and cADPR-mediated Ca2+ release, 
NAADP-mediated Ca2+ release was unaffected by the extravesicular Ca2+ 
concentration and by a pH change from 7.2 to 6.7 and 8.0 (Chini et al., 1996; 
Genazzani et al., 1997).  This has also been confirmed in microsomes derived from 
mammalian cells (Yusufi et al., 2002).  Another unique pharmacological property of 
NAADP-dependent Ca2+ release is inhibition by L-type VGCC antagonists.  In the sea 
urchin egg and in rat brain microsomes L-type VGCC inhibitors such as varapamil, 
nifedipine and diltiazem blocked NAADP-evoked Ca2+ release without blocking Ca2+ 
release by cADPR and IP3 (Bak et al., 1999; Genazzani et al., 1996a; Genazzani et 
al., 1997).  This suggests that NAADP activates a receptor that is structurally related 
to L-type voltage-gated Ca2+ channels.  That a distinct channel was involved is 
highlighted by the observation that the L-type VGCC agonist Bay K 8644 inhibited 
rather than potentiated NAADP-mediated Ca2+ release in sea urchin egg homogenate 
(Genazzani et al., 1996a; Genazzani et al., 1997).   
Further evidence for a discreet NAADP receptor comes from the homologous 
desensitisation studies in sea urchin egg homogenate.  Briefly, NAADP-mediated 
Ca2+ release is desensitized by sequential additions of saturating concentrations of 
NAADP.  This inhibition by sequential additions was also exhibited by both IP3- and 
cADPR-mediated Ca2+ mechanisms (Chini et al., 1995a; Genazzani et al., 1996a).  
However in each case desensitisation was homologous, such that desensitisation to 
NAADP had no effect on cADPR- or IP3-mediated Ca2+ release (Chini et al., 1995a; 
Genazzani et al., 1996a).  This absence of cross-desensitisation demonstrates further 
that each of these Ca2+ mobilising second messenger mediate their effects via the 
activation of pharmacologically distinct receptors. 
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The process of desensitisation to NAADP is also different.  In the sea urchin 
egg not only does a threshold concentration of NAADP elicit release of Ca2+ and 
prevent further Ca2+ release by subsequent additions of NAADP for up to 11 minutes 
(Aarhus et al., 1996), but subthreshold concentrations (1-5 nM) of NAADP block 
Ca2+ release by the later addition of a saturating concentration (0.5-1 µM) of NAADP 
(Aarhus et al., 1996; Genazzani et al., 1996a).  This inactivation / desensitisation also 
appears to be time-dependent as preincubation of microsomes with 1 nM NAADP for 
1 minute reduced subsequent NAADP-mediated Ca2+ release, whereas preincubation 
for 10 minutes resulted in complete block of release by the subsequent addition of ~1 
µM NAADP (Aarhus et al., 1996).  In the sea urchin egg, the persistent (1500 s) self-
inactivation of NAADP differs from that of IP3 and cADPR inactivation which is 
transient and can be reversed within 30 minutes (Genazzani et al., 1996a).  In contrast 
to the sea urchin egg, in mammalian cells NAADP-mediated Ca2+ release appears to 
conform to a bell-shaped concentration-response curve (Berg et al., 2000; Cancela et 
al., 1999; Masgrau et al., 2003).  This has been shown in T-lymphocytes, pancreatic 
β-cells and pancreatic acinar cells, where low (nanomolar) concentrations of NAADP 
elicit Ca2+ release, whereas supra-threshold (micromolar) concentrations are 
ineffective (Berg et al., 2000; Cancela et al., 1999; Masgrau et al., 2003).  However, 
PASMCs exhibited a more variable degree of inactivation in response to intracellular 
dialysis of 100 µM NAADP (Boittin et al., 2002).  The different inactivation 
properties of NAADP between cell types is likely to be as a result of the variation in 
specific function of each cell type and possibly the nature of the NAADP receptor or 
regulation of the Ca2+ release process. 
The functional role of homologous inactivation of NAADP-mediated Ca2+ 
signalling was further investigated by Churchill & Galione.  In the sea urchin egg, 
global Ca2+ transients were evoked by repeated application of IP3, cADPR or 
NAADP.  Repeated application of either IP3 or cADPR resulted in a gradual decrease 
in the peak amplitude of Ca2+ release.  However self-inhibition was not observed 
when the interval between application was increased from 20 s to 120 s (Churchill et 
al., 2001b).  In contrast, repetitive NAADP stimulation resulted in a decrease in the 
peak Ca2+ released regardless of the time interval between application (Churchill et 
al., 2001b).  Furthermore, local (compartmentalised) photo-release of caged NAADP 
by a UV laser targeted to a subsection of a sea urchin egg blocked further release by 
 30 
NAADP in that region of the cell, but was without effect on Ca2+ release triggered by 
photolysis of caged NAADP in regions of the cell distant from the initial volume in 
which photorelease was triggered.  This localised inactivation could last for 
approximately 20 minutes (Churchill et al., 2001b).  Local IP3 and cADPR release on 
the other hand, did not affect the pattern of the Ca2+ increase evoked by the later 
global release of the messenger.  This not only adds further weight to the view that 
NAADP does not act via RyRs or IP3Rs, but also suggests that the self-desensitisation 
by NAADP may confer a spatiotemporal memory with respect to Ca2+ release events 
triggered (Churchill et al., 2001b). 
 
1.5.4  NAADP mediates Ca2+ release via a two-pool system in sea urchin eggs 
 
In the sea urchin egg, NAADP has been shown to evoke long-term Ca2+ 
oscillations that require CICR from the ER (Churchill et al., 2001a). Thus, 
preincubation block of IP3Rs with heparin or RyR-dependent Ca2+ release with 8-
NH2-cADPR resulted in the inhibition of the first Ca2+ oscillation after an initial phase 
of NAADP-evoked Ca2+ release (Churchill et al., 2001a).  Furthermore, depletion of 
ER stores by inhibition of SERCA with thapsigargin partially inhibited NAADP-
induced Ca2+ release but did not abolish it.  Importantly, however, thapsigargin 
inhibited the Ca2+ oscillations that normally followed the initial phase of Ca2+ release 
in response to photorelease of NAADP (Churchill et al., 2001a).  This led the authors 
to propose a two-pool system whereby NAADP initially mobilises Ca2+ from a 
distinct, NAADP-sensitive store which is subsequently amplified by CICR from the 
ER via IP3Rs and RyRs.  It was proposed, therefore, that the oscillations result from 
the uptake into the ER of Ca2+ initially released by NAADP and that this may then 
‘prime’ the ER for subsequent Ca2+ release via IP3Rs and RyRs (Churchill et al., 
2001a). 
 
1.5.5  NAADP mobilises Ca2+ from a lysosome-related acidic Ca2+ store 
 
1.5.5.1  Acidic Ca2+ stores 
 
Despite the identification of the aforementioned two-pool system of NAADP-
mediated Ca2+ release, the identity of the NAADP-sensitive store remained elusive 
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until 2002, when Churchill and colleagues showed that NAADP evoked Ca2+ release 
from acidic organelles called reserve granules in sea urchin eggs (Churchill et al., 
2002). 
That acidic organelles could act as releasable Ca2+ stores was not widely 
accepted as, traditionally, lysosomes were considered to be acidic cellular 
compartments with the specific role of degrading both endogenous and exogenous 
macromolecules (Dell'Angelica et al., 2000).  However it was observed that 
lysosomes, in addition to the stores mentioned above, also contain a high luminal Ca2+ 
concentration and could thus act as a releasable Ca2+ store (Christensen et al., 2002; 
Yagodin et al., 1999). 
The concept of a lysosomal-related, releasable Ca2+ store is consistent with 
earlier experiments which showed that Ca2+ release in response to pentylenetetrazole 
originated from dense lysosome-like granules in snail neurons (Sugaya et al., 1978).  
Further support for a lysosome-related Ca2+ store came from the use of glycyl-
phenalanine 2-napthylamide (GPN).  GPN is a known substrate for cathepsin C which 
is an exopeptidase found exclusively within lysosomes.  Once GPN enters the 
lysosome, it is broken down by cathepsin C into its constituent amino acids.  These 
amino acids are unable to cross the lysosomal membrane and therefore their 
accumulation within the lumen increases the osmotic pressure until the lysosome is 
ruptured (Berg et al., 1994; Jadot et al., 1984).  Addition of GPN resulted in an 
increase in the intracellular Ca2+ concentration in both mammalian and non-
mammalian cells, suggesting that lysosomes may function as a Ca2+ store (Churchill 
et al., 2002; Haller et al., 1996; Srinivas et al., 2002; Yagodin et al., 1999).  The 
process by which lysosomes sequester Ca2+ is not so clear.  However, it appears to be 
dependent upon the formation of a proton gradient, which was demonstrated by the 
observation that the intracellular Ca2+ concentration of the lysosome decreased as the 
luminal pH increased (Christensen et al., 2002).  This was confirmed shortly after by 
the finding that 3 compounds FCCP, nigecerin and NH3, all of which disrupt the 
lysosomal proton gradient, inhibited Ca2+ uptake into lysosome-related organelles 
(Churchill et al., 2002) and by the finding that the vacuolar proton pump (V-H+-
ATPase) inhibitor bafilomycin A1 inhibited Ca2+ uptake into lysosomes (Christensen 
et al., 2002).  This led to the proposal that lysosome-related Ca2+ stores contain a V-
H+-ATPase which generates a proton gradient that is then utilised by a H+/Ca2+ 
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exchanger to accumulate Ca2+ (Christensen et al., 2002; Churchill et al., 2002) 
(Fig.1.3). 
 
 
Fig. 1.3.  Schematic representation of the mechanisms involved in Ca2+ extrusion/influx across 
the plasma membrane and sequestering/release of Ca2+ by intracellular Ca2+ stores including 
acidic organelles 
Depicted are some of the mechanisms by which Ca2+ is able cross the plasma membrane and the 
membranes of organelles recognised as intracellular Ca2+ stores.  The putative NAADP receptor is 
indicated by ‘?’.  Cav, voltage gated Ca2+ channel; ROC, receptor operated channel; PMCA, plasma 
membrane Ca2+ ATPase; NCX, Na+/Ca2+ exchanger; KCa, Ca2+-activated K+ channel; ClCa, Ca2+-
activated Cl- channel; STIM, stromal interaction molecule; SERCA, Sarco/endoplasmic reticulum Ca2+ 
ATPase; RyR, Ryanodine receptor; IP3R, IP3 receptor; SPCA, secretory pathway Ca2+ ATPase; MCU, 
mitochondrial Ca2+ uniporter; RaM, rapid mode of mitochondrial Ca2+ uptake; V-H-ATPase, vacuolar 
proton pump. 
 
 
Similar to lysosomes, the contribution of endosomes to Ca2+ homeostasis has 
not been widely studied.  However, endosomes are capable of storing Ca2+ with initial 
studies suggesting that endosomes sequester Ca2+ via a H+/Ca2+ exchanger that is 
driven by a proton gradient maintained by a H+-ATPase (Hilden et al., 1989).  Later 
reports suggest that the main mechanism by which endosomes take up Ca2+ is via 
endocytosis and that this Ca2+ is released over time as the endosome undergoes 
acidification (Gerasimenko et al., 1998).  Endosomes are not recognised as major 
releasable stores, however Ca2+ release is required for the fusion of endosomal 
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membranes after the formation of the SNARE complex (Peters et al., 1998).  This 
post-docking Ca2+-dependent event is important for the fusion of early- and late-
endosomal membranes and late-endosomal to lysosomal membranes (Holroyd et al., 
1999; Pryor et al., 2000).  Importantly, endosomes could be a possible additional 
organellar Ca2+ store that can be distinguished from lysosomes as, due to the specific 
lysosomal localisation of cathepsin C, endosomes would be unaffected by GPN (Berg 
et al., 1994). 
In fact the literature suggests that an endolysosomal Ca2+ store was identified as 
early as 1991 by Pozzan and co-workers (Fasolato et al., 1991).  However, little 
progress was made in terms of function as neither a RyR- or IP3R-dependent Ca2+ 
release mechanism were identified and at this point in time a role of NAADP in Ca2+ 
signalling had not been suggested.  However there is now a growing body of evidence 
that suggests that an endolysosomal Ca2+ store is mobilised by NAADP in a variety of 
cell types (Churchill et al., 2002; Kinnear et al., 2004; Yamasaki et al., 2004; Zhang 
et al., 2006a). 
 
1.5.5.2  Acidic lysosome-related organelles function as NAADP-sensitive Ca2+ stores 
 
A pivotal advance in the investigations on the mechanism of NAADP-
dependent Ca2+ signalling was provided by the finding that lysis, with GPN, of 
reserve granules (the sea urchin egg equivalent of lysosomes) resulted in the block of 
NAADP-induced Ca2+ release, yet was without effect on Ca2+ release by IP3 and 
cADPR.  This suggested that these lysosome-related organelles functioned as a 
separate NAADP-sensitive store proposed as pool 1 in the two-pool system of 
Churchill and co-workers (Churchill et al., 2002).  To verify that the reserve granules 
could be the NAADP-sensitive store, the location of reserve granules in stratified sea 
urchin eggs were visualised using LysoTracker Red, a fluorescent label of acidic 
organelles.  LysoTracker Red labelling revealed that the pole associated with 
NAADP-mediated Ca2+ release was enriched with acidic organelles whereas the 
opposing nuclear pole was depleted of acidic organelles (Churchill et al., 2002).  This 
is consistent with the spatial pattern of Ca2+ release mediated by NAADP, IP3 and 
cADPR previously observed in stratified eggs (Lee et al., 2000).  As mentioned above 
with reference to lysosomes as Ca2+ stores, it was proposed that lysosome-related 
stores utilise the bafilomycin-sensitive V-H+-ATPase pump to generate a proton 
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gradient which may then be utilised in turn to mediate Ca2+ accumulation via a 
H+/Ca2+ exchanger.  Consistent with this proposal, preincubation of sea urchin eggs 
with bafilomycin in order to block refilling of the acidic organelle Ca2+ stores, 
resulted in the inhibition of NAADP-mediated but not IP3- or cADPR-mediated Ca2+ 
release (Churchill et al., 2002).  Given these observations and the previously proposed 
two-pool system, it was suggested that NAADP mediates Ca2+ release from a 
lysosome-related Ca2+ store which is then amplified by CICR via the ER (Churchill et 
al., 2002) (Fig.1.3).  However, a lysosome-related, NAADP-sensitive Ca2+ store could 
be a unique property of the sea urchin egg, and it therefore needed to be verified in 
other cell types, mammalian in particular, in which NAADP-mediated Ca2+ release 
had been identified in order to determine whether or not this was a general 
mechanism of Ca2+ signalling. 
 
 
1.5.6  NAADP-mediated Ca2+ release in mammalian cells 
 
Since the initial experiments showing the ability of NAADP to evoke Ca2+ 
release in sea urchin egg, NAADP has been shown to mobilise Ca2+ in a number of 
mammalian cell types including PASMCs, cerebral cortex neurons, pancreatic acinar 
cells, and T-lymphocytes (Bak et al., 1999; Berg et al., 2000; Boittin et al., 2002; 
Brailoiu et al., 2005; Cancela et al., 1999; Yamasaki et al., 2004).  NAADP-mediated 
Ca2+ mobilisation in mammalian cells was first shown in 1999 in pancreatic acinar 
cells (Cancela et al., 1999).  These experiments identified a bell-shaped 
concentration-response curve in mammalian cells such that high concentrations of 
NAADP failed to evoke Ca2+ release due to desensitisation of the NAADP receptor.  
Importantly, it was shown that an inhibitory concentration of NAADP (100 µM) had 
no effect on IP3- and cADPR-mediated Ca2+ release, but abolished the Ca2+ spiking 
associated with the application of the secretory hormone cholecystokinin (CCK) 
(Cancela et al., 1999).  This study verified NAADP as an important intracellular 
messenger in mammalian cells, and in addition suggested that CCK mediated its 
effects via NAADP-evoked Ca2+ signalling. 
The bell-shaped concentration-response curve of NAADP-mediated Ca2+ 
release has also been shown in isolated PASMCs which have proved an important cell 
type in the development of our understanding of NAADP-mediated Ca2+ release in 
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mammalian cells (Boittin et al., 2002).  Evans and colleagues showed that in 
PASMCs intracellular dialysis of NAADP triggers a global Ca2+ wave and contraction 
(Boittin et al., 2002).  Furthermore, the global Ca2+ wave was often preceded by a 
spatially restricted “Ca2+ burst” which either declined back to basal levels or 
subsequently triggered a global Ca2+ wave.  This spatially restricted Ca2+ burst 
appeared to initiate a global Ca2+ wave only once a given threshold for CICR from the 
SR was breached (threshold Ca2+ concentration, ~ 400 nM) (Boittin et al., 2002).  
This was consistent with the proposed two-pool model of NAADP-mediated Ca2+ 
signalling observed in sea urchin eggs (Churchill et al., 2001a) and was indicative of 
the presence of an NAADP-sensitive store that releases a spatially restricted Ca2+ 
burst that can then be amplified by Ca2+ release via RyRs and/or IP3Rs on the SR 
(Boittin et al., 2002).  This two-pool model was confirmed by the observation that, 
following inhibition of RyRs by ryanodine and depletion of SR Ca2+ stores by the 
block of SERCA pumps with thapsigargin, NAADP failed to elicit global Ca2+ waves 
yet still produced spatially restricted Ca2+ bursts.  Interestingly, blockade of IP3Rs 
with xestospongin C abolished signals in response to IP3R, but was without effect on 
NAADP-mediated global Ca2+ waves (Boittin et al., 2002).  Thus, it was suggested 
that in PASMC, NAADP mobilises Ca2+ from a separate store which is then amplified 
by Ca2+ release from the SR via the progressive recruitment of RyRs but not via 
IP3Rs.  This is not without significance, as the fact that NAADP-dependent signals 
may be amplified by CICR via IP3Rs and RyRs in other cell types strongly suggests 
that there is inherent flexibility in the coupling process that may be utilised by 
different cells to generate NAADP-dependent Ca2+ signals with discrete 
spatiotemporal patterns.  Furthermore, it suggests that endolysosomal Ca2+ stores may 
expand or restrict the nature of their coupling to different populations of Ca2+ release 
channels on the S / ER in a cell-specific manner. 
 
1.5.6.1  NAADP mobilises Ca2+ from lysosome-related organelles in mammalian cells 
 
Following the identification of a lysosome-related, NAADP-sensitive Ca2+ store 
in sea urchin eggs (Churchill et al., 2002) the identity of the mammalian NAADP-
sensitive Ca2+ store was investigated.  Using PASMCs, Kinnear et al. showed that 
both NAADP-induced Ca2+ bursts and subsequent global Ca2+ waves were abolished 
by preincubation of PASMCs with bafilomycin A1 (Kinnear et al., 2004).  
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Bafilomycin was also shown to inhibit Ca2+ release by flash photolysis of caged-
NAADP in the pancreatic acinar cell (Yamasaki et al., 2004).  Furthermore, 
LysoTracker labelling of lysosome-related organelles in pancreatic acinar cells 
revealed that these organelles were localised in the apical pole, which is the region of 
highest NAADP sensitivity (Cancela et al., 2002; Yamasaki et al., 2004). 
LysoTracker labelling of lysosomes in PASMCs also exhibited dense clustering in a 
manner consistent with the spatial nature of identified, NAADP-dependent Ca2+ 
bursts. In marked contrast, LysoTracker labelling of lysosomes within pancreatic β 
cells showed a much more diffuse pattern which also mirrored the global nature of 
NAADP-mediated Ca2+ release observed in these cells (Yamasaki et al., 2004).  
Most significantly, however, depletion of acidic stores with bafilomycin has 
been shown to block Ca2+ signalling by NAADP in, for example, PASMCs (Kinnear 
et al., 2004) and pancreatic acinar cells (Yamasaki et al., 2004) and has also been 
shown to block, in an agonist-specific manner, Ca2+ signalling in response to a variety 
of hormones / transmitters that have been shown to increase NAADP levels in 
PASMCs by activation of cell surface receptors in these and other cell types. 
 
1.5.6.2  The NAADP “trigger zone” underpins NAADP-mediated Ca2+ release 
 
In order for NAADP to mediate Ca2+ release via a two-pool, system tight 
coupling must exist between the NAADP-sensitive lysosome-related store and the 
ER/SR.  Clear evidence for such coupling was provided by the finding that 
LysoTracker Red-labelled lysosomes form spatially organised clusters which are in a 
close association with a subpopulation of RyRs in PASMCs (Kinnear et al., 2004).  
The junctional gap between the lysosome clusters and RyRs could not be resolved by 
deconvolution microscopy and is likely ≤ 0.1 µm.  This junction has been proposed to 
function as an intracellular synapse or “trigger zone” for Ca2+ signalling by NAADP 
(Fig. 1.4) (Kinnear et al., 2004).   
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Fig. 1.4.  Schematic representation of the trigger zone for Ca2+ release by NAADP in pulmonary 
arterial smooth muscle cells  
The trigger zone consists of lysosomes closely opposed to ryanodine receptors (RyR) on the 
sarcoplasmic reticulum (SR).  The lysosomes are thought to sequester Ca2+ via the action of the 
vacuolar proton pump (V-H+-ATPase) coupled to a Ca2+/H+ exchanger.  NAADP acts on putative 
NAADP receptors causing Ca2+ release into the trigger zone.  If the Ca2+ released breaches a given 
threshold concentration the burst may be amplified into a global Ca2+ wave by Ca2+-induced Ca2+ 
release (CICR) via proximal RyRs on the SR. 
 
1.5.7  The NAADP receptor 
 
Despite the wealth of data suggesting that NAADP not only elicits Ca2+ from a 
store separate to that of the S / ER, but also acts on its own pharmacologically distinct 
receptor, the molecular identity of such a receptor has remained elusive.  
Nevertheless, high affinity binding sites (Kd ~200 pM) have been identified in both 
sea urchin eggs and the mammalian brain (Billington et al., 2000; Patel et al., 2000a; 
Patel et al., 2000b).  NAADP binding to sea urchin egg homogenate is irreversible at 
physiological concentrations of K+ which can be exploited as a tool by which 
NAADP receptors can be ‘tagged’ (Dickinson et al., 2003).  Protein purification 
studies of NAADP binding sites suggest that the NAADP receptor may be an 
oligomeric structure of approximately 450 kDa derived from subunits of 
approximately 150 kDa which is markedly different from that determined by the same 
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method (gel filtration) for both IP3 and RyRs (~1000 kDa and ~2000 kDa 
respectively) and therefore adds further weight to the proposal that the target of 
NAADP is a discrete receptor  (Berridge et al., 2002).   
However, until the NAADP receptor is identified further studies on NAADP-
mediated Ca2+ release will remain limited.  Therefore, this remains one of the key 
experimental objectives in the field of Ca2+ signalling. 
 
 
1.6  Aims of this thesis 
 
1. To determine whether ryanodine receptor subtype 1, 2 or 3, each of which is 
expressed in pulmonary arterial smooth muscle cells, is targeted to lysosome-
sarcoplasmic reticulum junctions to comprise the trigger zone for the 
amplification of NAADP-induced Ca2+ bursts into global Ca2+ waves.  
 
2. To determine whether or not a novel family of two-pore channels (TPCs) 
represent NAADP-gated endolysosomal calcium release channels.  
 
3. To determine whether or not two-pore channels underpin NAADP-dependent 
calcium signals in pulmonary arterial smooth muscle cells. 
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Chapter 2:  Materials and Methods 
 
 
2.1  Dissection and cell isolation  
 
2.1.1  Identification and dissection of 2nd order pulmonary arteries 
 
Adult male Wistar rats (150-300 g) were humanely sacrificed by the Schedule 1 
method of cervical dislocation (according to section 6.3 of the Home Office Code of 
Practice for the Humane Killing of Animals under Schedule 1 of the Animals 
(Scientific Procedures) Act 1986).  The heart and lungs were removed en bloc and 
placed into HEPES buffered salt solution (HBSS) of the following composition 
(mM): 130 NaCl, 5.2 KCl, 1 MgCl2, 1.7 CaCl2, 10 glucose, 10 HEPES, pH 7.4, and 
kept on ice.  Subsequent dissection was carried out under a dissection microscope 
(PZM, World Precision Instruments, USA) during which the tissue was bathed in cold 
(4 °C) HBSS.  Each lobe was pinned out on a Sylgard-based dissection dish with the 
parietal surface facing upwards.  At the point where the bronchus entered the lobe, the 
airway was cut open lengthways from the initial incision down the length of the lobe.  
Once the intrapulmonary artery was identified the airway tissue above, and the 
connective tissue either side of the artery was carefully removed in order to expose 
the artery ready for dissection.  Handling the artery via a small piece of connective 
tissue that was left attached to the proximal end, the artery was then removed by 
cutting the connective tissue. 
 
2.1.2  Isolation of pulmonary arterial smooth muscle cells 
 
Each artery was cut open lengthways before being placed into low Ca2+ 
dissociation solution (DS) of the following composition (mM): 124 NaCl, 5 KCl, 1 
MgCl2, 0.5 NaH2PO4, 0.5 KH2PO4, 15 NaHCO3, 0.16 CaCl2, 0.5 EDTA, 10 glucose, 
10 Taurine, 10 HEPES, pH 7.4, and maintained at 4°C.  After 10 minutes arteries 
were transferred to fresh DS containing 0.5 mg/ml papain and 1 mg/ml bovine serum 
albumin and stored overnight at 4 °C.  Papain is a cysteine protease consisting of a 
single polypeptide chain and has a broad substrate specificity.  Contained within the 
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polypeptide chain are 3 residues (Cys-25, His-159 and Asn-175) that form a 
characteristic catalytic triad (Polgar et al., 1982; Wiederanders, 2003) and it is the 
sulfhydryl group on the cysteine residue which is responsible for the nucleophylic 
attack involved in the protease activity. 
The following day, 0.2 mM 1,4-Dithio-DL-thretiol (DTT) was added to the 
preparation in order to activate the papain, which was incubated for 1 hour at room 
temperature (22°C).  DTT is a reducing agent that activates papain by maintaining the 
sulfhydryl groups present on the protease in a reduced state, thus exposing the 
catalytic triad to the peptide substrate.  Following incubation with papain and DTT 
the arteries were washed 5 times in 1 ml of fresh, papain-free DS (4°C) and placed in 
2 ml of fresh DS.  The arteries were gently triturated using a fire-polished Pasteur 
pipette in order to break up tissue fragments and isolate single pulmonary arterial 
smooth muscle cells (PASMCs).  The cell suspension was then kept at 4°C until 
required. 
 
 
2.2  Cell culture 
 
Human Embryonic Kidney 293 (HEK293) cells have long been used as an ideal 
system in which to observe the function of both stably and transiently transfected 
recombinant proteins.  They are an ideal expression system due to the relative ease 
with which investigators are able to manipulate the expression of particular proteins 
by the incorporation of plasmid vectors (Thomas et al., 2005).  Of particular 
relevance to the experiments described in this thesis, is the reported absence of 
ryanodine receptor (RyR) expression in HEK293 cells (Aoyama et al., 2004).  This 
makes the HEK293 expression system particularly useful for studying candidate 
NAADP receptors, as one controversial proposal is that NAADP binds directly to and 
thereby activate RyRs (Dammermann et al., 2005; Langhorst et al., 2004). 
I sought to use HEK293 cells to determine whether or not a novel family of 
two-pore ion channels functioned as NAADP receptors and Ca2+ release channels.  To 
achieve this goal HEK293 cell lines were developed by my collaborator (Dr Mike 
Zhu, Ohio State University), which stably over-express human two-pore channel 
subtype 2 (hTPC2) with either a hemagglutinin (HA-) or an mCherry tag, and human 
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two-pore channel subtype 1 (hTPC1) with a poly-histidine tag (His6-) or a green 
fluorescent protein (GFP-) tag, and chicken two-pore channel subtype 3 (cTPC3) with 
a GFP-tag.  All cell culture was performed within a class II biological safety cabinet 
(Microflow, Biquell UK Ltd., UK) in order to uphold aseptic conditions. 
 
2.2.1  Maintenance of HEK293 cells  
 
A cryotube of HEK293 cells (either wild-type or stably over-expressing HA-
hTPC2, mCherry-hTPC2, His6-hTPC1, GFP-cTPC3 or GFP-hTPC1) containing 
approximately 1 x 106 cells was retrieved from a liquid nitrogen storage facility and 
rapidly thawed for approximately 2 minutes by partial submersion in a water bath set 
at 37 °C.  Once thawed, the cell suspension was gently mixed with a pipette tip and 
then aliquoted into 3 T25cm2 vent-capped tissue culture flasks.  5 ml of fresh tissue 
culture media (37°C) was then added to each flask.  The growth media used for all 
cell types was Dulbecco’s modified eagle medium (D-MEM; composition (mM): 0.4 
glycine, 0.4 L-arginine hydrochloride, 0.2 L-Cystine 2HCl, 4 L-Glutamine, 0.2 L-
histidine hydrochloride, 0.8 L-isoleucine, 0.8 L-leucine, 0.8 L-lysine hydrochloride, 
0.2 L-methionine, 0.4 L-phenylalanine, 0.4 L-serine, 0.8 L-threonine, 0.08 L-
tryptophan, 0.4 L-tyrosine, 0.8 L-valine, 0.029 choline chloride, 0.008 D-calcium 
pantothenate, 0.009 folic acid, 0.033 niacinamide, 0.02 pyridoxine hydrochloride, 
0.001 riboflavin, 0.12 thiamine hydrochloride, 0.04 i-inositol, 1.8 calcium chloride, 
0.00025 ferric nitrate, 0.81 magnesium sulphate, 5.33 potassium chloride, 44.0 
sodium bicarbonate, 110.3 sodium chloride, 25 D-glucose, 0.04 Phenol Red) 
supplemented with 10% FBS, 50 units/ml penicillin, 50 µg/ml streptomycin.  For 
cells stably over-expressing HA-hTPC2, GFP-hTPC1 or GFP-cTPC3 the growth 
media was additionally supplemented with 400 µg/ml geneticin G418 sulphate 
(G418).  For cells stably over-expressing mCherry-hTPC2, or His6-hTPC1 the growth 
media was additionally supplemented with 50 µg/ml Zeocin or 100 µg/ml 
Hygromycin B respectively.  
G418 is a member of the aminoglycoside family of antibiotics and was first 
reported by Wagman and colleagues in 1974 (Wagman et al., 1974).  This antibiotic 
inhibits protein synthesis and subsequently causes growth inhibition in both 
eukaryotic and prokaryotic cells (Eustice et al., 1984).  Inhibition of protein synthesis 
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is achieved by G418 binding with, and therefore interfering with the usual ribosomal 
function.  Zeocin is a glycopeptide antibiotic produced by Streptomyces verticillus.  
Upon entering the cell the Cu2+ collated to Zeocin is removed resulting in the 
activation of the antibiotic.  Once activated, Zeocin then binds to and cleaves DNA 
leading to cell death (Hwang et al., 2005).  Hygromycin B is also a member of the 
aminoglycoside antibiotic family and therefore interferes with RNA recognition and 
subsequent protein translation (Rao et al., 1983).  Thus, when cells are transfected 
with plasmids containing the appropriate resistance gene in addition to the gene 
encoding the target protein, inclusion of these selection pressures in the growth media 
can be used to successfully select for cells expressing the desired protein. 
The flasks containing the newly thawed cell suspension was gently swirled and 
then placed overnight in a humidified incubator (LEEC Ltd., UK) maintained at 37°C 
and gassed with 95% air, 5% CO2.  The following day the growth media from each 
flask was removed and 5 ml of fresh growth media (37°C) was added to each flask.  
The flasks were then returned to the incubator and the cell-line maintained by regular 
passaging. 
All cell lines were maintained by passaging every 3-4 days at which point the 
cells had reached 70-90% confluency.  The growth medium was removed and 1ml of 
Trypsin-EDTA solution was added to the flask and incubated for 3 minutes, so that 
the cells were no longer adherent to the base of the flask.  The Trypsin-EDTA 
solution was then diluted to 10 ml with fresh growth medium and transferred to a 15 
ml centrifuge tube.  The tube was centrifuged for 3 minutes at 1000 x r.p.m. .  The 
supernatant was removed and the pellet resuspended in 2 ml of fresh media.  A 20 µl 
aliquot of this suspension was then used to perform a cell count.  The cell suspension 
was thoroughly mixed with 1% trypan blue at a ratio of 1:1.  20µl of this mixture was 
then added via capillary action to a Hawksley haemocytometer (Hawksley, UK) with 
its appropriate cover slip attached.  The number of viable cells occupying 0.0001 ml 
was then counted and the approximate number of cells/ml was calculated.  The 
suspension was then diluted with fresh growth media such that the new flask 
contained 6 ml of a 1.5 - 3 x 105 cells/ml suspension.  The flasks were then placed in 
the humidified incubator (37 °C, 95% air, 5% CO2). 
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2.2.2  Preparation of HEK293 cells for Ca2+ imaging and visualisation of 
intracellular proteins using fluorescent labelling 
 
Sterile 35 mm glass-bottomed tissue culture dishes (FluoroDish; World 
Precision Instruments, FL, USA) were prepared beforehand by coating the glass base 
of each dish with 1 ml of sterile 100 µg/ml poly-D-lysine hydrobromide (PDL) for 5 
minutes.  PDL coats the glass surface with an extracellular matrix that provides a net 
positive charge and therefore promotes cell attachment.  For the preparation of cells 
for immunocytochemical labelling, glass coverslips were first sterilised by 
submersion in 100% ethanol for 15 minutes at room temperature.  The coverslips 
were then placed in 30 mm sterile tissue culture dishes and PDL was added for 5 
minutes.  Following incubation with PDL, the excess PDL was removed and the 
FluoroDishes / coverslips washed with 2 ml sterile, double distilled water (dd.H2O).  
The excess liquid was removed and the FluoroDishes / coverslips were allowed to dry 
within the safety cabinet until required.   
A flask of HEK293, HA- / mCherry-hTPC2, GFP/ His6-hTPC1 or GFP-cTPC3 
cells was taken and treated with trypsin-EDTA and centrifuged as described above.  
Upon resuspension the cells were diluted to a seeding density of approximately 0.5 - 
1.0 x 105 cells per ml.  2 ml of this suspension was added to either a coverslip within a 
30 mm petri dish, or directly to a FluoroDish.  Dishes were then incubated overnight 
at 37 °C, 5% CO2. 
 
2.2.3  Long-term storage of cells 
 
In order to use cells of the same cell line in future experiments without using an 
excessive number of passages, cells were frozen and kept in a liquid nitrogen storage 
facility.  To freeze down cells, a number of flasks were allowed to reach full 
confluency.  Upon reaching this level, the cells were treated with trypsin-EDTA and 
centrifuged as described above.  The supernatant was removed and the pellet re-
suspended in freezing media (D-MEM, 10% FBS, 10% dimethyl sulphoxide 
(DMSO)).  The suspension was then aliquoted by 1 ml volumes into cryotubes (Nunc, 
Fisher Scientific, UK) at a density of approximately 1 x 106 cells/ml.  The tubes were 
transferred to an insulated container and cooled to -80 °C at an approximate rate of 
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1°C/min.  After 24 hours the cryotubes were transferred to a liquid nitrogen store until 
required. 
 
 
2.3  Immunocytochemistry 
 
2.3.1  Fixation and labelling of isolated pulmonary arterial smooth muscle cells and 
HEK293 cells 
 
PASMCs were isolated as described above.  Glass coverslips were coated with 
PDL prior to fixation.  200 µl of the PASMC suspension was placed onto each 
coverslip and the cells were allowed to adhere for 1 hour at room temperature.  Once 
the cells had been allowed to adhere, the coverslips were placed in cold (-20°C) 
methanol for 15 minutes.  Methanol fixation dehydrates the cell and precipitates the 
proteins which are anchored to the cytoskeleton or membranes.  This method quickly 
fixes cells but its main disadvantages are that it can lose soluble non-anchored 
proteins and that proteins can be denatured by the methanol.  After fixation the 
coverslips were removed from the methanol and placed on individual stands in 
preparation for permeabilisation and labelling. 
Transfected and non-transfected HEK293 cells were prepared for fluorescent 
labelling of intracellular proteins as described above.  The growth medium was 
removed and the cells were washed twice with fresh PBS.  4 % paraformaldehyde in 
PBS (pH 7.4) was added and the cells incubated at 37 °C for 20 minutes.  
Paraformaldehyde fixes the cells by forming crosslinks between proteins.  These 
crosslinks are methylene bridges formed between nitrogen containing side chains of 
basic amino acids.  The main disadvantage with using paraformaldehyde is that it may 
autofluoresce, however this can be corrected for by appropriate background correction 
/ subtraction.  Following fixation, the fixing media was removed and the cells were 
again washed twice with PBS.  The coverslips were removed from the dishes and 
placed on individual stands in preparation for permeabilisation and labelling. 
In order to allow the antibodies access into the cells, the cells were 
permeabilised with 0.3% Triton X-100 (polyethyrene glycol mono-p-iso-octylphenyl 
ether) in PBS for 3 x 5 minutes at room temperature.  Triton X-100 is a non-ionic 
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detergent which can solvate cellular membranes, forming small pores.  After 
permeabilization, the cells were washed for 3 x 5 minutes with blocking solution (1% 
bovine serum albumin (BSA), 4% goat serum in PBS) at room temperature.  Blocking 
buffer was used to minimize any non-specific binding which may occur between the 
antibodies and structures of no specific interest.  Blocking is achieved by using a 
protein solution (serum) which competes for and binds to non-specific binding sites.  
Normally the serum used is from the species in which the secondary antibody was 
raised. 
The cells were then incubated with the desired primary antibodies (Table 2.1) 
diluted to the appropriate concentration in blocking solution, overnight at 4°C.  The 
following day, the primary antibody solution was removed, and the coverslips were 
washed for 3 x 5 minutes with fresh blocking solution at room temperature.  After 
washing, the cells were then incubated with the desired fluorophore-conjugated 
secondary antibody (Table 2.1) diluted to the appropriate concentration with blocking 
solution for 2 hours in the dark at room temperature.  The binding of the primary 
antibody and subsequent location of the protein of interest can be visualised using a 
fluorescent molecule.  This fluorophore is conjugated to a secondary antibody which 
is raised to specifically bind to antibodies of the primary antibody host species.  Cells 
were then washed with fresh PBS for 5 x 5 minutes in the dark at room temperature.  
The excess PBS was removed and the coverslips were mounted on microscope slides 
using either Gel/Mount (BioMedia) or a Mowiol (Calbiochem, Merck Chemicals Ltd., 
UK) based mountant of the following composition: 0.1 g/ml Mowiol, 0.25 g/ml 
glycerol, 0.2 M Tris, pH 8.5 containing 4’6-diamidino-2-phenylindole (DAPI; 
excitation 360 nm, emission 457 nm).  DAPI is a fluorescent, membrane-permeable 
nuclear dye that predominantly binds to AT nucleotide sequences in the minor groove 
of DNA.  Upon binding the minor groove, DAPI exhibits a large increase in 
fluorescent yield (Reddy et al., 1999) and therefore it is very useful in visualising the 
nuclei of fixed cells.  15 µl of the mountant was placed on a microscope slide and the 
coverslip was carefully lowered on top, ensuring that no air bubbles were trapped.  
The mounted slides were allowed to set for 2-4 hours in the dark at room temperature 
and stored in the dark at 4 °C until required.  Slides were viewed using the Applied 
Precision Deltavision imaging system or Leica TCS laser scanning confocal system. 
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Primary Antibody 
(dilution) 
 
Secondary Antibody 
(dilution) 
Conjugated 
fluorescent 
probe 
Excitation and emission 
Rabbit anti-RyR1 
(1:500) 
 
Goat anti-rabbit 
(1:200) 
Texas Red Ex. 555 nm 
Em. 617 nm 
Rabbit anti-RyR2 
(1:500) 
 
Goat anti-rabbit 
(1:200) 
Texas Red Ex. 555 nm 
Em. 617 nm 
Rabbit anti-RyR3 
(1:500) 
 
Goat anti-rabbit  
(1:200) 
Texas Red Ex. 555 nm 
Em. 617 nm 
Mouse anti-αIgp120 
(1:200) 
 
Goat anti-mouse 
(1:200) 
FITC Ex. 490 nm 
Em. 528 nm 
Rat Anti-HA 
(1:500) 
 
Goat anti-rat IgG 
(1:200) 
FITC Ex. 490 nm 
Em. 528 nm 
Mouse Anti-LAMP-2 
(1:500) 
 
Goat anti-mouse 
(1:250) 
Texas Red/ 
Alexa-594 
Ex. 555 nm/Em 617 nm 
Ex. 590 nm/Em 618 nm 
Mouse anti-GM130 
(1:250) 
 
Rabbit anti-mouse 
(1:500) 
Alexa-594 Ex. 590 nm 
Em. 618 nm 
Mouse anti-cytochrome C 
(1:500) 
 
Rabbit anti-mouse 
(1:500) 
Alexa-594 Ex. 590 nm 
Em. 618 nm 
Mouse anti-EEA1 
(1:250) 
 
Rabbit anti-mouse 
(1:500) 
Alexa-594 Ex. 590 nm 
Em. 618 nm 
Mouse anti-M6PR 
(1:500) 
 
Rabbit anti-mouse 
(1:500) 
Alexa-594 Ex. 590 nm 
Em. 618 nm 
Mouse Anti-transferrin 
(1:500) 
 
Rabbit anti-mouse 
(1:500) 
Alexa-594 Ex. 590 nm 
Em. 618 nm 
Mouse anti-PDI 
(1:200) 
 
Rabbit anti-mouse 
(1:500) 
 
Alexa-594 Ex. 590 nm 
Em. 618 nm 
 
Table 2.1.  Host species, conjugated fluorescent probes and dilution factor of the antibodies for 
immunocytochemical investigations 
For source of antibodies see section 2.8. 
 
 
2.3.2  Preparation of control slides for immunocytochemical investigations 
 
In order for the images obtained from the fluorescently labelled intracellular 
proteins to be a true representation of specific binding, the background fluorescence 
must be corrected for.  This can be done with the aid of control slides.  These control 
slides are prepared in an identical way as the test slides, with the only exception being 
that the control slides are incubated overnight with blocking solution instead of with a 
primary antibody solution. 
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2.3.3  Labelling of lysosomes within isolated pulmonary arterial smooth muscle 
cells and HEK293 cells stably expressing HA-hTPC2 / mCherry-hTPC2 
 
PASMCs were prepared by adding 0.5 ml of PASMC suspension to a PDL 
coated FluoroDish and the cells were allowed to adhere for 15 minutes at room 
temperature.  The dish was then made up to 2 ml with fresh HBSS and washed with a 
further 5 x 1 ml of fresh HBSS.  For HA-hTPC2 cells, the growth medium within 
FluoroDishes containing HA-hTPC2 cells was removed and the cells washed with 5 x 
1 ml fresh HBSS.  Dishes were incubated with 200 nM LysoTracker Red (excitation 
577 nm, emission 590 nm) for 40 minutes in the dark at room temperature.  In some 
experiments involving the visualisation of lysosomes, Ned-19 was also visualised.  
Ned-19 is a newly characterised antagonist of NAADP-mediated Ca2+ signalling 
which has also been shown to fluorescently label NAADP receptors (Naylor et al., 
2009).  For experiments involving visualisation of Ned-19 (excitation 360 nm, 
emission 458 nm) labelling, 100 µM Ned-19 was added for the last 20 minutes of the 
incubation period for LysoTracker Red.  The cells were then washed with 10 x 1 ml 
of HBSS and imaged using the Deltavision imaging system. 
Control images for correcting the threshold for red fluorescence (590 nm) were 
obtained by using cells incubated with only Ned-19.  The threshold was then set such 
that no red fluorescence was observed.  Similarly, the threshold for blue fluorescence 
(458 nm) was obtained using cells incubated with only LysoTracker Red, and the 
threshold was set such that no blue fluorescence was observed.  Setting these 
threshold levels eliminates any background fluorescence within the cell and imaging 
system and therefore ensures that any red or blue fluorescence measured was only due 
to the presence of LysoTracker Red and Ned-19, respectively.  When using 
fluorescent compounds such as Ned-19 that do not irreversibly bind to cellular 
components or accumulate within organelles one would expect the fluorescent 
labelling to be present throughout the cell.  Thus, the thresholds for fluorescent 
labelling were raised above that of the background threshold level in order to visualise 
the areas in which Ned-19 labelling was concentrated. 
For mCherry-hTPC2 cells, imaging was carried out in an identical manner to 
that used for HA-hTPC2 cells with the exception that LysoTracker Green (excitation 
504 nm, emission 511 nm) was used in place of LysoTracker Red.  As mCherry-
hTPC2 cells inherently exhibit red fluorescence, control images for the correction of 
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thresholds of red fluorescence (590 nm) were obtained using HA-hTPC2 cells 
prepared in parallel, and incubated with LysoTracker Green only.  To obtain green 
(511 nm) background fluorescence levels mCherry-hTPC2 cells were incubated with 
LysoTracker-free HBSS.  
 
 
2.4  Deconvolution microscopy 
 
2.4.1  Visualisation of fluorescently labelled intracellular proteins in isolated 
pulmonary arterial smooth muscle cells and HEK293 cells 
 
Fluorescently labelled isolated PASMCs and HEK293 cells were visualised 
using the Applied Precision Deltavision imaging system (Applied Precision Inc., WA, 
USA).  The Deltavision microscope system uses Beamsplitter filters to control the 
wavelength of light (emitted from a 100 W mercury arc lamp) used to excite the cells.  
The cells were viewed using an inverted microscope (Olympus IX70) equipped with a 
60X 1.4-numerical aperture oil immersion objective lens (Olympus).  Images were 
obtained using a Photometric CH300 CCD camera.  Images were collected as a series 
of Z sections (focal depth 0.28 µm, Z step 0.2 µm) taken through the cell at intervals 
0.2 µm.  This results in a stack of 2D images representing the fluorescent staining 
throughout the cell.  Each image contains out of focus light which must be removed 
or resolved.  The out of focus light is removed via a process called deconvolution.  
The Deltavision system uses constrained-iterative deconvolution which reassigns out 
of focus light to its original source.  This method uses a series of complex algorithms 
which first take the raw image, and then convolve this image using the point spread 
function (PSF) creating a ‘blurred estimate’.  The PSF is a measure of how a single 
point source would appear if imaged by the apparatus.  As light passes through the 
lens its path will be altered in three dimensions.  The blurred estimate is then 
compared to the original raw image and the error is calculated which indicates the 
similarity between the blurred estimate and the raw image.  This error calculation is 
then used to make a new iteration which is also compared to the original file to create 
another error calculation.  This process is repeated until the error criterion is 
minimized leaving the final restored image.  Following deconvolution, 3D 
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reconstruction and analysis was performed using Softworx (Applied Precision Inc.) 
and Volocity (PerkinElmer, Waltham, MA, USA) software. 
 
2.4.2  Analysis of fluorescent labelling of intracellular proteins within isolated 
pulmonary arterial smooth muscle cells and HEK293 cells 
 
Volumetric analysis of the fluorescent labelling of the cells was performed 
using Volocity software (Improvision, UK).  In order to analyse the volume of 
fluorescent labelling within individual cells the resolution limit of the DeltaVision 
imaging system must first be considered.  The imaging system can accurately resolve 
sources of light / labelling smaller than 0.2 µm in X-, Y- and Z-planes under optimal 
conditions.  However, in order to introduce a margin of safety to the analysis a more 
conservative estimate was used.  The resolution limit was set such that 0.5 µm was 
considered to be the smallest resolvable distance, and therefore volumes of labelling 
less than 0.125 µm3 were excluded from the analysis. 
 
 
2.5  Ca2+ imaging within isolated pulmonary artery smooth muscle 
cells and HEK293 cells 
 
2.5.1  Fluorescence as a biological tool 
 
In the experiments covered within this thesis both the Ca2+ imaging and the 
fluorescent labelling and visualisation of intracellular proteins utilises fluorescent 
dyes and sequence-specific antibodies conjugated to fluorescent probes.  Fluorescence 
describes the process whereby a photon of light is emitted from a fluorophore 
(fluorescent molecule) as it returns from a higher energy level.  Particular 
wavelengths of light can be absorbed by a fluorophore providing it with energy.  If 
this energy is sufficient then an electron within the molecule will achieve a higher 
energy state; a process known as excitation.  This excited state is relatively unstable 
and cannot be maintained for long.  While the electron is in an excited state, it will 
‘drop’ to an intermediate energy level due to the loss of some energy in a process 
known as internal conversion.  After a short period of time the electron will return to 
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its ground (low energy) state.  In doing so, the excess energy is released in the form of 
light.  As the excited electron had dropped to an intermediate excited state prior to 
returning to its ground state, the emitted light will be lower in energy than the 
excitation wavelength.  This cycle can be repeated multiple times allowing detection 
and visualisation of the fluorophore.  These fluorophores can be used to visualise the 
localisation of proteins within a cell by attaching them to probes such as secondary 
antibodies. 
Fluorophores can also be attached to ion chelating molecules to act as reporter 
dyes that can be used to visualise changes in ion concentrations over a period of time.  
Fura-2 is an example of an ion specific fluorescent indicator dye.  These indicator 
dyes are fluorescent molecules which are attached to a structure capable of binding 
ions.  For this reason, fluorescent Ca2+ indicator dyes are often derivatives of Ca2+ 
chelators such as EGTA or BAPTA (Takahashi et al., 1999; Tsien, 1980).  
Fluorescent Ca2+ indicator dyes are divided into two groups based upon their mode of 
operation: single-wavelength intensity wavelength dyes and dual-wavelength 
ratiometric dyes (referred to as single wavelength and ratiometric indicators 
respectively).  For single wavelength Ca2+ indicators, changes in the intracellular Ca2+ 
concentration results in a change in the intensity of the fluorescence excitation and 
emission spectra.  For example, upon binding Ca2+, fluo-3 may undergo up to a 200-
fold increase in fluorescence emission (525 nm) following excitation at 506 nm 
(Takahashi et al., 1999).  Thus, an increase in Ca2+ is reported as an increase in the 
fluorescence detected when using a single excitation wavelength of light.  However, 
there are a number of limitations associated with single wavelength indicators as the 
intensity of the fluorescence emission is dependent upon a number of potential 
variables.  Firstly, the concentration of the indicator within the cell of interest will 
greatly affect the intensity of the signal.  For example, if 2 cells of equal intracellular 
Ca2+ concentration contained different concentrations of accumulated indicator dye, a 
difference in Ca2+ concentration between the 2 cells would be reported due to the 
difference in emission intensity.  Also, if the cell under investigation changes shape / 
size during the experiment due to contraction / relaxation, then the relative 
concentration of the indicator could change and more importantly, the distance of the 
emitted light will change thus affecting the intensity of the signal.  Nonratiometric 
indicators can also be particularly susceptible to photobleaching affecting the 
perceived change in ion concentration.  Photobleaching describes the permanent loss 
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of a molecules ability to fluoresce, due to covalent modification which may occur 
after repeated excitation.  This results in a reduced intensity of fluorescent emission 
with time.  Therefore, if a single wavelength dye undergoes photobleaching then the 
resultant decrease in emission intensity will be perceived as a decrease in the Ca2+ 
bound form of the indicator dye. 
In contrast to single wavelength indicators, the Ca2+-free and Ca2+ bound forms 
of ratiometric indicator dyes have either a common excitation wavelength (Indo-1) or 
dual excitation wavelengths (Fura-2), coupled to dual emission wavelengths (Indo-1) 
or a common emission wavelength (Fura-2).  Importantly, these ratiometric dyes 
show differential changes in fluorescence emission due to the dual excitation/dual 
emission which allows for the ratiometric analysis of the output.  In the example of 
Fura-2, increasing Ca2+ concentration results in increased emission when excited at 
340 nm and a decrease in emission when excited at 380 nm.  The resulting ratio of 
fluorescence at these 2 excitation wavelengths (F340/F380) varies as a function of Ca2+ 
concentration.  Ratiometric dyes can minimise the limitations associated with single 
wavelength indicators, as factors unrelated to changes in Ca2+ concentration that alter 
the fluorescence intensity (e.g. alterations in cell shape/size) will equally affect the 
intensity of the fluorescence emitted at each excitation wavelength used, and therefore 
the ratio will not be altered. 
For the Ca2+ imaging experiments described within this thesis, the ratiometric 
Ca2+ indicator dye Fura-2 was used to report changes in the intracellular Ca2+ 
concentration.  This indicator was first described in 1985 (Grynkiewicz et al., 1985) 
and, upon binding Ca2+, exhibits significant shifts in the excitation spectra but little 
shift in the emission spectra (Fig. 2.3).  The structure of Fura-2 is derived from EGTA 
(ethylene glycol-bis(2-aminoethylether)-tetraacetic acid) and therefore has a 
tetracarboxylic structure and is able to bind Ca2+ via interaction with 4 carboxyl 
groups.  The aromatic amino groups present on the molecule confer the fluorescent 
properties of this EGTA analogue.  Indeed, binding Ca2+ alters the electronic 
properties of the fluorophore thus altering the absorption spectrum.  Upon binding 
Ca2+ to these binding sites the Fura-2 molecule exhibits an absorption shift from 380 
nm towards 340 nm wavelengths of light.  By monitoring the relative intensity of 
emission at 510 nm using separate excitation wavelengths of 340 nm and 380 nm and 
taking a ratio of the two values (340 nm/380 nm) one can determine the relative 
amount of Ca2+-bound Fura-2 versus non-Ca2+-bound Fura-2.  Thus by monitoring 
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changes in this ratio, changes in the cytoplasmic concentration of Ca2+ can be 
detected and measured. 
 
 
 
Fig. 2.3.  Representative excitation and emission spectra of Fura-2   
Fura-2 exhibits different spectra depending on whether it is present in its Ca2+-free form (black line) or 
Ca2+-bound form (green line).  The emission spectra (solid line) remain the same whereas the 
excitation spectra (dashed line) of Fura-2 exhibit a leftward shift upon binding Ca2+. 
 
As previously mentioned, Fura-2 contains multiple carboxyl groups and is thus 
strongly negatively charged.  As a result the Fura-2 molecule is unable to cross the 
lipid bilayer of the cell membrane without assistance.  Therefore, in order to ‘load’ 
multiple cells with Fura-2 within the experimental chamber and without disrupting the 
cell membrane, Fura-2 is commonly combined with an acetoxymethyl (AM) ester to 
create Fura-2-AM.  The AM ester masks the negative charge of Fura-2 and therefore 
the molecule can diffuse across the membrane bilayer.  The Fura-2-AM ester is non-
fluorescent, however once within the cell the AM ester is cleaved by esterases leaving 
the fluorescent form, Fura-2 within the cytoplasm. 
 
2.5.2  Loading of HEK293 cells and isolated pulmonary arterial smooth muscle 
cells with the Ca2+ indicator dye Fura-2 
 
For cultured cells, the growth medium of FluoroDish containing HEK293, HA-
hTPC2, His6-hTPC1 cells or HA-hTPC2 cells transfected with shRNA, was removed 
and the cells washed with 10 x 1 ml of fresh HBSS.  1 ml of fresh HBSS containing 5 
µM Fura-2-AM was added and the dish was incubated for 30 minutes in the dark at 
room temperature.  For PASMCs, 0.5 ml of the PASMC suspension was incubated 
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with 5 µM Fura-2-AM for 15 minutes in the dark at room temperature (22 °C).  After 
this initial incubation with Fura-2-AM, the cell suspension was transferred to an 
experimental chamber, the bottom of which consists of a glass coverslip.  The cells 
were incubated for a further 20 minutes in the dark at room temperature in order to 
allow time for the cells to adhere to the coverslip. 
Following incubation with Fura-2-AM the FluoroDish/experimental chamber 
was washed with 10 x 1 ml of fresh HBSS, and incubated for a further 20 minutes in 
the dark at room temperature.  The cells were washed with a further 5 x 1 ml of fresh 
HBSS before the FluoroDish/experimental chamber was mounted on the inverted 
microscope. 
 
 
2.5.3  Imaging of changes in Ca2+ within HEK293 cells and isolated pulmonary 
arterial smooth muscle cells 
 
The generation of specific excitation wavelengths of light was achieved using a 
TILL Photonics Polychrome II monochromator (TILL Photonics, Germany).  The 
monochromator uses a Xenon lamp to produce white light which passes through a slit 
at the entrance of the monochromator.  The light then reflects off of the first mirror 
which columnates the light, towards the diffraction grating.  The diffraction grating 
has a highly reflective surface within which are finely etched grooves with specific 
spacing.  When the light hits this surface the specific angles of reflection created by 
the grooves cause the reflected light to exhibit combinations of constructive and 
deconstructive patterns of interference, such that each wavelength of light is reflected 
at a slightly different angle.  The original white light is now separated into discrete 
colour bands of light depending on wavelength.  The light then hits the second mirror 
which reflects the light towards the exit slit.  As the light has undergone dispersion 
the separate wavelengths of light diverge from the diffraction grating and continue to 
diverge from the second mirror.  This results in only a single wavelength of light 
which is able to pass through the exit slit.  The angle of the diffraction grating can be 
accurately adjusted in order to allow different wavelengths of light to exit via the exit 
slit.  On the external side of the slit there is an optical fibre that the light can travel 
down to the microscope with minimal loss of intensity.  At this point the light enters 
the fluorescence filter block whereby the light undergoes further selection of 
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particular wavelengths.  Upon entering the filter block the excitation light passes 
through an emission filter.  This filter only permits the passage of light that exhibit 
wavelengths within a specific range/band that encompasses the desired excitation 
wavelength.  Wavelengths outwith this bandwidth are either reflected or absorbed.  
The light at the selected excitation wavelength is then reflected onto the experimental 
chamber by a dichroic mirror.  Dichroic mirrors are able to reflect wavelengths of 
light that are below a predetermined wavelength such as the excitation wavelength, 
whereas light of wavelengths above this threshold such as the emission wavelength 
are able to pass through.  The excitation light is below this threshold and therefore 
reflected onto the cells.  The resultant emitted light is at a higher wavelength and is 
able to pass through the dichroic mirror.  The emitted light continues through the 
emission filter that absorbs or reflects light outwith a narrow bandwidth (which 
encompasses the emission maxima), and into the detection device. 
Once the desired excitation wavelengths of light have excited the Fura-2, the 
resultant emitted light is detected using a Hammamatsu 4480 image intensifying 
charge-coupled device (CCD) camera.  CCD cameras allow the conversion of an 
analogue signal (e.g. a number of photons of light) into a digital signal which can then 
be analysed.  It uses a photoactive region made of a layer of photodiodes on a silicon 
base which can be considered as an array of capacitors.  When light hits and is 
absorbed by the photoactive layer it causes it to temporarily store this charge.  The 
greater the number of photons that hit a given area the more electrical charge is stored 
by the capacitor.  The capacitors then discharge their stored charge into a charge 
amplifier which converts the charge pulse to a voltage.  The greater voltages 
correspond to the greater intensity of light which is converted into a number.  The 
array is then considered as a whole by the software which allows the construction of 
an image with the pixels representing the corresponding area of the photoactive layer 
within the CCD camera.  The computer software will then convert these varying 
voltages into a set of levels.  For example, the intensity / voltage represented by each 
pixel is assigned a grey value based on 256 levels of grey (white through to black).  
Thus the CCD camera can give an accurate spatial depiction of the light intensity 
within a single image.  The CCD camera was attached to an inverted microscope 
(Leica, DMIRBE).  The microscope was equipped with a 40x, 1.3-numerical aperture 
oil immersion lens (Zeiss).  The CCD camera was also coupled to an Apple 
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Macintosh G4 personal computer running Openlab software which was used to record 
and analyse the fluorescence intensity throughout each experiment. 
In order to ensure that changes in the fluorescence ratio were not affected by 
autofluorescence within the experimental apparatus or HBSS, background subtraction 
was required.  This was achieved by moving the lens away from the experimental 
chamber / dish so that the focal plane of the lens was positioned such that the cells 
were not in focus.  Images were then captured of any emitted fluorescence (510 nm) 
when the chamber/dish was exposed to 340 nm and 380 nm wavelengths of light.  
These images represented the background fluorescence that the camera would detect 
during the experiment.  The software would therefore subtract the corresponding 
intensity from each image captured during the experiment.  This minimised the 
potential variability between multiple chambers/dishes.  The Openlab software was 
used to control the parameters of the experiment with the imaging and recording 
following a pre-set automation (Written by A. M. Evans, Centre for Integrative 
Physiology, University of Edinburgh) which would loop until manually terminated or 
until it reached a pre-set number of cycles.  Firstly the monochromator is triggered to 
generate 340 nm wavelength light and the resultant fluorescence emitted is captured 
by the CCD camera (exposure time 30 ms) and the image is saved.  The 
monochromator is then switched so that it generates 380 nm wavelength of light and 
the resultant emitted fluorescence is again recorded by the CCD camera and the image 
is saved.  The background fluorescence for each of the images is subtracted using the 
background images recorded previously.  The computer then generates a ratio image 
by dividing the intensity of the pixels in the 340 nm image by the intensity of the 
corresponding pixels in the 380 nm image.  This ratio image contains a grey-scale 
image whereby a given intensity is assigned a specific level of grey within the 256 
grey-scale.  The grey-scale images are then converted to a range of colours 
(increasing intensity represented as blue <green <yellow <orange <red) which can be 
used to quickly and easily visualise the changes in the Fura-2 fluorescence ratio 
during the experiment.  This type of depiction is known as a pseudocolour 
representation.  
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2.6  Whole-cell patch clamping 
 
Pharmacological agents such as NAADP that dissolve readily in water are often 
unable to diffuse across the plasma membrane.  This property is useful for an 
intracellular signalling molecule, however observing the effect of exogenous NAADP 
is therefore far from straight forward.  In order to deliver NAADP directly to the 
cytoplasm of both PASMCs and HEK293 cells the whole-cell configuration of the 
patch-clamp technique was used.  The key characteristic of this technique is the 
diffusional continuity of the patch pipette solution and the cell cytoplasm (Park et al., 
2002). 
 
2.6.1  Preparation and filling of patch pipettes 
 
In this thesis, whole-cell patch-clamping was used to apply the pharmacological 
agent of interest by intracellular dialysis within pipette solution of the following 
composition: 140 mM KCl; 10 mM HEPES; 1 mM MgCl2; 5 µM Fura-2 free acid, 
corrected to pH 7.4 with NaOH.  The pipette solution was ‘loaded’ into a glass 
electrode known as a patch pipette.  Patch-pipettes (2-3 MΩ resistance) were 
generated by ‘pulling’ filamented borosilicate glass capillaries (1.5 mm O.D., 0.86 
mm I.D.; Harvard Apparatus, UK) using a pipette puller (pp-830, Narishige, Japan).  
The pp-830 pipette puller uses a two stage pull technique to produce pipettes with a 
consistent pipette resistance.  Firstly, the glass capillary is fixed in position by screws 
above and below the nichrome heating coil, with the upper part fixed to the frame of 
the puller and the lower part attached to weights.  The heating coil is then switched on 
to the first heat setting which heats the capillary at a focal position.  As this part of the 
capillary heats up, the glass becomes molten and the glass is partially pulled apart by 
gravity pulling the weighted lower section down until it makes contact with a step.  
This first pull is typically over a length of 7-10 mm and produces a diameter of 
approximately 200 µm (Hamill et al., 1981).  The step physically stops the first stage 
in the pulling process and also switches off the heating coil thus allowing both the coil 
and capillary glass to cool down.  The coil is then re-centred with respect to the 
capillary’s new centre, the step is removed and the coil switched on to the second, 
lower heating setting.  This heat also focally softens the glass and therefore allows the 
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weights to pull apart the glass, leaving two patch-pipettes with tips consisting of an 
aperture of approximately 1 µm (Hamill et al., 1981). 
The filled patch pipettes were mounted onto the electrode attached to the 
headstage.  Once mounted, the pipette solution was in electrical contact with the head 
stage via an Ag/AgCl wire which sits within the pipette.  The headstage is attached to 
the patch-clamp amplifier, and the amplifier kept in electrical contact with the 
extracellular bath solution via an Ag/AgCl bath electrode. 
 
2.6.2  Generation of a seal and delivery of pharmacological agents 
 
Once a cell had been identified for patching, the patch pipette was positioned 
above the cell of interest using a piezoelectric micromanipulator (PCS 5000 series, 
EXFO Burleigh, Canada).  The piezoelectric micromanipulator allows smooth and 
stable positioning of the patch pipette within three planes.  The system uses ceramic 
actuators that expand under the application of increasing voltages.  Before a seal can 
be made with the cell of interest, the junction potential must be accounted for.  The 
junction potential develops when two solutions of different ionic compositions meet 
at an interface.  In this example, once the pipette is lowered into the experimental 
chamber, the bath solution and the pipette solution share an interface at the pipette 
aperture.  This causes a junction potential to develop due to the differences in 
concentration and mobility of ions between the solutions.  This potential can be offset 
by adjusting the Vref on the amplifier which uses an integrator to keep the current at 
zero.  Before making a seal the amplifier must first be set to voltage-clamp mode (V = 
0 mV) with a 5 mV ‘test’ pulse applied with a frequency of 50 Hz and a duration of 
10 ms.  The pulse produces a current step with a square waveform which is observed 
on an oscilloscope (Fig. 2.5).  The patch pipette is then lowered gradually using the 
micromanipulator until the patch pipette is in contact with the cell membrane.  
Contact with the cell can be determined using the oscilloscope whereby the increase 
in resistance results in a decrease in the observed current step.  At this juncture, 
negative pressure can then be applied to the system.  Negative pressure could be 
applied to the pipette via a length of silicon tubing that was attached to the electrode 
holder.  The other end of the tubing was attached to a port in a 3-way stopcock.  A 
plastic syringe was attached to another port of the stopcock to generate the negative 
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pressure whilst the remaining port was left free in order to release pressure from the 
otherwise closed system. 
 
 
 
Fig. 2.5.  Schematic representation of the process of intracellular dialysis of pharmacological 
agents via the whole-cell configuration of the patch-clamp technique 
A. The upper panel shows the positioning of the patch pipette above the cell.  Lower panel shows the 
corresponding trace shown on the oscilloscope after the application of a voltage step.  B. The upper 
panel shows the patch pipette now lowered so that it is contact with the cell plasma membrane, whilst 
the lower panel shows the resultant decrease in the voltage step as a result of an increased resistance.  
C. Application of slight negative pressure generates a gigaseal shown in the upper panel.  The lower 
panel shows the resultant oscilloscope trace after capacitance compensation.  D. The upper panel 
represents the whole-cell configuration.  Further negative pressure results in the removal of the patch of 
membrane immediately beneath the patch pipette.  The lower panel shows the oscilloscope trace with 
whole-cell configuration producing characteristic capacitance transients. 
 
Application of negative pressure results in an improved seal and increased 
electrode resistance resulting in a further reduction in the current step observed on the 
oscilloscope.  This was monitored until a gigaohm (GΩ) seal was obtained with 
additional negative pressure applied if required.  With a 10 GΩ seal the pipette and 
the membrane will be less than 1 nm apart (Hamill et al., 1981).  After forming a GΩ 
seal, capacity transients caused by stray pipette capacitance to the bath, are 
compensated for by adjusting the fast and slow capacitance compensation facilities on 
the integrator unit of the amplifier.  Further suction was then applied in order to 
rupture the patch of membrane covered by the pipette’s aperture.  Rupture of the 
patch is indicated by the sudden appearance of large capacity transients due to whole-
cell capacitance.  This is termed ‘break-in’.  Upon break-in the NAADP within the 
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pipette solution is able to dialyse into the cell and the resultant changes in the 
intracellular Ca2+ concentration was viewed using Fura-2 fluorescence ratio imaging.  
For all experiments involving the whole-cell configuration of the patch-clamp 
technique, the seal resistance was ≥ 2 GΩ, and the series resistance and pipette 
resistance were ≤ 10 MΩ and ≤ 3 MΩ respectively. 
NAADP and IP3 were delivered to individual cells using the whole-cell 
configuration of the patch-clamp technique and in current-clamp mode (PASMC; I = 
0) or voltage-clamp mode (HEK293 cells; V = -40 mV), using a CV 203BU headstage 
(Axon Instruments, Molecular Devices, USA) attached to an axopatch 200B 
integrating patch-clamp unit (Axon Instruments, Molecular Devices, USA). 
 
2.6.3  Extracellular application of pharmacological agents 
 
In Ca2+ imaging experiments in both PASMC and HEK293 cells, caffeine or 
carbachol (CCh) were added towards the end of the record in order to determine 
whether the cells were responsive to intracellular Ca2+ release via RyRs or IP3Rs 
respectively.  As both caffeine and CCh are cell membrane permeant, these 
compounds were applied extracellularly.  Also, is some of the experiments within this 
thesis, cells were pre-incubated with the antagonists, bafilomycin A1, thapsigargin, 
dantrolene and Ned-19.  These compounds are also cell permeable and were therefore 
applied extracellularly. 
 
 
2.7  Radioligand binding assay 
 
2.7.1  Preparation of sea urchin egg homogenate for use in radioligand binding 
assay 
 
For both the determination of NAADP binding to TPC2 and the subsequent 
competition of [32P]NAADP binding to TPC2 by Ned-19, homogenate was used from 
sea urchin egg, HA-hTPC2 cells and mouse liver.  Sea urchin egg homogenate had 
been prepared prior to the radioligand binding experiments by my collaborators 
Professor Antony Galione, Dr Margarida Ruas and Dr Xiaotong Cheng.  Briefly, eggs 
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were harvested from Lytechinus pictus (L. pictus) and Strongylocentrotus puratus (S. 
puratus) by injection with 0.5 M KCl and collected in ASW (artificial sea water: 435 
mM NaCl; 40 mM MgCl; 15 mM MgSO4; 11 mM CaCl2; 10 mM KCl; 2.5 mM 
NaHCO3 and 20 mM Tris base, pH 8.0).  The eggs were then washed by 
centrifugation at 800 g in the following number of solutions: Ca2+-free ASW with 
EGTA (twice), Ca2+-free ASW (twice), and then washed in gluconate intracellular-
like medium (Glu-IM) with the following composition (mM): 250 N-methyl-d-
glucamine, 250 potassium gluconate, 20 Hepes, 1 MgCl2 (pH 7.2).  Cells were then 
homogenized with a glass Dounce tissue homogeniser in intracellular medium with 
the following additions: 2 mM ATP, 20 mM phosphocreatine, 20 U/ml creatine 
phosphokinase, 50 µg/ml leupeptin (EDTA-free cocktail), 20 µg/ml aprotinin, and 
100 µg/ml soya bean trypsin inhibitor.  The cortical granules were then removed by 
centrifugation at 13,000 g for 10 s at 4 °C and the supernatant was removed and 
stored at -80 °C until required. 
 
2.7.2  Preparation of mouse liver homogenate for use in radioligand binding assay 
 
Mouse liver homogenate had been prepared prior to the radioligand binding 
experiments by my collaborators Professor Antony Galione, Dr Margarida Ruas and 
Dr Xiaotong Cheng.  Briefly, mouse liver tissue was dissected from C57/BL6 mice 
and was homogenised at 4 °C using an UltraTurax homogeniser in binding medium of 
the following composition: 20 mM HEPES, 1 mM EDTA (pH 7.2) and supplemented 
with a protease inhibitor cocktail (Roche).  The membranes were then washed twice 
by centrifugation at 20,000 g for 10 minutes and the supernatant was removed and 
stored at -80 °C until required. 
 
2.7.3  Preparation of wild-type HEK293 and HA-hTPC2 expressing cell 
homogenates for use in radioligand binding assay 
 
In order to determine whether over-expression on hTPC2 in HEK293 cells 
resulted in an increase in NAADP binding and whether Ned-19 competes with 
NAADP for TPC2 binding, homogenates were prepared prior to binding experiments.  
24 petri dishes (150 mm) containing either HA-hTPC2 or wild-type HEK293 cells 
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(90-100% confluency) were used in order to generate a suitable amount of protein.  
The cell culture medium was discarded and the cells washed once with cold (4°C) 
PBS.  Each petri dish was then placed on ice and a small amount of fresh cold PBS 
was added and the cells scraped into the PBS before being collected into centrifuge 
tubes.  The cell solution was centrifuged at 1500 g for 3 minutes at 4 °C.  Following 
centrifugation, the supernatant was removed and the cells were resuspended in cold 
hypotonic buffer of the following composition: 20 mM HEPES, 1 mM EDTA, 1 mM 
PMSF, pH 7.2 .  The suspension was then incubated for 30 minutes at 4°C, and the 
cells homogenised with 15 strokes from a glass Dounce tissue homogeniser and the 
homogenate centrifuged at 1500 g for 3 minutes at 4°C.  The supernatant was 
removed and retained and the pellet, containing the unbroken cells and nuclei was 
discarded.  The supernatant was centrifuged at 10,0000 g for 1 hour at 4°C.  The 
supernatant was removed and the pellet resuspended in fresh cold hypotonic buffer 
and the new suspension was incubated for 1 hour at 4 °C.  Following this, the 
suspension was centrifuged again at 10,0000 g for 1 hour at 4 °C.  The supernatant 
was removed and the pellet was finally resuspended in fresh cold hypotonic buffer 
using a needle and syringe to ensure that the pellet had been fully and uniformly 
resuspended.  The protein concentration was then determined using a BCA protein 
assay.  The remaining homogenate was aliquoted, snap frozen in liquid nitrogen and 
stored at -80°C until required. 
 
2.7.4  BCA protein assay for the determination of protein concentration 
 
In order to use membrane homogenates in radioligand binding experiments, the 
protein concentration of the homogenates must first be determined.  This can be done 
by comparing the samples against a set of known standards which, for the purpose of 
this experiment was BSA.  Protein concentration was determined by the bicinchoninic 
acid (BCA) protein assay using the following manufacturers protocol (Sigma-Aldrich, 
Dorset, UK).  This assay utilises a reaction whereby Cu2+ can be reduced by proteins 
to form Cu1+ in alkaline conditions.  This reduction can be mediated by cysteine, 
tryptophan and tyrosine residues, and the peptide bond.  The greater the reduction of 
the Cu2+ ions, the higher the protein concentration.  The BCA forms a blue/purple 
coloured complex with the reduced Cu1+ in alkaline conditions, which has an 
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absorption maxima of 562 nm.  Therefore with higher protein concentrations the 
solution will be less blue / purple and more green in colour.  8 parts of each of the 
protein standards (0-2000 µg/ml in duplicate) were mixed with 1 part of the BCA 
working reagent (containing 0.08 % copper sulphate pentahydrate) in a 96-well plate.  
In addition to the standards, the HEK293 cell homogenate (diluted 20-fold) was also 
mixed in the same proportions with the BCA working solution.  The plate was then 
incubated for 30 minutes at 37°C.  The absorbance of each sample was then measured 
at 562 nm and a standard curve constructed using Graphpad Prism analysis software 
using the results obtained from the protein standards.  Using this standard curve, the 
protein concentration of the homogenate could be determined by interpolation.  This 
was then adjusted according to the initial dilution factor and the value obtained used 
to ensure the appropriate amount of protein was used for the radioligand binding 
assay.  
 
2.7.5  Preparation of [32P]NAADP for use in radioligand binding assay 
 
[32P]NAADP can be synthesised via a two-step process as described previously 
(Patel et al., 2000a).  The first reaction was to synthesise [32P]NADP from [32P]NAD.  
This was done by incubating [32P]NAD with 0.5 U/ml human NAD kinase, 5 mM 
MgATP and 100 mM HEPES for 1 h at room temperature.  After this 100 mM 
nicotinic acid and 1 µg/ml ADP-ribosyl cyclase were added to the reaction chamber 
and the mixture was incubated for a further 1 h at room temperature in order to allow 
for the second synthesis phase to occur.  The final mixture was separated by running 
it through a high pressure liquid chromatography (HPLC) column.  Separation was 
achieved using an anion-exchange column packed with AGMP1 (Bio-Rad, UK).  
Elution was performed at a flow rate of 1 ml/minute using an increasing gradient of 
trifluoroacetic acid (TFA) as described previously (Patel et al., 2000a).  The 
[32P]NAADP fraction was then stored at 4 °C until required.  
 
2.7.6  Radioligand competition binding assay 
 
In order to show NAADP binding in membranes prepared from sea urchin egg, 
HEK293 cells expressing/not-expressing HA-hTPC and mouse liver homogenates, a 
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competition assay was performed whereby NAADP at increasing concentrations can 
compete with and therefore reduce the amount of [32P]NAADP binding to the 
homogenate.  Firstly, 25 µl of NAADP (in DMSO) in a range of concentrations was 
added to each tube.  175 µl of homogenate was then added and allowed to incubate 
for 1 hour at room temperature, 50 µl of [32P]NAADP added ([32P]NAADP final 
concentration, 0.2 nM) making a final volume of 250 µl, before incubation of the 
preparation for a further hour at room temperature in order to allow binding to reach 
equilibrium.  The bound [32P]NAADP was trapped using Whatman GF/B filter papers 
that were placed in a Brandel Cell Harvester.  The tubes were washed 3 times with 
Glu-IM (3 x 1 ml).  The filter papers were then collected and the amount of 
[32P]NAADP retained was determined either by Cerenkov spectrometry or by storage 
phosphor screen autoradiography.   
For Cerenkov spectrometry the filters are placed in scintillation vials containing 
10 ml H2O and the relative amount of [32P]NAADP retained within each vial was 
determined using a scintillation counter. 
For storage phosphor screen autoradiography filter papers were wrapped in 
cling film and then placed in an exposure cassette.  A storage phosphor screen (GE 
Healthcare) was then placed atop the filters and the cassette closed.  The screen was 
then exposed for 2 hours, and scanned using a Typhoon 9400 scanner (GE 
Healthcare: scanning at 633 nm) at a resolution of 100 µm.  The resulting image was 
quantified using IamgeQuant (GE Healthcare).  Analysis of radioactivity levels by the 
storage phosphor screen system has been utilised previously as part of the 
[32P]NAADP binding assay (Lewis et al., 2007).  As its name suggests the screen will 
‘store’ a record of the sample which can then be imaged using known wavelengths.  
The screen contains crystals of BaFBR:Eu2+ and, upon exposure to radiation,  the 
Eu2+ is oxidised to Eu3+ and the BaFBr is reduced to BaFBr-.  The oxidised/reduced 
ions remain in this state following the subsequent removal of the screen from the 
sample filters.  This energy is then released when the screen is excited by the 
appropriate wavelength of light.  The Typhoon scanner will scan the screen with a 
wavelength of 633 nm, and as a result 390 nm wavelength light is emitted which is 
allowed through the band-pass filter and is detected and measured by the detector.  
The intensity of this light is directly proportional to the level of radioactivity in the 
sample, and is transformed by the scanner into a grey scale image, with the areas 
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containing the higher intensity of emitted 390 nm light represented by the darker 
pixels.  The image can then be analysed to determine the relative amount of 
radioactivity in each sample using densitometry analysis (ImageQuant software, 
Amersham Biosciences, UK).  In order to compare this technique to scintillation 
counting, Lewis et al. generated a standard displacement curve with NAADP in sea 
urchin egg homogenate which was then analyzed by the Typhoon scanner and by the 
scintillation counter.  The resultant standard curves were identical and therefore 
validated the use of phosphor storage screens to report radioactivity of a given sample 
(Lewis et al., 2007).  
 
2.7.7  Radioligand competition binding assay to determine whether Ned-19 inhibits 
[32P]NAADP binding to TPC2 
 
In order to further validate Ned-19 as a competitive and specific antagonist of 
NAADP, an assay was performed to determine if increasing concentrations of Ned-19 
could displace [32P]NAADP binding in a competitive manner.  Firstly, 25 µl of Ned-
19 (in DMSO) in a range of concentrations was added to each tube.  175 µl of sea 
urchin egg homogenate or HA-hTPC2 cell homogenate was then added and allowed 
to incubate for 1 hour at room temperature, 50 µl of [32P]NAADP added 
([32P]NAADP final concentration, 0.2 nM) making a final volume of 250 µl, and the 
preparation incubated for a further hour at room temperature.  The bound 
[32P]NAADP was trapped using Whatman GF/B filter papers that were placed in a 
Brandel Cell Harvester.  The tubes were washed 3 times with Glu-IM (3 x 1 ml) as 
described previously.  The filter papers were then collected and the amount of 
[32P]NAADP retained was determined either by Cerenkov spectrometry or by storage 
phosphor screen autoradiography. 
Radioligand binding data were analysed using Prism analysis software 
(GraphPad Software Inc., USA).  Goodness of fit was assessed using the R2 value 
calculated using the following formula: R2 = 1.0 – (SSreg / SStot), where SSreg is the 
sum of squares of the vertical distance of each point from the best fit line, and SStot is 
the sum of squares of the vertical distance of each point from the mean y value. 
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2.8  Drugs and chemicals 
 
Fura-2-AM, Fura-2 pentapotassium salt, DAPI, LysoTracker Red, LysoTracker 
Green, DMEM, Opti-MEM, FBS, Trypsin-EDTA, Zeocin, Geneticin G418 sulphate, 
and Penicillin/Streptomycin were obtained from Invitrogen/Molecular probes 
(Invitrogen Ltd., USA).  GeneJammer transfection reagent was obtained from 
Stratagene (Agilent Technologies, USA).  Bafilomycin A1 and anti-M6PR antibody 
was obtained from Calbiochem (Merck, Germany).  Ned-19 was a kind gift from Dr. 
Grant Churchill.  Anti-RyR antibodies were a kind gift from Prof. Sidney Fleischer.  
Anti-Igp120 antibody was a kind gift from Prof. Paul Luzio. Mouse anti-LAMP-2 
antibody was obtained from the Developmental Studies Hybridoma Bank (University 
of Iowa, USA).  Anti-HA antibody was obtained from Roche (UK).  Anti-transferrin 
and anti-PDI antibodies were obtained from Abcam (UK).  Anti-GM130 and anti-
EEA1 antibodies were obtained from BD biosciences (USA).  Anti-cytochrome C 
antibody was obtained from Zymed (USA).  Texas Red-conjugated secondary 
antibodies were obtained from Jackson ImmunoResearch (USA).  Alexa594-
conjugated secondary antibodies were obtained from molecular probes (Invitrogen, 
UK).  [32P]NAD was a kind gift from Prof. Antony Galione.  All other compounds 
were obtained from Sigma-Aldrich (UK). 
 
 
2.9  Statistical analysis 
 
Where appropriate the data presented within this thesis are represented by the 
mean and standard error of the mean (S.E.M. ±) for ‘n’ experiments.  For comparing 
groups and determining statistical significance, analyses were carried out using a 
student’s t test or one-way analysis of variance with a Bonferroni post hoc test using 
the InStat3 statistical software (GraphPad Software Inc., USA).  Differences between 
groups were considered statistically significant if P ≤ 0.05. 
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Chapter 3:  Lysosomes co-localise with ryanodine 
receptor subtype 3 to form a trigger zone for Ca2+ 
signalling by NAADP in rat pulmonary arterial 
smooth muscle 
 
 
3.1  Introduction 
 
Since its discovery, NAADP has been shown to potently mobilise Ca2+ in a 
number of cell types and via a complex two-pool release mechanism (Boittin et al., 
2002; Churchill et al., 2001a; Churchill et al., 2002; Kinnear et al., 2004; Zhang et 
al., 2006b).  It is clear that in PASMCs, NAADP initiates global Ca2+ waves in an all-
or-none manner by triggering Ca2+ release from acidic lysosome-related Ca2+ stores 
that is subsequently amplified by CICR from the SR via the progressive recruitment 
of ryanodine receptors (RyRs) (Boittin et al., 2002; Kinnear et al., 2004).  That 
NAADP selectively mobilises Ca2+ from a lysosome-related Ca2+ store was shown 
using bafilomycin A1 (Kinnear et al., 2004).  Bafilomycin depletes lysosome-related 
Ca2+ stores by inhibiting the V-H+-ATPase pump and was found to abolish NAADP-
mediated Ca2+ release in PASMCs but not RyR- or IP3R-dependent Ca2+ release from 
the SR (Kinnear et al., 2004).  Furthermore, depletion of SR Ca2+ stores by block of 
sarcoplasmic / endoplasmic reticulum Ca2+ ATPase (SERCA) pumps with 
thapsigargin and blockade of RyRs with ryanodine, respectively, occluded global 
Ca2+ waves, but not spatially restricted Ca2+ bursts from lysosomes (Boittin et al., 
2002; Kinnear et al., 2004).   
An additional observation of some interest was that NAADP-dependent Ca2+ 
bursts from lysosomes either declined back to basal levels without inducing CICR, or 
breached a given threshold for the initiation of a global Ca2+ wave by CICR from the 
SR via RyRs.  In this respect, an important observation was that LysoTracker Red 
labelled lysosomes formed dense clusters in PASMCs, consistent with the spatially 
restricted nature of the Ca2+ bursts evoked by NAADP (Kinnear et al., 2004).  
Strikingly, these dense clusters of lysosomes were closely associated with a sub-
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population of BODIPY-ryanodine labelled RyRs.  Moreover, the separation between 
these closely associated RyRs and lysosomes was beyond the limit of the resolution of 
deconvolution microscopy (< 100 nm) i.e. they appeared to form a true junction 
(Kinnear et al., 2004).  Indeed, this separation is consistent with the junctional gap 
required for other organellar junctions such as between the S / ER and mitochondria, 
and the S / ER and the plasma membrane which measure 15-50 nm and 15-30 nm 
respectively (Poburko et al., 2004).  The small separation between RyRs and 
lysosomes is therefore indicative of the presence of lysosome-SR junctions akin to a 
synapse for Ca2+ signalling by NAADP, and this structure was proposed to be a 
“trigger zone” for initiation of global Ca2+ waves in response to NAADP.  This 
proposal is entirely consistent with the two-pool mechanism of Ca2+ signalling by 
NAADP and with the all-or-none manner in which NAADP triggers global Ca2+ 
waves (Boittin et al., 2002).  This finding is all the more intriguing given that all 3 
RyR subtypes are expressed in vascular smooth muscle (Neylon et al., 1995; Yang et 
al., 2005).  I therefore sought to determine whether or not a particular RyR subtype 
was targeted to the lysosome-SR junctions. 
 
 
3.2  Methods 
 
In order to investigate the lysosome-SR junction each element must first be 
visualised.  This was achieved using antibodies raised against specific sequences of 
each protein.  Lysosomes within acutely isolated PASMCs were visualised using the 
GM10 antibody raised against the lysosomal glycoprotein antigen αIgp120 (a kind 
gift from Professor Paul Luzio).  Previously, αIgp120 has been shown to be almost 
exclusively expressed on lysosomal membranes with little or no expression on the 
plasma membrane, Golgi apparatus, or endosomes (Lewis et al., 1985).  The anti-
αIgp120 antibody was in turn visualised using a goat anti-mouse secondary antibody 
conjugated to the fluorescent molecule FITC (excitation 490 nm, emission 528 nm).  
RyR subtypes were visualised using antibodies raised against specific sequences 
within each subtype (RyR1, residues 4681-4700; RyR2, 1344-1365; RyR3, 4326-
4336) and were a kind gift from Professor Sidney Fleischer.  Importantly, these anti-
bodies have been shown to bind specifically to sequences of either RyR1 (Lesh et al., 
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1993), RyR2 (Jeyakumar et al., 2001) or RyR3 (Jeyakumar et al., 1998).  RyR 
subtype labelling was in turn visualised using a secondary goat anti-rabbit antibody 
conjugated to the fluorescent molecule Texas Red (excitation 555 nm, emission 617 
nm).  The conjugated fluorescent probes Texas Red and FITC are suitable to be used 
simultaneously to co-label cells, as their excitation and emission spectra exhibit little 
overlap and therefore, excitation of one fluorophore will not cause the erroneous 
excitation and subsequent erroneous emission from the other.  Co-labelling of the 
PASMCs thus allowed for the analysis of areas in which both αIgp120 and RyR 
subtype labelling coincided, and therefore indicates areas of co-localisation between 
lysosomes and a particular RyR subtype. 
Importantly, fluorescence owing to specific binding of the fluorophore-
conjugated secondary antibody to the primary antibody must be distinguished from 
any background fluorescence due to non-specific binding of the primary antibody or 
inherent fluorescence within the slide/apparatus.  This was achieved using paired 
control slides which were generated using the method described in Chapter 2.  
Briefly, control slides were prepared in the same way as test slides but the primary 
antibody solution was replaced with blocking solution during the initial incubation.  
In these control slides any of the fluorophore-conjugated secondary antibody that 
binds to elements within the cell is non-specific.  Therefore, one can determine the 
level of background fluorescence, and effectively subtract/remove this from the 
images obtained from the test slides and thus ensure that the remaining fluorescence 
in due to specific labelling of the primary antibody. 
The labelled proteins within isolated PASMCs were visualised using the 
Applied Precision Deltavision imaging system.  The cells were viewed using an 
inverted microscope (Olympus IX70) equipped with a 60x 1.4-numerical aperture oil 
immersion objective lens (Olympus) and images were obtained using a Photometric 
CH300 CCD camera.  A series (30-40) of Z sections (focal depth 0.28 µm, interval 
step 0.2 µm) taken through the cell were obtained in the form of a Z stack of 2D 
images.  The out of focus light was removed by the imaging system using 
constrained-iterative deconvolution and a 3D image was generated as described in 
chapter 2. 
Each image was adjusted to remove background fluorescence which was 
achieved using the control slides described above.  The control slides were imaged to 
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determine the intensity of the fluorescence obtained from non-specific binding of the 
secondary fluorophore-conjugated antibody.  When the threshold intensity level was 
raised such that no fluorescence was observed, this was determined as the background 
fluorescence threshold for that fluorescent probe.  For all subsequent test cells, the 
threshold was raised to this level such that all fluorescence below this intensity 
threshold was excluded, thus ensuring that the observed fluorescence was solely due 
to specific labelling of the desired protein. 
Following deconvolution, volumetric analysis of RyR and αIgp120 labelling 
and co-localisation between the two elements was performed using Volocity software 
(PerkinElmer, Waltham, 
MA, USA).  First, in 
order to determine the 
degree of RyR and 
lysosomal labelling 
within the whole cell and 
sub-cellular regions of 
isolated PASMCs, a 
model was required that 
could be applied to each 
cell for analysis.  The 
model developed 
consists of the whole cell 
and 3 sub-cellular 
regions termed the 
‘perinuclear region’, the 
‘extra-perinuclear 
region’, and the ‘sub-
plasmalemmal region’ 
(Fig. 3.1). 
Analysis of the 
distribution of labelling 
across these regional 
volumes of cells was 
 
 
 
Fig. 3.1.  Schematic representation of the subdivision of 
regions within isolated pulmonary arterial smooth muscle 
cells  
Isolated cells were divided into three regions, namely the 
perinuclear (yellow), extra-perinuclear (pink), and sub-
plasmalemmal (light blue) regions.  The perinuclear region was 
determined as the volume of cytoplasm within 1.5 µm of the 
DAPI labelled nucleus (dark blue).  The sub-plasmalemmal 
region was determined as the volume of cytoplasm within 1.5 µm 
of the plasma membrane.  The extra-perinuclear region was 
determined as being the remaining volume of cytoplasm that 
resides between the sub-plasmalemmal and perinuclear regions. 
 70 
then carried out using Volocity software.  This was achieved using 3D reconstructions 
of deconvolved Z sections (focal depth 0.28 µm, Z step 0.2 µm) taken through each 
cell selected for study and in the following manner: 
 
1. The total cell volume was measured by drawing a 3D region of interest (ROI) 
around the perimeter of the cell.  The resultant template was termed the ‘whole 
cell mask’. 
2. A 3D ROI was then drawn around the perimeter of the DAPI labelled nucleus 
and the nuclear volume measured. 
3. A third ROI was drawn at a distance of 1.5 µm from the perimeter of the 
DAPI labelled nucleus.  The perinuclear volume was then determined by 
subtracting the nuclear volume from the volume contained within this ROI, 
and termed the ‘perinuclear mask’ 
4. The sub-plasmalemmal volume was then determined by drawing a further 3D 
ROI 1.5 µm from the intracellular face of the plasma membrane.  The volume 
within this ROI was then subtracted from the volume of the whole cell to 
provide the sub-plasmalemmal ‘mask’. 
5. Finally, the extra-perinuclear region was determined by subtracting the 
nuclear, perinuclear, and sub-plasmalemmal volume from the total cell 
volume.  The extra-perinuclear volume being equal to the remaining volume. 
6. Note, in individual cells where regions of the plasma membrane were ≤ 3 µm 
from the nucleus, the total distance between the nucleus and plasma membrane 
was measured, and a 3D ROI drawn at half this distance.  Thus, allowing for 
no extra-perinuclear volume at this point. 
 
These defined masks were used as templates, such that the volume of 
labelling/co-localisation was determined for each region but with all labelling 
occupying a space outside the given regional template excluded.  The thresholds for 
each fluorescent probe used (known as a channel) were set to exclude background 
fluorescence leaving 3D elements of labelling that are of an intensity above that of the 
background threshold.  Volocity is then able to measure the volume of these 
remaining fluorescent elements.  First, the desired mask is applied to the cell such that 
only fluorescent elements that are within this volume are measured.  The number of 
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voxels (3D pixels) that each element of labelling occupies within the mask is 
measured and the number of voxels is then converted into an SI unit (µm3) value.  
The volume of each element is recorded and the total volume of labelling summated.  
This process was repeated for each fluorescent channel and for each regional mask. 
For assessing the volume of co-localisation between αIgp120 and RyR subtype 
labelling, the software merged / overlaid the masks relating to the 2 fluorescent 
channels used.  The number of voxels occupied by both RyR and αIgp120 labelling in 
the merged mask was then determined and the corresponding µm3 values calculated. 
In order to analyse the volume of individual elements the resolution limit of the 
Deltavision imaging system must first be considered.  Under carefully controlled 
“optimal” experimental conditions, the Deltavision imaging system used in these 
investigations is able to accurately resolve elements of labelling smaller than 0.2 µm 
in size.  However, these precisely controlled conditions cannot be duplicated under 
my experimental conditions.  Therefore, in these analyses, I set a more conservative 
value on the limit of resolution.  To this end, I included only those volumes of 
labelling measuring at least 0.5 µm in the X-, Y- and Z-planes (volume 0.125 µm3) 
with any element of labelling smaller than this excluded from consideration. 
As expected, the total volume of the PASMCs imaged and each of the 3 
subdivided regions varied between region type and between individual cells.  
Therefore, in order to allow for direct comparison of labelling across the 3 regions 
and between individual cells, labelling was expressed as a density.  This was achieved 
by dividing the volume occupied by fluorescent labelling (µm3) for a given protein by 
the total volume of that particular region (µm3).  Thus, data are presented as the mean 
± S.E.M. of the density of labelling (µm3 per µm3). 
 
 
 72 
3.3  Results 
 
3.3.1  Examination of the spatial distribution of lysosomal labelling in isolated 
pulmonary arterial smooth muscle cells 
 
3.3.1.1  Lysosomes are predominantly localised to the perinuclear region of isolated 
pulmonary arterial smooth muscle cells 
 
In experiments carried out in association with Dr. Nicholas Kinnear the 
distribution of lysosomes within acutely isolated PASMCs was visualised using the 
GM10 antibody raised against the lysosomal glycoprotein antigen αIgp120.  3D 
reconstructions of deconvolved Z-sections taken through isolated PASMCs, revealed 
that αIgp120 labelling formed tight clusters.  Fig. 3.2Aa shows a transmitted light 
image of an exemplar cell and (b) the distribution of labelling for αIgp120 (green) 
relative to the DAPI labelled nucleus in a deconvolved Z-section (focal depth 0.28 
µm) taken through the cell and corrected to remove background fluorescence 
determined from matched control slides.  As mentioned above, in these and all 
subsequent analyses only those volumes of labelling measuring ≥ 0.5 µm in the X-, 
Y- and Z-planes (volume 0.125 µm3) were included in the analysis.  Fig. 3.2Ac shows 
the distribution of labelling for αIgp120 (green) relative to the DAPI labelled nucleus 
in a 3D reconstruction of a series of deconvolved Z-sections (focal depth 0.28 µm, Z 
step 0.2 µm).  Fig. 3.2Ad shows a 3D representation of the position of each individual 
volume of labelling ≥ 0.125 µm3 coloured to denote whether it was registered in the 
perinuclear (orange), extra-perinuclear (pink) or subplasmalemmal (light blue) region.  
Even visual consideration of the distribution of αIgp120 labelling here strongly 
suggests that the majority was concentrated in the perinuclear region of the cell. 
In order to quantify the spatial distribution of αIgp120 labelling within 
PASMCs, the cells were divided into 3 regions (perinuclear, extra-perinuclear, sub-
plasmalemmal) as described above (Fig. 3.1).  To this end, the volume of labelling in 
each region was divided by the volume represented by the respective region, thus 
providing a density of labelling (µm3 of labelling per µm3 volume of region).  This 
therefore allowed direct comparison of αIgp120 labelling between different regions 
within individual cells and between all the cells analysed.   
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Fig. 3.2.  Cellular distribution of αIgp120-labelled lysosomes within isolated pulmonary arterial 
smooth muscle cells  
Aa Transmitted light image of the isolated PASMC imaged.  Ab Deconvolved Z-section (focal depth 
0.28 µm) taken through the cell showing the distribution of αIgp120 labelling (green) in relation to the 
nucleus of the cell (dark blue) and plasma membrane (dotted line).  Ac 3D reconstruction of a series of 
Z-sections taken through the cell shown in panel a (Z step 0.2 µm) showing the spatial distribution of 
αIgp120 labelling (green) in relation to the plasma membrane (dotted line) and nucleus (dark blue).  
Ad shows a 3D reconstruction as shown in panel b, with the individual αIgp120 labelling coloured 
according to region; perinuclear region (orange) extra-perinuclear region (pink) and sub-plasmalemmal 
region (light blue).  B Bar chart showing the density of αIgp120 labelling in each region (µm3 per µm3; 
mean ± S.E.M.) across all the PASMCs studied (n = 35).  * indicates a statistically significant 
difference (P<0.05) when compared to the density of αIgp120 labelling in the perinuclear region, 
whereas ϕ indicates a statistically significant difference (P<0.05) when compared to the density of 
αIgp120 labelling in the extra-perinuclear region. 
 
Fig. 3.2B shows the mean (± S.E.M.) density of αIgp120 labelling in each 
region of the subdivided PASMCs imaged.  The density of αIgp120 labelling across 
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these 3 regions was non-uniform, with a predominance of labelling within the 
perinuclear region.  The density of αIgp120 labelling declined markedly from a peak 
value of 0.04 ± 0.003 µm3 per µm3 within the perinuclear region (n = 35; Appendix, 
Table 3.3), to 0.02 ± 0.003 µm3 per µm3 in the extra-perinuclear region (n = 35; 
Appendix 1, Table 3.4) and still further to as little as 0.01 ± 0.002 µm3 per µm3 in the 
sub-plasmalemmal region (n = 35 Fig. 3.2B; Appendix 1, Table 3.5).  When 
comparing the sub-plasmalemmal or extra-perinuclear regions to the perinuclear 
region, these differences were significant (P < 0.05).  Across all PASMCs studied, 
lysosomal labelling in the perinuclear region represented 56 ± 3 % (n = 35) of all 
lysosomal labelling, despite the perinuclear region only representing 31 ± 1 % (n = 
35) of the whole cell volume (Appendix 1, Table 3.6).  Clearly, therefore, lysosomes 
are primarily located within the perinuclear region of the cell. 
 
3.3.1.2  Lysosomes cluster preferentially in the perinuclear region of isolated 
pulmonary arterial smooth muscle cells 
 
Further analysis was then carried out to determine whether or not there was 
significant clustering of lysosomes and if so, within which region.  Here I measured 
the volume of each individual element of labelling, which included as one element all 
elements of labelling separated by a distance below the resolution of the 
deconvolution microscopy used here (< 100 nm).  Thus, larger volumes of αIgp120 
labelling would indicate a greater degree of clustering.  The bar chart in Fig. 3.3 
shows that the mean volume of labelling was highest in the perinuclear region 
measuring 0.76 ± 0.06 µm3 (n = 35; Appendix 1, Table 3.3), and declined to 0.62 ± 
0.09 µm3 (n = 35; Appendix 1, Table 3.4) in the extra-perinuclear region and then still 
further to 0.31 ± 0.03 µm3 (n = 35; Appendix 1, Table 3.5) in the sub-plasmalemmal 
region of the cell.  Thus, it is evident that lysosomes form dense clusters within the 
perinuclear region of the cell and in a manner consistent with previous reports from 
this laboratory in which clustering of LysoTracker Red labelled lysosomes was 
identified in living cells (Kinnear et al., 2004).  In each case the clustering mirrors the 
spatially restricted nature of NAADP-mediated Ca2+ bursts observed in PASMCs 
(Boittin et al., 2002; Kinnear et al., 2004).  Fig. 3.4 shows an example of this 
clustering of lysosomes and the resultant spatially restricted Ca2+ burst in response to 
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NAADP.  Fig. 3.4Aa 
shows a transmitted 
light image of an 
example cell and (b) 
the corresponding 3D 
reconstruction of a 
series of deconvolved 
Z-sections (focal depth 
0.28 µm, Z step 0.2 
µm) showing the 
distribution of clusters 
of LysoTracker Red 
(excitation 568 nm, 
emission 590 nm) 
within the cell.  Fig. 
3.4B shows the Fura-2 
fluorescence ratio 
recorded in a different cell showing a Ca2+ burst (indicated by the white arrow) 
elicited by intracellular dialysis of NAADP (10 nM).  This is also consistent with 
previous observations of αIgp120 labelling of lysosomes within rat kidney 
fibroblastic cells, that found small punctate labelling throughout the cytoplasm but 
which was concentrated in the perinuclear region (Reaves et al., 1996) 
 
 
 
Fig. 3.4.  Lysosomes form clusters in pulmonary arterial smooth muscle cells 
Aa Transmitted light image of the isolated PASMC imaged.  Ab 3D reconstruction of a series of Z-
sections taken through the cell shown in panel a (Z step 0.2 µm) showing the spatial distribution of 
LysoTracker Red fluorescence in relation to the plasma membrane (dotted line).  A cluster of 
LysoTracker labelling is indicated by the white arrow.  B A pseudocolour image of the Fura-2 
fluorescence ratio recorded in a different cell showing a spatially restricted Ca2+ burst (indicated by the 
white arrow) in response to the intracellular dialysis of 10 nM NAADP. 
 
 
Fig. 3.3.  Lysosomes are preferentially clustered in the perinuclar 
region of  pulmonary arterial smooth muscle cells 
Bar chart showing the mean volume of individual elements of 
αIgp120 labelling in each region (µm3; mean ± S.E.M.) across all the 
PASMCs studied (n = 35).  * indicates a statistically significant 
difference (P<0.05) when compared to the mean volume of αIgp120 
labelling in the perinuclear region, whereas ϕ indicates a statistically 
significant difference (P<0.05) when compared to the mean volume of 
αIgp120 labelling in the extra-perinuclear region. 
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3.3.2  Ryanodine receptor subtypes 1, 2, and 3 are differentially distributed within 
isolated pulmonary arterial smooth muscle cells 
 
Having established that lysosomes are not uniformly distributed throughout 
individual isolated PASMCs, the spatial distribution of RyR subtypes was then 
examined.  3D reconstructions of deconvolved Z-sections taken through isolated 
PASMCs labelled for each RyR subtype, revealed that RyR subtype labelling was not 
uniformly distributed throughout the cytoplasm and that each RyR subtype exhibited 
a different spatial distribution “profile”. 
 
3.3.2.1  Ryanodine receptor subtype 3 is predominantly targeted to the perinuclear 
region of isolated pulmonary arterial smooth muscle cells 
 
Fig. 3.5A shows the distribution of RyR3 within an example cell.  For this, and 
the subsequent analysis of RyR1 and RyR2 distribution within PASMCs (Fig. 3.5B-
C) the panels represent the following: (a) shows a transmitted light image of an 
exemplar cell; (b) shows the distribution of labelling for each RyR subtype (red) 
relative to the DAPI labelled nucleus in a deconvolved Z-section (focal depth 0.28 
µm) taken through the cell; (c) A 3D reconstruction of a series of deconvolved Z-
sections (focal depth 0.28 µm, Z step 0.2 µm) showing the distribution of labelling for 
RyR (red) relative to the DAPI labelled nucleus; (d) shows a 3D representation with 
the position of each individual volume of labelling (≥ 0.125 µm3) coloured to denote 
its location in the perinuclear (orange), extra-perinuclear (pink) and sub-
plasmalemmal (light blue) region.  Visual assessment of the distribution of RyR3 
within isolated PASMCs (Fig. 3.5A), suggests that RyR3 labelling formed clusters 
that were predominantly found in the perinuclear region, consistent with the 
distribution of lysosomes.  Fig. 3.6 shows the mean (± S.E.M.) density of RyR 
labelling for each RyR subtype within each region of the cells studied.  The 
perinuclear predominance of RyR3 labelling shown in Fig. 3.5A is reflected in the 
mean density of RyR3 labelling in each of the 3 regions (Fig. 3.6), which was 
approximately 4-fold greater in the perinuclear region (0.072 ± 0.008 µm3 per µm3, n 
= 11; Appendix 1, Table 3.16) when compared to the extra-perinuclear region (0.019 
± 0.005 µm3 per µm3; n = 11; Appendix 1, Table 3.17) and approximately 14-fold 
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greater than that observed in the sub-plasmalemmal region (0.005 ± 0.001 µm3 per 
µm3; n = 11; Appendix 1, Table 3.18).  Thus, similar to the spatial distribution of 
αIgp120-labelled lysosomes, RyR3 is preferentially targeted to the perinuclear region 
of PASMCs. 
 
 
 
Fig. 3.5.  All 3 ryanodine receptor subtypes exhibit different regional distribution within 
pulmonary arterial smooth muscle cells  
Example cells showing the cellular distribution of RyR-labelling are shown for RyR1 (A), RyR2 (B), 
and RyR3 (C).  In each case the panels show the following: Panel a shows a transmitted light image of 
the isolated PASMC imaged; Panel b shows a deconvolved Z-section (focal depth 0.28 µm) taken 
through the cell showing the distribution of RyR subtype labelling (red) in relation to the nucleus of the 
cell (dark blue) and plasma membrane (dotted line); Panel c shows a 3D reconstruction of a series of Z-
sections taken through the cell shown in panel a showing the spatial distribution of the RyR subtype 
(red) in relation to the plasma membrane (dotted line) and nucleus (dark blue); Panel d shows a 3D 
reconstruction with the individual RyR subtype labelling coloured according to region; perinuclear 
region (orange) extra-perinuclear region (pink) and sub-plasmalemmal region (light blue). 
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3.3.2.2  Ryanodine receptor subtype 2 is predominantly targeted to the extra-
perinuclear region of isolated pulmonary arterial smooth muscle cells 
 
In marked contrast to RyR3, RyR2 labelling was predominantly targeted to the 
extra-perinuclear region of isolated PASMCs.  Fig. 3.5Bb shows the distribution of 
RyR2 labelling (red) relative to the DAPI labelled nucleus (blue) in the exemplar 
isolated PASMC (a).  Fig. 3.5Bc shows a 3D reconstruction of a series of 
deconvolved Z-sections (focal depth 0.28 µm, Z step 0.2 µm) showing the distribution 
of RyR2 labelling (red) relative to the DAPI labelled nucleus (blue), whereas panel d 
shows the 3D representation with the position of each individual volume of labelling 
(≥ 0.125 µm3) coloured to denote its location in the perinuclear (orange), extra-
perinuclear (pink) and sub-plasmalemmal (light blue) region within the isolated 
PASMC.  Visual consideration of the distribution of RyR2 labelling here suggests that 
the majority of labelling was localised to the extra-perinuclear region of the cell.  
Consistent with this apparent distribution, comparison of the density of RyR2 
labelling in each region (Fig. 3.6) reveals that RyR2 labelling in the extra-perinuclear 
region (0.065 ± 0.009 µm3 per µm3, n = 14; Appendix 1, Table 3.13) was 
approximately 2-fold greater than in the perinuclear region (0.039 ± 0.002 µm3 per 
µm3; Appendix 1, Table 3.12) and approximately 6-fold greater than was measured in 
the sub-plasmalemmal region (0.011 ± 0.002 µm3 per µm3; Appendix 1, Table 3.14).  
These data suggest that although it is found in all 3 regions of the cell the distribution 
of RyR2, in contrast to lysosomes and RyR3, is preferentially targeted to the extra-
perinuclear region. 
 
3.3.2.3  Ryanodine receptor subtype 1 is uniformly distributed within isolated 
pulmonary arterial smooth muscle cells 
 
RyR3 and RyR2 appear to be predominantly targeted to the perinuclear and 
extra-perinuclear regions respectively.  Conversely, RyR1 appears to have a different 
spatial distribution than either RyR3 or RyR2 within PASMCs.  Fig. 3.5Cb shows the 
distribution of RyR1 labelling (red) relative to the DAPI labelled nucleus (blue) in the 
exemplar isolated PASMC (a).  Fig. 3.5Cc shows a 3D reconstruction of a series of 
deconvolved Z-sections (focal depth 0.28 µm, Z step 0.2 µm) showing the distribution 
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of RyR1 labelling (red) relative to the DAPI labelled nucleus (blue), whereas panel d 
shows the 3D representation with the position of each individual volume of labelling 
(≥ 0.125 µm3) coloured to denote its location in the perinuclear (orange), extra-
perinuclear (pink) and sub-plasmalemmal (light blue) region within the isolated 
PASMC.  This reveals that the distribution of RyR1 is relatively uniform across all 3 
regions of isolated PASMCs (Fig. 3.3A).  Thus, Fig. 3.6 shows that RyR1 labelling in 
the perinuclear region (0.041 ± 0.007 µm3 per µm3, n = 10; Appendix 1, Table 3.8) is 
not significantly different from labelling in the extra-perinuclear region (0.025 ± 
0.005 µm3 per µm3; Appendix 1, Table 3.9) or the sub-plasmalemmal region (0.031 ± 
0.005 µm3 per µm3; Appendix 1, Table 3.10). 
 
3.3.2.4  Each ryanodine receptor subtype exhibits a different distribution profile 
 
For clarity of consideration the bar chart shown in Fig. 3.6 compares the relative 
density of each RyR subtype labelling within each region of PASMCs.  Fig. 3.6 
confirms that within these cells RyRs exhibit subtype-specific distribution “profiles” 
(Fig. 3.6).  Comparison of the regional distribution of each RyR subtype supports the 
conclusions above, such that within the perinuclear region, RyR3 is the predominant 
subtype, with an approximately 2-fold greater density of labelling (0.072 ± 0.008 µm3 
per µm3, n = 11; Appendix 1, Table 3.16) than for either RyR2 (0.039 ± 0.002 µm3 
per µm3, n = 14; Appendix 1, Table 3.12) or RyR1 (0.041 ± 0.007 µm3 per µm3, n = 
10; Appendix 1, Table 3.8).  In contrast, RyR2 labelling predominates within the 
extra-perinuclear region (0.065 ± 0.009 µm3 per µm3, n = 14; Appendix 1, Table 
3.13), with an approximately 3-fold greater density of labelling than for either RyR3 
(0.019 ± 0.005 µm3 per µm3, n = 11; Appendix 1, Table 3.17) or RyR1 (0.025 ± 0.005 
µm3 per µm3, n = 10; Appendix 1, Table 3.9).  Within the sub-plasmalemmal region, 
due to its uniform distribution, RyR1 appears to be the predominate subtype with an 
approximately 3-fold greater density of labelling (0.031 ± 0.005 µm3 per µm3, n = 10; 
Appendix 1, Table 3.10) than RyR2 (0.011 ± 0.002 µm3 per µm3, n = 14; Appendix 1, 
Table 3.14) and 6-fold greater density of labelling than observed for RyR3 (0.005 ± 
0.001 µm3 per µm3, n = 11; Appendix 1, Table 3.18). 
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Fig. 3.6.  Summary of ryanodine receptor subtype distribution within isolated pulmonary arterial 
smooth muscle cells  
Bar chart showing the density of RyR labelling (µm3 per µm3; mean ± S.E.M.) for each RyR subtype 
within the 3 designated regions of sub-divided PASMCs.  The charts are grouped by region in order to 
show the predominance of particular subtypes within a given region.  * indicates a statistically 
significant difference (P < 0.05) when compared to the RyR3 labelling in the perinuclear region.  ϕ 
indicates a statistically significant difference (P < 0.05) when compared to the density of RyR2 
labelling in the extra-perinuclear region.  θ indicates a statistically significant difference (P < 0.05) 
when compared to the density of RyR1 labelling in the sub-plasmalemmal region (RyR1 n = 10; RyR2 
n = 14; RyR3 n = 11). 
 
 
3.3.2.5  Ryanodine receptor subtype 3 preferentially clusters in the perinuclear region 
of isolated pulmonary arterial smooth muscle cells 
 
As with the lysosomal labelling, further analysis was carried out to determine 
whether any of the RyR subtypes exhibit a greater propensity to form clusters and, if 
so, whether these clusters are present in any particular region of PASMCs.  The mean 
volume of individual elements of RyR subtype labelling within each region of the 
cells studied was therefore compared, as a larger mean volume would be indicative of 
a greater degree of clustering.  Fig. 3.7 shows that the mean volume of distinct 
elements of RyR3 labelling within the perinuclear region was 2.40 ± 0.33 µm3 (n = 
11; Appendix 1, Table 3.16) which was significantly greater than was observed in 
either the extra-perinuclear (0.72 ± 0.15 µm3, n = 11; P < 0.05; Appendix 1, Table 
3.17) or sub-plasmalemmal (0.47 ± 0.11 µm3, n = 11; P < 0.05; Appendix 1, Table 
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3.18) regions of PASMCs.  Therefore, it would appear that RyR3 clusters, similar to 
lysosomal clusters, are preferentially targeted to the perinuclear region in PASMCs. 
Fig. 3.7 also shows that examination of the mean volume of individual elements 
of RyR2 labelling revealed a greater degree of RyR2 clustering in the extra-
perinuclear region (1.60 ± 0.30 µm3, n = 11; Appendix 1, Table 3.13) when compared 
to the perinuclear region (0.97 ± 0.15 µm3, n = 11; Appendix 1, Table 3.12), though 
this difference was not deemed statistically significant (P > 0.05).  However, the 
mean volume of RyR2 labelling declined significantly in the sub-plasmalemmal 
region (0.46 ± 0.06 µm3, n = 11; P < 0.05; Appendix 1, Table 3.14) when compared 
to either the perinuclear or extra-perinuclear regions.  Thus, in contrast to RyR3 and 
lysosomes, RyR2 clusters appear to be preferentially targeted to the extra-perinuclear 
region of PASMCs. 
Comparison of the mean volume of individual elements of RyR1 labelling (Fig. 
3.7) revealed that there was little difference in the degree of RyR1 clustering between 
the perinuclear (1.04 ± 0.27 µm3, n = 11; Appendix 1, Table 3.8), the extra-
perinuclear (0.71 ± 0.21 µm3, n = 11; Appendix 1, Table 3.9), and the sub-
plasmalemmal regions (0.53 ± 0.08 µm3, n = 11; Appendix 1, Table 3.10).  Thus, 
consistent with the relatively uniform regional density of RyR1 labelling, RyR1 does 
not appear to cluster preferentially within any given region of PASMCs. 
Comparison of the mean volumes of individual elements of RyR subtype 
labelling in Fig. 3.7 demonstrates that RyR3 forms dense clusters in the perinuclear 
region of PASMCs.  This was evident from the finding that RyR3 exhibits a 2-fold 
greater mean volume of labelling (2.40 ± 0.33 µm3, n = 11; Appendix 1, Table 3.16) 
in the perinuclear region than either RyR1 (1.04 ± 0.27 µm3, n = 11; P < 0.05; 
Appendix 1, Table 3.8) or RyR2 (0.97 ± 0.15 µm3, n = 11; P < 0.05; Appendix 1, 
Table 3.12).  By mean volume, there is also evidence for clustering of RyR2 in the 
extra-perinuclear region (1.60 ± 0.30 µm3, n = 11; Appendix 1, Table 3.9) which was 
approximately 2-fold greater within this region than exhibited by either RyR1 (0.71 ± 
0.21 µm3, n = 11; P < 0.05; Appendix 1, Table 3.9) or RyR3 (0.72 ± 0.15 µm3, n = 
11; P < 0.05; Appendix 1, Table 3.17).  However this is approximately 1.5-fold less 
than the mean volume of labelling exhibited by RyR3 in the perinuclear region, 
further demonstrating the preferential localisation of RyR3 clusters in the perinuclear 
region of PASMCs. 
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Fig. 3.7.  Ryanodine receptor subtype 3 preferentially cluster in the perinuclar region of 
pulmonary arterial smooth muscle cells 
Bar chart showing the mean volume of individual elements of RyR subtype labelling in each region 
(µm3; mean ± S.E.M.) across all the PASMCs studied (RyR1, n = 10; RyR2 n = 14; RyR3 n = 11).  * 
indicates a statistically significant difference (P<0.05) when compared to the mean volume of RyR3 
labelling in the perinuclear region. ϕ indicates a statistically significant difference (P < 0.05) when 
compared to mean volume of RyR2 labelling in the extra-perinuclear region. 
 
3.3.3  Examination of the co-localisation between lysosomes and each ryanodine 
receptor subtype in isolated pulmonary arterial smooth muscle cells 
 
From the analysis of the distribution profiles of RyR subtypes and αIgp120 
labelling, perhaps the most striking observation is that dense clusters of both αIgp120 
and RyR3 labelling were found within the perinuclear region of PASMCs.  The 
similar distribution profiles of both αIgp120 and RyR3 labelling would suggest that 
lysosomes may couple with a specific subtype of RyRs, namely RyR3.  With this in 
mind, the co-localisation between each RyR subtype and lysosomes within isolated 
PASMCs was investigated.  This was achieved by analysing the total density, and the 
regional distribution of co-localisation between labelling for αIgp120 and each RyR 
subtype. 
 
3.3.3.1  Lysosomes preferentially co-localise with ryanodine receptor subtype 3 in 
isolated pulmonary arterial smooth muscle cells.  
 
RyR3 showed significantly greater co-localisation with αIgp120 labelling than 
either RyR1 or RyR2.  This is consistent with the observed distribution of both 
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αIgp120 and RyR3, which are both predominantly localised in the perinuclear region.  
Example cells co-labelled for αIgp120 and either RyR3, RyR2 or RyR1 are shown in 
Fig. 3.8A, B and C respectively.  In each example panel a shows a transmitted light 
image of an exemplar cell and panel b shows the distribution of labelling for αIgp120 
(green) relative to the DAPI labelled nucleus (blue) in a 3D reconstruction of a series 
of deconvolved Z-sections (focal depth 0.28 µm, Z step 0.2 µm).  Panel c shows 
another 3D reconstruction of deconvolved Z-section in the same cell representing the 
distribution of labelling for the given RyR subtype (red) relative to the DAPI labelled 
nucleus.  To visualise areas of co-localisation Z-sections were superimposed resulting 
in a deconvolved Z-section showing the distribution of RyR subtype (red), αIgp120 
(green) and areas of co-localisation visualised in yellow, shown in panel d.  Panel e 
shows a 3D reconstruction of the superimposed deconvolved Z-sections showing the 
distribution of labelling for the given RyR subtype (red), αIgp120 (green) and co-
localisation between the two labels (yellow) relative to the DAPI labelled nucleus.  In 
order to allow for visualisation of the position of co-localisation between αIgp120 and 
a given RyR subtype, panel f shows the distribution of each individual element of co-
localisation (yellow) in a 3D reconstruction of deconvolved Z-sections with non-co-
localised elements of αIgp120 and RyR-labelling removed. 
Visual comparison of the cells presented in Fig. 3.8 would suggest that although 
αIgp120 co-localises with all RyR subtypes, there is a greater degree of co-
localisation with RyR3 than with either RyR2 or RyR1.  This is further illustrated in 
Fig. 3.9A which shows the mean (± S.E.M.) density of co-localisation between 
αIgp120 and each RyR subtype across the entire cell volume of the PASMCs 
examined (i.e. no regional subdivision).  RyR3 showed a significantly greater density 
of co-localisation with αIgp120 (0.006 ± 0.0006 µm3 per µm3, n = 11; Appendix 1, 
Table 3.27) when compared to either RyR2 (0.0034 ± 0.0007 µm3 per µm3; n = 14; P 
< 0.05; Appendix 1, Table 3.23) or RyR1 (0.0031 ± 0.0007 µm3 per µm3, n = 10; P < 
0.05; Appendix 1, Table 3.19).  This 2-fold greater density of co-localisation of RyR3 
with αIgp120 provides further confirmation that lysosomes preferentially co-localise 
with RyR3 in PASMCs.  This is also evident from the fact that within the whole cell, 
RyR3 was found to co-localise with 26 ± 3 % (n = 11; Appendix 1, Table 3.31) of the 
total volume of lysosome labelling, whereas labelling for RyR2 and RyR1 co-
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localised with only 16 ± 2 % (n = 10; Appendix 1, Table 3.31) and 15 ± 3 % (n = 14; 
Appendix 1, Table 3.31) of the total volume of lysosomal labelling respectively.   
 
 
 
Fig. 3.8.  Lysosomes preferentially co-localise with ryanodine receptor subtype 3 within isolated 
pulmonary arterial smooth muscle cells  
Example cells showing the degree and spatial distribution of co-localisation between αIgp120 labelling 
and labelling of RyR3 (A), RyR2 (B), and RyR1 (C).  In each case the panels show the following: 
Panel a shows a transmitted light image of the isolated PASMC imaged; Panel b shows a 3D 
reconstruction of a series of deconvolved Z-sections (Z step 0.2 µm) taken through the cell shown in 
panel a showing the spatial distribution of αIgp120-labelled lysosomes (green) in relation to the 
plasma membrane (dotted line) and nucleus (dark blue); Panel c shows a 3D reconstruction of 
deconvolved Z-sections showing the distribution of RyR labelling (red) in relation to the plasma 
membrane and nucleus as indicated in panel b; Panel d shows a deconvolved Z-section (focal depth 
0.28 µm) taken through the PASMC showing the distribution of labelling for αIgp120, the given RyR 
subtype and the co-localisation between the two in relation to the nucleus of the cell (dark blue) and the 
plasma membrane, with areas of co-localisation shown in yellow; Panel e shows a 3D representation of 
RyR subtype and αIgp120 labelling (red and green respectively); Panel f is a 3D reconstruction 
showing individual volumes of co-localisation between αIgp120 and a given RyR subtype. 
 
The preferential co-localisation of lysosomes with RyR3 is further demonstrated 
in Fig. 3.9B, which shows the Pearson product-moment correlation coefficient values 
for the co-localisation between αIgp120 and each RyR subtype.  This coefficient 
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value (ranging from -1 to 1) is an indication of the strength of association between 
two continuous variables.  Fig. 3.9B shows that the co-localisation between αIgp120 
and RyR3 had a significantly greater correlation (0.26 ± 0.01, n = 11; Appendix 1, 
Table 3.27) than observed for either RyR2 and αIgp120 labelling (0.18 ± 0.01, n = 
14; P < 0.05; Appendix 1, Table 3.23) or RyR1 and αIgp120 labelling (0.16 ± 0.01, n 
= 10; P < 0.05; Appendix 1, Table 3.19).  It is important to note, that the Pearson 
product-moment correlation coefficient value is a measure of the correlation in the 
whole cell and not focussed on any particular region.  Therefore, despite the greater 
degree of correlation between αIgp120 and RyR3 than for either RyR2 or RyR1, this 
is likely to be an underestimate of the degree of correlation between αIgp120 and 
RyR3 in the perinuclear region.  The greater Pearson coefficient values, together with 
the greater density of co-localisation across the entire cell volume does, however, 
provide further evidence in support of the proposal that lysosomes preferentially co-
localise with RyR3 in PASMCs. 
 
 
 
 
Fig. 3.9.  Co-localisation is greater in cells co-labelled for RyR3 than those co-labelled for RyR2 
and RyR1  
A Bar chart showing the density of co-localisation (µm3 per µm3; mean ± S.E.M.) between αIgp120 
labelling and each RyR subtype within the whole cell volume.  B The Pearson product-moment 
correlation coefficient for each RyR subtype indicating linear dependence (mean ± S.E.M.).  * 
indicates a statistically significant difference ( P< 0.05) when compared to the RyR3/αIgp120 co-
localisation density or Pearson correlation coefficient (RyR1, n = 10; RyR2, n = 14; RyR3, n = 11). 
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3.3.4  Examination of the regional distribution of co-localisation between lysosomes 
and each ryanodine receptor subtype in isolated pulmonary arterial smooth muscle 
cells 
 
The initial comparison of αIgp120 co-localisation with each RyR subtype 
suggests that αIgp120 preferentially co-localises with RyR3 (Fig. 3.8, Fig. 3.9).  
Furthermore, visual comparison of αIgp120-labelled cells co-labelled for RyR1, 
RyR2 or RyR3 strongly suggests that the majority of co-localisation was concentrated 
in the perinuclear region of the cell (Fig. 3.8).  However, further analysis of the 
intracellular distribution of co-localisation between αIgp120 and each RyR subtype 
was required in order to determine whether co-localisation is localised to any 
particular region of PASMCs.  Fig. 3.10 shows the mean (± S.E.M.) density of co-
localisation between αIgp120 labelling and labelling for each RyR subtype within 
each region of the cells studied.   
 
3.3.4.1  Lysosomes preferentially co-localise with ryanodine receptor subtype 3 in the 
perinuclear region of isolated pulmonary arterial smooth muscle cells 
 
Comparing the density of co-localisation across the 3 regions it appears that 
αIgp120 not only preferentially co-localises with RyR3, but in addition this co-
localisation is preferentially targeted to a particular region of the cell.  Fig. 3.10 shows 
that the density of co-localisation between αIgp120 and RyR3 was greatest in the 
perinuclear region (0.012 ± 0.002 µm3 per µm3, n = 11; Appendix 1, Table 3.28), 
which was approximately 4-fold greater than in the extra-perinuclear region (0.003 ± 
0.001 µm3 per µm3, n = 11; P < 0.05; Appendix 1, Table 3.29) and 60-fold greater 
than in the sub-plasmalemmal region (0.0002 ± 0.0002 µm3 per µm3, n = 11; P < 
0.05; Appendix 1, Table 3.30).  Moreover, 41 ± 6 % of the total volume of lysosomal 
labelling in the perinuclear region was co-localised with RyR3 (n = 11, Appendix 1, 
Table 3.32).  This is in marked contrast to the extra-perinuclear region and sub-
plasmalemmal regions, in which only 17 ± 7 % and 2 ± 1 % (n = 11, Appendix 1, 
Table 3.32), respectively, of the lysosomal labelling was co-localised with RyR3.   
Importantly, Fig. 3.10 also shows that the density of co-localisation between 
RyR3 and αIgp120 in the perinuclear region (0.012 ± 0.002 µm3 per µm3, n = 11; 
 87 
Appendix 1, Table 3.28) was significantly greater than the density of co-localisation 
in the perinuclear region of cells co-labelled for αIgp120 and either RyR2 (0.0064 ± 
0.0010 µm3 per µm3, n = 14; P<0.05; Appendix 1, Table 3.24) or RyR1 (0.0057 ± 
0.0015 µm3 per µm3, n = 10; P<0.05; Appendix 1, Table 3.20).  This is consistent 
with the distribution profiles exhibited by both αIgp120 and RyR3 labelling and 
suggests that lysosomes preferentially co-localise with RyR3 in the perinuclear region 
of PASMCs. 
 
3.3.4.2  Co-localisation of lysosomes with each ryanodine receptor subtype in the 
extra-perinuclear region of isolated pulmonary arterial smooth muscle cells 
 
In contrast to the perinuclear region, Fig. 3.10 also shows that within the extra-
perinuclear region there was no significant difference in the density of co-localisation 
between cells co-labelled for RyR3 and αIgp120 (0.0033 ± 0.0012, n = 11; Appendix 
1, Table 3.29) and either RyR2 and αIgp120 (0.0053 ± 0.0018, n = 14, Appendix 1, 
Table 3.25) or RyR1 and αIgp120 (0.0027 ± 0.0009, n = 10; Appendix 1, Table 3.21).  
Although there was a greater degree of co-localisation between RyR2 and lysosomes, 
the difference between the each of the RyR subtypes was not statistically significant.  
Given the predominance of RyR2 within the extra-perinuclear region, one might 
expect a significant difference in the degree of co-localisation of lysosomes with this 
RyR subtype.  The absence of any significant difference would therefore suggest that 
within this region, lysosomes do not preferentially co-localise with a particular RyR 
subtype.  The greater degree of co-localisation of RyR2 with lysosomes is likely to be 
due to the greater density of RyR2 labelling when compared to RyR1 or RyR3 (Fig. 
3.6) and therefore the coincidence of αIgp120 and RyR2 labelling occurring within a 
given area would be greater than for either RyR1 or RyR3.  Given the marked decline 
in RyR3 labelling between the perinuclear and extra-perinuclear regions, this would 
indicate that there is a high degree of co-localisation of lysosomes and RyR3 relative 
to RyR1 or RyR2. 
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3.3.4.3  Co-localisation of lysosomes with each ryanodine receptor subtype in the 
sub-plasmalemmal region of isolated pulmonary arterial smooth muscle cells 
 
Fig. 3.10 also shows that there was little or no co-localisation between αIgp120 
and any of the 3 RyR subtypes in the sub-plasmalemmal region.  Furthermore, similar 
to the extra-perinuclear region, there was no significant difference in the density of 
co-localisation between the 3 RyR subtypes and αIgp120 in the sub-plasmalemmal 
region, with cells co-labelled for RyR3 and αIgp120 measuring 0.0002 ± 0.00015 
µm3 per µm3 (n = 11; Appendix 1, Table 3.30) compared to cells co-labelled for 
αIgp120 and either RyR2 or RyR1 measuring 0.0005 ± 0.0002 µm3 per µm3 (n = 14; 
Appendix 1, Table 3.26) and 0.0011 ± 0.0003 µm3 per µm3 (n = 10; Appendix 1, 
Table 3.22) respectively. 
Thus, it would appear that lysosomes not only co-localise preferentially with 
RyR3, but they are also spatially localised such that this co-localisation is 
predominantly found in the perinuclear region of PASMCs.  This is consistent with 
the predominance of perinuclear localisation observed in both RyR3 and αIgp120 
labelling.   
 
 
 
Fig. 3.10.  Lysosomes preferentially co-localise with ryanodine receptor subtype 3 in the 
perinuclear region of pulmonary arterial smooth muscle cells  
Bar chart showing the density of co-localisation between αIgp120 labelling and each RyR subtype 
(µm3 per µm3; mean ± S.E.M.) within all 3 of the designated regions of subdivided PASMCs.  * 
indicates a statistically significant difference (P < 0.05) when compared to the RyR3 labelling in the 
perinuclear region (RyR1, n = 10; RyR2, n = 14; RyR3, n = 11). 
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3.3.4.4  Lysosomes preferentially cluster with ryanodine receptor subtype 3 in the 
perinuclear region of isolated pulmonary arterial smooth muscle cells 
 
In addition to the density of co-localisation between αIgp120 and each RyR 
subtype, the mean (± S.E.M.) volume of individual elements of co-localisation was 
also examined.  Fig. 3.11 shows that the mean volume of co-localisation between 
RyR3 and αIgp120 was approximately 2-fold and 20-fold greater in the perinuclear 
region (0.81 ± 0.15 µm3, n = 11; Appendix 1, Table 3.28) than in the extra-perinuclear 
(0.35 ± 0.08 µm3, n = 11; P < 0.05; Appendix 1, Table 3.29) and sub-plasmalemmal 
(0.04 ± 0.02 µm3, n = 11; P < 0.05; Appendix 1, Table 3.30) regions respectively.  
Furthermore, in the perinuclear region, the mean volume of co-localisation between 
RyR3 and αIgp120 was 3-fold and 2-fold greater than the mean volume of co-
localisation between αIgp120 and either RyR1 (0.30 ± 0.03 µm3, n = 10; P < 0.05; 
Appendix 1, Table 3.20), or RyR2 (0.38 ± 0.04 µm3, n = 14; P < 0.05; Appendix 1, 
Table 3.24) in the same region (Fig. 3.11).   
 
 
 
Fig. 3.11.  Lysosome clusters preferentially co-localise with clusters of ryanodine receptor 3 in the 
perinuclar region of pulmonary arterial smooth muscle cells 
Bar chart showing the mean volume of individual elements of co-localisation within each region (µm3; 
mean ± S.E.M.) between αIgp120 and each RyR subtype across all the PASMCs studied (RyR1, n = 
10; RyR2 n = 14; RyR3 n = 11).  * indicates a statistically significant difference (P < 0.05) when 
compared to the mean volume of co-localisation between αIgp120 and RyR3 labelling in the 
perinuclear region.  θ indicates a statistically significant difference (P < 0.05) when compared to mean 
volume of co-localisation between αIgp120 and RyR1 labelling in the sub-plasmalemmal region. 
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Greater volumes of individual elements of co-localisation are indicative of a 
greater degree of clustering and therefore, the data presented in Fig. 3.11 is consistent 
with the greatest density of co-localisation occurring between RyR3 and αIgp120 in 
the perinuclear region of PASMCs.  Taken together these data strongly suggest that, 
not only do lysosomal clusters preferentially co-localise with clusters of RyR3, but 
also these lysosome-RyR3 clusters are targeted to the perinuclear region of PASMCs. 
 
3.3.4.5  The density of ryanodine receptor subtype and lysosomal labelling was equal 
across all isolated pulmonary arterial smooth muscle cells studied  
 
It is worth noting that the significant difference in co-localisation between 
αIgp120 and the 3 RyR subtypes is not due to unequal labelling of either αIgp120 or 
RyR across the cells examined.  This is demonstrated in Fig. 3.12 which shows that 
there is no significant difference in the density of αIgp120 labelling in cells co-
labelled for either RyR3 (0.023 ± 0.002 µm3 per µm3, n = 11; Appendix 1, Table 
3.33) RyR2 (0.021 ± 0.0017 µm3 per µm3, n = 14; Appendix 1, Table 3.33) or RyR1 
(0.019 ± 0.0035 µm3 per µm3, n = 10; Appendix 1, Table 3.33).   
 
 
 
Fig. 3.12.  Differences in co-localisation is not due to unequal antibody labelling between RyR 
subtypes. 
Bar chart showing the density of labelling (µm3 per µm3; mean ± S.E.M.) for both αIgp120 and RyR 
subtype within the whole cell volume.  αIgp120 labelling was divided according to the RyR subtype 
with which it was co-labelled.  
 
Similarly Fig. 3.12 shows that there was no significant difference in the whole 
cell density of RyR3 (0.032 ± 0.0028 µm3 per µm3, n = 11; Appendix 1, Table 3.33) 
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RyR2 (0.0328 ± 0.0038 µm3 per µm3, n = 14; Appendix 1, Table 3.33) or RyR1 
labelling (0.032 ± 0.004 µm3 per µm3, n = 10; Appendix 1, Table 3.33).  Thus, with 
equal total labelling across the cells, the preferential co-localisation of αIgp120 with 
RyR3 suggests that, in PASMCs RyR3 forms a close association with clusters of 
lysosomes. 
 
3.3.5  Inhibition of ryanodine receptor subtypes 1 and 3 by dantrolene abolishes 
global Ca2+ waves but not Ca2+ bursts in response to NAADP 
 
The data presented thus far suggest that lysosomes are predominantly localised 
in the perinuclear region of isolated PASMCs.  Labelling of RyR subtypes revealed 
that RyR3 is the predominant subtype within this region.  Furthermore, measurement 
of the density of co-localisation between αIgp120 and individual RyR subtypes 
revealed that the greatest degree of co-localisation was in the following order: RyR3 
>> RyR2 ≥ RyR1 suggesting that lysosomes and RyR3 form a trigger zone for Ca2+ 
signalling by NAADP.  To further verify this proposal, the effect on NAADP-
mediated Ca2+ release by selectively blocking RyR1 and RyR3 with dantrolene was 
examined.  Dantrolene selectively blocks Ca2+ release via RyR3 and RyR1 but is 
without effect on RyR2 (Zhao et al., 2001).  Thus, the rank order of co-localisation 
between lysosomes and the 3 subtypes (RyR3 >> RyR2 ≥ RyR1) offered the 
opportunity to determine whether or not RyR3 underpinned the amplification of 
NAADP-mediated Ca2+ bursts into global Ca2+ waves. 
The effect of dantrolene on Ca2+ transients triggered by intracellular dialysis 
from a patch pipette of NAADP (10 nM) was studied in the whole-cell configuration 
of the patch clamp technique and under current clamp conditions (I = 0), with changes 
in the intracellular Ca2+ concentration reported by the Fura-2 fluorescence ratio 
(F340/F380).  An exemplar record is shown in Fig. 3.13A.  The upper panel shows a 
series of pseudocolour images of the Fura-2 fluorescence ratio recorded in an isolated 
PASMC during the intracellular dialysis of 10 nM NAADP, with the record of the 
Fura-2 fluorescence ratio against time shown in the bottom panel.  Intracellular 
dialysis of 10 nM NAADP induced spatially restricted Ca2+ bursts (indicated by the 
white arrow in Fig. 3.13A, Image 2) which either returned to basal levels or 
proceeded and then triggered a global Ca2+ wave.  The mean Fura-2 fluorescence ratio 
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(± S.E.M.) increased from a basal level of 0.51 ± 0.05 to a peak of 1.42 ± 0.21 before 
returning to baseline (n = 5).  
 
 
 
Fig. 3.13.  Dantrolene inhibits the NAADP-evoked global Ca2+ wave in pulmonary arterial 
smooth muscle cells 
A Top panel, series of pseudocolour images of the Fura-2 fluorescence ratio recorded in an isolated 
PASMC during the intracellular dialysis of 10 nM NAADP.  NAADP evokes a Ca2+ burst indicated by 
the white arrow (image 2) which precedes a global Ca2+ wave.  Bottom panel, corresponding record of 
the Fura-2 fluorescence ratio against time for the cell imaged in the top panel.  Access to the cytosol 
via the formation of the whole-cell configuration is indicated by the two bars at the beginning of the 
record.  Note, the loss of a GΩ seal is indicated at the end of the record by three bars.  B Top panel, 
series of pseudocolour images of the Fura-2 fluorescence ratio recorded in an isolate PASMC during 
the intracellular dialysis of 10 nM NAADP following the preincubation (15 min) with 30 µM 
dantrolene.  Dantrolene inhibited the global Ca2+ wave but not the localised Ca2+ bursts (indicated in 
image 3 by the white arrow) in response to NAADP.  Bottom panel, corresponding record of the Fura-2 
fluorescence ratio against time for the cell imaged in the top panel. 
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Following preincubation (15 min) of PASMCs with 30 µM dantrolene, 
intracellular dialysis of 10 nM NAADP failed to induce a global Ca2+ wave.  
However, dantrolene did not inhibit NAADP-induced Ca2+ bursts.  Fig. 3.13B shows 
one such record.  The upper panel shows a series of pseudocolour images in which the 
NAADP-induced Ca2+ burst is indicated (white arrow, image 3) with the record of the 
Fura-2 fluorescence ratio against time shown in the lower panel.  In the presence of 
dantrolene the change in the Fura-2 fluorescence ratio was markedly attenuated, 
increasing from a basal level of 0.55 ± 0.03 to a peak of only 0.83 ± 0.05 (n = 6).  The 
bar chart in Figure 3.14 shows that the mean change in the Fura-2 fluorescence ratio 
triggered by NAADP was markedly decreased from 0.91 ± 0.2 in the absence of 
dantrolene (n = 5; Appendix 1, Table 3.34) to 0.28 ± 0.03 (n = 6, P < 0.05; Fig 3.13; 
Appendix 1, Table 3.35) in the presence of dantrolene (30 µM).  The fact that 
dantrolene abolished the global Ca2+ wave but not the preceding Ca2+ burst triggered 
by NAADP is consistent with the effect of blocking all RyRs with ryanodine and of 
depleting SR Ca2+ stores with thapsigargin (Boittin et al., 2002).  When taken 
together these data therefore support the proposal that RyR3 is a pre-requisite for the 
amplification of NAADP-induced Ca2+ bursts into global Ca2+ waves.  Thus, it is 
likely that RyR3, but not RyR1 or RyR2 is targeted to lysosome-SR junctions to 
comprise a trigger zone for Ca2+ signalling by NAADP. 
 
3.3.5.1  Dantrolene is without effect on ionomycin-induced Ca2+ influx in pulmonary 
arterial smooth muscle cells 
 
A previous report has suggested that dantrolene may inhibit the fluorescence 
reporting capability of Fura-2 (Nohmi et al., 1991).  Therefore, it was important to 
determine whether or not dantrolene, when applied to PASMCs, compromised the 
ability of Fura-2 to reliably report changes in intracellular Ca2+.  To this end I 
investigated the effects of dantrolene on the ability of the ionophore ionomycin to 
raise the intracellular Ca2+ concentration in PASMCs.  Application of ionomycin (1 
µM) induced an increase in the Fura-2 fluorescence ratio from 0.43 ± 0.02 to 0.74 ± 
0.05 in the absence, and from 0.42 ± 0.01 to 0.78 ± 0.05 in the presence of 30 µM 
dantrolene.  The bar chart in Fig. 3.14 shows the mean (± S.E.M.) change in the 
fluorescence ratio in response to ionomycin (1 µM) in the absence (0.31 ± 0.04, n = 
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11; Appendix 1, Table 3.36) and following pre-incubation (15 minutes) with 30 µM 
dantrolene (0.36 ± 0.05, n = 12; Fig. 3.14; Appendix 1, Table 3.36).  These data show 
quite clearly that dantrolene was without effect on the change in the Fura-2 
fluorescence ratio resulting from ionomycin-induced Ca2+ influx, in marked contrast 
to its inhibitory effect on Ca2+ signalling by NAADP.  It is unlikely, therefore, that 
dantrolene compromises the ability of Fura-2 to report changes in intracellular Ca2+ 
concentration under the conditions of my experiments. 
 
 
 
Fig. 3.14.  Dantrolene inhibits the global Ca2+ release in response to NAADP but not ionomycin in 
pulmonary arterial smooth muscle cells 
Bar chart showing the peak change in the Fura-2 fluorescence ratio (mean ± S.E.M.) recorded in 
PASMCs in response to either the intracellular dialysis of NAADP (10 nM) or extracellular application 
of ionomycin (1 mM).  The response to NAADP and ionomycin were recorded in either the absence 
(white box; NAADP n = 5; ionomycin n = 11) or presence of 30 µM dantrolene (grey box; NAADP n 
= 6; ionomycin n = 12).  * indicates a statistically significant difference (P < 0.05) when compared to 
the peak change in fluorescence ratio in response to 10 nM NAADP in the absence of 30 µM 
dantrolene. 
 
 
3.4  Discussion 
 
The data presented in this chapter provide further evidence in support of a two-
pool mechanism for NAADP-dependent Ca2+ signalling in pulmonary arterial smooth 
muscle cells (Boittin et al., 2002; Churchill et al., 2001a).  These data also strongly 
suggest that this two-pool mechanism is dependent upon lysosomal clusters that 
preferentially co-localise with SR regions to which a subpopulation of RyRs, namely 
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RyR3, is targeted to form a trigger zone for Ca2+ signalling by NAADP within the 
perinuclear region of PASMCs. 
 
3.4.1  Lysosomes are predominantly localised in the perinuclear region of 
pulmonary arterial smooth muscle cells. 
 
Visualisation of lysosomes with the lysosomal marker aIgp120 revealed that 
these organelles were present throughout the cytoplasm of PASMCs.  However, the 
cellular distribution of lysosomes labelled with aIgp120 was clearly non-uniform, 
with the majority of labelling present within the perinuclear region of PASMCs.  
Indeed, the density of lysosomal labelling in the perinuclear region was 
approximately 2-fold and 4-fold greater than that observed in the extra-perinuclear 
and subplasmalemmal regions, respectively.  Furthermore, lysosomes appeared to 
form dense clusters within the perinuclear region, whereas outside this region a more 
diffuse labelling pattern was observed.  This is reflected in the mean volume of 
individual elements of lysosomal labelling (which included as one all elements of 
labelling separated by a distance below the resolution of the deconvolution 
microscopy used here, < 100 nm).  This was greatest in the perinuclear region and 
declined in the extra-perinuclear region, and further still in the subplasmalemmal 
region.  It would appear, therefore, that lysosomes form dense clusters within the 
perinuclear region of the cell.  This is consistent with previous reports in which 
LysoTracker Red labelled lysosomes were shown to form dense clusters in PASMCs 
(Kinnear et al., 2004).  Furthermore, this clustering mirrored the spatially restricted 
nature of the NAADP-mediated Ca2+ bursts observed in PASMCs, which has been 
proposed to be due to the mobilisation by NAADP of lysosome-related Ca2+ stores 
(Boittin et al., 2002; Kinnear et al., 2004) as illustrated in Fig. 3.4.  It is notable, 
therefore, that there have been reports of lysosome clusters in the perinuclear region 
of other mammalian cells such as mouse fibroblasts (Falcon-Perez et al., 2005) a rat 
kidney fibroblast cell line (Reaves et al., 1996) and the COS-7 cell line (Matsushita et 
al., 2004). 
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3.4.2  Ryanodine receptor subtypes exhibit different spatial distributions 
 
In an identical method used for the analysis of lysosomal labelling, examination 
of the distribution of RyR subtypes 1, 2 and 3 revealed that, despite a similar density 
of labelling in PASMCs, each subtype exhibited quite different patterns of spatial 
organisation. 
 
3.4.2.1  Ryanodine receptor subtype 3 is predominantly targeted to the perinuclear 
region of isolated pulmonary arterial smooth muscle cells  
 
Analogous to the distribution of lysosomes, RyR3 exhibited a highly polarised 
spatial distribution, with the greatest density of RyR3 labelling localised to the 
perinuclear region.  The density of labelling in this region was found to be 
approximately 4-fold greater than in the extra-perinuclear region and 14-fold greater 
than in the sub-plasmalemmal region.  Moreover RyR3 was found to be the 
predominant RyR subtype within the perinuclear region, with a 2-fold greater density 
of labelling than for either RyR1 or RyR2.  Furthermore, the mean volume of 
individual elements of RyR3 labelling was greatest within the perinuclear region and 
declined 3-fold and 5-fold in the extra-perinuclear and sub-plasmalemmal region, 
respectively.  The mean volume of individual elements of RyR3 labelling was also 2-
fold greater than was observed for either RyR1 or RyR2.  Therefore, RyR3 exhibits a 
high degree of clustering within the perinuclear region of PASMCs, and such 
extensive clustering was not observed for either RyR1 or RyR2.  That RyR3 is the 
predominant subtype found in the perinuclear region of PASMCs and declines in 
density outside of this region may indicate that RyR3 performs a highly specialised 
function within this region of the cell. 
 
3.4.2.2  Ryanodine receptor subtype 2 is predominantly localised to the extra-
perinuclear region of isolated pulmonary arterial smooth muscle cells 
 
In marked contrast to the immediate decline of RyR3 labelling outside the 
perinuclear region, the density of RyR2 labelling increased significantly between the 
perinuclear and the extra-perinuclear region.  Thus, RyR2 labelling in the extra-
perinuclear region was 2-fold and 6-fold greater than was observed in the perinuclear 
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and sub-plasmalemmal region respectively.  Such a concentration of RyR2 labelling 
within the extra-perinuclear region was also reflected in the mean volume of 
individual elements of labelling.  This was approximately 2-fold greater than that 
observed in the perinuclear region, and 3-fold greater than the sub-plasmalemmal 
region.  It seems likely, therefore that RyR2 may form clusters preferentially within 
this region.  Not only was RyR2 labelling concentrated in the extra-perinuclear 
region, but it would also appear that it is the predominant RyR subtype within this 
region.  This was confirmed by the fact that that the density of RyR2 labelling was 3-
fold greater within this region than for either RyR1 or RyR3.  Moreover the mean 
volume of labelling was 2-fold greater than was observed for RyR1 and RyR3.  
Together these suggest that RyR2 is the predominant subtype within this region and 
this may inform on its role with respect to Ca2+ signalling in pulmonary arterial 
smooth muscle cells (see below). 
 
3.4.2.3  Ryanodine receptor subtype 1 is the predominant subtype present in the sub-
plasmalemmal region of isolated pulmonary arterial smooth muscle cells 
 
In contrast to both RyR3 and RyR2, RyR1 was uniformly distributed 
throughout the cell with no significant difference in the density of labelling between 
all 3 regions.  Due to this even distribution profile, RyR1 would appear to be the 
predominant RyR subtype present in the sub-plasmalemmal region, with a 3-fold and 
6-fold greater density of labelling than for RyR2 and RyR3, respectively.  This 
suggests that RyR1 may play a significant role with respect to Ca2+ signalling 
between the SR and the plasma membrane and may therefore couple to Ca2+-activated 
ion channels in the plasma membrane, such as the large-conductance Ca2+-activated 
potassium channels (KCa1.1).  RyR1 may therefore be the RyR subtype responsible 
for Ca2+ release from “peripheral” SR that, via the activation of KCa1.1, underpins 
cADPR-mediated hyperpolarisation of PASMCs and dilation of pulmonary arteries in 
response to the activation of adenylyl cyclase by G-protein coupled receptors (Boittin 
et al., 2003).  This possibility is highlighted by findings in other cell types that 
suggest that RyR1 may form a close association with and therefore modulate the 
activity of the plasma membrane-bound TRPC3 (Woo et al., 2008). 
The above data suggest that within each region of the subdivided PASMCs 
studied there exists a predominant RyR subtype, with RyR3, RyR2 and RyR1 being 
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the foremost subtype in the perinuclear, extra-perinuclear and sub-plasmalemmal 
regions, respectively. 
 
3.4.3  Lysosomes preferentially co-localise with ryanodine receptor subtype 3 in the 
perinuclear region to comprise a trigger zone for Ca2+ signalling by NAADP 
 
3.4.3.1  Lysosomes predominantly co-localise with ryanodine receptor 3 in the 
perinuclear region of pulmonary arterial smooth muscle cells 
 
Despite there being no cell-to-cell variation in the density of labelling for 
aIgp120 or either of the RyR subtypes, the density of co-localisation between 
αIgp120 and RyR within the whole cell was approximately 2-fold greater than for 
either RyR1 or RyR2.  This suggests that lysosomes preferentially co-localise with 
RyR3. However, analysis of co-localisation between αIgp120 and each RyR subtype 
by region of the cell was required in order to provide further insight into the 
components that underpin the mechanism of NAADP-mediated Ca2+ signalling in 
PASMCs.  
Within the perinuclear region, 41 % of all lysosomal labelling co-localised with 
RyR3 compared with 17 % and 2 % in the extra-perinuclear and sub-plasmalemmal 
regions, respectively.  This produced a density of co-localisation in the perinuclear 
region that was 4-fold greater than was observed in the extra-perinuclear region and 
60-fold greater than observed in the sub-plasmalemmal region.  In marked contrast to 
RyR3, only 13 % of lysosomal labelling co-localised with either RyR2 or RyR1 
respectively in the perinuclear region.  That lysosomes may associate with RyR1 and 
RyR2 to a lesser degree than with RyR3 in this region was also reflected in the fact 
that the density of co-localisation between aIgp120 and either RyR2 or RyR1 was 2-
fold lower than for RyR3.  Moreover, the mean volume of individual elements of co-
localisation between RyR3 and lysosomal labelling was 2-fold and 20-fold greater in 
the perinuclear region than in the extra-perinuclear and sub-plasmalemmal regions, 
respectively.  Furthermore, the mean volume of co-localisation between RyR3 and 
lysosomes was 2-fold greater than for either RyR2 or RyR1 in the perinuclear region.   
When taken together with the above, these data suggest that lysosomes 
primarily cluster within the perinuclear region of PASMCs and that these clusters 
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preferentially co-localise with RyR3 and provides a rank order of co-localisation of: 
RyR3 >> RyR2 ≥ RyR1.  It would appear, therefore, that lysosomes and RyR3 are 
held in a close association in PASMCs and thereby comprise a trigger zone for Ca2+ 
signalling by NAADP.  
 
3.4.3.2  Dantrolene inhibits NAADP-induced global Ca2+ waves but not Ca2+ bursts 
in isolated pulmonary arterial smooth muscle cells 
 
In order to functionally confirm that lysosomes co-localise with RyR3 to form a 
trigger zone for NAADP-dependent Ca2+ signalling, dantrolene was used to 
distinguish between RyR2 and RyR3 / RyR1.  Intracellular dialysis of 10 nM NAADP 
into isolated PASMCs resulted in global Ca2+ waves.  These waves were the result of 
Ca2+ bursts that breached the threshold for, and were subsequently amplified by CICR 
via RyRs as described in previous reports (Boittin et al., 2002).  Pre-incubation with 
dantrolene resulted in the inhibition of NAADP-mediated global Ca2+ waves.  
However, in the presence of dantrolene Ca2+ bursts were still observed, suggesting 
that dantrolene was not inhibiting NAADP-mediated Ca2+ release from lysosomes but 
rather the initial amplification process via CICR.  That Ca2+ bursts were observed in 
the presence of dantrolene without initiation of a global Ca2+ wave was reminiscent of 
the effect of both ryanodine and thapsigargin on NAADP-mediated Ca2+ release in 
PASMCs (Boittin et al., 2002).  The effect of dantrolene is therefore consistent with 
the immunocytochemical data presented above, in that it supports the view that 
NAADP-mediated Ca2+ bursts from lysosomes are initially amplified by CICR from 
the SR via RyR3.  This first step is pivotal to the amplification of spatially restricted 
Ca2+ bursts into global Ca2+ waves, but the onward propagation into a global Ca2+ 
wave may be more complex. 
 
3.4.4  Why might ryanodine receptor subtype 3 be specifically targeted to lysosome-
SR junctions? 
 
Clearly, my data suggest that lysosomes and RyR3 comprise a trigger zone for 
Ca2+ signalling by NAADP.  However, it is important to ask why this association may 
be RyR subtype specific.  One potential factor that could be of relevance in this 
respect is that of identified variations in the regulation of each RyR subtype by Ca2+. 
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The threshold for activation of RyR1, RyR2 and RyR3 by cytoplasmic Ca2+ 
concentration is approximately 100 nM for all 3 subtypes (Chen et al., 1997a; Chen et 
al., 1997b; Li et al., 2001).  However, of particular note is that the estimated EC50 for 
RyR2 and RyR3 differ significantly with half maximal activation at ~250 nM and 
~400 nM for RyR2 and RyR3, respectively (Chen et al., 1997b; Li et al., 2001).  The 
higher level of half maximal activation by Ca2+ exhibited by RyR3 allows for a higher 
“margin of safety” with respect to amplification of initial NAADP-mediated Ca2+ 
bursts via CICR.  For example, the higher threshold for activation by CICR of RyR3 
when compared to RyR2 could reduce the possibility of false amplification of 
subthreshold Ca2+ release events within the lysosome-SR junction. 
In addition to the EC50, the mean channel open time versus the cytoplasmic Ca2+ 
concentration for each RyR subtype is different.  The mean open time for RyR2 and 
RyR3 are similar and each exhibit a ~10-fold increase in mean open time over their 
activation range.  By contrast, the mean open time for RyR1 is much lower and only 
increases 2-fold over the range of Ca2+ concentration that confers channel activation 
(Chen et al., 1997b; Li et al., 2001).  Furthermore, the observed open probability (Po) 
versus cytoplasmic Ca2+ concentration curves for each subtype show that RyR3 
exhibits a greater increase in the Po (0-1) than does RyR2 (0-0.9) and even more so 
than for RyR1 (0-0.2) which exhibits little gain in Po with increasing Ca2+ 
concentration (Chen et al., 1997b; Li et al., 2001).  Thus, of the 3 RyR subtypes 
RyR3 would provide the greatest degree of amplification of Ca2+ bursts from 
lysosome-related Ca2+ stores. 
A further factor that may be of significance is the sensitivity of each RyR to 
inactivation by Ca2+, which also varies between each of the RyR subtypes.  The IC50 
for RyR3 is 3 mM, which may be significantly less sensitive to inactivation than 
RyR2 (IC50 = 2mM).  Nevertheless, both RyR3 and RyR2 activity have been 
observed at Ca2+ concentrations > 10 mM (Chen et al., 1997b; Li et al., 2001).  In 
contrast, RyR1 is inactivated by Ca2+ within the µM range and can be completely 
inactivated at 1 mM Ca2+ (Chen et al., 1997b).  The far greater sensitivity of RyR1 to 
inactivation by Ca2+ may also explain, in part, the reduced gain in Po for RyR1 
relative to RyR2 and RyR3.  It is clear, therefore, that RyR1 would be poorly suited to 
a role in the amplification of Ca2+ bursts within lysosome-SR junctions as it would 
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likely be inactivated at the high Ca2+ concentrations reached within the junctional 
space upon release of Ca2+ bursts from the lysosome-related stores.   
With the aforementioned facts considered, it is clear that RyR3 would provide a 
greater margin of safety with respect to the amplification of Ca2+ bursts within 
lysosome-SR junctions. Moreover, once the threshold for CICR via RyR3 is 
breached, RyR3 would offer the greatest potential amplification via CICR and its 
relative insensitivity to inactivation by high (mM) Ca2+ concentrations would limit the 
possibility of failure with respect to amplification of received Ca2+ signals. It is also 
possible, therefore, that the targeting of RyR3 to lysosome-SR junctions may be key 
to the all-or-none manner in which NAADP-induced Ca2+ bursts trigger global Ca2+ 
waves.  However, the density of RyR3 labelling declines markedly outside the 
perinuclear region and this fact does not suggest that RyR3 is key to the development 
of a propagating and global Ca2+ wave.   
 
3.4.5  How may a propagating global Ca2+ wave be precipitated following 
amplification of Ca2+ bursts by ryanodine receptor subtype 3 within lysosome-SR 
junctions? 
 
Following amplification of NAADP-mediated Ca2+ bursts a propagating, global  
Ca2+ wave must arise from the lysosome-SR junction.  However, the density of RyR3 
labelling declines by approximately 4-fold between the perinuclear region and the 
extra-perinuclear region, and there is a 14-fold decline in the density of RyR3 labeling 
from the perinuclear region to the sub-plasmalemmal region.  This polarised 
distribution suggests that RyR3 is unlikely to play a role in signal propagation beyond 
the perinuclear region after the initial amplification process has occurred. 
In marked contrast to what was observed with RyR3, the density of RyR2 
labelling increased markedly (2-fold) within the extraperinuclear region of the cell 
when compared to the perinuclear region, but decreased 6-fold in the sub-
plasmalemmal region relative to the extra-perinuclear region.  Furthermore, RyR2 
was found to be the predominant subtype within the extra-perinuclear region with a 
~3-fold greater density of labelling than for either RyR1 or RyR3.  This distribution in 
itself suggests that RyR2 rather than RyR1, may function to carry a propagating Ca2+ 
wave away from lysosome-SR junctions, and this suggestion is supported by 
consideration of the properties of RyR regulation by Ca2+.  Thus, RyR2 has a lower 
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EC50 for CICR than RyR3 and is less sensitive to inactivation by Ca2+ than RyR1.  
Therefore, RyR2 would ensure that, once a Ca2+ wave has been initially amplified by 
RyR3, propagation by CICR would be less prone to failure.  Thus the functional 
properties of RyR2 lend it well to a role in the propagation of a global Ca2+ wave 
away from lysosome-SR junctions, in much the same way as RyR2 supports the 
propagating wave initiated by CICR in response to voltage-gated Ca2+ influx in 
cardiac muscle (Macgregor et al., 2007). 
In conclusion, lysosomes form junctional complexes with regions of the SR 
containing a high density of RyR3 to comprise a trigger zone for Ca2+ signalling by 
NAADP. Within this trigger zone NAADP-dependent Ca2+ bursts are amplified in an 
all-or-none manner by CICR via RyR3.  Thereafter, a propagating global Ca2+ wave 
could be developed by subsequent recruitment of RyR2 by CICR as this amplified 
signal exits lysosome-SR junctions (Fig. 3.15). 
 
Fig. 3.15.  Schematic representation of the trigger zone for Ca2+ signalling by NAADP in 
pulmonary arterial smooth muscle cells 
The trigger zone comprises lysosomes closely opposed to RyR3 on the SR.  NAADP evokes Ca2+ 
bursts from the lysosomes which are then amplified by Ca2+-induced Ca2+ release (CICR) via RyR3.  
The propagating global Ca2+ wave is likely amplified beyond the lysosome-SR junctions by further 
CICR via RyR2. 
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Chapter 4:  Two-pore channels are targeted to 
endosomes and lysosomes and mobilise Ca2+ in 
response to NAADP 
 
 
4.1  Introduction 
 
In Chapter 3 my studies developed from the original observation that lysosomes 
form junctional complexes with the sarcoplasmic reticulum (SR) in pulmonary 
arterial smooth muscle cells (PASMCs) to comprise a trigger zone for Ca2+ signalling 
by NAADP.  I not only provided further support for the presence of lysosome-SR 
junctions but also confirmed that these junctions may be formed in a manner that 
confers selective regulation of a subpopulation of ryanodine receptors (RyR), namely 
RyR3.  The identification of such junctional complexes supports the view that 
NAADP mobilises Ca2+ from a lysosome-related acidic organelle that is then 
amplified by Ca2+-induced Ca2+ release (CICR) from the sarco / endoplasmic 
reticulum (S / ER) (Churchill et al., 2002; Kinnear et al., 2004; Yamasaki et al., 2004; 
Zhang et al., 2006b) and may, given that the initial phase of Ca2+ release can prove 
difficult to resolve, explain why others have concluded that NAADP directly activates 
RyRs (Dammermann et al., 2005; Hohenegger et al., 2002).  It is becoming 
increasingly clear, therefore, that NAADP mobilises Ca2+ from lysosomes in an IP3R- 
and RyR-independent manner via the activation of its own receptor. 
 
4.1.1  Transient receptor potential mucolipin 1 and NAADP-dependent Ca2+ 
signalling  
 
Recently it was proposed that the lysosome-bound transient receptor potential 
mucolipin 1 (TRPML1) functioned as the molecular target of NAADP (Zhang et al., 
2008).  In this study using lipid bilayers, blockade of TRPML1 with anti-TRPML1 
antibodies was shown to block NAADP-induced activation of lysosomal Ca2+ 
channels (Zhang et al., 2008).  However, others have shown that membranes derived 
from normal rat kidney (NRK) cells over-expressing TRPML1 exhibit no increase in 
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[32P]NAADP binding, and that TRPML1 channel activity was not increased by the 
addition of NAADP in Xenopus oocytes expressing TRPML1 (Pryor et al., 2006).  
Thus, there is significant evidence contrary to the view that TRPML1 is an NAADP-
sensitive Ca2+ release channel and this point is emphasised by the finding that the 
antibody used by Zhang and co-workers to label / block TRPML1 has been shown to 
label elements within TRPML1 null cells suggesting that it is non-selective (Prof. 
Antony Galione, personal correspondence).  That TRPML1 may not represent an 
NAADP-activated Ca2+ release channel, is also suggested by two independent studies 
that identify TRPML1 not as a Ca2+ permeable channel, but as either a Fe2+ (Dong et 
al., 2008) or a H+ release channel in lysosome membranes (Soyombo et al., 2006).  
Despite extensive investigations, therefore, the identity of the NAADP receptor 
remains elusive. 
 
4.1.2  Two-pore channels 
 
4.1.2.1  Identification of two-pore channels as novel members of the voltage-gated 
cation channel superfamily  
 
In 2000 the two-pore channel subtype 1 (TPC1; gene name TPCN1) was first 
cloned and identified as a novel two-domain channel (Ishibashi et al., 2000).  The 
protein, deduced from screening the rat kidney cDNA library, was reported as being 
819 amino acid residues with a calculated molecular weight of 94.6 kDa (Ishibashi et 
al., 2000).  Mammalian TPCs are comprised of 12 transmembrane (TM) α-helices 
containing 2 homologous domains of 6 TM α-helices (S1-S6) and a re-entrant P-loop 
incorporated between S5 and S6 of each domain (Fig. 4.1A).  Their characteristic 
structure indicates that TPCs are new members of a family of proteins belonging to 
the superfamily of voltage-gated cation channels, which is composed of over 140 
members that are related by both structural and functional motifs (Yu et al., 2005).  
The P-loop is one of the important functional elements of this ion channel superfamily 
and is thought to sit within the pore and contribute towards ion conductance and ion 
selectivity (Yu et al., 2005).  As previously stated, the pore-forming subunits of 
voltage-gated sodium (Nav) and calcium (Cav) channels have 4 domains whereas 
single-domain proteins such as TRP channels function as tetramers.  Single-domain 
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proteins are therefore thought to have undergone two rounds of duplication in order to 
develop the necessary number of domains required to provide the pore region 
consistent with that conferred to Nav and Cav channels.  This led Ishibashi et al. to 
suggest that TPCs could be the intermediate product of the 2 rounds of duplication 
(Ishibashi et al., 2000).  Therefore, their structure would likely suggest that TPCs 
form dimers with each subunit contributing 2 P-loops.  Thus upon the formation of a 
dimer, 4 P-loops come together to form a functional pore (Fig. 4.1A). 
 
 
 
Fig. 4.1.  Two-pore channels share structural similarity with single-pore and four-pore domain 
channels and exhibit a wide tissue distribution 
A Comparison of the phylogenetic relationship between TPC subtypes and both single-pore and four-
pore domain channels suggesting that TPCs may form an intermediate stage between the two rounds of 
duplication that separate these two gene families.  Abbreviations used: at, Arabidopsis thaliana; CaV, 
voltage-gated Ca2+ channel; d, dog; h, human; NaV, voltage-gated Na+ channel; r, rat.  B Northern blot 
analysis of TPC2 expression in human tissues showing that TPC2 exhibits a wide tissue distribution 
with abundant expression in liver and kidney in particular.  This figure was kindly provided by Mike 
Zhu. 
 
The structural similarity of TPC1 to Cav channels led Ishibashi et al. to 
postulate that TPC1 would be a membrane bound, voltage-gated cation channel 
(Ishibashi et al., 2000).  However, xenopus oocytes injected with TPC1 cRNA 
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showed no significant difference in membrane currents from the background currents 
recorded in control cells.  Also, isotopic studies with the same cells failed to show any 
significant Na+ or Ca2+ uptake from the extracellular media.  Furthermore Chinese 
hamster ovary cells (CHOs) expressing TPC1 also failed to demonstrate membrane 
currents significantly above background (Ishibashi et al., 2000).  These data led the 
authors to suggest that TPCs may need additional proteins for either effective 
processing and delivery to the membrane, or for the formation of a functional pore.  A 
further suggestion by Ishibashi et al. was that TPCs may require something other than 
voltage for appropriate gating of the pore.  Lastly, the authors suggested that the 
cellular distribution of the TPC1 protein must be determined in order to establish 
whether or not TPC1 is targeted to membranes other than the plasma membrane 
(Ishibashi et al., 2000).  This point is most pertinent to the question of the molecular 
identity of the NAADP receptor, as this would reasonably be expected to be present 
on the membranes of lysosome-related organelles. 
Following the identification of TPC1 in the rat, plant TPC1 was first identified 
and cloned from Arabidopsis and was termed AtTPC1 (Furuichi et al., 2001).  The 
AtTPC1 protein is 733 amino acid residues in length with an estimated molecular 
weight of approximately 85 kDa and, similar to rat TPC1 has a predicted 12 TM 
structure divided into two domains of 6 TM regions each (Furuichi et al., 2001).  
AtTPC1 expression rescued the Ca2+ uptake activity in the yeast mutant cch1 
(Furuichi et al., 2001) and also, sugar-induced luminescence, acting as an indicator 
for increased cytoplasmic Ca2+ in Arabidopsis leaves, was enhanced by over 
expression of AtTPC1 and was suppressed by expression of antisense AtTPC1 
(Furuichi et al., 2001).  In 2005, Sanders and colleagues used a GFP-TPC1 fusion 
protein to show that AtTPC1 is expressed on membranes distinct from the plasma 
membrane, and is associated with the vacuolar membrane (Peiter et al., 2005).  Using 
TPC1 over-expressing cells they then determined that AtTPC1 has a role in the 
development of the cytoplasmic Ca2+-dependent slow vacuolar channel current, which 
is responsible for Ca2+-dependent Ca2+-release from intracellular vacuoles of plant 
cells (Peiter et al., 2005).  Further confirmation of plant TPC1 functioning as a cation 
channel present on the vacuolar membrane was provided by Dietrich and colleagues, 
though the authors suggest that plant TPC1 is a vacuolar Ca2+-gated Ca2+ release 
channel (Kawano et al., 2004; Ranf et al., 2008).  That plant TPC1 may be activated 
in response to Ca2+ is not inconsistent with its structure, as a notable difference 
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between plant TPC1 and mammalian TPCs is the presence of EF-hands on plant 
TPC1 (Ranf et al., 2008).  The ability of EF-hands to bind Ca2+ would thus provide 
plant TPC1 with a degree of Ca2+-sensitivity.  Therefore, investigations using plant 
cell types have shown that plant TPC1 is involved in intracellular Ca2+ signalling and, 
of particular importance to the present study, that plant TPC1 is located on the 
membrane of vacuoles rather than the plasma membrane (Fig. 4.2) (Furuichi et al., 
2001; Kawano et al., 2004; Peiter et al., 2005; Ranf et al., 2008). 
 
 
Fig. 4.2.  Schematic representation of the major Ca2+ signalling pathways in an Arabidopsis 
thaliana cell 
Depicted are some of the mechanisms by which Ca2+ is able cross the plasma membrane and some of 
the major Ca2+ storing organelles including the central vacuole, plastids and the ER. Ca2+ is sequestered 
into organelles or removed across the cell membrane by autoinhibited Ca2+ ATPases (Pacaud et al.).  
Ca2+ influx may occur via depolarisation-activated Ca2+ channels (DACC), hyperpolarisation-activated 
Ca2+ channels (HACC), and voltage-independent Ca2+ channels (VICC).  The ER also sequesters Ca2+ 
via the ER-type Ca2+ ATPase (ECA) and may be mobilised via activation of RyRs and IP3Rs.  The 
large Ca2+-storing central vacuole sequesters Ca2+ via ACA and the action of the Ca2+/H+ antiporter 
(CAX) coupled to a V-type ATPase.  Ca2+ may be mobilised from the vacuole via the activation of 
IP3Rs, RyRs, HACCs, the slow-activating vacuolar channel (SV) and the plant two-pore channel 
(TPC1). 
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4.1.2.2  Two-pore channels are expressed in a broad range of species and exhibit an 
extensive mammalian tissue distribution  
 
3 subtypes of TPC have been identified in the animal kingdom (TPC1, TPC2 
and TPC3) and one subtype in plants (plant TPC1; also known as AtTPC1).  
However, it is important to note that plant TPC1 shows low sequence homology to 
either animal TPC1, TPC2 or TPC3, and is considered to be a plant counterpart to all 
animal TPCs and not exclusively comparable to animal TPC1.  That plant TPC1 is 
distantly related to all 3 animal subtypes is exemplified by comparison of the 
conserved TM regions with ≤ 30 % amino acid sequence homology shared with the 3 
animal TPC subtypes, which are also equally distant from each other.  Fig. 4.3 shows 
the phylogenetic tree generated from all known TPC sequences.  This shows that all 3 
TPCs are present in sea urchins and most vertebrates.  However, TPC3 appears to be 
absent in primates and some rodents (e.g. mice and rats; Fig. 4.3).  Such a broad 
species distribution including both animal and plant kingdoms suggests that the genes 
encoding these proteins are from a common / ancient gene family, further supporting 
the notion that TPCs present an intermediate between the 6-TM structured channels 
such as TRPs and the 4-repeat, 24-TM pore forming subunits of, for example, Nav and 
Cav.  Not only do TPCs exhibit a broad species distribution but they also appear to 
have an extensive tissue distribution.  Analysis of TPC2 tissue expression by Northern 
blot shows that TPC2 mRNA is present in most human tissues, including the 
cardiovascular system, with a particularly high level of expression in the liver and 
kidney (Fig. 4.1B), very similar to the tissue distribution of TPC1 in rat (Ishibashi et 
al., 2000).  The broad range of tissue expression observed with TPC1 and TPC2 in 
mammals suggests a potentially important role for TPCs in cell function within the 
animal kingdom. 
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Fig. 4.3.  Comparison of TPCs from multiple species 
Comparison of the phylogenetic relationship between known TPC sequences plotted and 
aligned by my collaborator Dr. Mike Zhu using ClusterW (http://align.genome.jp) and plotted 
using a Neighbour-Joining algorithm.  Representative sequences for the third and fourth TM 
domains of the pore-forming subunits of family members of CaV and NaV channels are also 
included for comparison.  GenBank accession numbers are shown in parentheses. * Indicates 
that corrections were made to these sequences based on multi-sequence alignments and splice 
donor and acceptor sites in genomic sequences. ** Indicates that sequence was assembled 
from genomic sequences.  † Indicates that this sequence was previously designated as Ci-
TPC1 (Okamura et al., 2005). 
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4.1.3  Are two-pore channels candidates for the NAADP receptor? 
 
Despite the lack of functional data available for TPCs, a number of 
characteristics exhibited by these channels lend them to further investigation as 
putative NAADP receptors.  For example, the similarity of these channels to VGCCs 
is consistent with previous reports that NAADP-mediated Ca2+ release is inhibited by 
both L-type Ca2+ channel agonists and antagonists (both phenylalkylamines and 
dihydropyridines) (Genazzani et al., 1996a; Genazzani et al., 1997).  In addition to its 
structure, the reported size of human TPC1 and plant TPC1 of 94.6 and 85 kDa, 
respectively, are both similar to the reported size (150 kDa) of NAADP binding sites 
isolated by protein purification studies from sea urchin egg homogenate (Berridge et 
al., 2002).  There is indirect evidence, therefore, that TPCs may be the molecular 
target of NAADP.  Furthermore, animal TPCs are present in many of the species from 
which cells have been shown to exhibit NAADP-dependent Ca2+ signals, including 
sea urchin, rat, mouse, rabbit, dog, cow and human (Bak et al., 2001; Cancela et al., 
1999; Chini et al., 1995a; Lee et al., 1995; Mojzisova et al., 2001; Zhang et al., 
2006b).  Moreover, the ubiquitous tissue expression of mammalian TPCs is consistent 
with the finding that NAADP has been shown to mediate Ca2+ signalling in a wide 
variety of tissues including heart, brain, endocrine, exocrine, and smooth muscle (Bak 
et al., 2001; Bak et al., 1999; Boittin et al., 2002; Cancela et al., 1999; Chini et al., 
2002; Mitchell et al., 2003).  This further emphasises the fact that TPCs may play an 
important role in Ca2+ homeostasis in animal cells and, of particular importance, may 
function as the NAADP receptor.  The vacuolar location of plant TPC1 is also 
consistent with the proposal that TPCs may be involved in NAADP-mediated Ca2+ 
release from lysosome-related organellar stores.  In this chapter I therefore sought to 
determine whether or not TPCs function as NAADP receptors. 
 
 
4.2  Methods 
 
The experiments included in this chapter use HEK293 cells stably over-
expressing human TPC1 (hTPC1), human TPC2 (hTPC2) or chicken TPC3 (cTPC3) 
which were generated for me by my collaborator Mike Zhu by incorporating the 
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cDNA into the following vectors: TPC1 cDNA was placed in a pIREShyg2 vector 
(BD Biosciences); TPC2 cDNA was placed in a pIRESneo vector (BD Biosciences); 
and TPC3 cDNA was placed in a pEGFPC3 (BD Biosciences).  HEK293 cells were 
transfected with the vectors using Lipofectamine 2000 (Invitrogen) following the 
manufacturer’s protocol.  In order to allow for studies on the cellular location of TPCs 
the cDNA of each subtype was attached with an tag such that the cDNA for TPC1 
was attached to a His6-tag (C terminus), TPC2 with an HA epitope or mCherry-tag (N 
terminus) and TPC3 with a GFP-tag (N-terminus).  Tissue culture and maintenance of 
the created cell lines was carried out as described above (Chapter 2). 
 
4.2.1  shRNA-mediated knockdown of two-pore channel subtype 2 in HEK293 cells 
 
In order to verify that the NAADP-mediated Ca2+ transient observed in HA-
hTPC2 cells was due to the over-expression of hTPC2, sequence-specific short 
hairpin RNA (shRNA) was used in order to knockdown / knockout hTPC2 protein 
expression.  4 plasmids encoding anti-hTPC2 shRNA and an mRFP reporter were 
designed and prepared by my collaborators, Professor Jianjie Ma and Dr. Zui Pan. 
RNA interference (RNAi) is a form of gene regulation that occurs post-
transcriptionally.  It was first observed in 1998 when double stranded RNA (dsRNA) 
selectively abolished the twitching phenotype of Caenorhabditis elegans when 
injected directly into the body (Fire et al., 1998).  This led the way for investigations 
involving the silencing of functional genes by exogenous application of dsRNA.  
RNAi can be achieved by incorporating DNA encoding shRNA into an expression 
vector.  When this sequence is expressed, the resultant RNA consists of a sense and 
anti-sense strand which, due to its own complementarity, associates with itself by 
forming a hairpin structure that is able to interact with both the target mRNA and the 
cell machinery capable of mediating RNAi. 
The 4 shRNA probes used in these experiments were targeted to specific 
sequences of hTPC2 (Fig. 4.4, Table 4.1) and were annealed to the BamH1 and EcoRI 
restriction sites of the pSIREN-DNR plasmid (Clontech, CA, USA).  Each probe 
contained a sequence encoding a mRFP reporter protein.  The presence of the mRFP 
reporter allowed for the visual determination of successful shRNA transfection.  To 
maximise the success of shRNA mediated knockdown/knockout of hTPC2, the 4 
probes were mixed in equal proportions and treated as a single solution for subsequent 
 112 
experiments.  It is important to note that the process of transfection of a plasmid into 
the cells could adversely affect protein expression/synthesis in cells.  Thus, in order to 
discern whether the knockdown of hTPC2 was due to the shRNA rather than the 
transfection process, a control plasmid containing scrambled shRNA was also used in 
parallel to the test plasmids (Table 4.1).  The effect of shRNA-mediated knockout / 
knockdown of hTPC2 expression in HA-hTPC2 cells was characterised using Ca2+ 
imaging.  However, the ability of shRNA against hTPC2 to reduce hTPC2 expression 
was first verified using both Western blot and immunocytochemical labelling of 
intracellular proteins.  When verifying the shRNA by Western blot, the level of β-
actin in each sample was used as a further control.  If the transfection process does not 
adversely affect protein expression / synthesis one would expect, therefore, the level 
of β-actin in shRNA-transfected cells to be similar to non-transfected cells. 
 
 
MAEPQAESEP  LLGGARGGGG  DWPAGLTTYR  SIQVGPGAAA  RWDLCIDQAV  VFIEDAIQYR 
 
60 
SINHRVDASS  MWLYRRYYSN  VCQRTLSFTI  FLILFLAFIE  TPSSLTSTAD  VRYRAAPWEP 
 
120 
PCGLTESVEV  LCLLVFAADL  SVKGYLFGWA  HFQKNLWLLG  YLVVLVVSLV  DWTVSLSLVC 
 
180 
HEPLRIRRLL  RPFFLLQNSS  MMKKTLKCIR  WSLPEMASVG  LLLAIHLCLF  TMFGMLLFAG 
 
240 
GKQDDGQDRE  RLTYFQNLPE  SLTSLLVLLT  TANNPDVMIP  AYSKNRAYAI  FFIVFTVIGS 
 
300 
LFLMNLLTAI  IYSQFRGYLM  KSLQTSLFRR  RLGTRAAFEV  LSSMVGEGGA  FPQAVGVKPQ 
 
360 
NLLQVLQKVQ  LDSSHKQAMM  EKVRSYGSVL  LSAEEFQKLF  NELDRSVVKE  HPPRPEYQSP 
 
420 
FLQSAQFLFG  HYYFDYLGNL  IALANLVSIC  VFLVLDADVL  PAERDDFILG  ILNCVFIVYY 
 
480 
LLEMLLKVFA  LGLRGYLSYP  SNVFDGLLTV  VLLVLEISTL  AVYRLPHPGW  RPEMVGLLSL 
 
540 
WDMTRMLNML  IVFRFLRIIP  SMKPMAVVAS  TVLGLVQNMR  AFGGILVVVY  YVFAIIGINL 
 
600 
FRGVIVALPG  NSSLAPANGS  APCGSFEQLE  YWANNFDDFA  AALVTLWNLM  VVNNWQVFLD 
 
660 
AYRRYSGPWS  KIYFVLWWLV  SSVIWVNLFL  ALILENFLHK  WDPRSHLQPL  AGTPEATYQM 
 
720 
TVELLFRDIL  EEPEEDELTE  RLSQHPHLWL  CR 
 
752 
 
Fig. 4.4.  Amino acid sequence for human two-pore channel subtype 2 
The amino acid sequence of human TPC2 (hTPC2).  The predicted transmembrane and P-loop regions 
are highlighted in yellow and cyan respectively.  The 4 amino acid sequences corresponding to the 
mRNA sequences against which the 4 shRNA probes are targeted, are indicated by red italics. 
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Name of Probe 
 
Nucleotide number Nucleotide sequence 
Si-hTPC2 A 
 
216-238 GCTTTACCGACGGTATTACTCGA 
Si-hTPC2 B  
 
585-608 GCTGCAGAACTCCTCTATGATGAA 
Si-hTPC2 C 
 
923-945 GCAGCCATCATCTACAGTCAGTTC 
Si-hTPC2 D 
 
1556-1578 GCTCTGGCTGTGTACCGATTGCCA 
Control  GATCCGTGCGCTGCTGGTGCCA-
ACTTCAAGAGATTTTTTGCTAGCG 
 
Table 4.1.  Name and nucleotide sequence of the shRNA probes used in studies involving RNA 
interference. 
 
 
4.2.1.1  shRNA transfection of HEK293 cells 
 
Cells were prepared 24 hours prior to shRNA transfection.  For Ca2+ imaging 
experiments and verification by Western blot, transfection was carried out in 
FluoroDishes and 60 mm sterile petri dishes respectively.  These were prepared 
beforehand as described above.  For verification by fluorescent labelling, shRNA 
transfection was carried out using cells seeded onto poly-D-lysine coated coverslips 
placed within sterile 30 mm tissue culture dishes as described in Chapter 2. 
HA-hTPC2 cells were transfected with the shRNA plasmids using the 
transfection agent GeneJammer (Stratagene, Ailent Technologies, CA, USA).  The 
quantities of reagents used varied according to the number of dishes that were to be 
transfected.  Therefore the following method describes the transfection of 1 dish of 
HA-hTPC2 cells and was scaled up as appropriate:  94 µl of sterile, serum-free, 
antibiotic-free D-MEM (Opti-MEM; at room temperature) was transferred to a 
polystyrene tube.  6 µl of GeneJammer transfection reagent was pipetted directly into 
the serum-free media and the solution was gently mixed with the pipette tip before 
being incubated for 5 minutes at room temperature (22°C).  2 µl of the shRNA 
plasmid solution (1 µg/µl) was then added to the solution and mixed gently with the 
pipette tip.  This solution was then incubated for 30 minutes at room temperature. 
GeneJammer is a polyamine based transfection reagent that is positively 
charged.  Due to their polarity, polyamines are able to bind effectively to nucleic 
acids, which are negatively charged, in solution.  Upon binding to the shRNA plasmid 
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in solution, particles are formed in which the plasmid is surrounded by the positively 
charged polyamine molecules.  This then allows the plasmid/polyamine particle to 
interact with the negatively charged plasma membrane of the cell.  Following this 
interaction it is thought that the plasmid / polyamine particles are internalized by the 
cell via endocytosis (Kanatani et al., 2006; Orth et al., 2008). 
A previously prepared dish containing HA-hTPC2 cells was taken and the 
growth media was removed and replaced with 900 µl of fresh growth media.  
Following the incubation of the GeneJammer transfection reagent with the shRNA 
plasmid, 100 µl of this transfection mixture was added drop-wise and the dish was 
gently mixed.  The dish was incubated for 8 hours at 37°C, 5% CO2.  A further 1 ml 
of fresh growth media was then added and the dish was returned to the incubator 
whereby it was incubated for a further 3-4 days. 
 
 
4.2.2  Determination of shRNA-mediated knockdown of two-pore channel subtype 2 
in HEK293 cells by use of Western blot 
 
4.2.2.1  Lysis of cells and preparation of protein samples 
 
HA-hTPC2 cells were prepared and transfected with shRNA prior to lysis, as 
described above.  The media was removed and each dish was washed twice with fresh 
sterile PBS (2 ml).  The cells were lysed using Radio Immunoprecipitation Assay 
(RIPA) buffer of the following composition: 150 mM NaCl, 20 mM Na3PO4, 50 mM 
NaF, 2 mM EDTA, 0.1% SDS, 1% Na deoxycholate, 1% Triton X-100, 1:100 dilution 
Protease Inhibitor Cocktail (Sigma P8340), pH 7.2.  100 µl of fresh RIPA buffer was 
added to each dish and the cells were incubated for 30 minutes at 4 °C.  The cells 
were thoroughly scraped and collected at one area at the base of the dish.  The 
solution was collected and aliquoted into sterile 0.5 ml ependorf tubes and then 
centrifuged at 14,000 r.p.m. for 15 minutes at 4 °C.  The supernatant was collected, 
the protein concentration determined and the remaining samples were stored at -80 °C 
until required. 
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4.2.2.2  Determination of protein concentration by Bradford assay 
 
The Bradford assay was first described in 1976 (Bradford, 1976) and is 
established as a quick and inexpensive assay for determining protein concentrations.  
The assay utilises the characteristic of Coomassie Brilliant Blue G-250 whereby the 
absorbance maximum shifts from 470 nm to 595 nm upon binding to protein.  This is 
achieved by interactions with amino acid residues of the protein that serve to stabilize 
the anionic form of the dye.  The anionic form has an absorbance maximum of 595 
nm whereas the unbound cationic form of the dye has an absorbance maximum of 470 
nm.  The assay is then read in a spectrophotometer at a wavelength of 595 nm which 
indicates the level of bound dye within the solution.  By comparing the protein 
samples of unknown 
concentration with 
known standards, the 
concentration of the 
samples can be 
determined. 
The protein 
standards were prepared 
in dd.H2O from a stock 
of BSA 1.45 mg/ml and 
consisted of the 
following concentrations 
(mg protein/ml): 0, 0.1, 
0.25, 0.5, 0.75, 1, and 
1.45.  Appropriate 
volumes (10 µl) of each 
protein sample and 
standard was added to 
separate plastic cuvettes.  
2 ml of Bradford reagent 
(Coomassie brilliant blue 
G-250, 95 % ethanol and 
 
 
BSA conc. 
(mg/ml) 
A595 
(OD) 
Sample Protein 
conc. (mg/ml) 
0.00 0.000  
0.10 0.034  
0.25 0.061  
0.50 0.113  
0.75 0.154  
1.00 0.192  
 0.082 0.378 
 0.100 0.474 
 
Fig. 4.5.  Example BSA standard curve used for interpolating 
the protein concentration of 2 unknown samples 
A Example of the standard curve generated by plotting the 
absorbance at 595 nm against the protein concentration of the BSA 
standards.  Standard curve was generated using linear regression.  B 
Corresponding table of the values for the absorbance (595 nm) for 
the BSA protein standards.  The values obtained for the samples 
were interpolated using the standard curve to estimate the protein 
concentration of each sample (bold italics). 
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85 % orthophosphoric acid) was added to each cuvette and the solution was mixed 
and the cuvettes were incubated at room temperature for 10 minutes.  Each cuvette 
was then placed into the spectrophotometer (CE 393 Digital Grating 
Spectrophotometer, Cecil Instruments Ltd., UK) and the absorption at 595 nm was 
measured.  The readings from the protein standards were used to generate a standard 
curve of protein concentrations (Fig. 4.5), from which the concentration of the 
samples was determined using the interpolation function of the Prism analysis 
software (GraphPad Software Inc., USA). 
 
4.2.2.3  SDS-polyacrylamide gel electrophoresis 
 
Sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis (SDS-
PAGE) is a process whereby proteins migrate towards an anode at various velocities 
through a polacrylamide gel in response to an applied electric field.  Importantly with 
SDS-PAGE, proteins have varying migratory velocities due to different molecular 
weight.  Polyacrylamide gels consist of a porous matrix that provides resistance to 
protein migration depending upon their size, such that low molecular weight proteins 
can migrate at a faster rate.  SDS is an anionic detergent which denatures the proteins 
and binds to them and therefore, the overall charge of the protein becomes highly 
negative.  The denatured protein is no longer able to maintain its secondary / tertiary 
structure and so is reduced to a negatively charged ‘rod’ shape or random coil 
configuration.  SDS binds to peptides with a constant weight ratio and so the charge is 
uniform along its length.  Therefore the intrinsic charge of the peptide is insignificant 
to the overall charge inferred by the SDS-peptide complex and thus charge is 
proportional to the molecular weight of the protein. 
For the experiments covered in this thesis, a discontinuous gel electrophoresis 
system was used.  This system uses two gels: a stacking gel (pH 6.8) and a resolving 
gel (pH 8.8).  The stacking gel contains much larger, non-restrictive pores than the 
resolving gel, which results in the protein samples becoming concentrated at the 
stacking/resolving gel interface leading to a greater resolution.  The resolving gel is 
made first with the stacking gel formed on top of the resolving gel once the latter has 
set.  The gels are made by co-polymerisation of acrylamide and bis-acrylamide.  This 
polymerisation relies upon the generation of free radicals and is initiated by the 
addition of TEMED to the reaction mixture.  TEMED is a tertiary amine base which 
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is added in order to catalyze the formation of free radicals from ammonium persulfate 
(APS).  These free radicals add an unpaired electron to an acrylamide monomer 
effectively creating an acrylamide free radical.  This activated monomer is then able 
to react with a non-activated monomer and thus initiate the polymerisation reaction.  
The polymers can be cross-linked by units of bis-acrylamide which forms a gel-like 
mesh with the characteristic pores.  Proteins were resolved using a 10 % gel (10 % 
acrylamide, 0.375 M Tris, 0.1 % w/v SDS, 0.05 % w/v APS and 0.05 % TEMED) 
which was poured into Novex gel cassettes (Invitrogen, UK).  dd.H2O was carefully 
poured on top and the gel allowed to set for 30-40 minutes.  Once the polymerisation 
reaction was completed the overlaid H2O was discarded and any unpolymerised gel 
was removed by washing with fresh dd.H2O.  The stacking gel (4.2 % acrylamide, 
0.375 M Tris, 0.1 % w/v SDS, 0.05 % w/v APS and 0.05 % TEMED) was then 
poured on top of the resolving gel and a 10-well comb was inserted to create the wells 
within the stacking gel.  The gel was then allowed to set for 30 minutes. 
The protein samples were mixed with Laemmli buffer containing SDS, β-
mercaptoethanol, glycerol and bromophenol blue.  The β-mercaptoethanol reduces the 
disulfide bonds within the protein, which is then further reduced by the SDS as 
described previously.  The glycerol increases the sample density so that it will layer in 
the wells, and bromophenol blue is a dye that will allow the migration of the sample 
to be tracked visually.  The cassette was then placed and run in an XCell surelock 
Mini-Cell system (Invitrogen, UK).  5 µl of Precision Plus Protein standards (Bio-
Rad, UK) were loaded into a free well.  The gels were run for 30 minutes at 50 V and 
then at 125 V for approximately 2 hours. 
 
4.2.2.4  Immunoblotting 
 
In order to detect and visualise protein bands, they must first be transferred onto 
a nitrocellulose membrane.  Once the protein bands had migrated sufficiently, the 
SDS-PAGE gels were removed from the cassettes and placed into transfer buffer 
(42.9 mM Tris, 38.9 glycine, 0.038 % w/v SDS, 20 % methanol.  Grade 1F electrode 
filter paper and Hybond ECL nitrocellulose membranes were cut so that they would 
match the shape of the gel and then pre-soaked in transfer buffer along with blotting 
pads.  A piece of filter paper was placed on the bottom of the transfer stack on top of 
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which the gel was placed.  The pre-soaked nitrocellulose membrane was placed on 
top of the gel followed by a further piece of filter paper.  The stack was then placed in 
an XCell II blot module Mini Cell system (Invitrogen, UK), with 2 pre-soaked 
blotting pads placed on each side of the stack.  The module was orientated such that 
the gel faced the cathode whereas the nitrocellulose membrane faced the anode.  As a 
result the proteins would move towards the anode and subsequently transfer to the 
membrane.  The gels were blotted for 1.5 hours at 25 V. 
 
4.2.2.5  Immunodetection (by ECL) 
 
After the immunoblotting was complete the membranes were carefully removed 
from the stack and placed in blocking buffer (20 mM Tris base, 150 mM NaCl, 0.1 % 
Tween 20, 5 % non-fat milk powder, pH 7.5) for 1 hour at room temperature.  This is 
to ensure that any regions of the membrane that have not bound sample protein are 
‘blocked’ by binding constituents of the blocking buffer.  This prevents non-specific 
binding of the antibody to the membrane.  The membranes were then washed with 
TBST (20 mM Tris base, 150 mM NaCl, 0.1 % Tween 20, pH 7.5) 3 x 10 minutes.  
The primary anti-HA or anti-βactin antibody was diluted (1:1000) in 1 % blocking 
buffer (20 mM Tris base, 150 mM NaCl, 0.1 % Tween 20, 1 % non-fat powder milk, 
pH 7.5).  The membrane was then incubated with the primary antibody solution 
overnight at 4°C.  The following day the membrane was washed 3 x 10 minutes with 
TBST in order to remove any unbound primary antibody.  The secondary horseradish 
peroxidase (HRP)-conjugated anti-rat or anti-mouse antibodies (when anti-HA and 
anti-βactin primary antibodies were used respectively) were diluted to 1:1000 in 1 % 
blocking buffer.  The membrane was then incubated with the secondary antibody 
solution for 2 hours at room temperature.  Following this incubation period, the 
membrane was washed 3 x 10 minutes with TBST.  The binding of the primary 
antibody and subsequent location of the protein of interest was detected using a 
chemiluminescence detection system which utilises an HRP substrate, luminol.  This 
substrate is oxidised by HRP and when the excited electron returns to its normal 
energy state a photon of light is emitted (maximum wavelength 428 nm).  These 
photons can be detected upon exposure to ECL Hyperfilm (Amersham, UK).  The 
regions of primary antibody binding will have a high concentration of HRP present 
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and therefore the light emitted from this area will be significantly enhanced.  The 
membrane was incubated with a 1:1 mixture of ECL Western blotting detection 
Reagents 1 and 2 (Amersham Bioscience, UK) for 1 minute at room temperature.  
The Reagent mixture was removed and the membrane was placed in an exposure 
cassette.  A sheet of ECL Hyperfilm (Amersham, UK) was placed on top of the 
membrane in a dark room, the cassette was closed and the film exposed for 30-120 
seconds.  The film was then developed using RG fixer and developer (Photon 
Imaging Systems Ltd., UK). 
 
4.2.3  Flash photolysis of caged NAADP 
 
In order to confirm the biphasic pattern of NAADP-evoked Ca2+ release in 
HEK293 cells stably over-expressing HA-hTPC2 flash photolysis experiments were 
carried out by Dr. Abdelilah Arredouani (University of Oxford).  Briefly, HA-hTPC2 
cells, seeded onto poly-D-lysine coated FluoroDishes, were bathed in a bath solution 
of the following composition: 130 mM NaCl, 5.2 mM KCl, 1 mM MgCl2, 10 mM 
glucose, and 10 mM HEPES (pH 7.4).  The pipette solution contained the following: 
140 mM KCl, 1 mM MgCl2, 10 mM HEPES and 0.1 mM Fluo3 pentapotassium (pH 
7.2).  10 µM caged-NAADP was then added to the pipette solution.  For the 
experiments requiring IP3R antagonism, heparin (200 µg/ml) was added to the pipette 
solution.  Cells were held at -40 mV in the whole-cell configuration of the patch-
clamp technique.  The caged-NAADP was photolysed using several ultraviolet flashes 
(each 10 ms in duration) generated using a XF-10 arc lamp (HI-TECH Scientific).  
The resultant change in the intracellular Ca2+ concentration was reported using Fluo3 
fluorescence (excitation 490 nm, emission 530 nm) monitored by a photomultiplier 
tube. 
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4.3  Results 
 
4.3.1  Two-pore channels are targeted to endosomes and lysosomes 
 
4.3.1.1  Two-pore channel subtype 2 is specifically targeted to lysosomes  
 
As NAADP is known to mobilise Ca2+ from acidic lysosome-related organelles 
(Churchill et al., 2002; Kinnear et al., 2004; Yamasaki et al., 2004; Zhang et al., 
2004), one would expect a putative NAADP receptor to be targeted, possibly 
exclusively, to the membranes of these acidic organelles.  In collaboration with Dr. 
Mike Zhu I therefore examined the intracellular localisation of TPCs and their co-
localisation with various organellar markers.  
Fig 4.6A shows a 3D reconstruction of a series of deconvolved Z-sections (focal 
depth 0.28 µm, Z step 0.2 µm) taken through a HEK293 cell stably expressing 
mCherry-tagged (excitation 587 nm, emission 610 nm) hTPC2 which had been pre-
incubated (40 minutes) with LysoTracker Green (200 nM; excitation 504 nm, 
emission 511 nm).  Panel Aa shows a transmitted light image of the cell under study, 
with subsequent panels showing the distribution of (b) mCherry fluorescence 
labelling (red), (c) LysoTracker Green fluorescent labelling (green), (d) a merged 
image of (b) and (c).  Panel (e) reveals the areas of co-localisation (yellow) between 
mCherry and LysoTracker Green labelling.  Visual inspection of these images alone 
strongly suggests that TPC2 is targeted to the membranes of acidic organelles.  
Further analysis added weight to this viewpoint, as the density of co-localisation 
between mCherry-TPC2 and LysoTracker Green was 0.0033 ± 0.0012 µm3 per µm3 
(n = 6; Fig. 4.7A; Appendix 2, Table 4.2) and accounted for 26 ± 5 % and 24 ± 6 % of 
the total volume of mCherry and LysoTracker Green labelling, respectively.  
Furthermore, the Pearson product-moment correlation coefficient value for mCherry-
hTPC2 and LysoTracker Green labelling was 0.30 ± 0.06 (n = 6; Fig. 4.7B; Appendix 
2, Table 4.2).  This illustrates that there is a strong linear correlation between 
mCherry-hTPC2 and LysoTracker Green staining and suggests that TPC2 is targeted 
to acidic organelles.  
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Fig. 4.6.  TPC2 is targeted to lysosomes in HA-TPC2 and mCherry-TPC2 cells. 
A Example cell showing the co-localisation between mCherry labelled hTPC2 (red; excitation 587 nm, 
emission 610 nm) and lysosomes labelled with LysoTracker Green (green; excitation 504 nm, emission 
511 nm).  Panel a shows a transmitted light image of the isolated mCherry-hTPC2 cell imaged; Panel b 
shows a 3D reconstruction of a series of deconvolved Z-sections taken through the cell shown in panel 
a showing the distribution of mCherry-tagged (red) hTPC2 in relation to the plasma membrane (dotted 
line); Panel c shows a 3D reconstruction of deconvolved Z-sections showing the distribution of 
LysoTracker Green labelling (green) in relation to the plasma membrane as indicated in panel b; Panel 
d shows a 3D representation of mCherry-hTPC2 and LysoTracker Green labelling (red and green 
respectively); Panel e is a 3D reconstruction showing individual elements of co-localisation between 
hTPC2 and LysoTracker Green.  B Example cell showing the co-localisation between FITC labelled 
hTPC2 (green; excitation 490 nm, emission 528 nm) and LAMP2 labelling (red; excitation 555 nm, 
emission 617 nm).  Panel a shows a transmitted light image of the isolated HA-hTPC2 cell imaged; 
Panel b shows a 3D reconstruction of a series of deconvolved Z-sections taken through the cell shown 
in panel a showing the distribution of HA-tagged hTPC2 (green) in relation to the nucleus (dark blue) 
plasma membrane (dotted line); Panel c shows a 3D reconstruction of deconvolved Z-sections showing 
the distribution of LAMP2 labelling (red) in relation to the nucleus and plasma membrane as indicated 
in panel b; Panel d shows a 3D representation of HA-hTPC2 and LAMP2 labelling (green and red 
respectively); Panel e is a 3D reconstruction showing individual volumes of co-localisation between 
hTPC2 and LAMP2 labelled lysosomes.  Both elements appear to co-localise around a large vesicular 
structure highlighted in Panel e by the white arrow.  
 
This apparent targeting of TPC2 to acidic organelles is entirely consistent with 
the proposed location of the NAADP receptors, and such specific targeting was 
confirmed by studies on the co-localisation of TPC2 with labelling for lysosomes 
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using antibodies specific for lysosome-associated membrane protein 2 (LAMP2).  
Fig. 4.6B shows a 3D reconstruction of a series of deconvolved Z-sections (focal 
depth 0.28 µm, Z step 0.2 µm) taken through a HEK293 cell stably expressing HA-
hTPC2 that had been labelled for HA and LAMP2.  Panel Ba shows a transmitted 
light image of the cell under study and (b) shows the distribution of labelling for HA-
hTPC2 (green) relative to the DAPI labelled nucleus (blue) whereas (c) shows the 
distribution of LAMP2 labelling (red).  Panel (d) shows the merged image of (b) and 
(c), and (e) shows the areas of the cell in which HA-hTPC2 and LAMP2 labelling co-
localised (yellow).  From visual consideration of these images it is clear that TPC2 
co-localises with LAMP2-labelled lysosomes and provides support for the view that 
TPC2 is targeted to acidic organelles.  This is further highlighted by the clear co-
localisation between LAMP2 and TPC2 around a large vesicular structure as shown in 
Fig. 4.6Be (highlighted by the white arrow).  Moreover, consideration of LAMP2 
labelling with respect to the DAPI-labelled nucleus shows that, similar to PASMCs 
(Chapter 3), lysosomes appear to cluster in the perinuclear region of HEK293 cells.  
Across the whole cell the density of co-localisation between HA-hTPC2 and LAMP2 
labelling was 0.0068 ± 0.0008 µm3 per µm3 (n = 7; Fig. 4.7A; Appendix 2, Table 4.4) 
which was significantly greater when compared to the co-localisation between 
LysoTracker Green and mCherry-hTPC2 (0.0033 ± 0.0012 µm3 per µm3, n = 6; 
P<0.05).  Furthermore the volume of HA-hTPC2/LAMP2 co-localisation represented 
51 ± 2 % and 63 ± 4 % of the total volume of HA-hTPC2 and LAMP2 labelling, 
respectively.  This greater degree of co-localisation was also reflected in the Pearson 
product-moment correlation coefficient value which measured 0.64 ± 0.01 (n = 7; Fig. 
4.7B; Appendix 2, Table 4.4) which was also greater than observed for mCherry-
hTPC2 and LysoTracker Green labelling (0.30 ± 0.06, n = 6; P<0.05). 
These data highlight the important distinction between the two methods of 
lysosomal labelling.  LysoTracker consists of a fluorophore attached to a weak base 
that accumulates in the lumen of acidic organelles.  Conversely, LAMP2 is a 
membrane-bound protein present on the lysosomal membrane.  Therefore, an ion 
channel targeted to lysosomal membranes would be expected to exhibit greater 
overlapping distribution with LAMP2 than with LysoTracker Green. 
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Fig. 4.7.  TPC2 co-localisation is greater with lysosomes labelled with LAMP2 than with 
LysoTracker Green  
A Bar chart showing the density of co-localisation (µm3 per µm3; mean ± S.E.M.) between hTPC2 and 
either LysoTracker or LAMP2 labelling.  B The Pearson product-moment correlation coefficient for 
TPC2 and either LysoTracker labelled- or LAMP2-labelled lysosomes, indicating linear dependence 
(mean ± S.E.M.).  * indicates a statistically significant difference (P<0.05) when compared to the 
hTPC2/LAMP2 co-localisation density or Pearson correlation coefficient (LysoTracker n = 6; LAMP2 
n = 7). 
 
The apparent targeting of TPC2 to acidic organelles is entirely consistent with 
the proposed location of the NAADP receptors, and such specific targeting was 
confirmed by higher resolution confocal imaging studies (in collaboration with Dr. 
Mike Zhu, see Calcraft et al., 2009 for methods) on the co-localisation of TPC2 with 
labels for a variety of intracellular organelles.  Fig. 4.8A shows single Z-sections 
taken through HEK293 cells stably expressing HA-hTPC2 and labelled with sequence 
specific antibodies for HA and LAMP2.  Panel a shows a transmitted light image of 
the cell under study and (b) shows the distribution of HA-hTPC2 (green) and (c) the 
distribution of LAMP2 (red).  Panel d shows the merged image of (b) and (c) with 
areas of co-localisation shown as yellow.  Visual consideration of these images shows 
that, consistent with the deconvolution microscopy data (Fig. 4.6), TPC2 appears to 
co-localise with lysosomes.  Furthermore, the Pearson product-moment correlation 
coefficient value for HA and LAMP2 labelling was 0.906 ± 0.003 (n = 5; Appendix 2, 
Table 4.5).  Such a high coefficient value (i.e. close to +1) demonstrates that a strong 
linear correlation exists between HA-hTPC2 and LAMP2 labelling and thus further 
demonstrates that TPC2 is targeted to the membranes of lysosomes.  
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Fig. 4.8.  TPC2 is targeted to lysosomal membranes 
A Example cell showing the co-localisation between FITC labelled (excitation 490 nm, emission 528 
nm) HA-hTPC2 (green) and Alexa 594-labelled (excitation 590 nm, emission 617 nm) LAMP2 (red).  
Panel a shows a transmitted light image of the isolated HA-hTPC2 cell imaged; Panel b shows a single 
Z section showing the distribution of HA-hTPC2 (green).  Panel c shows a single Z-section showing 
the distribution of LAMP2 (red). Panel d shows a merged image of panels b and c revealing areas of 
co-localisation between the 2 labels (yellow).  B,C Example cells showing the degree of co-localisation 
between mCherry-tagged (excitation 587 nm, emission 610 nm) hTPC2 and GFP-tagged (excitation 
489 nm, emission 510 nm) hTPC1 (B) or cTPC3 (C).  In each case Panel a shows a transmitted light 
image of the cell imaged.  Panel b shows a single Z-section, showing the distribution of either GFP-
hTPC1 (green) or GFP-cTPC3.  Panel c shows a single Z-section, showing the distribution of mCherry-
hTPC2 (red).  Panel d is a merged image of panels b and c showing areas of co-localisation (yellow).  
D Example cells showing merged images indicating co-localisation between FITC labelled HA-hTPC2 
(green) and the following selected organelle markers visualised with Alexa 594-conjugated secondary 
antibody:  Panel a, EEA1; labelling of early endosomes; Panel b, M6PR labelling of late endosomes; 
Panel c, PDI labelling of ER; Panel d, GM130 labelling of Golgi apparatus; Panel e, CytC labelling of 
mitochondria. 
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Fig. 4.8B and Fig. 4.8C show single Z-sections taken through HEK293 cells 
stably expressing mCherry-tagged (excitation 587 nm, emission 610 nm) hTPC2 and 
either GFP-tagged (excitation 489 nm, emission 510 nm) hTPC1 or GFP-cTPC3 
respectively.  In each case, panel a shows a transmitted light image of the cell under 
study and (b) shows the distribution of GFP-hTPC1 (Ab) or GFP-cTPC3 (Bb) (green) 
and (c) the distribution of mCherry fluorescence (red).  Panel d shows the merged 
image of (b) and (c) with areas of co-localisation shown as yellow.  These images 
show that TPC2 does not appear to co-localise with either TPC1 or TPC3.  Therefore, 
TPC1 and TPC3 may be targeted to the membranes of organelles other than 
lysosomes.  Fig. 4.8D shows merged single Z-sections taken through HEK293 cells 
expressing HA-hTPC2 and labels for various intracellular organelles.  In each cell the 
green labelling indicates the distribution of HA-hTPC2, with red labelling identifying 
the distribution of the following: (a) early endosomes, early endosome marker 1 
(EEA1); (b) late endosomes, manose-6-phosphate receptor (M6PR); (c) ER, protein 
disulphide isomerase (PDI); (d) Golgi apparatus, Golgi matrix protein (GM130); (e) 
mitochondria, cytochrome C.  These images show that there is little or no co-
localisation between hTPC2 and these organelles, adding further support to the view 
that TPC2 is specifically targeted to lysosomal membranes. 
 
 
4.3.1.2  Two-pore channel subtypes 1 and 3 are targeted to endosomes and other 
unidentified organelles 
 
That TPC2 does not appear to co-localise with either TPC1 or TPC3 suggests 
that each TPC subtype may be targeted to different organelles and this was confirmed 
by further co-localisation analysis.   
Fig. 4.9A shows single Z-sections taken through an exemplar HEK293 cell 
stably expressing GFP-tagged (excitation 489 nm, emission 510 nm) hTPC1 that had 
been fixed and labelled for LAMP2 and visualised via an Alexa-594 (excitation 590 
nm, emission 610 nm) conjugated secondary antibody.  Panel (a) shows a transmitted 
light image of the cell under study and subsequently shows the distribution of (b) GFP 
fluorescence labelling (green), (c) LAMP2 labelling (red), (d) a merged image of (b) 
and (c) with areas of co-localisation indicated (yellow).  Similarly Fig. 4.9B shows 
single Z-sections taken through an exemplar HEK293 cell expressing GFP-hTPC1 
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labelled for transferrin and visualised using an Alexa-594 secondary antibody.  Panel 
(a) shows a transmitted light image of the cell under study and subsequently shows 
the distribution of (b) GFP fluorescence labelling of hTPC1 (green), (c) transferrin 
labelling (red), (d) a merged image of (b) and (c) with areas of co-localisation 
indicated (yellow).  Fig. 4.9C-D reveal the cellular distribution of cTPC3 with Fig. 
4.19C showing single Z-sections taken through a HEK293 cell stably expressing 
GFP-cTPC3 that had been fixed and labelled for LAMP2 and visualised via an Alexa-
594 conjugated secondary antibody.  Panel (a) shows a transmitted light image of the 
cell under study and subsequently shows the distribution of (b) GFP fluorescence 
(green), (c) LAMP2 labelling (red), (d) a merged image of (b) and (c) with areas of 
co-localisation indicated (yellow).  Similarly Fig. 4.9D shows single Z-sections taken 
through an exemplar HEK293 cell expressing GFP-cTPC3 labelled for M6PR and 
visualised using an Alexa-594 secondary antibody.  Panel (a) shows a transmitted 
light image of the cell under study and subsequently shows the distribution of (b) GFP 
fluorescence labelling of hTPC1 (green), (c) M6PR labelling (red), (d) a merged 
image of (b) and (c) with areas of co-localisation indicated (yellow).  Visual 
consideration of these images reveals that, in marked contrast to hTPC2, both hTPC1 
and cTPC3 exhibited little or no co-localisation with LAMP2-labelling of lysosomes.  
This is consistent with the images presented in Fig. 4.8A and Fig. 4.8B which show 
that there was little or no co-localisation between hTPC2 and either hTPC1 or cTPC3 
and suggests that, in contrast to TPC2, these subtypes are targeted to organelles other 
than lysosomes.  Indeed, Fig. 4.9B and Fig. 4.9D shows that there was a high degree 
of co-localisation between hTPC1 and transferrin-labelled early endosomes, and 
between cTPC3 and M6PR-labelled late endosomes.  It is important to note that the 
TPC1 and TPC3 did not exhibit a complete co-labelling with either transferrin or 
M6PR respectively, and therefore these TPC subtypes may also be targeted to the 
membranes of as yet unidentified intracellular organelles. 
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Fig. 4.9.  TPC1 and TPC3 are targeted to the membranes of endosomes 
A, B Example cells showing the degree of co-localisation between GFP-tagged (excitation 489 nm, 
emission 510 nm) hTPC1 and either LAMP2-labelled lysosomes (A) or transferrin-labelled early 
endosomes (B) visualised via an Alexa-594 conjugated secondary antibody (excitation 590 nm, 
emission 618 nm).  In each case, Panel a shows a transmitted light image of an exemplar cell.  Panel b 
shows a single Z-section, showing the distribution of GFP-hTPC1 (green).  Panel c shows a single Z-
section, showing the distribution of either LAMP2 (A) or transferrin (B) (red).  Panel d is a merged 
image of panels b and c showing areas of co-localisation (yellow).  C, D Example cells showing the 
degree of co-localisation between GFP-cTPC3 and either LAMP2-labelled lysosomes (C) or M6PR-
labelled late endosomes (D) visualised via an Alexa-594 conjugated secondary antibody.  In each case, 
Panel a shows a transmitted light image of an exemplar cell.  Panel b shows a single Z-section, 
showing the distribution of GFP-cTPC3 (green).  Panel c shows a single Z-section, showing the 
distribution of either LAMP2 (C) or M6PR (D) (red).  Panel d is a merged image of panels b and c 
showing areas of co-localisation (yellow). 
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Furthermore, the Pearson product-moment correlation coefficient value for 
LAMP2 and either GFP-hTPC1 or GFP-cTPC3 was 0.590 ± 0.039 (n = 9) and 0.538 
± 0.028 (n = 6) respectively (Appendix 4, Table 4.5).  These are significantly lower 
than the correlation coefficient obtained using the same method for HA-hTPC2 and 
LAMP2 (0.906 ± 0.003; n = 5) and suggest that in contrast to TPC2, TPC1 and TPC3 
are not specifically targeted to lysosomes.  Moreover, the Pearson product-moment 
correlation coefficient value for GFP-hTPC1 and transferrin was 0.590 ± 0.026 (n = 8; 
Appendix 4, Table 4.5), and for GFP-cTPC3 and M6PR was 0.485 ± 0.024 (n = 2; 
Appendix 4, Table 4.5).  These values are also significantly lower than the correlation 
between TPC2 and LAMP2 and thus further suggests that although TPC1 and TPC3 
appear to co-localise with early and late endosomes respectively, they may also be 
targeted to the membranes of as yet unidentified intracellular organelles.  
That TPC2 is targeted specifically to lysosomes and TPC1 and TPC3 are 
targeted to endosomes is consistent with the previously reported vacuolar location of 
plant TPC1 (Peiter et al., 2005) and further indicates a potential role for TPCs in 
intracellular Ca2+ signalling.  Furthermore the specific lysosomal location of TPC2 
would make this an ideal candidate receptor for Ca2+ signalling by NAADP. 
 
4.3.2  [32P]NAADP binds to two-pore channel subtype 2 with two binding affinities 
 
The localisation of TPC2 to lysosomes shown above, and their similarity to Cav 
supports the view that TPC2 may represent the NAADP receptor.  To this end I, in 
collaboration with Dr. Margarida Ruas and Dr. Xiaotong Cheng (See Chapter 5 also), 
investigated whether [32P]NAADP bound to TPC2, and whether over-expression of 
hTPC2 in HEK293 cells resulted in increased [32P]NAADP binding.  Fig. 4.10A 
shows a comparison of the maximal specific binding of [32P]NAADP in membranes 
prepared from either HEK293 cells or HA-hTPC2 cells.  This shows that stable over-
expression of hTPC2 in HEK293 cells resulted in a 3-fold increase in [32P]NAADP 
binding in membranes with TPC2 enriched membranes exhibiting 338.0 ± 25.9 % of 
the maximal specific binding in wild-type cells (Appendix 2, Table 4.6).  This 
increase in the specific binding of [32P]NAADP strongly suggests that TPC2 is 
capable of binding NAADP.  This is of particular significance as TRPML1, which has 
been previously proposed to be an NAADP receptor, showed no increase in 
[32P]NAADP binding when over-expressed in NRK cells (Pryor et al., 2006).  Fig. 
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4.10B and C shows a ligand competition assay using membranes prepared from HA-
hTPC2 cells (B) and mouse liver (C).  The liver was selected for comparison of 
endogenous binding sites as this tissue type was shown to have the highest level of 
TPC2 mRNA expression by Northern blot analysis (Fig. 4.1B).  In these ligand 
binding assays (carried out by Dr. Xiaotong Cheng alone / in my absence) the affinity 
of NAADP for recombinant hTPC2 and endogenous NAADP binding sites in mouse 
liver was determined via analysis of the competitive binding between 0.2 nM 
[32P]NAADP and a range of concentrations (1 pM to 1 mM) of unlabelled NAADP.  
Fig. 4.10B shows that the hTPC2-containing membranes derived from HA-hTPC2 
cells exhibit two NAADP binding affinities with the goodness of fit determined by the 
R2 value (based on the sum of squares; Chapter 2) with dissociation constants (Kd) of 
5.0 ± 4.2 nM and 7.2 ± 0.8 µM (mean ± S.E.M.; n = 3; Appendix 2, Table 4.7).  This 
binding curve closely resembled the resultant curve obtained from competitive 
displacement of [32P]NAADP using mouse liver membranes which also exhibited 2 
affinities with Kd values of 6.6 ± 3.5 nM and 4.6 ± 2.4 µM (n = 4; Fig. 4.10C; 
Appendix 2, Table 4.9).  Thus, hTPC2 exhibits similar binding characteristics to 
endogenous mammalian NAADP binding sites derived from liver, which is also 
notable because this tissue displayed the highest density of TPC2 expression by 
Northern blot analysis.  Furthermore, the high-affinity binding site is comparable with 
previous values reported in other mammalian preparations such as the heart and brain 
(Bak et al., 2001; Masgrau et al., 2003; Patel et al., 2000b) and high affinity binding 
sites identified in sea urchin egg homogenates (Billington et al., 2000; Patel et al., 
2000a).  The identification of 2 [32P]NAADP binding affinities in both HA-hTPC2 
cells and mouse liver homogenates is consistent with previous reports on a pancreatic 
β-cell line (MIN6) which also exhibited 2 [32P]NAADP  binding sites with Kd values 
of 130 ± 31 nM and 12 ± 0.6 µM (Masgrau et al., 2003).  The presence of two 
NAADP binding sites has also been proposed in sea urchin eggs (Patel, 2004). 
In marked contrast, the precursor of NAADP, β-NADP+ showed only low-
affinity binding with a Kd of 10.3 ± 3.1 µM in HA-hTPC2 cells (n = 3; Fig. 4.10B; 
Appendix 2, Table 4.8) and 4.5 ± 2.3 µM in mouse liver membranes (n = 4; Fig. 
4.10C; Appendix 2, Table 4.9).  Such a low affinity is expected as β-NADP+ does not 
mobilise Ca2+ from lysosome-related stores and therefore would not be expected to 
bind to a putative NAADP receptor with the same affinity as NAADP.  This low 
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affinity of β-NADP+ relative to NAADP binding is also consistent with previous 
reports in the rabbit heart and in sea urchin egg (Bak et al., 2001; Patel et al., 2000a).  
Indeed, it is possible that the binding observed may reflect contamination of β-
NADP+ preparations with NAADP as previously suggested and reported (Lee et al., 
1995; Patel et al., 2000a). 
 
 
 
Fig. 4.10.  [32P]NAADP binds to TPC2 in membranes prepared from HA-hTPC2 cells 
A Specific binding for membranes prepared from wild-type HEK293 cells (W-T) and HA-hTPC2 cells.  
* indicates a statistically significant difference (P<0.05) when compared to the mean maximal specific 
binding obtained from membranes prepared from wild-type HEK293 cells (n = 3).  B Displacement of 
[32P]NAADP binding from the total membrane prepared from HA-hTPC2 cells reveals that NAADP 
binds to TPC2 with 2 affinities.  Displacement with NAADP produced a Kd1 of 5.0 ± 4.2 nM and a Kd2 
of 7.2 ± 0.8 µM (n = 4), and displacement with NADP produced a Kd of 10.3 ± 3.1 µM (n = 4).  C 
Displacement of [32P]NAADP binding from the total membrane was prepared from mouse liver reveals 
that NAADP binds to TPC2 with 2 affinities.  Displacement with NAADP produced a Kd1 of 6.6 ± 3.5 
nM and a Kd2 of 4.6 ± 2.4 µM (n = 3), and displacement with NADP produced a Kd of 4.5 ± 3.3 µM (n 
= 3). 
 
Over-expression of HA-hTPC2 in HEK293 cells resulted in a significant 
increase in [32P]NAADP binding and strongly suggests that NAADP binds to TPC2.  
That NAADP binds to TPC2 via both a low and high affinity site may, at least in part, 
provide for a mechanism to explain the bell-shaped concentration-response curve 
observed with respect to NAADP-induced Ca2+ signals in mammalian preparations 
(Berg et al., 2000; Cancela et al., 1999; Masgrau et al., 2003) and also the unique 
inactivation properties observed sea urchin eggs.  However, in sea urchin egg low 
sub-threshold concentrations of NAADP desensitise / inactivate the receptor to 
subsequent activation by maximal NAADP concentrations, whereas higher 
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concentrations activate the receptor (Aarhus et al., 1996; Dickinson et al., 2003; 
Genazzani et al., 1996a).  In the mammalian system it is speculated that the 
significance of these findings may be that NAADP activates its receptor by binding to 
the low affinity binding site, and when the concentration of NAADP is sufficiently 
high, occupancy of the low affinity site would additionally confer “self-inactivation” 
of the NAADP-receptor complex. 
Together these data show that TPC2 exhibits the key characteristics of NAADP 
binding sites previously observed in mammalian cells and thus provides further 
support for the proposal that TPC2 may function as an NAADP receptor. 
 
4.3.3  NAADP mobilises Ca2+ in HEK293 cells that stably over-express two-pore 
channel subtype 2 
 
Having established that NAADP binds to hTPC2 with two affinities and that 
hTPC2 is targeted to lysosomal membranes when over-expressed in HEK293 cells, I 
sought to determine whether NAADP was able to mobilise Ca2+ via hTPC2.  In order 
to achieve this NAADP (100 pM to 1 mM) was applied intracellularly into HEK293 
cells stably over-expressing HA-hTPC2 by dialysis from a patch pipette in the whole-
cell configuration of the patch-clamp technique and under voltage-clamp conditions 
(V = -40 mV) to ensure inactivation of any voltage-activated Ca2+currents, with 
resultant changes in the intracellular Ca2+ concentration reported by the Fura-2 
fluorescence ratio (F340/F380).  A representative record showing the response to 
intracellular dialysis of 10 nM NAADP in a HA-hTPC2 expressing HEK293 cell is 
shown in Fig. 4.11A.  The upper panel shows a series of pseudocolour images of the 
cell in question that are representative of the F340/F380 ratio recorded at the time points 
labelled on the record of the F340/F380 ratio against time shown in the lower panel.  
Clearly, a global Ca2+ wave is triggered with a peak change in the F340/F380 ratio of 
0.92 ± 0.14 (n = 44; Appendix 2, Table 4.10). 
In marked contrast to the Ca2+ transient evoked by intracellular dialysis of 10 
nM NAADP, no such Ca2+ signal was observed when NAADP was omitted from the 
pipette solution (n = 14; Fig. 4.11B; Appendix 2, Table 4.11), consistent with the Ca2+ 
wave being triggered in response to intracellular dialysis of NAADP rather than being 
representative of an artefact of the process of intracellular dialysis per se. 
 
 132 
 
 
Fig. 4.11.  NAADP evokes global Ca2+ transients in HA-hTPC2 cells 
A Top panel, series of pseudocolour images of the Fura-2 fluorescence ratio (F340/F380) recorded in an 
HA-hTPC2 cell during the intracellular dialysis of 10 nM NAADP.  NAADP evokes a global Ca2+ 
transient.  Bottom panel, corresponding record of the F340/F380 ratio against time for the cell imaged in 
the top panel.  For this, and the subsequent record, access to the cytoplasm via the formation of the 
whole-cell configuration is indicated by the two bars at the beginning of the record, and the loss of a 
GΩ seal is indicated at the end of the record by three bars.  B Record of the F340/F380 ratio against time 
recorded in an HA-hTPC2 cell during the intracellular dialysis of NAADP-free pipette solution. 
 
Closer inspection of the NAADP-mediated Ca2+ transients in cells over-
expressing HA-hTPC2 reveals that the pattern of Ca2+ release elicited was biphasic, 
and therefore reminiscent of the two-pool mechanism of Ca2+ release by NAADP 
observed in PASMC, whereby NAADP evokes Ca2+ bursts that either return to basal 
levels or precede and then trigger a global Ca2+ wave by CICR from the SR via RyRs 
(Boittin et al., 2002).  With respect to the biphasic nature of NAADP-dependent Ca2+ 
signals in HA-hTPC2 expressing HEK293 cells, Fig. 4.12A-C shows that there was 
marked cell-to-cell variation.  The initial “shoulder” or “pacemaker phase” of the Ca2+ 
transient identified in Fig. 4.11A was not always observed, as in some cells only a 
monophasic Ca2+ transient was observed (Fig. 12A).  This is most likely due to the 
fact that the speed of coupling (see below) can vary and thereby, on occasion, limit 
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the capacity of the imaging system to discriminate between the two phases of Ca2+ 
release observed in other records.  A further variation observed is shown in Fig. 4.12B 
in which a much smaller initial rise in Ca2+, or “shoulder” precedes a global Ca2+ 
transient.  Finally, Fig. 4.13C shows that a large (>0.5 ratio units) initial phase 
preceded a large, global Ca2+ transient of the secondary phase.  However, closer 
inspection reveals that this large initial phase occurs at a higher resting Ca2+ 
concentration.  Thus, it is possible that the cytoplasmic concentration may alter the 
magnitude of Ca2+ release in response to NAADP during both the initial “shoulder” 
and the secondary amplification phase. 
 
 
 
Fig. 4.12.  NAADP evokes varied Ca2+ transients in HEK293 cells expressing HA-hTPC2 
Example records showing the Fura-2 fluorescence ratio against time recorded in HA-hTPC2 cells in 
response to intracellular dialysis of 10 nM NAADP.  The observed initial phase of the response was 
varied and an example of each is highlighted in the following panels: no clearly discernable initial 
phase (A); a small initial phase (B); a large initial phase (>0.5 ratio units) prior to a secondary phase 
(C).  For all records, access to the cytoplasm via the formation of the whole-cell configuration is 
indicated by the two bars at the beginning of the record and the loss of a GΩ seal is indicated at the end 
of the record by three bars. 
 
Of equal importance to my studies was the finding, that intracellular dialysis of 
10 nM NAADP into wild-type HEK293 cells failed to evoke a significant change in 
the Fura-2 fluorescence ratio relative to basal levels recorded before or immediately 
after entering the whole-cell configuration (n = 15; Fig. 4.13A; Appendix 2, Table 
4.12).  This is despite the fact that my collaborator, Dr Mike Zhu, cloned TPC2 from 
HEK293 cells that must, therefore, exhibit endogenous expression of this channel.  In 
light of this fact I determined the effect of increasing the NAADP concentration 
applied via the patch pipette 100-fold to 1 µM.  Fig. 4.13B shows an exemplar record, 
with pseudocolour images shown in the upper panel and the record of the F340/F380 
ratio shown in the lower panel and inset at an expanded scale.  Close inspection of the 
pseudocolour images identified (white arrow) a small, spatially restricted Ca2+ 
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transient, with similar events being observed in 3 out of 5 cells studied.  This resulted 
in a mean peak change in the F340/F380 ratio of 0.19 ± 0.04 (n = 5; Appendix 2, Table 
4.13).   
 
 
 
Fig. 4.13.  NAADP may evoke spatially restricted Ca2+ transients but not does not evoke global 
Ca2+ transients in wild-type HEK293 cells 
A Record of the Fura-2 fluorescence ratio (F340/F380) against time recorded in a wild-type HEK293 cell 
during the intracellular dialysis of 10 nM NAADP.  For this, and the subsequent record, access to the 
cytoplasm via the formation of the whole-cell configuration is indicated by the two bars at the 
beginning of the record and the loss of a GΩ seal is indicated at the end of the record by three bars.  B 
Top panel, series of pseudocolour images of the F340/F380 ratio recorded in a wild-type HEK293 cell 
during the intracellular dialysis of 1 µM NAADP.  At this concentration NAADP evokes spatially 
restricted Ca2+ transients indicated by the white arrow.  Bottom panel, corresponding record of the 
F340/F380 ratio against time for the cell imaged in the top panel.  Inset, spatially restricted Ca2+ transients 
are evoked by 1 µM NAADP. 
 
That 1 µM NAADP was required to evoke small, spatially restricted Ca2+ 
transients in wild-type HEK293 cells suggests that the endogenous level of TPC2 
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expression may be less than required for the initiation of global Ca2+ waves.  This 
view is supported by comparison of the mean change in the F340/F380 ratio in both HA-
hTPC2 cells and wild-type HEK293 cells (Fig. 4.14).  This confirms the binding data 
presented above whereby over-expression of hTPC2 in HEK293 cells resulted in a 3-
fold increase in [32P]NAADP binding and by the lack of clear specific binding in 
wild-type HEK293 cells.  Consistent with this, Dr. Mike Zhu has demonstrated by 
real time Q-RT-PCR that mRNA levels are ≤ 1,000 times lower in wild-type HEK293 
cells when compared to cells that stably over-express hTPC2 (see Calcraft et al., 2009 
– supplementary data). 
 
 
 
Fig. 4.14.  Comparison of the change in the Fura-2 fluorescence ratio resulting from intracellular 
dialysis of NAADP in HA-hTPC2 and wild-type HEK293 cells 
Bar chart showing the mean change in the Fura-2 fluorescence ratio (F340/F380) recorded in HA-hTPC2 
cells in response to 10 nM (n = 44) and 0 nM (n = 14) NAADP, and wild-type HEK293 cells in 
response to dialysis of 10 nM (n = 15) or 1 µM (n = 5) NAADP.  The columns are presented as the 
basal level (mean ± S.E.M.) to the peak change in the F340/F380 ratio (mean ± S.E.M.).  When no 
discernable change in the ratio beyond basal levels was observed, data are presented as a line 
representing the mean basal level (mean ± S.E.M.).  * indicates a statistically significant difference (P 
< 0.05) when compared to the peak change in fluorescence ratio in response to 10 nM NAADP in HA-
hTPC2 cells. 
 
4.3.4  NAADP-dependent Ca2+ release exhibits a bell-shaped concentration-
response curve in HEK293 cells over-expressing two-pore channel subtype 2 
 
The data presented above show that NAADP (10 nM) evokes a global Ca2+ 
transient in HEK293 cells over-expressing HA-hTPC2 but not in non-transfected 
(wild-type) HEK293 cells, suggesting that NAADP evokes Ca2+ release via the 
activation of hTPC2.  I therefore sought to further characterise this channel by 
determining whether hTPC2 exhibits similar functional characteristics to those 
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previously observed in mammalian cells.  One such characteristic is the bell-shaped 
concentration-response curve, whereby intracellular dialysis of concentrations of 
NAADP that are considerably higher than the threshold for initiation of Ca2+ release 
result in a failure of NAADP-induced Ca2+ release, which has been proposed to be 
due to homologous desensitization (Berg et al., 2000; Boittin et al., 2002; Cancela et 
al., 1999; Masgrau et al., 2003). 
 
 
 
Fig. 4.15. TPC2 exhibits a bell-shaped concentration-response curve to NAADP in HA-hTPC2 
cells 
Example records showing the Fura-2 fluorescence ratio (F340/F380) against time recorded in HA-hTPC2 
cells in response to intracellular dialysis of NAADP at the following concentrations: 100 pM (A); 10 
nM (B); 1 µM (C); 100 µM (D); 1 mM (E).  Access to the cytoplasm via the formation of the whole-
cell configuration is indicated by the two bars at the beginning of the record.  Note, the loss of a GΩ 
seal is indicated at the end of the record by three bars.  When no transient in response to NAADP was 
observed, 1 mM carbachol (CCh) was added extracellularly.  F Curve showing the mean (± S.E.M) of 
the peak change in the Fura-2 fluorescence ratio plotted against the log concentration of NAADP in the 
patch pipette, recorded in HA-hTPC2 cells in response to dialysis of NAADP at the following 
concentrations: 100 pM (n = 4), 10 nM (n = 44), 1 µM (n = 2), 100  µM (n = 11), and 1 mM (n = 10).  
Note, for n = 2 the range is plotted as indicated by the unfilled circles joined by a dashed line. 
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Fig. 4.15A shows a representative record of the F340/F380 ratio against time 
recorded in an HA-hTPC2 expressing cell during intracellular dialysis of 100 pM 
NAADP.  This figure shows that, as observed during intracellular dialysis of 
NAADP-free pipette solution, 100 pM NAADP failed to evoke a global Ca2+ wave 
(0.074 ± 0.004; n = 4; P<0.05; Appendix 2, Table 4.14).  As 10 nM NAADP evoked 
global Ca2+ transients in HA-hTPC2 cells (Fig. 4.15B) this would suggest that the 
threshold for activation of hTPC2 by NAADP is within the nanomolar concentration 
range.  This is consistent with the radioligand binding data which revealed a high 
affinity binding site with a Kd value of 5.0 ± 4.2 nM.  That TPC2 is activated within 
the nanomolar concentration range is also consistent with the previously reported 
level of activation observed in both mammalian and non-mammalian preparations 
including sea urchin egg, pancreatic acinar cells, T-lymphocytes, pancreatic β-cells 
and PASMC (Berg et al., 2000; Boittin et al., 2002; Cancela et al., 1999; Lee et al., 
1995; Masgrau et al., 2003).  Intracellular dialysis of either 1 µM or 100 µM also 
evoked large Ca2+ transients, reported as an increase in the F340/F380 ratio of 1.21 ± 
0.42 (n = 2; Fig. 4.15C; Appendix 2, Table 4.15) and 1.31 ± 0.43 (n = 11; Fig. 4.15D; 
Appendix 2, Table 4.16) respectively.  The mean peak change in the F340/F380 ratio 
increased as the concentration of NAADP was increased from 10 nM to 100 µM, 
although this difference is not considered statistically significant.  In marked contrast, 
intracellular dialysis of 1 mM NAADP failed to induce a Ca2+ transient (n = 10; 
P<0.05; Fig. 4.15E; Appendix 2, Table 4.17).  This is consistent with previous reports 
on NAADP-dependent Ca2+ signalling in a variety of cell types and is indicative of 
self-inactivation / desensitisation of the Ca2+ release process.  Importantly, 1 mM 
NAADP did not inhibit global Ca2+ signals triggered by 1 mM carbachol (CCh; Fig. 
4.15E) which mediates Ca2+ signals via IP3-dependent mechanisms.  Thus, 
desensitisation by NAADP of Ca2+ signalling via hTPC2 appears to be homologous.  
This is consistent with observations in other mammalian cells whereby low 
(nanomolar) concentrations of NAADP elicit Ca2+ release, whereas supra-maximal 
(micromolar) concentrations are ineffective (Berg et al., 2000; Cancela et al., 1999; 
Masgrau et al., 2003).  The inactivation / desensitisation of hTPC2 by high 
concentrations of NAADP may well be conferred by the low affinity binding site 
identified above (Fig. 4.10) i.e. occupation of the high-affinity binding site likely 
confers channel activation whereas occupation of the low-affinity binding site likely 
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confers inactivation.  Fig. 4.15F shows the concentration-response curve for 
intracellular dialysis of NAADP (100 pM to 1 mM) into HA-hTPC2 expressing cells, 
which exhibits a bell-shaped profile consistent with that observed in a variety of 
mammalian preparations (Berg et al., 2000; Cancela et al., 1999; Masgrau et al., 
2003). 
 
4.3.5  The concentration delay kinetics for intracellular dialysis of NAADP 
 
During the intracellular dialysis of 10 nM NAADP into HA-hTPC2 cells, when 
a clear point of initiation was observed, the average time to the initiation of the Ca2+ 
transient was 28.2 ± 3.3 s (n = 22; Appendix 2, Table 4.18) after the whole-cell 
configuration was achieved.  The time taken for diffusional equilibrium between the 
patch pipette and the cell to become established varies according to size of molecule.  
In 1988 Pusch and Neher provided a model to calculate the diffusion coefficient of a 
given molecule used in the whole-cell configuration of the patch-clamp technique 
(Eqn. 4.1) (Pusch et al., 1988): 
 
τ = (0.6 ± 0.17) ⋅ Rs ⋅ Mr1/3   (Eqn. 4.1) 
 
where τ is the diffusion coefficient (seconds), Rs the series resistance (MΩ), and Mr is 
the molecular mass.  Using the formula presented in Eqn. 4.1 and assuming the 
maximal series resistance of 10 MΩ and the relative molecular mass of NAADP to be 
744, the diffusional time constant for NAADP is 54.4 ± 15.4 s.  This constant can 
then be inserted into the formula presented in Eqn. 4.2 to determine the relative 
concentration of NAADP in the cell compared to the patch pipette at a given time: 
 
c(t) = c(p) – c(1) ⋅ exp(-t / τ)    (Eqn. 4.2) 
 
where the relative concentration of NAADP in the cell at a given time t is ct, cp is the 
constant concentration inside the pipette, τ is the diffusional time constant (seconds), 
and c1 is the concentration determined by cp – c(t = 0).  For these experiments the 
resting concentration of NAADP in the cell is assumed to be 0 and therefore c(1) = c(p). 
Fig. 4.16A shows the relative concentration of NAADP in the cell, based upon 
the values obtained using Eqn. 4.2.  From this curve, it is evident that at the average 
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time to the initiation of the response to 10 nM NAADP (28.2 ± 3.3 s), the 
concentration of NAADP in the cell would be approximately 4 nM.  This is consistent 
with previous reports in PASMCs which have shown that 10 nM NAADP evoked 
global Ca2+ waves whereas concentrations ≤ 2 nM failed to initiate global Ca2+ waves 
(Boittin et al., 2002).  These data provide further indirect confirmation that the Ca2+ 
transient observed in HA-hTPC2 cells in response to intracellular dialysis of 10 nM 
NAADP is as a direct response to the intracellular dialysis of NAADP.  
 
 
 
Fig. 4.16.  Concentration-delay kinetics for the intracellular dialysis of NAADP 
A Graph showing the relative concentration of NAADP in the cell compared to the constant 
concentration present in the patch-pipette (%) against time (seconds) following the formation of the 
whole-cell configuration.  Calculations have been performed using the formulae presented in Eqns. 4.1 
and 4.2.  B Graph showing the mean delay time (seconds) to the initiation of the NAADP-mediated 
Ca2+ transient versus the log concentration of NAADP in the patch pipette (black circles, left y-axis).  
Also plotted is the predicted log concentration of NAADP in the cell ([NAADP]cyt) at the time of the 
initiation of the NAADP-mediated Ca2+ transient, plotted against the log of each concentration tested 
(gray squares, right y-axis).  The predicted concentration was calculated using the formulae presented 
in Eqns. 4.1 and 4.2. 
 
In addition to 10 nM NAADP, intracellular dialysis of 1 µM and 100 µM 
NAADP evoked global Ca2+ transients in HEK293 cells stably expressing HA-
hTPC2, with the average time delay to the initiation of the Ca2+ transient measuring 
20 ± 5.0 s (n = 2; Appendix 2, Table 4.18) and 18.8 ± 2.8 (n = 4; Appendix 2, Table 
4.17) respectively.  Fig. 4.16B shows the delay time for the initiation of the peak Ca2+ 
transient for each concentration of NAADP used.  This clearly shows that the delay 
time for the initiation of the NAADP-evoked Ca2+ transient is reduced when the 
concentration of NAADP in the patch pipette is increased.  Fig. 4.16 also shows the 
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predicted concentration of NAADP in the cell at the time of initiation of the Ca2+ 
transient for each concentration of NAADP ([NAADP]pipette) examined.  If the 
diffusion of NAADP were to conform exactly to the model proposed by Pusch and 
Neher the predicted concentration at the point of initiation should be equal for each 
concentration of NAADP examined.  However, Fig. 4.16B shows that there is some 
deviation from this model (from 4 nM, 308 nM to 29 µM corresponding to a pipette 
concentration of 10 nM, 1 µM and 100 µM respectively).  This may be due to a 
number of factors that are not taken into account in the concentration-delay kinetic 
(Eqn. 4.2).  For example, the rate of NAADP metabolism within the cytoplasm or the 
non-uniform distribution of lysosomal clusters within the cell (Chapter 3) would 
affect the perceived rate of NAADP diffusion.  Moreover, the mechanism of 
NAADP-mediated Ca2+ release via TPC2 may be complicated by the requirement for 
time-dependent interactions with accessory proteins or phosphorylation of the 
channel.  Thus, this model of diffusion is an indication of the diffusional delay and 
should therefore be used as a guide only.  Nevertheless, that the delay time to the 
initiation of the Ca2+ transient is inversely proportional to the concentration of 
NAADP in the pipette, suggests that the diffusion of NAADP conforms 
approximately to the proposal that there is an associated concentration-delay kinetic 
when using intracellular dialysis (Pusch et al., 1988) and therefore further suggests 
that the Ca2+ transient observed in HA-hTPC2 cells at each concentration (10 nM, 1 
µM and 100 µM) of NAADP is as a direct response to the intracellular dialysis of 
NAADP. 
 
4.3.6  NAADP mobilises Ca2+ from lysosome-related acidic organelles via two-pore 
channel subtype 2 
 
As mentioned previously, NAADP has previously been shown to mobilise Ca2+ 
from lysosome-related acidic organelles in mammalian and non-mammalian cells 
(Churchill et al., 2002; Kinnear et al., 2004).  One of the primary indicators of this 
fact in both the sea urchin egg and mammalian cells was the finding that pre-
incubation with bafilomycin A1, a vacuolar H+ pump (V-H+-ATPase) inhibitor, can 
deplete lysosomal Ca2+ stores and thereby block subsequent Ca2+ release in response 
to NAADP (Churchill et al., 2002; Kinnear et al., 2004).  As mentioned previously, 
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through analysis of hTPC2 co-localisation with LysoTracker and LAMP2 I have 
shown that hTPC2 is preferentially targeted to lysosomes in HEK293 cells.  
Therefore, one would expect bafilomycin to confer block of NAADP-dependent Ca2+ 
signalling via hTPC2.  I therefore investigated the effect of bafilomycin on NAADP-
mediated Ca2+ release in HA-hTPC2 expressing cells.  
 
 
 
Fig. 4.17.  NAADP-mediated Ca2+ release is inhibited fully by bafilomycin and partially by 
thapsigargin  
A Top panel, series of pseudocolour images of the Fura-2 fluorescence ratio (F340/F380) recorded in an 
HA-hTPC2 cell pre-incubated (45 min) with 100 nM bafilomycin A1 (baf) during the intracellular 
dialysis of 10 nM NAADP.  Bottom panel, corresponding record of the F340/F380 ratio against time for 
the cell imaged in the top panel.  For this and the subsequent record access to the cytoplasm via the 
formation of the whole-cell configuration is indicated by the two bars at the beginning of the record.  B 
Top panel, series of pseudocolour images of the F340/F380 ratio recorded in an HA-hTPC2 cell pre-
incubated (30 min) with thapsigargin (1 µM) during the intracellular dialysis of 10 nM NAADP.  
Bottom panel, corresponding record of the F340/F380 ratio against time for the cell imaged in the top 
panel.  The loss of a GΩ seal is indicated at the end of the record by three bars. 
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Following pre-incubation (45 minutes) of HA-hTPC2 expressing cells with 100 
nM bafilomycin, 10 nM NAADP failed to evoke a global Ca2+ transient (n = 11; Fig. 
4.17A; Appendix 2, Table 4.19) and thus, no increase in the Fura-2 fluorescence ratio 
above basal levels was observed.  However, pre-incubation with 100 nM bafilomycin 
did not inhibit Ca2+ transients evoked by the application of 1 mM CCh.  This suggests 
that bafilomycin depletes the lysosomal, NAADP-releasable Ca2+ store without 
affecting the ability of IP3 to evoke Ca2+ release from the ER.  This therefore shows 
that NAADP-dependent Ca2+ signalling via hTPC2 exhibits a similar pharmacology to 
that observed with respect to NAADP-mediated Ca2+ release in other preparations 
(Churchill et al., 2002; Kinnear et al., 2004; Yamasaki et al., 2004) and suggests that 
the observed Ca2+ release is dependent upon an acidic lysosome-related Ca2+ store 
that is maintained, in part, by the activity of a V-H+-ATPase.  This is consistent with 
the fact that hTPC2 is targeted to lysosomes and with previous studies on a range of 
cells that demonstrate that NAADP releases Ca2+ from a bafilomycin-sensitive, 
lysosome-related acidic Ca2+ store and not from the ER (Brailoiu et al., 2005; 
Churchill et al., 2002; Kinnear et al., 2004; Yamasaki et al., 2004; Zhang et al., 
2006a). 
In marked contrast, depletion of ER Ca2+ stores with a SERCA pump inhibitor, 
thapsigargin, resulted in partial inhibition of NAADP-mediated Ca2+ release in HA-
hTPC2 expressing cells.  Thus, following pre-incubation (30 mins) of HA-hTPC2 
expressing cells with 1 µM thapsigargin, relatively small, spatially restricted Ca2+ 
signals were evoked by NAADP but the larger, global Ca2+ transient was not 
observed (Fig. 4.17B).  Thus, the increase in the Fura-2 fluorescence ratio measured 
only 0.23 ± 0.06 (Fig. 4.18; n = 5; Appendix 2, Table 4.20).  As expected, this is 
significantly lower than the change in the Fura-2 fluorescence ratio observed in HA-
hTPC2 expressing cells in the absence of thapsigargin (P<0.05; Fig. 4.18) and is 
indicative of residual lysosomal Ca2+ release.  This suggests that a functional ER is 
not required for the initiation of NAADP-mediated Ca2+ release but that the ER is a 
prerequisite for subsequent amplification of the initial phase of NAADP-dependent 
Ca2+ release into a global Ca2+ transient.  This is consistent with observations in other 
cell types such as sea urchin eggs, PASMCs and pancreatic acinar cells where 
NAADP-dependent Ca2+ release couples to the ER by CICR via RyRs and / or IP3Rs 
(Cancela et al., 1999; Cancela et al., 2000; Churchill et al., 2001a).  Given that 
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HEK293 cells do not express high levels of RyRs (Aoyama et al., 2004) it is therefore 
most likely that, in the absence of thapsigargin, NAADP-mediated Ca2+ release is 
amplified into a global Ca2+ transient by CICR from the ER via the progressive 
recruitment of IP3Rs. 
 
 
 
 
Fig. 4.18.  Comparison of the effect of thapsigargin and bafilomycin on NAADP-mediated Ca2+ 
release in HA-hTPC2 cells 
Bar chart comparing the mean change in the F340/F380 ratio in response to dialysis of 10 nM NAADP 
recorded in HA-hTPC2 cells either in the absence of antagonists (n = 44) or pre-incubated with 
thapsigargin (n = 5) or bafilomycin A1 (n = 11).  The columns are presented as the basal level (mean ± 
S.E.M.) to the peak change in the Fura-2 fluorescence ratio (mean ± S.E.M.).  When no discernable 
change in the ratio beyond basal levels was observed, data are presented as a line representing the mean 
basal level (mean ± S.E.M.) * indicates a statistically significant difference (P<0.05) when compared to 
the peak change in F340/F380 ratio in response to 10 nM NAADP in HA-hTPC2 cells. 
 
 
In order to confirm the requirement of IP3Rs for amplification of NAADP-
mediated Ca2+ bursts in HEK293 cells a specific IP3R antagonist was required.  
Xestospongin C is a specific IP3R antagonist and has previously been shown to inhibit 
IP3-mediated Ca2+ release in pulmonary arterial smooth muscle (Boittin et al., 2002).  
However, in HEK293 cells stably expressing HA-hTPC2, NAADP-evoked Ca2+ 
release appeared to remain unaffected in the presence of xestospongin C although it 
blocked Ca2+ release in response to CCh (not shown).  There was no clear explanation 
for this contrary observation.  Nevertheless, studies using a different IP3R antagonist, 
heparin, resolves this discrepancy.  Like NAADP heparin is unable to cross the 
plasma membrane and must be introduced into the cytoplasm via a patch pipette.  
However, given that heparin would be co-dialysed with NAADP, one could not 
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guarantee that heparin would block IP3Rs prior to NAADP-evoked Ca2+ release via 
TPCs.  Consequently, heparin was co-dialysed into the cell with caged-NAADP and 
allowed to equilibrate prior to the application of NAADP.  Following this, NAADP 
may be released via flash photolysis of the caged-NAADP.  My experimental 
apparatus was not able to perform flash photolysis and therefore these experiments 
were carried out by Dr. Abdelilah Arredouani (University of Oxford) as described 
above (see Methods).  Fig. 4.19A shows a representative record of the Fluo3 
fluorescence against time in response to the photorelease of NAADP in an HA-
hTPC2 expressing HEK293 cell.  As observed during the intracellular dialysis of 
NAADP in HA-HEK293 expressing cells, photorelease of NAADP triggered a global 
Ca2+ transient which appeared to be biphasic (n = 6).  In marked contrast, inclusion of 
heparin (200 µg/ml) in the pipette solution resulted in the inhibition of the second 
phase of the NAADP-evoked Ca2+ transient but not the first (Fig. 4.19B; n = 5).  This 
effect was similar to that observed during intracellular dialysis of NAADP in HA-
hTPC2 cells in the presence of thapsigargin (Fig. 4.17B).  Together these records 
demonstrate that in HEK293 cells NAADP-mediated Ca2+ release is amplified by 
CICR from the ER via IP3Rs. 
 
 
 
 
Fig. 4.19.  Effect of photoreleased NAADP in HEK293 cells expressing hTPC2 
A Record of the Fluo-3 fluorescence (F/F0) against time recorded in an HA-hTPC2 cell during the 
photorelease of caged NAADP (10 µM).  For this and the subsequent record, release of NAADP was 
evoked by flash photolysis of caged NAADP by ultraviolet (UV) irradiation.  B Record of the F/F0 
recorded in an HA-hTPC2 cell pre-incubated with heparin (200 µg/ml) during the photorelease of 
caged NAADP (10 µM). 
 
 
 145 
4.3.7  Knockdown of two-pore channel subtype 2 expression by shRNA blocks 
NAADP-dependent Ca2+ signalling 
 
In order to confirm that NAADP-dependent Ca2+ transients observed in HA-
hTPC2 expressing cells were dependent on hTPC2, transfection of shRNA (see 
Methods) against hTPC2 was used to knockdown hTPC2 expression. 
The presence of HA-hTPC2 protein in lysates of HA-hTPC2 expressing cells 
was determined by Western blot after transfection of cells with either shRNA against 
hTPC2 or a scrambled shRNA control, using an anti-HA antibody to identify HA-
hTPC2.  Fig. 4.20 shows a representative blot probed with sequence-specific 
antibodies raised against HA.  In protein 
obtained from control cells, a clear band 
was present that corresponded to a protein 
of approximately 100 kDa.  However, in 
cells transfected with shRNA against 
hTPC2 this band appeared to be markedly 
reduced.  As expected, in the lane loaded 
with protein obtained from wild-type 
HEK293 cells, there was no band 
corresponding to HA-hTPC2.  When the 
cells were re-probed for β-actin, the 
corresponding band (~40 kDa) appeared 
to be of equal intensity across all lanes 
(Fig. 4.20) indicating that any difference 
between the level of HA-hTPC2 detected 
is not due to unequal protein loading but 
rather the reduced expression of hTPC2 
resulting from transfection of shRNA 
against hTPC2. 
However, it is worth noting that the transfection efficiency was not complete 
(~70%) resulting in a reduction of, rather than complete abolition of hTPC 
expression.  The knockdown of hTPC2 in HA-hTPC2 cells by shRNA was therefore 
verified using immunocytochemical labelling of the HA-tag.  Both shRNA transfected 
HA-hTPC2 cells and untransfected HA-hTPC2 cells were labelled with a specific 
 
 
Fig. 4.20.  Effective knockdown of hTPC2 
expression in HA-hTPC2 cells 
Top panel shows the labelling with specific 
antibody for the HA tag present on hTPC2 
immunoblotted against homogenate protein 
samples obtained from either HA-hTPC2 cells 
transfected with shRNA against hTPC2 (lane 1) 
HA-hTPC2 cells transfected with scrambled 
shRNA (lane 2) or wild-type HEK293 cells 
(lane 3).  Lower panel shows the labelling when 
the blot was re-probed with a specific antibody 
against β-actin. 
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antibody raised against HA, as described previously.  This labelling was visualised 
using a secondary FITC-conjugated antibody.  Cells that were successfully transfected 
with shRNA were identified by the presence of fluorescence corresponding to the 
expression of the mRFP reporter gene present within the pSIREN-DNR plasmid.  Fig. 
4.21A shows a representative 3D reconstruction of a series of deconvolved Z-sections 
taken through an HA-hTPC2 cell labelled for HA.  This image shows that these cells 
present extensive and widespread HA-hTPC2 labelling (green).  When HA-hTPC2 
cells were transfected with shRNA against hTPC2, successful transfection was 
indicated by the presence of mRFP (red; Fig 4.21B) and in all cells expressing mRFP 
the level of HA-hTPC2 labelling was virtually abolished.  
Comparison of the density of HA-labelling (Fig. 4.21C) revealed that incubation 
with shRNA significantly reduced the density of HA-labelling in HA-hTPC2 cells by 
approximately 8-fold from 0.038 ± 0.009 µm3 per µm3 (n = 4; Appendix 2, Table 
4.21) to 0.0050 ± 0.0025 µm3 per µm3 (n = 6; P<0.05; Appendix 2, Table 4.22).  This 
significant reduction in HA-hTPC2 labelling is consistent with the reduced expression 
observed in the homogenates when assessed by Western blot (Fig. 4.20) and suggests 
that the sequence specific shRNA against hTPC2 is effective in reducing the 
expression of HA-hTPC2 in HEK293 cells.  Importantly, it is likely that this 8-fold 
reduction reduces TPC2 expression to below the expression level observed in wild-
type HEK293 cells, which exhibit 3-fold less [32P]NAADP binding when compared to 
cells stably over-expressing HA-hTPC2 (Fig. 4.10A) and importantly undetectable 
levels of specific binding.  However, it is important to note that the transfection 
efficiency, determined by the number of cells expressing mRFP, was approximately 
70 %.  This is consistent with the greatly reduced yet incomplete knockdown of HA-
hTPC2 protein observed in the Western blot.  This therefore implies that the presence 
of the mRFP reporter dye is a requirement for the selection of cells that have been 
transfected with shRNA, and therefore for cells in which an ~8-fold decrease in the 
density of HA-hTPC2 cells has been achieved.  Therefore, mRFP was used to identify 
cells for whole-cell patch clamp experiments on the effect of shRNA on NAADP-
dependent Ca2+ signalling via TPC2. 
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Fig. 4.21.  shRNA reduces expression of HA-hTPC2 in HEK293 cells 
Example cells showing the degree of HA-hTPC2 labelling in HA-hTPC2 cells (A) and HA-hTPC2 
cells transfected with shRNA (B).  In each case the panels show the following: Panel a shows a 
transmitted light image of the isolated HA-hTPC2 cell imaged; Panel b shows a 3D reconstruction of a 
series of deconvolved Z-sections taken through the cell shown in panel a showing the distribution of 
HA labelling (green) and the presence of mRFP (red) indicating successful shRNA transfection, 
relative to the nucleus (dark blue); Panel c shows a 3D reconstruction of deconvolved Z-sections as 
shown in panel b, showing the distribution of HA labelling relative to the nucleus (dark blue).  C Bar 
chart comparing the density of HA labelling (µm3 per µm3; mean ± S.E.M.) within the whole cell 
volume of HA-hTPC2 control cells (n = 4) and HA-hTPC2 cells transfected with shRNA (n = 6).  * 
indicates a statistically significant difference (P<0.05) when compared to the HA labelling density of 
HA-hTPC2 control cells. 
 
Having verified that shRNA against hTPC2 was effective in reducing hTPC2 
expression in HA-hTPC2 cells, I next investigated the effect of shRNA-mediated 
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hTPC2 knockdown on the response to intracellular dialysis of 10 nM NAADP.  The 
resultant change in the intracellular Ca2+ concentration was reported by changes in the 
Fura-2 fluorescence ratio.  Importantly, only cells that were seen to express mRFP, 
observed via a RFP Alpha Vivid filter, were selected for patching. 
 
 
 
Fig. 4.22.  shRNA against TPC2 abolishes NAADP-mediated Ca2+ transients in HA-hTPC2 cells 
Example records of the response to intracellular dialysis of 10 nM NAADP in HA-hTPC2 cells 
transfected with either shRNA against TPC2 (A) scrambled shRNA (B).  In both cases the panels 
contain the following: Top panel, series of pseudocolour images of the Fura-2 fluorescence ratio 
(F340/F380) recorded in HA-hTPC2 cells during the intracellular dialysis of 10 nM NAADP; Bottom left 
panel, corresponding record of the F340/F380 ratio against time for the cell imaged in the top panel.  
Access to the cytoplasm via the formation of the whole-cell configuration is indicated by the two bars 
at the beginning of the record and the loss of a GΩ seal is indicated at the end of the record by three 
bars; Bottom right panel, the transmission light image (Trans) and image of mRFP labelling (mRFP) 
within the selected cell verifying successful transfection. 
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A representative record showing the effect of pre-incubation (72-96 hours) with 
shRNA against hTPC2 on NAADP-mediated Ca2+ release is shown in Fig 4.22A.  
The upper panel shows a series of pseudocolour images of the Fura-2 fluorescence 
ratio recorded during the intracellular dialysis of 10 nM NAADP, with the record of 
the Fura-2 fluorescence ratio against time shown in the bottom left panel.  The bottom 
right panel shows the transmission light image and the corresponding image of mRFP 
labelling.  Transfection of hTPC2 expressing cells with shRNA abolished Ca2+ 
signalling in response to 10 nM NAADP, with no change in the Fura-2 fluorescence 
ratio above basal levels evident (n = 10; P<0.05; Fig. 4.23C; Appendix 2, Table 2.24).  
In marked contrast, HA-hTPC2 cells transfected with scrambled shRNA exhibited 
Ca2+ transients in response to intracellular dialysis of 10 nM NAADP, with a peak 
change in the Fura-2 fluorescence ratio of 1.15 ± 0.4 (n = 6; Fig. 4.22B; Appendix 2, 
Table 4.23) that was not significantly different to control hTPC2 expressing cells 
(0.92 ± 0.14; n = 44; Fig. 4.23).  I can conclude therefore, that shRNA knockdown of 
hTPC2 was effective in cells that stably over-expressed hTPC2 and that knockdown 
of hTPC2 blocked Ca2+ signalling induced by intracellular dialysis of 10 nM NAADP.  
Thus NAADP mediates Ca2+ signals in a manner that is dependent on the expression 
of hTPC2. 
 
 
 
Fig. 4.23.  shRNA against TPC2 but not scrambled shRNA abolishes NAADP-mediated Ca2+ 
transients in HA-hTPC2 cells 
Bar chart comparing the mean change in F340/F380 ratio recorded in shRNA transfected (n = 10), 
scrambled shRNA transfected (n = 6) and non-transfected (n = 44) HA-hTPC2 cells in response to 
dialysis of 10 nM NAADP.  The columns are presented as the basal level (mean ± S.E.M.) to the peak 
change in the F340/F380 ratio (mean ± S.E.M.).  When no discernable change in the ratio beyond basal 
levels was observed, data are presented as a line representing the mean basal level (mean ± S.E.M.) * 
indicates a statistically significant difference (P<0.05) when compared to the peak change in F340/F380 
ratio in response to 10 nM NAADP in HA-hTPC2 cells. 
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4.3.8  NAADP evokes Ca2+ bursts but not global Ca2+ transients in HEK293 cells 
that stably over-express two-pore channel subtype 1 
 
TPC1 is also ubiquitously expressed in primates (including humans), rats and 
mice and is targeted to endosomes which, like lysosomes, may represent acidic, Ca2+ 
storing organelles (Gerasimenko et al., 1998; Hilden et al., 1989).  Therefore I sought 
to determine whether or not NAADP could mediate Ca2+ signals in HEK293 cells that 
stably over-express His6-hTPC1.  As for studies on hTPC2, this was achieved by 
intracellular dialysis of 10 nM NAADP via a patch-pipette, in the whole-cell 
configuration of the patch-clamp technique and under voltage-clamp conditions (V = -
40 mV).  Resultant changes in the intracellular Ca2+ concentration were once again 
reported by changes in the Fura-2 fluorescence ratio. 
Fig. 4.24 shows a representative record of the effect of intracellular dialysis of 
10 nM NAADP on the Fura-2 fluorescence ratio in a His6-hTPC1 expressing cell.  
The upper panel shows a series of pseudocolour images, with the lower panel 
showing the corresponding record of the Fura-2 fluorescence ratio against time; inset 
shows record on an expanded scale.  Clearly, intracellular dialysis of 10 nM NAADP 
evoked small, spatially restricted Ca2+ transients, and this was observed in 3 out of 4 
cells studied.  These Ca2+ release events did not spread throughout the entirety of the 
cell and resulted in a mean peak change in the Fura-2 fluorescence ratio of 0.35 ± 
0.09 (n = 4; Appendix 2, Table 4.25).  These spatially restricted Ca2+ transients were 
reminiscent of the response to 10 nM NAADP observed in hTPC2 expressing cells 
following pre-incubation with thapsigargin, and of the response of wild-type HEK293 
cells to a higher concentration of NAADP (1 µM; Fig. 4.15).  As TPC1 appeared to 
be primarily targeted to endosomes, these data suggest that 10 nM NAADP mediates 
Ca2+ release from endosomes via TPC1 in a manner that is unable to breach the 
threshold for amplification by CICR via IP3Rs on the ER.  The spatially restricted 
nature of release via hTPC1 is consistent with the spatially restricted distribution of 
hTPC1 and the endosomes to which this channel subtype is targeted, as shown in the 
immunofluorescence images presented above (Fig. 4.19).  These findings therefore 
suggest that endosomes / TPC1 do not allow for efficient coupling to ER Ca2+ release 
mechanisms in HEK293 cells.  Nonetheless, these findings suggest that TPC1 may 
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also mediate Ca2+ signals in response to NAADP and that TPCs may therefore 
represent a family of NAADP receptors. 
 
 
 
 
Fig. 4.24.  His6-hTPC1 cells exhibit spatially restricted Ca2+ transients in response to 10 nM 
NAADP 
Top panel, series of pseudocolour images of the Fura-2 fluorescence ratio recorded in an His6-hTPC1 
cell during the intracellular dialysis of 10 nM NAADP.  NAADP evoked spatially restricted Ca2+ 
transients that did not spread throughout the whole cell.  Bottom panel, corresponding record of the 
Fura-2 fluorescence ratio against time for the cell imaged in the top panel.  Access to the cytoplasm via 
the formation of the whole-cell configuration is indicated by the two bars at the beginning of the 
record.  Note, the loss of a GΩ seal is indicated at the end of the record by three bars.  Inset, spatially 
restricted Ca2+ transients are evoked by 10 nM NAADP.  Similar observations were made in 3 out of 4 
His6-hTPC1 cells. 
 
 
4.4  Discussion 
 
The data presented in this chapter provide strong evidence in support of the 
view that that TPC2 constitutes, at least in part, an NAADP receptor that releases 
Ca2+ from lysosome-related acidic organelles that can trigger further Ca2+ release 
from the ER by CICR. 
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4.4.1  Two-pore channel subtype 2 is specifically targeted to lysosomes in HEK293 
cells. 
 
Examination of the cellular distribution of TPCs revealed that TPC2 co-
localises with the lysosome markers LAMP2 and LysoTracker, but not with markers 
of early endosomes, late endosomes, mitochondria, Golgi apparatus, or the ER.  In 
marked contrast, TPC1 and TPC3 showed little or no co-localisation with lysosomes 
or TPC2, but instead appeared to be targeted to endosomes and other unidentified 
organelles.  Therefore, all mammalian TPCs are expressed intracellularly on the 
membranes of endolysosomes, with TPC2 specifically targeted to lysosomes.  The 
presence of all 3 TPC subtypes on the membranes of intracellular endolysosomal Ca2+ 
stores is consistent with the vacuolar localisation of plant TPC1 (Peiter et al., 2005) 
and also with the suggestion of Ishibashi et al., that mammalian TPCs may exhibit an 
intracellular membrane localisation (Ishibashi et al., 2000).  Importantly, the cellular 
distribution of TPCs and particularly TPC2 is consistent with the view that NAADP 
receptors are localised to lysosome-related acidic organelles and that NAADP 
selectively releases Ca2+ from these stores (Brailoiu et al., 2006; Brailoiu et al., 2005; 
Churchill et al., 2002; Kinnear et al., 2004; Macgregor et al., 2007; Yamasaki et al., 
2004; Zhang et al., 2006a).  Due to its absence in primates and some rodent genomes 
(e.g. mouse and rat), TPC3 was excluded from consideration at the level of the 
expression system used.  However, the specific endolysosomal location of all 3 TPCs 
and in particular the lysosomal distribution of TPC2 suggested that TPCs may be 
ideal candidate NAADP receptors. 
 
4.4.2  NAADP binds to two-pore channel subtype 2 with two affinities 
 
In membranes prepared from HEK293 cells and HA-hTPC2 cells a ligand 
competition assay showed that the over-expression of HA-hTPC2 in HEK293 cells 
resulted in a 3-fold increase in the maximal specific binding of [32P]NAADP.  Such 
an increase in the maximal specific binding is indicative of NAADP binding to 
hTPC2 and thus further supports the view that TPC2 may act as an NAADP receptor.  
Furthermore, competitive [32P]NAADP displacement assays using membranes from 
HA-hTPC2 cells revealed that TPC2 exhibits two binding sites for NAADP, one with 
a high affinity and one with a low affinity.  Furthermore, paired studies on mouse 
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liver, which were identified as exhibiting the highest expression levels of TPC2 across 
all mammalian tissues studied thus far, revealed a similar binding curve.  Thus, Kd 
values of ~5 nM and ~7 µM were obtained with membranes isolated from hTPC2 
expressing cells compared with ~7 nM and ~5 µM with membranes from mouse liver.  
The high affinity (5 nM) binding site is consistent with the binding affinity reported in 
pancreatic β-cells, heart and brain preparations (Bak et al., 2001; Masgrau et al., 
2003; Patel et al., 2000b).  Moreover, the presence of 2 binding sites (~130 nM and  
~12 µM) has also been observed in previous studies on MIN6 cells.  In marked 
contrast, membranes derived from hTPC2 expressing HEK293 cells showed only 
low-affinity binding of NADP (Kd value of ~10 µM).  This low affinity is also 
consistent with previous reports using rabbit heart and in sea urchin egg preparations 
(Bak et al., 2001; Patel et al., 2000a) though it is important to note that the binding of 
NADP to TPC2 may be due to the molecules similarity to NAADP or may be due to 
contamination of NADP preparations with trace amounts of NAADP (Lee et al., 
1995). The presence of high and low affinity binding sites for NAADP has been 
suggested to underpin the bell-shaped concentration-response curve to NAADP by 
conferring homologous desensitisation (Berg et al., 2000; Cancela et al., 1999; 
Masgrau et al., 2003).  This proposed model predicts that occupancy of the high 
affinity binding site would confer activation of the NAADP receptor / Ca2+ release 
channel, whereas occupancy of the low affinity binding site would confer inactivation 
of the Ca2+ release mechanism.   
The increased maximal specific binding observed in HEK293 cells due to over-
expression of hTPC2 together with the similar binding affinities observed in mouse 
liver and other mammalian cell types, further suggests that TPC2 may be the putative 
NAADP receptor.  By contrast TRPML1, although expressed on lysosome 
membranes, does not appear to bind NAADP in NRK cells (Pryor et al., 2006).  The 
NAADP-binding properties of TPC2 therefore represent an important distinction 
between this protein channel and other proposed targets of NAADP.  Though 
unlikely, this does not exclude the possibility that accessory proteins may be required 
for appropriate NAADP / TPC2 interaction, although such an interaction would 
require a very close coupling in order to maintain the binding properties of TPC2 
shown above. 
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4.4.3  NAADP-mediated Ca2+ mobilisation via two-pore channel subtype 2 exhibits 
a bell-shaped concentration-response curve 
 
Intracellular dialysis of 10 nM NAADP into HA-hTPC2 expressing cells 
evoked global Ca2+ transients that were biphasic in nature, reminiscent of NAADP-
evoked Ca2+ signals observed in PASMCs in which global Ca2+ waves are preceded 
by spatially restricted Ca2+ bursts (Boittin et al., 2002).  No such Ca2+ transients were 
observed in hTPC2 expressing cells when NAADP was omitted from the pipette 
solution, nor when the concentration of NAADP was reduced to 100 pM.  
Furthermore, in wild-type HEK293 cells, 10 nM NAADP failed to evoke global Ca2+ 
transients and 1 µM NAADP only induced small, spatially restricted Ca2+ transients 
in 3 out of 5 cells.  These findings suggest that stable over-expression of hTPC2 
confers global Ca2+transients in response to 10 nM NAADP, and that the threshold for 
initiation of Ca2+ signalling via hTPC2 is in the nanomolar concentration range.  This 
is entirely consistent with both the high affinity binding site detected in membranes 
prepared from hTPC2 expressing cells and with the threshold for NAADP-mediated 
Ca2+ signals in PASMCs (Boittin et al., 2002). 
NAADP also evoked global Ca2+ transients at concentrations of 1 µM and 100 
µM.  In marked contrast, however, 1 mM NAADP failed to evoke any identifiable 
Ca2+ signal in hTPC2 expressing cells, despite the fact that all cells exhibited Ca2+ 
transients in response to CCh, which mediates Ca2+ release via IP3 (van Koppen et al., 
2001).  Thus, at high (mM) concentrations NAADP appears to desensitise TPC2 
without affecting Ca2+ release via IP3Rs i.e. observed desensitisation is homologous.  
Furthermore, the inhibitory effect of high concentrations of NAADP indicates that in 
hTPC2 expressing cells, NAADP-mediated Ca2+ release exhibits a bell-shaped 
concentration-response curve consistent with other mammalian cells (Berg et al., 
2000; Cancela et al., 1999; Masgrau et al., 2003).  That low concentrations (nM) of 
NAADP activates TPC2 whereas high concentrations (mM) are inhibitory is also 
consistent with the 2 binding affinities for NAADP that are exhibited by hTPC2.  
Thus, it is likely that a high affinity binding site, occupied at ~10 nM NAADP, 
confers channel activation, whereas when the low affinity binding site, occupied at 
NAADP concentrations ≥1 mM, confers inactivation / desensitisation. 
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4.4.4  Two-pore channel subtype 2 expression is knocked down by shRNA in 
HEK293 cells stably over-expressing two-pore channel subtype 2 
 
Transfection with shRNA against hTPC2 was used in order to confirm that the 
Ca2+ transients observed in hTPC2 expressing cells in response to NAADP were 
entirely dependent on over-expression of hTPC2.  Western blot and 
immunocytochemistry confirmed successful knockdown of hTPC2.  Although the 
transfection efficiency was not complete (~70%), transfected cells were successfully 
identified using an RFP reporter, and in cells expressing this reporter the density of 
HA-hTPC2 labelling was reduced by approximately 8-fold.  All cells that exhibited 
mRFP fluorescence as a result of shRNA transfection failed to respond to intracellular 
dialysis of 10 nM NAADP.  In marked contrast, the Ca2+ transient in response to the 
application of 1 mM CCh remained unaffected.  Furthermore, intracellular dialysis of 
NAADP into hTPC2 expressing cells that had been transfected with scrambled 
shRNA evoked global Ca2+ transients that were similar to those observed in control 
cells.  I can conclude, therefore, that NAADP mediates Ca2+ signals via hTPC2. 
 
4.4.5  NAADP mobilises Ca2+ via two-pore channel subtype 2 from lysosome-related 
acidic organelles 
 
Pre-incubation of hTPC2 expressing cells with thapsigargin (1 µM) resulted in 
the inhibition of global Ca2+ transients and revealed smaller, spatially restricted Ca2+ 
transients.  The effect of thapsigargin on NAADP-mediated Ca2+ release in hTPC2 
expressing cells suggests that the initiation of Ca2+ signals does not require a 
functional ER store, but that a functional ER store is required for subsequent 
amplification of initial NAADP-induced Ca2+ signals into a global Ca2+ transient.  
This partial inhibition of the total Ca2+ release is reminiscent of the inhibition of the 
NAADP-mediated global Ca2+ wave but not spatially restricted Ca2+ bursts in 
PASMC by thapsigargin (Boittin et al., 2002) and dantrolene (Chapter 3).  The partial 
inhibition of NAADP-mediated Ca2+ signalling in hTPC2 expressing cells by 
thapsigargin is therefore consistent with the view that NAADP initiates Ca2+ signals 
via a two-pool mechanism in sea urchin eggs and PASMCs, whereby NAADP 
initially releases Ca2+ from a thapsigargin-insensitive Ca2+ store that is then amplified 
by CICR from the S / ER (Boittin et al., 2002; Churchill et al., 2001a).  Furthermore, 
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given the fact that HEK293 cells do not express high levels of RyRs (Aoyama et al., 
2004), amplification is most likely to occur by CICR via the activation of IP3Rs, and 
this was confirmed by the fact that heparin, like thapsigargin, blocked only the 
amplification of local NAADP-dependent Ca2+ signals into global Ca2+ waves.  That 
NAADP-mediated Ca2+ release is amplified by CICR via IP3Rs is consistent with 
previous reports (Berg et al., 2000; Cancela et al., 1999; Churchill et al., 2000).  
Furthermore, that IP3Rs may form junctional complexes is consistent with a recent 
study that demonstrated that IP3R2, present in the ER, may form tight complexes with 
adenylyl cyclase subtype 6 present on the plasma membrane (Tovey et al., 2008). 
When the above is taken together with the fact that only localised Ca2+ 
transients were observed in response to relatively high concentrations (1 micromolar) 
NAADP in wild-type HEK293 cells, this suggests that the expression level of 
endogenous TPC2 in HEK293 cells may not be sufficient for effective coupling 
between TPC2 and the ER.  This could be explained by the spatial distribution of 
lysosome-related Ca2+ stores in HEK293 cells, which may form “loose junctions” 
with the ER such that the Ca2+ released via endogenous TPC is not sufficient to 
breach the threshold for CICR via IP3Rs. 
That TPC2 releases Ca2+ from lysosome-related stores in response to NAADP 
was confirmed using the V-H+-ATPase inhibitor bafilomycin A1, which is thought to 
deplete lysosome-related acidic organelles of Ca2+ by collapsing the proton gradient 
(Christensen et al., 2002; Churchill et al., 2002).  Pre-incubation of HA-hTPC2 
expressing cells with bafilomycin A1 abolished both phases of the NAADP-mediated 
Ca2+ transient, unlike thapsigargin and heparin.  This therefore suggests that NAADP 
mobilises Ca2+ from a lysosomal store in hTPC2 expressing cells and in a manner 
dependent on hTPC2.  This is consistent with the specific targeting of TPC2 to 
lysosomes, as indicated by co-localisation of hTPC2 with the lysosome markers 
LAMP2 and LysoTracker.  This is entirely consistent with the concept that NAADP 
mobilises Ca2+ from lysosome-related acidic organelles in a number of cell types 
including sea urchin eggs, neuronal cell lines (PC12), coronary artery SMCs, cerebral 
cortex neurons, PASMCs and ventricular myocytes (Brailoiu et al., 2006; Brailoiu et 
al., 2005; Churchill et al., 2002; Kinnear et al., 2004; Macgregor et al., 2007; 
Yamasaki et al., 2004; Zhang et al., 2006a). 
Importantly, bafilomycin did not inhibit the Ca2+ transient evoked by CCh.  
Therefore, bafilomycin is without effect on Ca2+ release from the ER via IP3Rs in 
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HEK293 cells.  Thus, it would appear that in hTPC2 expressing cells, NAADP 
mobilises Ca2+ from a lysosome-related Ca2+ store which is then amplified into a 
global Ca2+ transient by CICR via IP3Rs present on the ER.   
 
4.4.6  NAADP evokes Ca2+ bursts via two-pore channel subtype 1 
 
A potential role for TPC1 in NAADP-mediated Ca2+ signalling was also 
identified.  Thus, in hTPC1 expressing cells, NAADP evoked small, spatially 
restricted Ca2+ release events.  However, unlike hTPC2 expressing cells, no global 
signals were observed.  This is consistent with the restricted distribution of TPC1 
compared to TPC2, and, for that matter, with the distribution of the endosomes to 
which hTPC1 appears to be specifically targeted.  Therefore, it would appear that 
activation of endosome-bound TPC1 by NAADP results in the release of Ca2+ that is 
insufficient to initiate CICR via IP3Rs.  This could be due to the absence of significant 
coupling between endosomes and IP3R rich regions of the ER.  However, the 
endosomal localisation of TPC1 together with the NAADP-evoked Ca2+ release in 
hTPC1 expressing cells suggests that TPC1 may be activated directly by NAADP and 
thus TPC1 may also contribute to NAADP-dependent Ca2+ signalling.  Thus, TPCs 
may represent a family of NAADP receptors, although further investigation will be 
required to confirm whether or not this is the case. 
 
4.4.7  Two-pore channel subtype 2 is a molecular target of NAADP 
 
In summary, the results presented in this chapter provide compelling evidence 
in support of TPC2 as a molecular target of NAADP.  Over-expression of TPC2 in 
HEK293 cells confers sensitivity to NAADP, such that intracellular dialysis of 10 nM 
NAADP elicited a global Ca2+ transient that is absent in wild-type HEK293 cells.  
This transient is abolished by sequence-specific knockdown of hTPC2 expression by 
shRNA.  Furthermore, hTPC2 exhibits a bell-shaped concentration-response curve to 
NAADP consistent with observations of NAADP-mediated Ca2+ signalling in other 
mammalian cells (Berg et al., 2000; Cancela et al., 1999; Masgrau et al., 2003).  
Importantly, NAADP-evoked Ca2+ transients in HA-hTPC2 expressing cells were 
abolished by pre-incubation with bafilomycin whereas pre-incubation with 
thapsigargin resulted in the inhibition of the second but not the first phase of Ca2+ 
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release evoked by NAADP.  This is consistent with the lysosomal distribution of 
TPC2 and with previous reports of NAADP-mediated Ca2+ signalling via a 2-pool 
mechanism (Boittin et al., 2002; Churchill et al., 2001a; Kinnear et al., 2004).  These 
data show that TPC2 exhibits the characteristics observed with respect to native 
mammalian NAADP receptors and thus TPC2 likely forms NAADP receptors that 
release Ca2+ from lysosome-related acidic organelles.  Furthermore, TPCs may 
represent a family of NAADP receptors as indicated by the fact that TPC1 also 
underpins NAADP-mediated Ca2+ signals (Brailoiu et al., 2009). 
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Chapter 5:  NAADP elicits Ca2+ release via two-pore 
channels in rat pulmonary arterial smooth muscle 
cells 
 
 
5.1  Introduction 
 
The results presented in Chapter 3 show that in pulmonary arterial smooth 
muscle cells (PASMCs) lysosomes form junctional complexes with regions of the 
sarcoplasmic reticulum (SR) that contain a high density of ryanodine receptor subtype 
3 (RyR3) to comprise a trigger zone for Ca2+ signalling by NAADP.  This model 
proposes that NAADP acts on a putative NAADP receptor to release a Ca2+ burst 
from lysosome-related organelles.  Thereafter these Ca2+ bursts are amplified in an 
all-or-none manner by Ca2+-induced Ca2+ release (CICR) from the SR via RyR3, with 
a resultant propagating Ca2+ wave likely carried away from the trigger zone by 
recruitment of RyR2 by CICR. 
Further to this, in Chapter 4 I have provided compelling evidence to suggest that 
two-pore channels (TPCs) may represent a family of NAADP receptors.  In particular, 
human TPC2 (hTPC2) was shown to be specifically targeted to the membranes of 
lysosomes and when over-expressed in HEK293 cells these channels bound 
[32P]NAADP with 2 affinities, consistent with previous reports of NAADP binding to 
both sea urchin egg and mammalian NAADP receptors (Bak et al., 2001; Billington et 
al., 2000; Masgrau et al., 2003; Patel, 2004; Patel et al., 2000b).  Using HEK293 cells 
over-expressing hTPC2 I also showed that TPC2 underpins NAADP-mediated Ca2+ 
release from lysosome-related organelles.  An initial phase of Ca2+ release from acidic 
stores was clearly amplified by CICR from the ER via IP3Rs resulting in a biphasic 
response to NAADP reminiscent of the two-pool mechanism of NAADP-mediated 
Ca2+ signalling in sea urchin egg and PASMCs (Boittin et al., 2002; Churchill et al., 
2001a).  In marked contrast, NAADP evoked localised Ca2+ transients in HEK293 
cells over-expressing hTPC1, which did not appear to be amplified into global Ca2+ 
transients by CICR from the ER.  Moreover, in contrast to hTPC2, 
immunofluorescence studies revealed that TPC1 appears to be targeted to endosomal 
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membranes which exhibit a more spatially restricted distribution than does TPC2 / 
lysosomes.  It therefore seems likely that NAADP also acts on hTPC1 to mobilise 
Ca2+ from endosomes.  Thus, it would appear that there is insufficient coupling 
between TPC1 / endosomes and the ER to support the generation of global Ca2+ 
waves through amplification by CICR from the ER.  Therefore, these results indicated 
that all TPCs may represent a family of NAADP receptors, but that TPC2 is likely of 
primary importance to the regulation of primary cell function (e.g. smooth muscle 
contraction) through the generation of propagating, global Ca2+ signals. 
In order to further characterise the mechanisms underpinning NAADP-mediated 
Ca2+ release in rat PASMCs I therefore sought to determine the involvement of TPCs.  
Given that TPC3 is not present in primates, rats and mice, although it is present in all 
other mammals studied thus far.  Therefore, TPC3 was excluded from further 
consideration. 
 
 
5.2  Methods 
 
5.2.1  RNA extraction for the analysis of two-pore channel content in pulmonary 
arterial smooth muscle 
 
2nd order branches of the pulmonary artery were identified and dissected out as 
described previously.  Arteries were cut longitudinally and the endothelium was 
removed by gently rubbing the luminal wall with a cotton bud.  The tissue was 
weighed and snap frozen in liquid nitrogen and stored at -80°C until required.  The 
sample was taken out of the -80°C freezer and TRIzol (10 µl/mg; Invitrogen Ltd., 
USA) was added to the frozen tissue and the tissue was homogenised using a 
motorised pestle.  The homogenate was divided into aliquots of 1 ml in 
microcentrifuge tubes and left for 5 minutes at room temperature.  200 µl of 
chloroform was then added to each tube, mixed and incubated for 2 minutes at room 
temperature.  The samples were then centrifuged at 12000 g for 15 minutes at 4 °C.  
The supernatant was removed and placed into a clean microcentrifuge tube.  0.5 µl of 
isopropanol per 1 ml of sample was added and the mixture was incubated for 10 
minutes at 4 °C.  The samples were centrifuged at 12000 g for 15 minutes at 4 °C, the 
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supernatant was removed and discarded and the pellet was washed with 80 % ethanol 
before being centrifuged at 7500 g for 5 minutes at 4°C.  Following centrifugation, 
the ethanol was removed and the pellet was allowed to dry for approximately 10 
minutes at room temperature.  The dry pellet was resuspended in sterile pure-filtered 
H2O containing a ribonuclease inhibitor RNaseOUT (Invitrogen Ltd., USA). Samples 
were stored at -80°C until required. 
 
5.2.2  Examination of two-pore channel subtype 2 expression in pulmonary arterial 
smooth muscle by RT-PCR 
 
Reverse transcription was performed in a 200 µl PCR tube containing the 
following 6 µg of RNA, 1 µl of oligo dT primer and made up to 10 µl with pure-
filtered H2O.  The mixture was heated at 70 °C for 5 minutes and then placed on ice 
for 5 minutes.  Following this, the following was added to the reaction mixture: 7 µl 
pure-filtered H2O, 0.5 µl RNasin, 5 µl RT buffer, deoxynucleotide trisphosphate 
mixture (dNTPs; 10 mM) and 1 µl Moloney Murine Leukaemia Virus (MMLV) 
reverse transcriptase.  The reaction mixture was placed in a PCR thermal cycler and 
heated at 40 °C for 10 minutes, 42 °C for 3 hours, 70 °C for 10 minutes.  The cDNA 
was stored at -20 °C until required. 
Polymerase chain reaction was carried out in a 200 µl thin walled PCR tube 
containing the following mixture: 0.3 µl cDNA, 1 µl of each sense/antisense primer 
(Table 5.1), 0.2 mM each dNTP, 1.5 mM MgCl2, 0.125 µl Taq polymerase and made 
up to a final volume of 25 µl with 1 x PCR buffer.  The reaction mixture was placed 
in a PCR thermal cycler (Applied Biosystems) and the following programme was run: 
95 °C for 4 minutes followed by 35 cycles of 95 °C for 1 minutes, 54 °C for 1 minute, 
and 72 °C for 1 minute.  Following the 35 cycles the tube was maintained at 72 °C for 
10 minutes.  The PCR products were then separated on a 2 % agarose gel.  2 g 
agarose was mixed with 1 ml 100 x Tris Acetate EDTA (TAE) buffer and made up to 
a final volume of 100 ml with pure filtered H2O.  The mixture was heated until the 
agarose was dissolved and then allowed to cool.  10 µl SYBR Safe gel stain 
(Invitrogen) was added and the mixture poured into a taped mould, a comb was 
inserted and the gel allowed to set for approximately 40 minutes.  The comb was 
removed and the mould was placed into the gel tank containing 1 x TAE.  10 µl of 
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PCR product (1 µg/ml) was mixed with 2 µl of loading buffer before being loaded 
onto the gel.  In one outer well 2 µl Trackit 1 kb DNA ladder (Invitrogen) was mixed 
with 18 µl TAE (1 x) and 2 µl loading buffer and loaded onto the gel.  The gel was 
run for 2 minutes at 230 V, followed by approximately 40 minutes at 130 V.  The gel 
was imaged using a Synagene Bio imaging system (Synagene, Synoptics, UK). 
 
Gene Sense Primer Sequence 
 
Antisense Primer Sequence 
TPC2 
 
TGGAGAACTTTCTCCAC TCACCTGCACAGATGCAAG 
TRP6  
 
GCATTCACAACAGTTGAGGA GGAAAACCACAATTTGGCCCTTGC 
TRP7 
 
GCTGTCCATCTTCGTGGCCTCCTTC AGAAAATGACCATGAACTTGAAGAT 
G3PDH 
 
TCCTGCACCACCAACTGCTTAGC CACCACCCTGTTGCTGTAGC 
 
Table 5.1.  Sense and antisense primer sequence for each probe used in reverse transcription 
polymerase chain reaction studies 
Primers of the above sequences correspond to two-pore channel subtype 2 (TPC2), canonical transient 
receptor potential (TRPC) subtypes 6 and 7, and glyceraldehyde-3-phsophate dehydrogenase 
(G3PDH). 
 
5.3  Results 
 
5.3.1  Two-pore channel subtype 2 is expressed in pulmonary arterial smooth 
muscle cells 
 
Previous reports from this laboratory have shown that NAADP mobilises Ca2+ 
from a lysosome-related acidic store in rat PASMCs (Boittin et al., 2002; Kinnear et 
al., 2004).  This is supported by evidence presented in chapter 3 which demonstrated 
that the initial NAADP-evoked Ca2+ burst from lysosomes is amplified by CICR from 
the SR via the activation of RyR3.  To complete this picture I therefore sought to 
determine whether TPC2 underpins NAADP-mediated Ca2+ signalling via lysosomes 
in PASMCs.  In order to determine whether or not TPC2 was expressed in rat 
PASMCs, lysates of pulmonary arteries (without adventitia or endothelium) were 
prepared for reverse-transcription polymerase chain reaction (RT-PCR) as described 
above, and amplification of message from the cDNA obtained was used to determine 
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whether or not TPC2 is expressed in this tissue.  In Fig. 5.1 an agarose gel shows the 
amplification products from the cDNA obtained from the reverse transcription of 
RNA within rat PASMC lysates.  A clear band is present in the lane corresponding to 
the sample containing the TPC2 primer and at the appropriate size (~170 bp).  Lanes 
corresponding to the control primers 
(lane 1-3) show that samples 
containing the primer for canonical 
transient receptor potential channel 
(TRPC) subtype 6 and 
glyceraldehyde-3-phosphate 
dehydrogenase (G3PDH) also 
present clear bands at the 
appropriate sizes (185 bp and 524 
bp respectively).  TRPC7 served as 
a negative control and thus, no clear 
band was indentified in the lane 
corresponding to this primer.  
Therefore, TPC2 is expressed in rat 
PASMCs, consistent with the 
proposed ubiquitous expression of 
TPC2 across all mammalian species 
and tissues, as discussed in Chapter 
4.  
 
5.3.2  Ned-19 displaces [32P]NAADP binding in sea urchin egg homogenates and 
HEK293 cells stably over-expressing two-pore channel subtype 2  
 
In order to determine whether TPC2 underpins NAADP-mediated Ca2+ release 
in PASMCs a novel, fluorescent NAADP antagonist was used.  This was recently 
developed by Churchill and colleagues through virtual screening using a large 
chemical library (Naylor et al., 2009).  Of the candidates tested Ned-19 had a high 
degree of 3D overlap and proved to be the most potent inhibitor of NAADP-mediated 
Ca2+ release in a sea urchin egg homogenate high-throughput screening assay (Naylor 
et al., 2009).  Inhibition of [32P]NAADP binding by Ned-19 was also shown to be 
 
 
Fig. 5.1.  Two-pore channel subtype 2 is 
expressed in rat pulmonary arterial smooth 
muscle cells 
RT-PCR amplification (35 cycles) of TPC2 cDNA 
derived from PASMC lysates.  Lane 4 shows a clear 
band corresponding to TPC2 expression.  Lanes 1-3 
represent control lanes with lanes 1 and 2 containing 
transcripts for canonical transient receptor potential 
(TRPC) channel subtypes 6 and 7 respectively and 
lane 3 containing transcripts for glyceraldehyde-3-
phsophate dehydrogenase (G3PDH). 
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dose-dependent with an IC50 of 2 µM (Naylor et al., 2009).  Moreover, pre-incubation 
of both sea urchin eggs and mouse pancreatic beta cells with Ned-19 resulted in the 
inhibition of NAADP-evoked Ca2+ release (Naylor et al., 2009), demonstrating that 
Ned-19 may be used as an effective cell permeable and selective antagonist of 
NAADP-mediated Ca2+ signalling in both mammalian and non-mammalian cells. 
In chapter 4, I showed that over-expression of hTPC2 in HEK293 cells confers 
a 3-fold increase in the maximal binding of [32P]NAADP.  Therefore, in order to 
verify that Ned-19 would be suitable for use as an antagonist of NAADP-mediated 
Ca2+ signalling and as a fluorescent label of NAADP receptors the ability of Ned-19 
to bind to TPC2 and displace NAADP was first determined.  To this end, I (in 
collaboration with Dr. 
Margarida Ruas and Dr. 
Xiaotong Cheng) investigated 
whether Ned-19 displaced 
[32P]NAADP binding to TPC2 
in homogenates prepared from 
either HA-hTPC2 expressing 
cells or sea urchin eggs.  Fig. 5.2 
shows a ligand competition 
assay using membranes derived 
from HA-hTPC2 cells (filled 
circles, solid line; Appendix 3, 
Table 5.1) and sea urchin egg 
homogenates (open circles, 
dotted line; Appendix 3, Table 
5.2).  The displacement of 
[32P]NAADP was achieved 
using membranes incubated with 
a range of Ned-19 
concentrations (0.1 µM – 1 mM) 
prior to the addition of 0.2 nM 
[32P]NAADP.  Fig. 5.2 shows 
that increasing concentrations of 
 
 
Fig. 5.2. Ned-19 inhibits [32P]NAADP binding in both 
HA-hTPC2 cells and sea urchin eggs homogenates 
0.2 nM [32P]NAADP was displaced using a range of 
Ned-19 concentrations.  Displacement of [32P]NAADP 
binding from the total membrane prepared from HA-
hTPC2 cells reveals that Ned-19 binds to TPC2 and thus 
displaces NAADP in both HA-hTPC2 cells (n = 3; filled 
circles, black line) and sea urchin egg homogenates (n = 
2; open circles, dotted line).  * indicates a statistically 
significant difference (P<0.05) when compared to the % 
[32P]NAADP bound in the presence of 100 nM Ned-19 
in HA-hTPC2 cell homogenates.  ϕ indicates a 
statistically significant difference (P < 0.05) when 
compared to the % [32P]NAADP bound in the presence 
of 100 nM Ned-19 in sea urchin egg homogenates. 
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Ned-19 displaced the binding of [32P]NAADP in membranes derived from both HA-
hTPC2 cells and sea urchin eggs with the half maximal inhibitory concentration 
(IC50) value calculated for sea urchin eggs as 702 µM.  This suggests that Ned-19 
binds to TPC2, displacing NAADP and is therefore consistent with Ned-19 acting as 
an NAADP antagonist in both mammalian and non-mammalian cells.  This is also 
consistent with the characterisation of Ned-19 by Naylor et al. which, in addition to 
the results described above, also showed that Ned-19 does not accumulate in the 
lumen of acidic organelles but rather it labels NAADP receptors (Naylor et al., 2009) 
suggesting that its inhibitory effect is specifically due to binding of the NAADP 
receptor.  From considering Fig. 5.2 it is apparent that although there is a significant 
inhibition of [32P]NAADP binding by Ned-19 (1 mM) in both cell-types there is 
variation in the potency of inhibition.  This may be explained by the fact that NAADP 
is thought to act as a non-competitive antagonist and therefore its inhibition of 
[32P]NAADP binding due to Ned-19 binding altering the NAADP binding site 
indirectly (Dr. Grant Churchill, personal communication).  Given that the sequence 
homology between sea urchin egg TPCs and mammalian TPCs is <50% this may 
therefore explain the variation between the ability of Ned-19 to inhibit [32P]NAADP 
binding in each cell type.  Nevertheless, the displacement of [32P]NAADP binding is 
evident in both sea urchin egg and HEK293 cells and is consistent with Ned-19 acting 
as a selective NAADP antagonist (Naylor et al., 2009).  Therefore, the use of Ned-19 
is suitable for determining whether or not TPC2 underpins NAADP-mediated Ca2+ 
release in PASMCs. 
 
5.3.3  The NAADP antagonist Ned-19 specifically labels two-pore channel subtype 
2 stably expressed in HEK29 cells 
 
To date, no specific antibody for labelling of rat TPC2 has been developed.  
However, Ned-19, due to it being a tryptophan derivative, is a fluorescent molecule 
(excitation 360 nm, emission 458 nm) (Naylor et al., 2009).  To circumvent the lack 
of specific antibodies I therefore determined whether or not the fluorescent NAADP 
antagonist Ned-19 could be used as a label for hTPC2, encouraged by the fact that 
Ned-19 displaced [32P]NAADP binding to hTPC2.  In this respect, it is important to 
note that in cells preincubated with the membrane permeable Ned-19, one would 
expect low levels of the antagonist to be present throughout the cytoplasm even after 
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washing.  Therefore, in order to determine whether or not Ned-19 labels TPC2, the 
threshold settings for detection of fluorescence in cells incubated with Ned-19 were 
raised, in a stepwise manner, beyond the background level.  This was used to expose 
those areas of the cell in which Ned-19 was most concentrated and thus reveal the 
distribution of Ned-19 binding sites.  Fig. 5.3 shows a 3D reconstruction of a series of 
deconvolved Z-sections (focal depth 0.28 µm, Z step 0.2 µm) taken through a 
HEK293 cell stably expressing mCherry-tagged (excitation 587 nm, emission 610 
nm) hTPC2 that had been pre-incubated (20 minutes) with Ned-19 (100 µM; 
excitation 360 nm, emission 458 nm).  Panel a shows the distribution of mCherry-
hTPC2 fluorescence labelling (red) and subsequently (b) shows the distribution of 
Ned-19 (blue) at a threshold setting of 90, which was used to remove background 
fluorescence.  The threshold for detection of Ned-19 fluorescence was then increased 
beyond this initial setting such that the areas of the cell in which Ned-19 was most 
concentrated were revealed.  This is shown in the subsequent panels in which the 
distribution of Ned-19 fluorescence (blue) is shown with the threshold set at (c) 100, 
(d) 110, and (e) 120.  Fig. 5.3 clearly shows that, as expected for a membrane 
permeable pharmacological agent, Ned-19 was present throughout the cytoplasm.  
However, raising the fluorescence intensity threshold corresponding to Ned-19 
fluorescence revealed a more spatially restricted distribution of Ned-19.  That this 
restricted distribution was non-uniform in nature is indicative of areas in which Ned-
19 is more concentrated than others.  Moreover, visual comparison of these areas of 
Ned-19 concentration (Fig.5.3, panel e) with the distribution of mCherry-hTPC2 
fluorescence (Fig. 5.3, panel a) suggests that Ned-19 concentrates in those regions of 
the cell that mirror regions in which clusters of mCherry-hTPC2 are specifically 
distributed.  It would appear, therefore, that this method can be used successfully to 
label TPC2 in living cells.  The adjustment of the thresholds for Ned-19 fluorescence 
beyond background levels consequently affects the apparent linear relationship 
between the 2 elements of labelling under study.  Therefore, it is inappropriate to use 
the Pearson product-moment correlation coefficient to assess the degree of co-
localisation.  Nonetheless, in regions in which Ned-19 was most concentrated the 
volume of co-localisation between mCherry-TPC2 and Ned-19 accounted for 24 ± 4 
% and 40 ± 7 % of the total volume of mCherry and Ned-19 labelling, respectively (n 
= 6; Appendix 3, Table 5.5).  Thus, consistent with the displacement of [32P]NAADP 
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binding by Ned-19, it would appear that Ned-19 selectively labels TPC2 in living 
cells. 
 
 
 
Fig. 5.3.  Raising the fluorescence intensity threshold reveals regions in which Ned-19 is 
concentrated 
An example mCherry-hTPC2 cell demonstrating that raising the fluorescence intensity threshold 
corresponding to Ned-19 fluorescence reveals areas in which Ned-19 is most concentrated.  Panel a 
shows a 3D reconstruction of a series of deconvolved Z-sections taken through a mCherry-hTPC2 cell 
shown showing the distribution of mCherry-labelling of hTPC2 (red; excitation 587 nm, emission 610 
nm).  Panels b-e show 3D reconstructions of deconvolved Z-sections showing the distribution of the 
fluorescent NAADP antagonist Ned-19 (blue; excitation 360 nm, emission 458 nm) within the same 
cell and with the fluorescence intensity threshold set at an increasingly higher level: b, 90; c, 100; d, 
110; e, 120. 
 
 
5.3.4  Ned-19 exhibits a high degree of concentration at the surface of LysoTracker 
labelled acidic organelles 
 
To confirm that Ned-19 binds to hTPC2 targeted to lysosome-related 
organelles, I performed an additional series of experiments on HEK293 cells 
expressing mCherry-tagged hTPC2.  In this instance cells were co-labelled with 
LysoTracker Green.  Fig. 5.4A shows a 3D reconstruction of a series of deconvolved 
Z-sections (focal depth 0.28 µm, Z step 0.2 µm) taken through a HEK293 cell stably 
expressing mCherry-tagged hTPC2 (excitation 587 nm, emission 610 nm) that had 
been pre-incubated (40 minutes) with LysoTracker Green (200 nM; excitation 504 
nm, emission 511 nm).  Panel Aa shows a transmitted light image of the cell under 
study and subsequently shows the distribution of (b) LysoTracker Green fluorescent 
labelling (green), (c) mCherry-hTPC2 fluorescent labelling (red), (d) a merged image 
of (b) and (c).  Panel (e) reveals the areas of co-localisation (yellow) between 
mCherry-hTPC2 and LysoTracker Green labelling.  These images, strongly suggest 
that TPC2 is targeted to the membranes of acidic organelles in mCherry-hTPC2 cells.  
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This is supported by the fact that the volume of co-localisation between mCherry-
TPC2 and LysoTracker Green accounted for 26 ± 5 % and 24 ± 6 % of the total 
volume of mCherry and LysoTracker Green labelling, respectively (n = 6; Appendix 
3, Table 5.3).  Furthermore, the Pearson product-moment correlation coefficient value 
for mCherry-hTPC2 and LysoTracker Green labelling was 0.30 ± 0.06 (n = 6; 
Appendix 3, Table 5.4), illustrating that there is a linear correlation between mCherry-
hTPC2 and LysoTracker Green, despite the fact that LysoTracker Green labels the 
lumen of acidic stores while mCherry-hTPC2 is expressed on the cytoplasmic surface 
of lysosomes. 
 
 
 
Fig. 5.4.  TPC2 is labelled by Ned-19 in HEK293 stably expressing mCherry-hTPC2 
Example cells showing the degree of co-localisation between mCherry-tagged hTPC2 (excitation 587 
nm, emission 610 nm) and either A, LysoTracker Green (excitation 504 nm, emission 511 nm) or B 
Ned-19 (excitation 360 nm, emission 458 nm).  In each case: Panel a shows a transmitted light image 
of the isolated mCherry-hTPC2 cell imaged; Panel b shows a 3D reconstruction of a series of 
deconvolved Z-sections taken through the cell shown in panel a showing the distribution of either A, 
LysoTracker Green labelling (green) or B, regions in which Ned-19 (blue) was most concentrated; 
Panel c shows a 3D reconstruction of deconvolved Z-sections showing the distribution of mCherry-
tagged (red) hTPC2; Panel d shows a merged image of both panels b and c; Panel e is a 3D 
reconstruction showing individual volumes of co-localisation (yellow) between hTPC2 and either A, 
LysoTracker Green or B, regions in which Ned-19 was most concentrated. 
 
Given the strong degree of co-localisation between mCherry-hTPC2 and both 
LysoTracker and Ned-19, one would expect a similar degree of co-localisation 
between Ned-19 and LysoTracker.  Indeed, Fig. 5.5 shows a 3D reconstruction of a 
series of deconvolved Z-sections (focal depth 0.28 µm, Z step 0.2 µm) taken through 
 169 
a HEK293 cell stably expressing HA-tagged hTPC2.  Panel a shows a transmitted 
light image of the cell under study and panel b shows regions in which Ned-19 was 
most concentrated (blue) whereas panel c shows the distribution of LysoTracker Red 
(red).  Panel d shows the merged image of panels b and c, and panel e shows the 
volumes represented by co-localisation (yellow) between Ned-19 and LysoTracker 
Red.  Consideration of these images strongly suggests that Ned-19 co-localises with 
acidic organelles labelled with LysoTracker Red.  Furthermore, in regions in which 
Ned-19 was most concentrated the volume of co-localisation between LysoTracker 
Red and Ned-19 accounted for 34 ± 7 % and 33 ± 11 % of the total volume of 
LysoTracker Red and Ned-19 labelling, respectively (n = 4; Appendix 3, Table 5.6).  
As TPC2 is present on the membranes of such organelles and shares a similar degree 
of co-localisation with LysoTracker Red it seems likely that Ned-19 labels TPC2, and 
that TPC2 is targeted to lysosomal membranes.   
Given these findings I concluded that Ned-19 could be successfully used to 
label TPC2 in other wild-type cells, such as PASMCs. 
 
 
 
 
Fig. 5.5.  TPC2 is labelled by Ned-19 and co-localises with lysosomes in HEK293 cells stably 
expressing HA-hTPC 
Example cell showing the degree of co-localisation between Ned-19 labelled TPC2 and (excitation 360 
nm, emission 458 nm) and LysoTracker Red (excitation 577 nm, emission 590 nm) in an HA-hTPC2 
cell.  Panel a shows a transmitted light image of the isolated cell imaged; Panel b shows a 3D 
reconstruction of a series of deconvolved Z-sections taken through the cell shown in panel a showing 
regions of the cell in which Ned-19 was most concentrated (blue); Panel c shows a 3D reconstruction 
of deconvolved Z-sections showing the distribution of LysoTracker Red labelling (red); Panel d shows 
a 3D representation of LysoTracker Red labelling and concentrated areas of Ned-19 (red and blue 
respectively); Panel e is a 3D reconstruction showing regions of co-localisation (yellow) between Ned-
19 labelling and LysoTracker Red labelled organelles. 
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5.3.5  Ned-19 labelling concentrates on LysoTracker labelled organelles in 
pulmonary arterial smooth muscle cells 
 
To establish whether Ned-19 binds to TPC2 / lysosomes in rat PASMCs I 
performed a series of fluorescent imaging experiments similar to those described 
above.  Fig. 5.6 shows a transmitted light image of an isolated rat PASMC under 
study.  Panel b shows regions of the cell in which Ned-19 was most concentrated 
(blue) whereas panel c shows the distribution of LysoTracker Red (red).  Panel d 
shows the merged image of panels b and c, and panel e shows the areas of 
LysoTracker Red and Ned-19 co-localisation (yellow).  Fig. 5.6 reveals that in 
PASMCs there is clear co-localisation between areas of high Ned-19 concentration 
and clusters of acidic organelles, consistent with observations made in HA-hTPC2 
expressing cells (Fig. 5.5). 
 
 
 
Fig. 5.6.  TPC2 is labelled by Ned-19 and co-localises with lysosomes in pulmonary arterial 
smooth muscle cells 
Example cell showing the degree of co-localisation between Ned-19 labelled TPC2 and (excitation 360 
nm, emission 458 nm) and LysoTracker Red (excitation 577 nm, emission 590 nm) in an isolated 
PASMC.  Panel a shows a transmitted light image of the isolated cell imaged; Panel b shows a 3D 
reconstruction of a series of deconvolved Z-sections taken through the cell shown in panel a showing 
regions of the cell in which Ned-19 was most concentrated (blue); Panel c shows a 3D reconstruction 
of deconvolved Z-sections showing the distribution of LysoTracker Red labelling (red); Panel d shows 
a 3D representation of LysoTracker Red labelling and concentrated areas of Ned-19 (red and blue 
respectively); Panel e is a 3D reconstruction showing regions of co-localisation (yellow) between Ned-
19 labelling and LysoTracker Red labelled organelles. 
 
In regions in which Ned-19 was most concentrated the volume of co-
localisation between LysoTracker Red and Ned-19 accounted for 39 ± 12 % and 20 ± 
1 % of the total volume of LysoTracker and Ned-19 labelling, respectively (n = 4; 
Appendix 3, Table 5.7).  Given the strong degree of co-localisation between Ned-19, 
LysoTracker Red / Green labelled acidic stores and mCherry-tagged hTPC2 in 
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HEK293 cells these images strongly suggest that Ned-19 binds to and thus 
fluorescently labels TPC2 in PASMCs.  This is consistent with the finding that Ned-
19 displaces [32P]NAADP binding from hTPC2 (Fig. 5.2). 
 
5.3.6  Ned-19 blocks NAADP-mediated Ca2+ transients in HEK293 cells stably over-
expressing two-pore channel subtype 2 
 
From the above it is clear that: (1) Ned-19 displaces [32P]NAADP binding to 
membranes from both sea urchin egg homogenates and from HEK293 cells that stably 
over-express HA-hTPC2; (2) Ned-19 selectively labels LysoTracker labelled acidic 
organelles in HEK293 cells and mCherry-tagged hTPC2 stably over-expressed in 
HEK293 cells.  I therefore sought to determine whether or not Ned-19 blocked Ca2+ 
signalling via hTPC2 (stably over-expressed in HEK293 cells), which I have 
previously shown to be a pre-requisite for NAADP-mediated Ca2+ release in HEK293 
cells that stably over-expressed hTPC2.   
In order to achieve this, NAADP (10 nM) was applied intracellularly into 
HEK293 cells stably over-expressing HA-hTPC2, by dialysis from a patch pipette in 
the whole-cell configuration of the patch-clamp technique and under voltage-clamp 
conditions (V = -40 mV).  The resultant changes in the intracellular Ca2+ 
concentration were reported by the Fura-2 fluorescence ratio (F340/F380) as described 
previously.  Fig. 5.7A shows an exemplar record of the Ca2+ transient triggered by the 
intracellular dialysis of 10 nM NAADP.  The upper panel shows a series of 
pseudocolour images of the cell in question, which are representative of the F340/F380 
ratio recorded at the time points labelled on the corresponding record of the F340/F380 
ratio against time (lower panel).  This record shows clearly, that a global Ca2+ 
transient is triggered in response to 10 nM NAADP with a peak change in the 
F340/F380 ratio of 0.92 ± 0.14 (n = 44; Appendix 3, Table 5.8).  In marked contrast, 
Fig. 5.7B shows that no such response was observed following pre-incubation (20 
minutes) of cells with 100 µM Ned-19, with a peak change in the F340/F380 ratio 
measuring only 0.08 ± 0.03 (n = 5; P < 0.05; Appendix 3, Table 5.9).  However, pre-
incubation with 100 µM Ned-19 did not inhibit Ca2+ transients evoked by the 
application of 1 mM carbachol (CCh) the change in the F340/F380 ratio measuring 2.19 
± 0.14 in the absence of Ned-19 (n = 7; Appendix 3, Table 5.10) and 2.04 ± 0.45 
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following pre-incubation (20 minutes) with 100 µM Ned-19 (n = 5; Appendix 3, 
Table 5.11).   
 
 
 
Fig. 5.7.  Ned-19 blocks NAADP-mediated but not IP3-mediated Ca2+ release in HA-hTPC2 cells 
A Top panel, series of pseudocolour images of the Fura-2 fluorescence ratio (F340/F380) recorded in a 
HA-hTPC2 cell during the intracellular dialysis of 10 nM NAADP.  NAADP evokes a global Ca2+ 
transient.  Bottom panel, corresponding record of the F340/F380 ratio against time for the cell imaged in 
the top panel.  For this, and the subsequent record, access to the cytoplasm via the formation of the 
whole-cell configuration is indicated by the two bars at the beginning of the record, and the loss of a 
GΩ seal is indicated at the end of the record by three bars.  B Record of the F340/F380 ratio against time 
recorded in a HA-hTPC2 cell pre-incubated (20 min) with 100 µM Ned-19 during the intracellular 
dialysis of 10 nM NAADP.  As no Ca2+ transient was observed 1 mM carbachol (CCh) was added 
towards the end of the record. 
 
That Ned-19 selectively blocks Ca2+ signalling in response to NAADP is clearly 
shown by the bar chart in Fig. 5.8.  These data suggest therefore, that the activation by 
NAADP of Ca2+ release via hTPC2 was selectively blocked by Ned-19, and that this 
was not a consequence of blocking the subsequent amplification of a given Ca2+ 
signal by CICR from the ER via IP3Rs.  This is clear from the fact that IP3R-
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dependent Ca2+ release (evoked by CCh) from the ER remained unaffected in the 
presence of Ned-19.  Therefore, consistent with both the binding and 
immunofluorescence data, Ned-19 appears to act as a selective antagonist of NAADP 
at hTPC2. 
 
 
 
Fig. 5.8.  Ned-19 inhibits the global Ca2+ release in response to NAADP but not carbachol in HA-
hTPC2 cells 
Bar chart showing the peak change in the Fura-2 fluorescence ratio (mean ± S.E.M.) recorded in HA-
hTPC2 cells in response to either the intracellular dialysis of 10 nM NAADP or extracellular 
application of 1 mM carbachol (CCh).  The responses to NAADP and CCh were recorded in either the 
absence (white box; NAADP n = 44; CCh n = 7) or presence of 100 µM Ned-19 (grey box; NAADP n 
= 5; CCh n = 5).  * indicates a statistically significant difference (P < 0.05) when compared to the peak 
change in fluorescence ratio in response to 10 nM NAADP in the absence of 100 µM Ned-19. 
 
5.3.7  Ned-19 blocks NAADP-mediated Ca2+ transients in pulmonary arterial 
smooth muscle cells 
 
Having established that Ned-19 binds to hTPC2 and subsequently inhibits 
NAADP-mediated Ca2+ release via hTPC2, Ned-19 was used to determine whether 
TPC2 functions as a NAADP receptor in PASMCs.  The effect of Ned-19 on Ca2+ 
transients evoked by the intracellular dialysis of NAADP (10 nM) from a patch 
pipette was studied in the whole-cell configuration of the patch clamp technique and 
under current clamp conditions (I = 0), with changes in the intracellular Ca2+ 
concentration reported by the Fura-2 fluorescence ratio (F340/F380).  An exemplar 
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record is shown in Fig. 5.9A.  The upper panel shows a series of pseudocolour images 
of the Fura-2 fluorescence ratio recorded in an isolated PASMC during the 
intracellular dialysis of 10 nM NAADP, with the record of the Fura-2 fluorescence 
ratio against time shown in the lower panel.  Intracellular dialysis of 10 nM NAADP 
induced global Ca2+ waves that resulted in a mean increase in the mean Fura-2 
fluorescence ratio of 0.91 ± 0.20 (n = 5; Appendix 3, Table 5.12).  In marked contrast, 
Fig. 5.9B shows that no such transient was evoked by 10 nM NAADP following pre-
incubation of PASMCs with Ned-19 100 µM, with the maximal change (non-
transient) in the Fura-2 fluorescence ratio measuring only 0.13 ± 0.06 (n = 5; P < 
0.05; Appendix 3, Table 5.13).  Significantly, neither spatially restricted Ca2+ bursts, 
nor global Ca2+ waves were observed.  Importantly, however, Ned-19 was without 
effect on Ca2+ transients evoked by the application of 2.5 mM caffeine in the same 
cells (Fig. 5.9B).  Indeed, Fig. 5.10 shows that there was no significant difference in 
the peak increase in the F340/F380 ratio triggered by extracellular application of 
caffeine (2.5 mM) in either the absence of Ned-19 (1.73 ± 0.18; n = 7; Appendix 3, 
Table 5.15) or following pre-incubation (20 minutes) with 100 µM Ned-19 (1.11 ± 
0.31; n = 3; Appendix 3, Table 5.16).  Thus, Ned-19 does not block SR Ca2+ release 
via RyRs nor, therefore, the ability of PASMCs to amplify any NAADP-dependent 
Ca2+ bursts from lysosomes by CICR from the SR via RyRs.  In contrast to the effect 
of RyR inhibition with dantrolene (Chapter 3), however, Ned-19 abolished NAADP-
induced Ca2+ signals and therefore blocked NAADP-dependent Ca2+ bursts, as does 
depletion of acidic Ca2+ stores with bafilomycin A1 (Kinnear et al., 2004).  These 
findings are consistent, therefore, with the view that Ned-19 blocks NAADP-
dependent Ca2+ release from lysosomes via TPCs without affecting RyR-dependent 
Ca2+ release from the SR.  Moreover, Fig. 5.9C shows that intracellular dialysis of 1 
µM IP3 induced global Ca2+ transients in PASMCs in the presence of 100 µM Ned-
19, resulting in a mean increase in the Fura-2 fluorescence ratio of 1.02 ± 0.41 (n = 4; 
Appendix 3, Table 5.14).  Thus, IP3R-dependent Ca2+ release from the SR in 
PASMCs would also appear to be unaffected by Ned-19.   
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Fig. 5.9.  Ned-19 blocks NAADP-mediated but not IP3-mediated Ca2+ release in pulmonary 
arterial smooth muscle cells 
A Top panel, series of pseudocolour images of the Fura-2 fluorescence ratio (F340/F380) recorded in a 
PASMC during the intracellular dialysis of 10 nM NAADP.  Bottom panel, corresponding record of 
the F340/F380 ratio against time for the cell imaged in the top panel.  For this, and the subsequent 
records, access to the cytoplasm via the formation of the whole-cell configuration is indicated by the 
two bars at the beginning of the record, and the loss of a GΩ seal is indicated at the end of the record 
by three bars.  B Record of the F340/F380 ratio against time recorded in a PASMC pre-incubated (20 
min) with 100 µM Ned-19 during the intracellular dialysis of 10 nM NAADP.  As no Ca2+ transient 
was observed 2.5 mM caffeine was added towards the end of the record.  C Top panel, series of 
pseudocolour images of the F340/F380 ratio recorded in a PASMC pre-incubated (20 min) with Ned-19 
(100 µM) during the intracellular dialysis of 1 µM IP3.  Bottom panel, corresponding record of the 
F340/F380 ratio against time for the cell imaged in the top panel. 
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Fig. 5.10.  Ned-19 inhibits the global Ca2+ release in response to NAADP but not caffeine in 
pulmonary arterial smooth muscle cells 
Bar chart showing the peak change in the Fura-2 fluorescence ratio (mean ± S.E.M.) recorded in 
PASMCs in response to either the intracellular dialysis of 10 nM NAADP or extracellular application 
of 2.5 mM caffeine.  The responses to NAADP and caffeine were recorded in either the absence (white 
box; NAADP n = 5; caffeine n = 7) or presence of 100 µM Ned-19 (grey box; NAADP n = 5; caffeine 
n = 3).  * indicates a statistically significant difference (P < 0.05) when compared to the peak change in 
fluorescence ratio in response to 10 nM NAADP in the absence of 100 µM Ned-19. 
 
 
5.4  Discussion 
 
5.4.1  Two-pore channel subtype 2 is present in pulmonary arterial smooth muscle 
cells and is targeted by the selective NAADP antagonist Ned-19 
 
The results presented in chapter 4 suggest that NAADP mediates Ca2+ release 
via TPC2 in HEK293 cells that stably over-express TPC2.  Consistent with this 
proposal, in this chapter RT-PCR analysis revealed that TPC2 is expressed in rat 
PASMC, which is an important observation given that NAADP-dependent Ca2+ 
release from lysosome-related stores is observed in rat PASMCs (Boittin et al., 2002; 
Kinnear et al., 2004).  
Over-expression of hTPC2 in HEK293 cells resulted in a 3-fold increase in the 
maximal binding of [32P]NAADP when compared to wild-type HEK293 cells 
(Chapter 4), and therefore TPC2 represents an NAADP receptor.  Thus, the 
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observation that the NAADP antagonist Ned-19 was found to displace 0.2 nM 
[32P]NAADP binding to TPC2 from membranes enriched with hTPC2, and from 
membranes derived from sea urchin egg homogenates provides further confirmation 
that: (1) TPC2 is an NAADP receptor and (2) Ned-19 is an NAADP antagonist and / 
or inhibitor of NAADP-dependent Ca2+ signalling via TPC2.  It is worth noting, 
however, that Ned-19 is thought to act as a non-competitive antagonist and therefore 
its inhibition of [32P]NAADP binding may not be due to competitive displacement of 
NAADP but rather due to Ned-19 binding altering the NAADP binding site indirectly 
(Dr. Grant Churchill, personal communication).  This may explain why Ned-19 
appeared less effective at reversing NAADP binding to HA-hTPC2 membranes than it 
was in reversing binding to sea urchin egg membranes, as the sequence homology 
between sea urchin egg TPCs and mammalian TPCs is <50%.  Nonetheless, the 
displacement of [32P]NAADP binding is consistent with Ned-19 acting as a selective 
antagonist of NAADP-mediated Ca2+ signalling in both mammalian and non-
mammalian cells (Naylor et al., 2009). 
As mentioned above, to date there are no specific antibodies raised against rat 
TPCs.  Therefore, in lieu of specific antibodies I exploited the useful fluorescent 
property of Ned-19 to demonstrate that TPCs are targeted to acidic stores in rat 
PASMCs.  In doing this, I first considered that the concentration of a given ligand 
within a solution that does not contain a receptor for said ligand (e.g. the cytoplasm) 
is uniform due to diffusion that conforms to Brownian motion.  However, this 
situation changes over time if a receptor for the ligand is present within the solution, 
due to ligand-receptor interactions.  At equilibrium, the number of ligand binding 
events equals the number of dissociation events and therefore there are multiple 
interactions per second per receptor.  Such interactions will affect the normal pattern 
of diffusion, with a distribution bias towards the receptor binding sites.  Therefore, as 
a result of multiple binding and dissociations a local concentration gradient will 
become established, with the concentration of the ligand (e.g. Ned-19) decreasing as 
the distance from the receptor (e.g. TPCs) increases.  Moreover, this local 
concentration gradient would be exaggerated when receptors are clustered, due to the 
diffusional distance between binding sites being reduced.  Thus, if Ned-19 binds to 
TPCs / NAADP receptors one would expect it to concentrate in regions of the cell 
proximal to clusters of TPCs on endo / lysosome membranes.  It seemed likely, 
therefore, that I could identify TPC binding sites by increasing the intensity threshold 
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setting for detection with respect to Ned-19 fluorescence, beyond that required for 
removal of background fluorescence.  In this way, I considered it likely that I could 
obtain 3D reconstructions of cells in which only those regions within the cell in which 
Ned-19 was most concentrated were visible.  Consistent with this view, examination 
of the cellular distribution of TPC2 in HEK293 cells that stably over-expressed 
mCherry-tagged hTPC2 revealed that TPC2 co-localises with LysoTracker labelled 
lysosomes, and furthermore, that hTPC2 and LysoTracker labelled acidic stores, 
respectively, co-localised with areas of the cell in which Ned-19 was most 
concentrated.  It is reasonable to conclude, therefore, that Ned-19 binds lysosome-
targeted TPC2 and can thus be used to label TPC2 and thereby the membranes of 
lysosome-related organelles in all cell types.  With this in mind, I examined the 
cellular distribution of Ned-19 labelling in acutely isolated rat PASMCs.  This 
revealed that areas of the cell in which Ned-19 was most concentrated co-localised 
with clusters of LysoTracker-labelled lysosomes.  Together these results support the 
view that TPC2 is present in PASMCs, is localised to lysosomal membranes and, of 
particular importance, is targeted by the selective NAADP antagonist Ned-19. 
 
5.4.2  Ned-19 inhibits NAADP-mediated Ca2+ release in both HEK293 cells that 
stably over-express two-pore channel subtype 2 and pulmonary arterial smooth 
muscle cells 
 
As described in chapter 4, intracellular dialysis of 10 nM NAADP into HEK293 
cells that stably over-express hTPC2 evoked global Ca2+ transients that were biphasic 
in nature.  Pre-incubation (20 minutes) of hTPC2 expressing HEK293 cells with Ned-
19 abolished both phases of the NAADP-induced Ca2+ transient.  This block of both 
phases was reminiscent of the effect of depletion of acidic Ca2+ stores with the 
vacuolar proton pump inhibitor bafilomycin A1 (see Chapter 4) and thus suggests that 
Ned-19 blocks NAADP-evoked Ca2+ release from lysosomes.  The fact that Ned-19 
was without effect on Ca2+ signals induced by carbachol (IP3) confirms that this is 
likely the case, rather than the observed block being due to attenuation by Ned-19 of 
the amplification of lysosomal Ca2+ signals by CICR from the ER.  This is consistent 
with the fluorescent labelling of hTPC2 by Ned-19 and with the displacement of 
[32P]NAADP binding to hTPC2 by Ned-19.  Given that HEK293 cells do not express 
high levels of RyRs (Aoyama et al., 2004) it is therefore unlikely that Ned-19 is 
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exhibiting its inhibitory effect via interaction with RyRs.  Therefore, these data show 
that Ned-19 targets TPC2 and thus selectively inhibits NAADP-mediated Ca2+ release 
in HEK293 cells. 
Intracellular dialysis of 10 nM NAADP into isolated PASMCs evoked global 
Ca2+ waves that were again biphasic in nature, as a result of Ca2+ bursts from 
lysosome-related stores being subsequently amplified by CICR from the SR via RyRs 
(Boittin et al., 2002; Churchill et al., 2001a; Kinnear et al., 2004).  Consistent with 
my observations on HEK293 cells expressing TPC2, Ned-19 blocked both NAADP-
mediated Ca2+ bursts and global Ca2+ waves in PASMCs, again consistent with the 
effect of depleting acidic Ca2+ stores with bafilomycin A1 on Ca2+ signalling by 
NAADP in this cell type (Kinnear et al., 2004).  When taken together with the co-
localisation of Ned-19 and LysoTracker fluorescence, these findings strongly suggest 
that TPCs are present on endo / lysosomal membranes in PASMCs and that Ned-19 
blocks NAADP-dependent Ca2+ release via these channels in PASMCs.  Importantly, 
I also found Ned-19 to be without effect on Ca2+ release by either intracellular 
dialysis of IP3 or extracellular application of caffeine (RyR activation) in isolated 
PASMCs.  Thus, in PASMCs IP3R- and RyR-dependent Ca2+ release pathways 
remained unaffected in the presence of Ned-19 and, therefore, the ability of the SR to 
amplify any Ca2+ burst remained intact.  Importantly, this conclusion is consistent 
with the original characterisation of Ned-19 which demonstrated that pre-incubation 
of both pancreatic acinar cells and sea urchin eggs with Ned-19 inhibited NAADP-
mediated Ca2+ release (Naylor et al., 2009).   
That TPC2 and not TPC1 mediates global Ca2+ signals in response to NAADP 
in PASMCs, seems likely given the inability of TPC1 / endosomes to couple to the 
ER via CICR in HEK293 cells.  Furthermore, previous studies have shown that the 
cathepsin C substrate glycyl-L-phenylalanine 2-napthylamide (GPN) specifically 
disrupts lysosomal Ca2+ stores via osmotic lysis and, subsequently, blocks the 
generation of Ca2+ signals in response to NAADP (Berg et al., 1994; Churchill et al., 
2002).  Importantly, cathepsin C is not present in endosomes and, therefore, GPN 
does not disrupt endosomal Ca2+ stores.  Thus, it would appear that NAADP-
dependent Ca2+ release via TPC1, endogenously expressed in wild-type cells, may be 
insufficient to generate clearly defined and measureable (with methods employed) 
local Ca2+ signals (Berg et al., 1994; Churchill et al., 2002).  
 180 
I conclude, therefore, that TPCs are expressed in PASMCs, are targeted to 
acidic stores and underpin NAADP-induced Ca2+ release from acidic, lysosome-
related Ca2+ stores in this cell type.  However, further experiments are required to 
confirm TPC2 and not TPC1 underpin global Ca2+ signals by NAADP in PASMCs. 
 
 181 
Chapter 6:  General Discussion 
 
 
Since its discovery in 1987 (Clapper et al., 1987) NAADP has been shown to 
mobilise Ca2+ in a wide variety of organisms including invertebrates, vertebrates and 
plants (Albrieux et al., 1998; Berg et al., 2000; Cancela et al., 1999; Chini et al., 
1995a; Chini et al., 1995b; Mojzisova et al., 2001; Navazio et al., 2000; Santella et 
al., 2000; Zhang et al., 2006a) and has been described as the most potent Ca2+-
mobilising molecule identified to date (Galione et al., 2009).  Given the broad range 
of species that exhibit NAADP-dependent Ca2+ signalling, it is clear that this Ca2+-
mobilising second messenger plays an important role in cellular Ca2+ homeostasis.  
Yet despite this, the molecular identity of the NAADP receptor has, until now 
remained elusive. 
Recently the transient receptor potential channel mucolipin 1 (TRPML1) which 
is a lysosome-bound channel, was proposed to function as a NAADP receptor (Zhang 
et al., 2008).  However, in normal rat kidney cells (NRK) over-expression of 
TRPML1 failed to increase NAADP binding (Pryor et al., 2006).  Other groups have 
also suggested that the primary function of TRPML1 is to act as either a Fe2+ (Dong 
et al., 2008) or a H+ release channel (Soyombo et al., 2006).  Further evidence 
contrary to the view that TRPML1 is an NAADP receptor comes from the finding that 
the antibody used by Zhang et al., to label / block TRPML1 would appear to label 
elements within TRPML1 null cells suggesting that the antibody is non-selective 
(Prof. Antony Galione, personal correspondence).  NAADP has also been proposed 
to act directly on ryanodine receptors (RyRs) to release Ca2+ (Dammermann et al., 
2005; Hohenegger et al., 2002).  However, RyR antagonists such as ryanodine, 
procaine and ruthenium red failed to abolish NAADP-dependent Ca2+ signalling in 
both mammalian and non-mammalian cells (Boittin et al., 2002; Chini et al., 1995a; 
Lee et al., 1995).  Moreover, RyR1 and RyR2 reconstituted into lipid bilayers did not 
appear to be activated by NAADP (Copello et al., 2001).  Therefore, there is 
significant evidence to suggest that NAADP does not directly activate either 
TRPML1 or RyRs but acts on a discrete receptor.  In 2000 the two-pore channel 
subtype 1 (TPC1) was first cloned and identified as a novel two-domain channel with 
an unknown function (Ishibashi et al., 2000).  In this thesis I have provided evidence 
in support of the view that TPCs represent a family of NAADP receptors 
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6.1  Two-pore channels in relation to other cation channels 
 
Two-pore channels (TPCs) are novel members of the voltage-gated cation 
channel superfamily.  Examination of their primary sequence revealed a predicted 
structure consisting of 12 transmembrane (TM) regions that are divided into 2 
homologous domains of 6 TM regions each (S1-S6).  Importantly, and characteristic 
of members of this superfamily, TPCs contain a re-entrant P-loop between S5 and S6 
of each domain.  This basic 6-TM unit is representative of all members within the 
voltage-gated ion channel superfamily, from the single domain channels such as 
transient receptor potential channels (TRPs) and the cation channel of spermatozoa 
(CatSpers), to the 4 repeat domain of the pore-forming subunit of voltage-gated Ca2+ 
channels (Cav) (Yu et al., 2005).  Of the voltage-gated cation channel superfamily 
members, TPCs share the greatest homology with Cav and voltage-gated Na+ 
channels.  TPCs are also closely related to CatSpers and some TRPs albeit to a lesser 
extent than either Nav or Cav.  This is particularly intriguing given that single domain 
channels such as TRPs form tetramers whereas only 1 of the 4-repeat domain 
containing α-subunit of Cav is required for the formation of a functional pore.  This 
has led others to propose that TPCs channels function as dimers with the 4 P-loops (2 
from each monomer) coming together in order to form the central pore (Zong et al., 
2009).  Given the similarity to both TRPs and Cav and the conserved 6-TM 
organisation found in each protein, TPCs are purported to be evolutionary 
intermediates resulting from 2 rounds of duplication from a common 6 TM, single 
domain protein to the 4-fold symmetry of 24 TM channels such as Cav and Nav 
(Anderson et al., 2001; Ishibashi et al., 2000). 
Further support for the view that TPCs may be intermediary steps is taken from 
the finding that the 3 animal TPC subtypes (TPC1, TPC2 and TPC3) and plant TPC1 
are expressed in a wide variety of species in both plant and animal kingdoms.  This 
suggests that they represent an ancient gene family.  However, it is important to note 
that TPC3 appears to be absent in primates and rodents such as mice and rats.  
Furthermore, species such as honeybees and silkworms contain only TPC1 encoding 
genes (TPCN1) whereas C. elegans and D. melanogaster do not appear to contain any 
sequence encoding TPCs.  Conversely, sequences for TPCN1 and TPCN3 but not 
TPCN2 are found in choanoflagellates.  Consideration of the species distribution of 
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TPCs suggests that although the genes encoding TPCs appear to be from an ancient 
gene family, the absence of 1 or more TPC subtypes (including a complete absence of 
TPCs) from a number of species would indicate that TPCs represent an important ion 
channel family that may not be essential for cell survival. 
 
 
6.2  NAADP mobilises Ca2+ via two-pore channels that are targeted 
to lysosome-related organelles 
 
Examination of the cellular distribution of TPCs revealed that TPC2 is targeted 
to the membranes of lysosomes but not those of early or late endosomes, Golgi 
apparatus, mitochondria or the ER.  Conversely, TPC1 and TPC3 showed little or no 
co-localisation with either lysosomal membrane markers and TPC2, but appeared to 
be primarily targeted to the membranes of endosomes in addition to other unidentified 
vesicular organelles.  Clearly, all mammalian TPCs are expressed on the membranes 
of endolysosomes, which is consistent with the targeting of plant TPC1 to the 
membranes of vacuoles (Peiter et al., 2005).  Given that NAADP releases Ca2+ from 
acidic lysosome-related organelles (Churchill et al., 2002; Kinnear et al., 2004; 
Yamasaki et al., 2004; Zhang et al., 2004) and that NAADP-mediated Ca2+ release is 
inhibited by both L-type Ca2+ channel agonists and antagonists (phenylalkylamines 
and dihydropyridines) (Genazzani et al., 1996a; Genazzani et al., 1997) the structure 
and localisation of TPCs and TPC2 in particular, naturally led me to investigate 
whether or not TPCs represent NAADP receptors. 
Consistent with a role for TPCs in NAADP-dependent Ca2+ signalling, HEK293 
cells that stably over-expressed TPC2 were used to provide, via cell lysates, 
membranes enriched with TPC2 upon which NAADP was found to bind at two sites, 
a high and low affinity site with Kd values of ~5 nM and ~7 µM, respectively.  This is 
consistent with the view that NAADP receptors exhibit high and low affinity binding 
sites that are proposed to underpin the bell-shaped concentration-response curve to 
NAADP.  The high affinity site has been suggested to mediate activation, while the 
low affinity binding site may confer homologous desensitisation of the receptor (Berg 
et al., 2000; Cancela et al., 1999; Masgrau et al., 2003). 
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In HEK293 cells stably over-expressing TPC2 NAADP elicited a biphasic 
global Ca2+ transient which was abolished by depletion of lysosomal Ca2+ stores with 
the vacuolar H+-ATPase inhibitor bafilomycin A1 or when cells were preincubated 
with shRNA against TPC2.  Moreover, the NAADP antagonist Ned-19, which was 
shown to fluorescently label TPC2 on the lysosomal membrane, selectively blocked 
NAADP-mediated Ca2+ signalling in HEK293 cells.  Together these findings suggest 
that TPC2 underpins NAADP-mediated Ca2+ release from lysosomes.  Consistent 
with the two site binding model, I further demonstrated that NAADP-dependent Ca2+ 
signalling via TPC2 exhibited an approximate activation threshold of 10 nM NAADP 
whereas no response was observed when the concentration of NAADP was increased 
to 1 mM suggesting significant desensitisation of the channel.  This characteristic 
bell-shaped concentration-response curve has been observed in other mammalian 
preparations (Berg et al., 2000; Cancela et al., 1999; Masgrau et al., 2003) and 
homologous desensitisation is also observed in sea urchin eggs (Aarhus et al., 1996; 
Dickinson et al., 2003; Genazzani et al., 1996a).  However, in sea urchin egg a 
distinction with respect to the desensitisation mechanism is apparent where low sub-
threshold concentrations of NAADP desensitise / inactivate the receptor to subsequent 
activation by maximal NAADP concentrations (Aarhus et al., 1996; Dickinson et al., 
2003; Genazzani et al., 1996a).  Given that sea urchin eggs express all 3 TPC 
subtypes whereas only TPC1 and TPC2 are present in human cells, the difference in 
the mechanisms of homologous desensitisation / inactivation between the cell types 
may be due to the variation in the individual properties of each TPC subtype which, 
for TPC1 and TPC3 remain to be determined. 
As mentioned above, TPC1 appears to be primarily targeted to the membranes 
of endosomes which likely represent a smaller Ca2+ store.  This is consistent with the 
spatially restricted Ca2+ release in response to NAADP in HEK293 cells stably over-
expressing TPC1.  It would appear, therefore that NAADP mobilises Ca2+ via TPC2 
and TPC1 from lysosomes and most likely endosomes respectively.  It is therefore 
probable that TPCs may represent a family of NAADP receptors each with a unique 
cellular distribution conferred by the organelles to which they are targeted, and this 
raises the possibility that each TPC may confer a degree of versatility to NAADP-
mediated Ca2+ signalling.  Yet more complexity is possible when one considers the 
fact that both lysosomes and endosomes are mobile within the cytoplasm (Herman et 
al., 1984; Prekeris et al., 1999; Taunton, 2001) and may utilise actin filaments and 
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myosin motors to direct trafficking (DePina et al., 1999).  Therefore, the targeted 
movement of these acidic, releasable Ca2+ stores may play an important role in 
region-specific, NAADP-dependent cellular functions such as neurite outgrowth 
(Brailoiu et al., 2005). 
 
 
6.3  Functional significance of two-pore channels 
 
6.3.1  Two-pore channels and lysosomal function 
 
Lysosomes are traditionally considered to function as sites of cellular 
degradation of macromolecules (Dell'Angelica et al., 2000).  Given that NAADP-
mediated Ca2+ release also evokes an alkalinisation of the lysososmal intralumenal pH 
(Morgan et al., 2007), Ca2+ release by NAADP via TPC2 may critically alter the 
intraluminal pH and thus affect the optimal functioning of hydrolytic lysosomal 
enzymes such as glucocerebrosidase which degrades glucocerebroside.  This enzyme 
exhibits a marked drop in function at pH ≥5 (van Weely et al., 1993).  TPC2-
dependent Ca2+ signalling may therefore regulate the degradation of macromolecules 
such as glucocerbroside, with TPC-dependent Ca2+ release potentially leading to 
accumulation of molecules such as glucocerbrosidase.  The dysfunction of such 
signalling may lead to the development of a number of diseases affecting lysosomes 
(see below). 
Lysosomes also play a significant role in the process of autophagy in which 
cytoplasmic constituents including organelles such as mitochondria are wrapped by a 
membrane to form autophagosomes that fuse with lysosomes and thus deliver their 
cargo for subsequent degradation.  The organelles are subsequently degraded by 
lysosomal hydrolases (Marino et al., 2004).  Autophagy allows the recycling of 
damaged organelles and is involved in programmed cell death and consequently the 
development of cancer is associated with reduced autophagy in malignant cells 
(Gozuacik et al., 2004; Marino et al., 2004).  Furthermore, low lysosomal enzyme 
activities have been observed in vesicles obtained from liver carcinomas (Gozuacik et 
al., 2004).  This suggests that, as mentioned above, NAADP-dependent Ca2+ 
signalling from lysosomes via TPC2 may affect the optimal functioning conditions of 
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lysosomal enzymes and thus regulate the process of autophagy.  Moreover, 
bafilomycin inhibits autophagosome-lysosome fusion and intriguingly, this block is 
believed to be an indirect result of the bafilomycin-induced acidification defect 
(Klionsky et al., 2008).  As inhibition of vacuolar H+-ATPase by bafilomycin which 
depletes lysosome-related Ca2+ stores and subsequently inhibits of NAADP-mediated 
Ca2+ release (Churchill et al., 2002; Kinnear et al., 2004), TPC2 may also underpin, in 
part, autophagosome-lysosome fusion. 
In HEK293 cells over-expressing hTPC2, but not wild-type HEK293 cells, I 
observed an element of mechanosensitivity (Fig. 6.1).  NAADP-mediated Ca2+ release 
via TPCs may therefore also be involved in mechanotransduction signalling such as 
that observed in mammalian 
hair cells, although further 
investigations are required in 
order to address a potential 
role for TPCs in this process. 
It also worth noting 
that due to their similarity to 
Cav and Nav, TPCs may be 
gated by other stimuli such 
as voltage in addition to 
NAADP.  Indeed, lysosomes 
contain a number of ion 
channels such as Cl- and Na+ 
channels (Carrithers et al., 2007; Suzuki et al., 2006) which, together with the 
electrogenic vacuolar proton pump (Van Dyke, 1996), may contribute to the 
development of a potential difference across the lysosomal membrane.  Changes in 
lysosomal membrane potential may therefore regulate the gating properties of TPCs.  
However the voltage-sensing S4 region of both Nav or Cav contain a greater number 
of conserved positively charged residues (5-9) (Keynes et al., 1999) than observed in 
TPCs (3-4) suggesting that TPCs may be weakly voltage-dependent if at all. 
 
 
 
 
Fig. 6.1.  Mechanosensitive response in HEK293 cell over-
expressing HA-hTPC2 
Record of the Fura-2 fluorescence ratio against time showing 
the effect of mechanical stimulation using a patch pipette 
(indicated on the record with a black arrow) in a HEK293 
cell over-expressing HA-hTPC2 using the tip of a patch 
pipette. 
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6.3.2  Two-pore channels and endosomal function 
 
Endosomes are critically involved in the sorting of endocytosed membrane-
bound proteins which may then be recycled to the plasma membrane via recycling 
endosomes or trafficked through the endolysosome system to lysosomes.  This 
trafficking requires multiple membrane fusion events that are dependent on Ca2+ 
release for the effective formation of the SNARE complex (Holroyd et al., 1999; 
Peters et al., 1998; Pryor et al., 2000).  This process requires intracellular Ca2+ as, for 
example, buffering of intracellular Ca2+ with EGTA has been shown to inhibit 
enodocytic protein transport from the ER to Golgi apparatus (Beckers et al., 1989) 
and increasing the Ca2+ concentration has been shown to increase fusion events 
observed in an in vitro assay (Mayorga et al., 1994).  Thus, transport of proteins 
between endolysosomes, Golgi apparatus, and plasma membrane via endosomes may 
be dependent on the spatially restricted Ca2+ release evoked by NAADP acting on 
TPC1.  Such a Ca2+ release mechanism via TPC1 may allow the cell to elicit spatially 
restricted intracellular Ca2+ release without triggering a global Ca2+ transient.  It is 
therefore possible that cells exhibiting high levels of endosomal protein trafficking 
may express greater levels of TPC1 than TPC2.  This, together with the fact that 
endolysosomes are mobile organelles may allow cells to specifically target NAADP-
sensitive stores to regions of the cell according to the specific function required. 
 
6.3.3  Two-pore channels and recycling endosome function 
 
Internalisation and transport of various plasma membrane bound receptors such 
as G-protein coupled receptors occurs via the endocytic pathway.  Once internalised 
the receptors are sorted via endosomes and are either down-regulated by 
transportation to lysosomes or are resensitised by dephosphorylation and recycled to 
the membrane via recycling endosomes.  This process is considered not only to 
regulate the number of receptors present on the plasma membrane, but may also 
transport the active ligand-receptor complex and thus propagate their respective 
signalling cascades (Sadowski et al., 2009; von Zastrow et al., 2007).  Endosomes, 
may therefore deliver active ligand-receptor signalling complexes to specific locations 
within the cell (Sadowski et al., 2009).  NAADP-mediated Ca2+ signalling via TPCs 
on endosomal membranes may therefore contribute to the regulation of GPCR 
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signalling pathways by determining which of the divergent pathways the internalized 
receptor follows and / or by indirectly controlling the length of time the receptor 
spends intracellularly via the regulation of membrane fusion.  For example in the 
human cervical cancer cell line (HeLa) bafilomycin abolishes transport of receptors to 
lysosomes but not recycling to the plasma membrane (Baravalle et al., 2005).  
Conversely, bafilomycin reduced the rate of receptor recycling in Chinese hamster 
ovary (CHO) derived cell lines (Johnson et al., 1993; Presley et al., 1997; Sadowski 
et al., 2009).  The effect of bafilomycin suggests that NAADP-mediated Ca2+ release 
via TPCs may, in part, determine the pathway of internalisation of receptors.  That the 
effect of bafilomycin on these divergent pathways varied according to the cell type 
used, suggests that this may be due to the relative expression of each TPC subtype in 
each cell type. 
One consideration with respect to the absence of TPCs such as TPC3 in some 
mammalian species is that their functional role may have been lost due to the 
development of other channels that render the subtype functionally redundant.  For 
example, the TRP melastatin subfamily type 2 (TRPM2) channel is established as a 
plasma membrane Ca2+ release channel that is activated by adenosine 
diphosphoribose (ADPR) and may be weakly gated by cADPR and NAADP (Beck et 
al., 2006; Lange et al., 2008).  Recently, Penner and colleagues have shown that 
TRPM2 acts as a Ca2+ release channel that is targeted to LAMP1-labelled lysosome-
related organelles as well as the plasma membrane in mouse pancreatic β-cells (Lange 
et al., 2009).  Given that TRPM2 would appear to have diverged at a later date than 
TPCs (Yu et al., 2005) it is plausible, therefore, that during the process of endocytic 
recycling from the plasma membrane this, or an as yet unidentified channel, may have 
exhibited similar functions to TPC3 thus rendering the latter channel redundant within 
some species. 
 
6.3.4  Two-pore channels and the function of lysosome-related acidic organelles 
 
TPCs may also play an important role in the functioning of lysosome-related 
organelles such as melanosomes which are responsible for the delivery of melanin to 
keratinocytes (Bhatnagar et al., 1993).  Melanosome-keratinocyte interaction triggers 
a transient rise in intracellular Ca2+ concentration within the keratinocyte which in 
turn evokes melanosome-dependent melanin transfer.  This Ca2+ rise is due to the 
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release of Ca2+ from intracellular stores and is unresponsive to further stimulation for 
up to 2 hours (Joshi et al., 2007).  This is reminiscent of the sperm-induced, NAADP-
dependent cortical Ca2+ flash in sea urchin eggs that is then desensitised to further 
activation by NAADP (Churchill et al., 2003).  Thus a particular TPC subtype(s) may 
be involved in some of the mechanisms that underpin pigmentation.  Consistent with 
this proposal, 2 coding variants in the TPCN2 gene are associated with determining 
blonde versus brown hair colour in a Europeans (Sulem et al., 2008). 
 
6.3.5  Possible function of TPC desensitisation / inactivation  
 
I have shown that, consistent with a number of other mammalian cell types 
(Berg et al., 2000; Cancela et al., 1999; Masgrau et al., 2003), TPC2 exhibits a bell-
shaped concentration-response curve in response to NAADP.  Given the fact that, 
unlike RyR- and IP3R-dependent Ca2+ release, NAADP-mediated Ca2+ release is 
insensitive to changes in cytoplasmic Ca2+ concentration (Chini et al., 1996; 
Genazzani et al., 1997), the inactivation of TPC2 at high concentrations of NAADP 
may provide a negative feedback mechanism.  This may contribute to cessation of 
signalling by agonists that evoke NAADP-mediated Ca2+ signalling such as glucose.  
For example, the glucose transporter in pancreatic β-cells does not exhibit 
desensitisation and therefore inactivation of TPCs may function as a downstream 
negative feedback mechanism for glucose-evoked Ca2+ release in pancreatic β-cells 
(Patel, 2003).  Excessive production of NAADP, evoked by glucose, would therefore 
result in the desensitisation of TPC2 and thus effectively inactivate further channel 
opening.  It is important to note that the desensitisation / inactivation properties of 
TPC1 and TPC3 remain to be determined and therefore any variation between the 
subtypes and their respective expression levels may, in part, explain the discrepancy 
between the inactivation mechanisms observed in sea urchin eggs and mammalian 
preparations (Aarhus et al., 1996; Berg et al., 2000; Cancela et al., 1999; Genazzani 
et al., 1996a; Masgrau et al., 2003). 
The proposed mechanism of homologous desensitisation may allow the cell to 
utilise this property in order to exhibit a degree of spatiotemporal memory of previous 
messenger-specific Ca2+ release events.  It is quite possible that such “spatiotemporal” 
controls could play a significant role in a variety of cellular processes.  For example, 
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during fertilisation in sea urchin eggs, upon sperm / egg contact NAADP triggers a 
cortical Ca2+ flash (Churchill et al., 2003).  Here desensitisation of TPCs could be 
vital to the production of an exclusive signalling event, with desensitisation ensuring 
that it is not repeated within a given time period.  This prolonged period of 
desensitisation following intracellular Ca2+ release has also been observed in 
keratinocytes following melanosome-mediated delivery of melanin (Joshi et al., 
2007).  Though the role of NAADP in this process has not been investigated, the 
observed inactivation may be as a result of the inactivation characteristic of NAADP-
mediated Ca2+ release via TPCs.  Therefore, desensitisation / inactivation of TPCs 
would avoid further and potentially detrimental membrane fusion. 
 
 
6.3.6  Significance of two-pore channel-dependent Ca2+ signalling in disease 
 
Lysosomal storage diseases (LSDs) are caused by the dysfunction of lysosomal 
enzymes, lysosome-associated proteins involved in lysosomal biogenesis, or enzyme 
activation / targeting (Parkinson-Lawrence et al., 2006).  One of the more common 
LSDs is Gaucher disease, which is caused by reduced activity of lysosomal 
glucocerebrosidase.  This aberrant function of glucocerebrosidase results in the 
accumulation of glucosylceramide transforming the cell into a Gaucher cell (Zhao et 
al., 2002).  Interestingly the L-type Ca2+ channel blockers diltiazem and verapamil 
have been shown to partially restore glucocerebrosidase function in Gaucher disease 
patient-derived fibroblasts (Mu et al., 2008).  This finding is particularly interesting 
given that NAADP-mediated Ca2+ release is inhibited by L-type Ca2+ channel 
blockers and agonists (Bak et al., 1999; Genazzani et al., 1996a; Genazzani et al., 
1997).  These findings, together with the fact that NAADP-mediated Ca2+ release 
alters the intraluminal pH of acidic stores (Morgan et al., 2007) suggests that TPC2 
may be involved in regulating the optimal functional conditions for lysosomal 
enzymes as proposed above (pH), and may therefore be responsible for some of the 
mechanisms implicated in LSDs such as altering the operating conditions of 
glucocerebrosidase. 
Another common example of LSDs is Niemann-Pick disease which is 
characterised by defects in the activity of sphingolipid degrading enzymes resulting in 
the excessive lysosomal storage of sphingolipids (Sturley et al., 2004).  Niemann-Pick 
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disease type A and B (NPA and NPB) occur due to mutations in the enzyme acid 
sphingomyelinase (SMase) structural gene whereas Niemann-Pick disease type C1 
(NPC1) is due to defective cholesterol transport from the lysosome with a secondary 
defect in SMase activity.  Dysfunctional SMase results in the accumulation of 
unesterified cholesterol in perinuclear lysosomes (Sturley et al., 2004).  In addition to 
defective hydrolysis of sphingolipids, LSDs such as NPC1 may occur due to defective 
transport of sphingolipids through the endocytic compartments (Marks et al., 2002).  
As mentioned above endocytic transport of molecules such as sphingolipids requires a 
number of endosomal / lysosomal membrane fusion events which, in turn, are 
dependent upon Ca2+ release from the acidic stores (Piper et al., 2004).  Consistent 
with this, recent evidence suggests that dysfunctional Ca2+ homeostasis precedes the 
excessive sphingosine storage associated with NPC1 (Lloyd-Evans et al., 2008).  As a 
result, NAADP-mediated Ca2+ release was reduced by ~70% in NPC1 mutant cells 
(Lloyd-Evans et al., 2008).  Thus, TPCs may be involved in Niemann-Pick disease 
either via the alkalinisation of lysosomes, leading to dysfunctional SMase activity, or 
via defective endosomal transport / membrane fusion. 
A further implication of the finding that NAADP mobilises Ca2+ via TPCs 
concerns an autosomal recessive nonsyndrommic deafness locus DFNB63.  This 
locus has been linked with chromosome 11q (Khan et al., 2007) which also contains 
the gene encoding human TPC2 (TPCN2).  However, sequencing of the coding 
regions for the 13 candidate genes including TPCN2 from an affected individual 
showed that there was no disease-causing mutations (Kalay et al., 2007).  
Nevertheless, given that audio abnormalities have been recognised as a symptom of a 
number of LSDs including Pompe disease, Gaucher disease and Hunter syndrome 
(Campbell et al., 2003; Kamphoven et al., 2004; Peck, 1984) the involvement of 
TPC2 in these diseases cannot be excluded.  Moreover, a disruption in the 
mechanotransduction apparatus of hair cells has been linked to a number of mouse 
models of deafness (Grant et al., 2007).  This is intriguing given the possible role of 
TPC2 in mechanotransduction mentioned above. 
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6.4  Junctional coupling of NAADP-mediated Ca2+ signalling via two-
pore channels 
 
In HEK293 cells stably over-expressing HA-hTPC2, NAADP evoked biphasic 
Ca2+ transients that are consistent with the 2-pool mechanism of NAADP-mediated 
Ca2+ release shown previously in both pulmonary arterial smooth muscle cells 
(PASMCs) and sea urchin eggs (Churchill et al., 2001a; Kinnear et al., 2004).  I 
further showed that the initial phase of NAADP-evoked Ca2+ release was from 
lysosomes via TPC2, which was then amplified into a global Ca2+ transient by 
subsequent amplification by Ca2+-induced Ca2+ release (CICR) from the ER via the 
progressive recruitment of IP3Rs (Fig. 6.2).  That NAADP mobilises Ca2+ from a 
lysosome-related store is consistent with the cellular distribution of TPCs and with 
previous reports from a number of cell types (Brailoiu et al., 2006; Brailoiu et al., 
2005; Churchill et al., 2002; Kinnear et al., 2004; Macgregor et al., 2007; Yamasaki 
et al., 2004; Zhang et al., 2006a).  Furthermore, amplification of NAADP mediated 
Ca2+ signalling by CICR from the S / ER has been proposed and demonstrated in a 
number of previous studies (Berg et al., 2000; Boittin et al., 2002; Brailoiu et al., 
2003; Cancela et al., 1999; Churchill et al., 2001a; Churchill et al., 2000; Macgregor 
et al., 2007).  However, it is important to note that in wild-type HEK293 cells 
NAADP evoked spatially restricted Ca2+ release that failed to propagate into a global 
Ca2+ transient suggesting that the endogenous expression level of TPC2 may not be 
sufficient for effective coupling between lysosomal Ca2+ release and the ER.  This 
absence of amplification may be explained by the formation of “loose junctions” 
between lysosomes and the ER in wild-type HEK293 cells.  This is in marked contrast 
to the data presented in Chapter 3 and by Kinnear and colleagues showing that 
PASMCs lysosomes form “tight junctions” with the SR (Kinnear et al., 2004).  As 
mentioned above, in HEK293 cells stably over-expressing TPC1, NAADP evoked 
spatially restricted Ca2+ transients that failed to propagate into a global Ca2+ transient.  
This may be indicative of a lower Ca2+ content in endosomes compared to lysosomes 
and / or that endosomes do not form junctional complexes with the ER in HEK293 
cells.  Therefore, the distribution and cell-specific organisation of organellar junctions 
may serve to determine the functional effects of NAADP-mediated Ca2+ signalling.  
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Fig. 6.2.  Schematic representation of the amplification of NAADP-evoked Ca2+ release from 
lysosome-related acidic organelles in HEK293 cells 
NAADP evokes spatially restricted Ca2+ release from lysosome-related acidic organelles via TPC2 
which are then amplified via Ca2+-induced Ca2+-release (CICR) from the endoplasmic reticulum (ER) 
via proximal IP3Rs.  Lysosomes are thought to sequester Ca2+ via the action of the vacuolar proton 
pump (V-H-ATPase) coupled to a Ca2+ / H+ exchanger (CHX) whereas the ER sequesters Ca2+ via the 
sarco / endoplasmic reticulum ATPase (SERCA) pump. 
 
6.4.1  Ca2+ release via two-pore channels generate elementary Ca2+ signals that may 
be amplified by coupling to the sarco / endoplasmic reticulum 
 
One consideration with respect to the coupling efficiency between NAADP-
evoked Ca2+ release and the S / ER is that endolysosomes represent small, discreet 
Ca2+ storage vesicles with the amount of Ca2+ released determined by the luminal 
Ca2+ concentration and size of a given vesicle.  As NAADP receptors are not sensitive 
to changes in cytoplasmic Ca2+ concentration (Chini et al., 1996; Gerasimenko et al., 
2003) the Ca2+ transients developed are not regenerative and therefore comprise 
scattered local Ca2+ release events.  Consequently, clustering in time and space of the 
acidic stores may be required in order to breach a given threshold for CICR from the 
S / ER.  This may be analogous to the neuromuscular junction whereby each synaptic 
vesicle delivers quanta of neurotransmitter that, if a given number are released, is 
sufficient to breach a given threshold and evoke a post-synaptic potential in an all-or-
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none manner.  Thus, the varying size of individual endolysosomes and the number of 
vesicles present in any given cluster, may contribute in part to the different sizes and 
types of elementary Ca2+ signals (e.g. blips, puffs, sparks) described during stimulus-
evoked Ca2+ transients in a number of cell types (Bootman et al., 1997).  However, 
these events may also be independent of TPCs and due to the recruitment of RyRs or 
IP3Rs alone and therefore further investigation is required in order to determine a role 
for TPCs in these elementary Ca2+ signalling events. 
The proximity of the S / ER store to the NAADP-sensitive acidic organelle may 
also determine the efficiency of coupling.  For example, in PASMCs a subpopulation 
of lysosomes appear to be in close apposition to RyRs in the SR and thus may form a 
“trigger zone” for Ca2+ signalling by NAADP (Kinnear et al., 2004).  These 
junctional complexes would allow for the amplification and propagation of Ca2+ 
signals evoked by NAADP.  Conversely, loose coupling between endolysosomes and 
the ER may be required to regulate a number of processes in a manner that does not 
require exclusive coupling.  Indeed, IP3Rs are present on the ER and Golgi apparatus, 
which are critically involved in the post-translation modification and trafficking of 
proteins.  As the luminal Ca2+ concentration of the ER regulates a number of 
molecular chaperones (Burdakov et al., 2005), coupling of NAADP-mediated Ca2+ 
release from endolysosomes to IP3Rs may therefore modulate post-translational 
protein processing.  This may not require a tight junction and as such, loose coupling 
may be sufficient to modulate a number of receptors on both organelles.  However, 
whether or not TPC2 and IP3Rs form close junctional complexes within HEK293 
cells remains to be determined. 
 
6.4.2  Coupling efficiency may be determined by the receptor subtype present on the 
sarco / endoplasmic reticulum  
 
The subtype of receptor present on the S / ER may also confer a degree of 
functional versatility with respect to TPC-dependent Ca2+ signalling.  For example, all 
3 IP3R subtypes exhibit biphasic regulation by cytoplasmic Ca2+ though with different 
sensitivities (Boehning et al., 2000; Iino, 1990; Missiaen et al., 1998; Miyakawa et 
al., 1999; Taylor et al., 2002).  Therefore the relative expression of each IP3R subtype 
in different cell types and / or their cellular distribution may also determine the 
coupling efficiency between endolysosome stores and the S / ER.  As both IP3 and 
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Ca2+ are required for IP3R channel opening the basal IP3 concentration in the region 
of the junctional complex will also regulate the coupling efficiency especially when 
one considers that IP3R subtypes exhibit different affinities for IP3 (Miyakawa et al., 
1999).  Therefore the cellular distribution of phospholipase C which generates IP3 
may also prove decisive in determining the relative threshold for CICR in a given 
region of the cell.  Furthermore, IP3Rs have been shown to aggregate and form 
clusters upon exposure to low concentrations of IP3 (Taufiq Ur et al., 2009).  
Clustering caused a decrease in the open probability and the mean opening time, 
though this inhibition may be reversed by an increase in the cytoplasmic Ca2+ 
concentration (Taufiq Ur et al., 2009).  If endolysosomes were to form junctional 
complexes with such clusters, then NAADP-evoked Ca2+ release may serve to remove 
the cluster-induced inhibition resulting in an increased open probability and 
simultaneous opening of clustered IP3Rs (Taufiq Ur et al., 2009).  This in turn would 
ensure that once the threshold for CICR via IP3R has been breached, the propagation 
of the resultant Ca2+ wave would be less likely to fail.  The subtype of IP3R in the 
junctional complex and the local IP3 concentration may therefore determine the 
spatiotemporal pattern of NAADP-mediated Ca2+ signalling. 
 
6.4.3  Targeted coupling may determine agonist-specific signalling 
 
In PASMCs and HEK293 cells the NAADP antagonist Ned-19 specifically 
blocked Ca2+ signalling by NAADP but not that of caffeine, carbachol and IP3.  It is 
clear, therefore, that signalling by some stimuli may occur independently of the 
NAADP / TPC pathway.  For example, in pancreatic acinar cells cholecystokinin 
(CCK) may evoke Ca2+ oscillations in an NAADP-dependent manner, whereas Ca2+ 
oscillations evoked by bombesin or acetylcholine may occur independently of 
NAADP (Burdakov et al., 2000; Cancela, 2001; Yamasaki et al., 2004).  Consistent 
with this, a transient increase in NAADP production is evoked by CCK but not 
acetylcholine (Yamasaki et al., 2005).  One particular advantage of TPC-independent 
Ca2+ release is that these signalling pathways may be regulated in a manner that does 
not alter the endolysosomal function discussed above.   
Conversely, the NAADP / TPC pathway may also function independently of ER 
coupling.  For example, in pancreatic β-cells NAADP production and subsequent 
Ca2+ release from lysosome-related organelles is triggered by extracellular glucose 
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which, together with Ca2+ influx results in insulin secretion (Masgrau et al., 2003; 
Yamasaki et al., 2004).  It is likely, therefore, that spatially restricted Ca2+ signals 
from acidic stores may gate Ca2+-activated cation channels located on the plasma 
membrane which may lead to membrane depolarisation and subsequent Ca2+ influx 
via voltage-gated Ca2+ channels.  This is demonstrated in β-cells obtained from TPC2 
null mice, in which the NAADP-evoked cation current is absent (Prof. Antony 
Galione, Personal Correspondence).  However, it is important to note that NAADP-
induced Ca2+ signals by NAADP may also be amplified by CICR from the ER via 
IP3Rs in response to insulin (Johnson et al., 2002), or via RyRs which may be 
involved in glucagon-like peptide 1 evoked Ca2+ signals (Kim et al., 2008).  Thus, the 
targeting of these acidic Ca2+ stores to regions of the cell such as the sub-
plasmalemmal region may prove decisive in determining the coupling and resultant 
characteristics of stimulus-specific NAADP-evoked Ca2+ transients (Fig. 6.3). 
The mobile nature of endolysosomes would also allow TPC-containing 
organelles to be targeted to regions such as the leading edge of the motile cell.  For 
example, NAADP has been shown to potentiate neurite outgrowth (Brailoiu et al., 
2005) a process that requires the development of actin rich filopodia (Mattila et al., 
2008).  The formation of these processes via actin polymerisation in a number of cell 
types such as vascular smooth muscle can be regulated by changes in cytoplasmic 
Ca2+ concentration (Gerthoffer, 2007).  NAADP-mediated Ca2+ release via TPCs 
proximal to the sites of actin polymerisation may therefore regulate the formation of 
filopodia.  Consistent with this proposal, bafilomycin has been shown to significantly 
reduce motility in mouse fibroblasts (Thomsen et al., 1999).  Should TPC-dependent 
Ca2+ release regulate processes such as cell motility then this will further demonstrate 
the versatility conferred by the targeted coupling of NAADP-sensitive endolysosomal 
stores. 
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Fig. 6.3.  The potential role of two-pore channels in Ca2+ signalling 
Schematic chart showing the potential Ca2+-dependent pathways regulated by NAADP.  The red 
dashed arrows indicate potential regenerative feedback loops implicated in IP3R- and RyR-dependent 
Ca2+ signalling.  The black dashed arrows indicate some of the potential functions that NAADP-evoked 
elementary Ca2+ signals may regulate.  S / ER, sarco / endoplasmic reticulum; CICR, Ca2+-induced 
Ca2+-release; SNARE, soluble NSF attachment protein (SNAP) receptor; ICa, plasma membrane Ca2+ 
current. 
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6.4.4  Two-pore channel subtype 2 and ryanodine receptor subtype 3 comprise a 
trigger zone for Ca2+ signalling by NAADP in pulmonary arterial smooth muscle 
cells  
 
It is clear that the versatility of coupling of NAADP-sensitive lysosome-related 
Ca2+ stores to various Ca2+ sensitive channels, and in particular those capable of 
mediating CICR, is important in determining the functional properties particular to a 
given cell.  One such example of dynamic coupling is the role of NAADP-mediated 
Ca2+ release in pulmonary arterial smooth muscle cells (PASMCs).  Previously, 
NAADP has been shown to evoke global Ca2+ waves via a two-pool system in 
PASMCs (Boittin et al., 2002; Kinnear et al., 2004).  Consistent with a role for TPCs 
in NAADP-mediated Ca2+ release, TPC2 is expressed in this cell type.  I have also 
shown that TPC2 was fluorescently labelled by the NAADP antagonist Ned-19 and 
that this channel is targeted to the membranes of lysosomes in both PASMCs and 
HEK293 cells.  This, together with the fact that Ned-19 selectively inhibited NAADP-
mediated Ca2+ release in both cell types suggests that TPC2 likely represents the 
NAADP receptor in PASMCs.  In PASMCs, NAADP is thought to produce spatially 
restricted Ca2+ bursts from lysosomes which are amplified in an all-or-none manner 
by CICR from the SR via RyRs (Boittin et al., 2002; Kinnear et al., 2004).  This is 
supported by the finding that lysosomes closely associate with RyRs to form a trigger 
zone for Ca2+ signalling by NAADP (Kinnear et al., 2004).  I have shown that RyR3 
was the predominant RyR subtype in the perinuclear region of PASMCs, which was 
also the region in which the greatest density of lysosomal labelling was observed.  
Consistent with this, lysosomes appeared to preferentially co-localise with RyR3 in 
the perinuclear region.  As discussed previously, consideration of the sensitivity to 
CICR, the maximum gain in response to Ca2+, and the sensitivity to inactivation by 
Ca2+ of each RyR subtype would suggest that RyR3 is well suited to the role in this 
initial all-or-none manner of amplification of NAADP-evoked Ca2+ bursts.  Briefly, 
the estimated half maximal activation (EC50) with respect to Ca2+  is ~250 nM and 
~400 nM for RyR2 and RyR3, respectively (Chen et al., 1997b; Li et al., 2001) 
suggesting that RyR3 may confer a higher “margin of safety” with respect to CICR.  
The observed open probability (Po) versus cytoplasmic Ca2+ concentration curves 
show that RyR3 exhibits a greater increase in the Po (0-1) than does RyR2 (0-0.9) and 
RyR1 (0-0.2) (Chen et al., 1997b; Li et al., 2001).  RyR3 also exhibits less sensitivity 
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to inactivation by Ca2+ than does RyR2 (IC50 ~3 mM and ~2 mM respectively) and 
markedly less than does RyR1 (complete inactivation observed at 1 mM) (Chen et al., 
1997b; Li et al., 2001).  Furthermore, both the marked decline in the density of RyR3 
labelling outside the perinuclear region, together with the fact that RyR2 appears to be 
the predominant subtype within the extra-perinuclear region suggest that RyR2 plays 
a role in propagating the global Ca2+ wave beyond the lysosome-SR junctions.  In 
marked contrast to both RyR2 and RyR3, the distribution of RyR1 was uniform 
throughout the cell.  Nevertheless, RyR1 appeared to be the predominant subtype 
within the subplasmalemmal region, suggesting that this subtype may play an 
important role in the regulation of Ca2+-sensitive ion channels in the plasma 
membrane. 
The tight lysosome-SR coupling observed in PASMCs may determine functions 
specific to this cell type such as, for example hypoxic pulmonary vasoconstriction 
(HPV).  HPV is a property of pulmonary arteries that allows blood to be redirected in 
order to maximise ventilation-perfusion matching.  However, this property can prove 
damaging in certain circumstances, whereby global, chronic HPV can lead to the 
development of pulmonary hypertension.  Upon exposure to hypoxic conditions 
pulmonary arteries exhibit an initial transient constriction (Phase 1) and a slow tonic 
constriction (Phase 2) (Dipp et al., 2001b).  It is generally accepted that Ca2+ release 
from the SR via RyRs underpins both Phases 1 and 2 (Evans et al., 2002; Evans et al., 
2005; Ward et al., 2009).  Importantly, the cADPR antagonist 8-bromo-cADPR 
appeared to block Phase 2 in an all-or-none manner which suggests that HPV may 
exhibit a “margin of safety” with respect to cADPR-dependent Ca2+ release  (Dipp et 
al., 2001a).  This “margin of safety” could be conferred by the components of the 
lysosome-SR junction and in particular the high threshold for CICR exhibited by 
RyR3.  cADPR is an endogenous regulator of RyRs and may also activate RyRs 
directly, or facilitate CICR via RyRs (Meszaros et al., 1993; Tanaka et al., 1995).  
Therefore, cADPR may sensitise RyR3 and RyR2 to activation by Ca2+ and thus 
determine the CICR threshold.  Such a role for cADPR has been demonstrated in 
cardiac myocytes, in which cADPR was shown to increase the depolarisation-induced 
contraction of myocytes due to sensitising RyR2 to CICR (Cui et al., 1999).  Thus, in 
PASMCs, cADPR may sensitise RyRs to activation by Ca2+ and subsequently 
increase the probability of NAADP-mediated Ca2+ bursts being amplified by CICR 
from the SR via RyRs (Fig. 6.4).  8-bromo-cADPR may therefore exhibit its all-or-
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none block by competitive antagonism of cADPR and consequently the threshold for 
CICR would be increased.  In the presence of 8-bromo-cADPR, Ca2+ release into the 
trigger zone via TPC2 may not be sufficient to breach the raised threshold for CICR.  
TPC2 dependent Ca2+ signalling via the lysosome-SR junction may therefore play a 
critical role in HPV.  Consistent with this proposal, pulmonary hypertension is one of 
the pathological effects of lysosomal storage diseases such as Gaucher and Pompe’s 
disease (Elstein et al., 1998; Jmoudiak et al., 2005; Noori et al., 2002) which, as 
mentioned above, may be underpinned by dysfunctional NAADP-signalling via 
TPCs.  Therefore, further investigation into Ca2+ signalling by NAADP via TPCs is 
required in order to better understand the mechanisms underpinning diverse 
spatiotemporal patterns of intracellular Ca2+ signalling and how these may determine 
cell type-specific function. 
 
In summary, the experiments described within this thesis provide compelling 
evidence to suggest that two-pore channels represent a family of NAADP-gated Ca2+-
releasable receptors.  These channels underpin localised Ca2+ signals in response to 
NAADP that, dependent on the cell and TPC subtype, may or may not couple to Ca2+ 
release channels present on the S / ER to evoke regenerative, global Ca2+ waves.  
TPCs are targeted to the membranes of endolysosomes and thus my data may shed 
new light on the potential functions of the organelles with respect to intracellular Ca2+ 
signalling. 
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Fig. 6.4. Lysosomes preferentially co-localise with ryanodine receptor subtype 3 to comprise a 
trigger zone for Ca2+ signalling by NAADP in pulmonary arterial smooth muscle cells 
Top panel, schematic diagram showing the proposed mechanism of amplification of NAADP-mediated 
Ca2+ bursts by Ca2+-induced Ca2+ release from the sarcoplasmic reticulum (SR).  Lower panel, 
schematic diagram representing the potential role for cADPR and NAADP in mediating hypoxic 
pulmonary vasoconstriction.  The dashed arrows indicate how cADPR may sensitise ryanodine 
receptors (RyR) to activation by Ca2+.  NAADP mobilises Ca2+ from lysosomes via TPC2 which are 
then amplified via Ca2+-induced Ca2+-release (CICR) from the sarcoplasmic reticulum (SR) via 
proximal RyRs.  Lysosomes are thought to sequester Ca2+ via the action of the vacuolar proton pump 
(V-H-ATPase) coupled to a Ca2+ / H+ exchanger (CHX). ADP ribosyl cyclase, ARC; sarco / 
endoplasmic reticulum ATPase, SERCA pump. 
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Chapter 7:  Future Directions / Experiments 
 
 
7.1  Are all two-pore channel subtypes NAADP receptors? 
 
The results presented in my thesis show that NAADP evokes Ca2+ release via 
both TPC1 and TPC2 and suggest, therefore, that TPCs represent a family of NAADP 
receptors.  However, experiments with respect to TPC1 were limited to identification 
of the organelles to which this subtype is targeted (endosomes) and preliminary Ca2+ 
imaging experiments. These studies were not supported by binding data, 
pharmacological intervention to determine the site of Ca2+ release (e.g. depletion of 
acidic stores with bafilomycin A1) or shRNA experiments; although Brailoiu and co-
workers have provided data which appear to show that TPC1 knockdown attenuates 
Ca2+ signalling in response to NAADP in SKBR3 cells that had been transiently 
transfected with TPC1 and that Ca2+ released via TPC1 is derived from acidic Ca2+ 
stores (Brailoiu et al., 2009).  In addition to TPC1 and TPC2, TPC3 is also expressed 
in many animal species, but we have only thus far determined the organelles to which 
TPC3 is primarily targeted (endosomes).  Therefore, an important direction for future 
investigations would be to determine whether or not all three animal TPCs comprise a 
family of NAADP receptors.  
Using similar techniques to those I have described in this thesis with respect to 
my studies on TPC2, I propose the following investigations on TPC1 and TPC3:  
 
1. Does over-expression of human TPC1 and chicken TPC3, respectively, 
increase the maximal binding of [32P]NAADP to membranes derived 
from HEK293 cells? 
2. Does stable over-expression of TPC1 and TPC3, respectively, in 
HEK293 cells confer Ca2+ transients in response to NAADP that are 
distinct from those observed in wild-type HEK293 cells? This could be 
confirmed by knockdown of TPC1 and TPC3 using sequence specific 
shRNA against TPC1 and TPC3, as I have done with respect to TPC2. 
3. Are NAADP-induced Ca2+ signals via TPC1 and TPC3 blocked 
following depletion of acidic stores with bafilomycin A1? If so are they 
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resistant to osmotic lysis of lysosomes with glycyl-L-phenylalanine 
(GPN), as would be expected if TPC1 and TPC3 are targeted to 
endosomes (which do not contain cathepsin C) and not lysosomes.  
4. Are NAADP-induced Ca2+ signals via TPC1 and / or TPC3 amplified by 
Ca2+-induced Ca2+ release from the ER via IP3Rs, as is the case with 
TPC2? As before this could be determined by studying the effect on the 
observed signals of depleting ER Ca2+ stores by thapsigargin and by 
blocking IP3Rs with heparin. 
 
7.2  Are either of the three ryanodine receptor subtypes NAADP 
receptors? 
 
One major controversy that remains despite my demonstrating that TPCs act as 
NAADP receptors is the suggestion that in T-cells and skeletal muscle, that ryanodine 
receptor subtype 1 (RyR1) may act as an NAADP-activated release channel 
(Dammermann et al., 2005; Guse, 2009; Hohenegger et al., 2002).  This also raises 
the question of RyR2 and RyR3 acting as NAADP receptors.  Because HEK293 cells, 
as discussed previously, express little or no RyR1, RyR2 or RyR3 and insufficient 
levels of either TPC1, TPC2 or TPC3 to support significant Ca2+ signalling in 
response to NAADP, these cells offer the perfect model system to address this issue.  
I would therefore determine by intracellular dialysis of NAADP, whether or not 
NAADP induces release from ER stores in HEK293 cells that stably over-express 
RyR1, RyR2 or RyR3. 
 
7.3  Is the antagonism of NAADP-mediated Ca2+ signalling by Ned-19 
two-pore channel subtype-selective?  
 
In order to use Ned-19 for further characterisation of NAADP-mediated Ca2+ 
signalling via TPCs it is important to determine whether or not Ned-19 inhibits 
[32P]NAADP to, and NAADP-evoked Ca2+ release via all three TPC subtypes.  This is 
particularly important given that in mammalian cells Ned-19 appears to be a non-
competitive antagonist of NAADP binding (Dr. Grant Churchill, personal 
communication).  Thus, Ned-19 appears to inhibit NAADP binding to TPC2 by 
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interacting with a site distinct from the NAADP-binding site.  Moreover, the sequence 
homology between TPC1, TPC2 and TPC3 is less than 30%.  Therefore, there 
remains the possibility that Ned-19 may bind to a site that is exclusive to TPC2 i.e. 
Ned-19 may show selectivity for one TPC subtype over another.  I would therefore 
examine further the effect of Ned-19 in the following manner: 
 
1. Does Ned-19 displace [32P]NAADP binding to membranes derived from 
HEK293 cells that stably over-express TPC1, TPC2 and TPC3, 
respectively? 
2. Does Ned-19 block NAADP-dependent Ca2+ signalling via TPC1, TPC2 
and TPC3, respectively, when stably over-expressed in HEK293 cells. 
 
7.4 Do voltage-gated Ca2+ channel agonists and antagonists block 
NAADP-dependent Ca2+ signalling via two-pore channels?  
 
Early studies on Ca2+ signalling by NAADP in sea urchin egg homogenates 
demonstrated that voltage-gated Ca2+ channel (VGCC) antagonists (both 
dihydropyridine and phenylalkylamines), the VGCC agonist BAYK8644 and 
SKF96365 were shown to block NAADP evoked Ca2+ release (Genazzani et al., 
1996a; Genazzani et al., 1997).  I would therefore plan to determine whether or not 
these agents block NAADP-dependent signalling via TPC1, TPC2 and TPC3, 
respectively, stably expressed in HEK293 cells.  In this way, I would also determine 
whether or not any of these agents show selectivity for one or other of the three TPC 
subtypes.  If any of the VGCC antagonists block TPCs, this may also explain some of 
the anomalous therapeutic effects of VGCC antagonists such as nimodipine (e.g. 
subarachnoid haemorrhage, migraine, cluster headache) (Solomon, 1989; Tomassoni 
et al., 2008).  It is also possible that VGCC antagonists may mediate some of their 
anti-hypertensive effects via block of TPCs, because Saida and van Breemen showed 
that VGCCs mediate vasodilation partly by inhibiting intracellular Ca2+ release (Saida 
et al., 1983). 
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7.5  Does two-pore channel subtype 2 tightly couple to inositol 1,4,5-
trisphosphate receptors in HEK293 cells? 
 
Within both pulmonary arterial smooth muscle cells (PASMCs) and HEK293 
cells expressing HA-hTPC2, NAADP appeared to evoke global Ca2+ transients via a 
2-pool mechanism.  However the precise mechanism underpinning this biphasic 
response differed slightly between the two cell types.  In both cell types NAADP 
mobilises Ca2+ from lysosome-related organelles.  In PASMCs this initial phase of 
Ca2+ release is amplified by Ca2+-induced Ca2+ release (CICR) from the sarcoplasmic 
reticulum (SR) via RyRs (Boittin et al., 2002; Kinnear et al., 2004) (Chapter 3).  On 
the other hand, in HA-hTPC2 expressing cells Ca2+ release from lysosomes via TPC2 
appears to be amplified by CICR from the endoplasmic reticulum (ER) via inositol 
1,4,5-trisphosphate receptors (IP3Rs) (Chapter 4).  Significantly, I have shown that in 
PASMCs RyR3 in particular is preferentially targeted to the junctional complex that 
exists between lysosomes and the SR (Chapter 3).  The initial amplification stage of 
NAADP-mediated Ca2+ bursts is therefore subtype-specific.  Given that all 3 IP3R 
subtypes are expressed in human cells, albeit with varying levels of expression 
(Taylor et al., 1999; Tovey et al., 2008; Wojcikiewicz, 1995), and that each IP3R 
subtype exhibit different sensitivities to Ca2+ (Bootman et al., 1999; Yule, 2001), 
TPC2 may form a tight association with a specific IP3R subtype to comprise a trigger 
zone for Ca2+ signalling by NAADP in HEK293 cells.  Alternatively, a Ca2+-regulated 
phospholipase C (PLC) subtype (e.g. PLCδ) may also be involved and generate IP3 in 
response to the initial phase of Ca2+ release via TPC2; this too could comprise, in part, 
a trigger zone.  I would therefore investigate any potential role of IP3Rs and PLC in 
the following manner: 
 
• Firstly the expression of all 3 IP3R subtypes and Ca2+-regulated PLC subtypes 
within HEK293 cells must be verified via RT-PCR, Western blot and / or 
immunocytochemical analysis of HA-hTPC2 expressing HEK293 cells.  
Using shRNA and the PLC antagonist U73122 (heparin has already been 
shown to block CICR via the ER in response to NAADP-evoked Ca2+ release 
via TPC2) the role of each of these components in mediating Ca2+ signalling 
by NAADP could be determined using intracellular dialysis of NAADP.  
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• Using the sequence specific antibodies, where available, HEK293 cells over-
expressing mCherry-tagged hTPC2 (mCherry-hTPC2 cells) can be used in 
immunocytochemical analysis in order to determine the degree of co-
localisation between mCherry-tagged hTPC2 and each IP3R / PLC subtype.  
This would indicate whether TPC2 preferentially co-localised with a specific 
IP3R and / or PLC subtype as described for RyRs in Chapter 3.  Immunogold 
labelling and electron microscopy could then be used to determine the 
junctional space between lysosome clusters and the ER.  If the junctional 
space was <100 nm it would constitute a tight junctional association, if any 
larger one would conclude that only loose junctions were in place.  
 
7.6  Does two-pore channel subtype 2 and ryanodine receptor 
subtype 3 co-localise in pulmonary arterial smooth muscle cells? 
 
In this thesis I have shown that αIgp120-labelled lysosomes preferentially co-
localised with RyR3 in the perinuclear region of PASMCs (Chapter 3).  I have also 
shown that Ned-19 labelled TPC2 co-localised with LysoTracker labelled lysosomes 
in PASMCs (Chapter 5).  Therefore, in order to further confirm that RyR3 and TPC2 
comprise a trigger zone for NAADP-mediated Ca2+ signalling in PASMCs it is 
important to determine the degree of co-localisation between these 2 elements.   
 
• Now that the NAADP receptor has been identified, sequence specific 
antibodies are being developed specifically against human, rat and mouse 
TPCs.  In the future these may be used along with anti-RyR3 antibodies to co-
label these proteins within isolated PASMCs.  The degree of co-localisation 
between RyR3 and TPC2 may then be analysed using the volumetric analysis 
described previously.  Immunogold labelling and electron microscopy could 
also be used to determine the junctional space between TPC2 / lysosomes and 
RyR3 / SR within the proposed trigger zone for signalling by NAADP 
 
• The contribution of both RyR3 and TPC2 towards NAADP-mediated Ca2+ 
signalling may then be verified using sequence specific shRNA against each 
 207 
element.  However, transfection and long-term incubation (> 48 h) of acutely 
isolated PASMCs may prove problematic.  Therefore, a cultured cell-line may 
be used such as human pulmonary artery smooth muscle cells (hPASMCs; 
TCS Cellworks, UK).  These cells are viable for ~15 population doublings and 
may therefore be suitable for shRNA transfection.  In order to use these cells 
their response to intracellular dialysis of 10 nM NAADP must first be 
characterised and compared to those of acutely isolated rat PASMCs.  
Secondly, co-localisation between TPC2 and RyR3 within hPASMCs must 
also be determined.  
 
7.7  Determination of a structural protein within the trigger zone 
 
Given that lysosomal clusters, likely a subpopulation of lysosomes, are held in 
close association with the sections of the SR containing a high density of RyR3 in 
PASMCs (Kinnear et al., 2004) a structural protein may exist that holds both TPC2 / 
lysosomes and RyR3 / SR in a junctional complex. 
Homer proteins are structural scaffolds that play an important role in Ca2+ 
signalling.  There are 3 identified homer genes encoding proteins Homer1 (including 
3 transcripts 1a, 1b and 1c), Homer2 and Homer3 (Worley et al., 2007).  With the 
exception of Homer1a which has a short C-terminal domain, homer proteins are 
comprised of an N-terminal EVH1 domain with a 200 amino acid C-terminus 
containing a coiled coil domain and 2 leucine zippers.  Interaction of the coiled coil 
domains allow Homer proteins to form tetramers (Worley et al., 2007).  The Homer 
protein subtypes exhibit different cellular distributions which is exemplified in 
pancreatic acinar cells whereby Homer1 and Homer2 were exclusively localised to 
the apical pole whereas Homer3 was located to the basal pole (Shin et al., 2003).  
Moreover, depletion of Homer2 expression did not appear to affect IP3-dependent 
Ca2+ signalling suggesting that it was involved in forming Ca2+ signalling complexes 
with Ca2+ release channels other than with IP3Rs (Shin et al., 2003).  Given that 
Homers have been shown to bind to RyRs in both cardiac and skeletal muscle cells 
(Ward et al., 2004; Westhoff et al., 2003) together with the fact that the NAADP-
sensitive lysosome-related Ca2+ store is also located in the apical pole of pancreatic 
acinar cells (Cancela et al., 2002; Yamasaki et al., 2004) a structural role for Homer1 
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and / or Homer2 in NAADP-mediated Ca2+ signalling in PASMCs should be 
examined. 
In cardiac muscle, skeletal muscle, smooth muscle and neurons, there exists 
close associations between the plasma membrane and the S / ER called junctional 
membrane complexes (JMCs) which couple RyRs and voltage-gated Ca2+ channels 
(Yamazaki et al., 2009).  However, co-expression of RyRs and voltage-gated Ca2+ 
channels in cells from a cultured cell line did not result in the formation of JMCs, 
suggesting that an additional protein is required for the maintenance of such a 
coupling (Takekura et al., 1995).  This protein was later identified as a member of the 
junctophilins (JPs), a novel family of structural proteins (Takeshima et al., 2000).  
There are 4 mammalian JP subtypes (JP1-4) which all express multiple MORN 
(membrane occupation and recognition nexus) sequences in the N-terminal region and 
a single transmembrane segment in the C-terminal that spans the S / ER membrane 
(Yamazaki et al., 2009).  JP1 is predominantly expressed in skeletal muscle, whereas 
JP3 and JP4 are exclusively expressed in the brain.  Conversely, JP2 appears to have a 
broader distribution of expression, with mRNA detected in cardiac, skeletal and 
smooth muscle tissue (Takeshima et al., 2000).  Given that JPs are able to effectively 
anchor two membrane-bound Ca2+ channels in close proximity, there may be an 
intracellular JMC-like association between lysosome-bound TPC2 and the SR-bound 
RyR3 that is maintained by a JP subtype.  Indeed, within cardiomyocytes, JPs are 
responsible for holding the components of the JMC at a gap of approximately 12 nm 
(Takeshima et al., 2000) which is consistent with a role for JPs in maintaining an 
intracellular junction.  As JP2 is expressed within smooth muscle, a structural role for 
JP2 in linking RyR3 and TPC2 should also be investigated.   
 
7.8  Investigation into cooperative Ca2+ signalling between cADPR 
and NAADP 
 
Given the tight coupling between lysosomes and RyRs present on the SR in 
PASMCs (Kinnear et al., 2004) it has been proposed that NAADP and cADPR may 
act in concert to provide further flexibility to the mechanisms regulating NAADP-
mediated Ca2+ signalling (Evans et al., 2005).  Furthermore, it was also suggested that 
as cADPR may sensitise RyRs to subsequent activation by Ca2+, cADPR may help to 
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determine the threshold for amplification of NAADP-evoked Ca2+ bursts by CICR via 
RyRs (Evans et al., 2005).  Thus a series of Ca2+ imaging experiments are required to 
answer the following questions: 
 
1. Do basal cADPR levels ‘prime’ RyRs by lowering the threshold for 
CICR?  This may be achieved by pre-incubating acutely isolated 
PASMCs with the cell-permeable cADPR antagonist 8-bromo-cADPR, 
prior to intracellular dialysis of NAADP (10 nM).  The resultant global 
Ca2+ wave may then be compared to those evoked in the absence of 8-
bromo-cADPR. 
 
2. Does an increase in intracellular cADPR concentration lower still further 
the threshold for CICR and facilitate the generation of regenerative Ca2+ 
waves.  A range of cADPR concentrations could be infused into 
PASMCs in conjunction with a set concentration of NAADP.  The 
resultant global Ca2+ waves can then be analysed and compared to those 
observed in response to NAADP alone.  Global Ca2+ waves may be 
analysed for variations in their duration, amplitude, and frequency. 
 
7.9  Investigation into the role of two-pore channels in vascular 
function 
 
In Chapter 5 of this thesis I have identified the expression of TPC2 in PASMCs 
and the heart.  TPCs may therefore play an important role in regulating cardiovascular 
function.  Given that Tpc2 knockout (KO) mice have been generated, this would 
allow one to study the effect of TPC2 expression on heart rate and blood pressure in-
vivo via radio telemetry or a pressure recording sensor combined with an occluding 
tail cuff.  One could also use in-situ organ perfusion to determine any the effects of 
TPC2 expression on the heart such as the contractile force.  Small vessel myography 
could be used to measure the vascular reactivity and basal tone of arterial rings from 
wild-type and Tpc2 KO mice could also be compared to determine the effect of TPC2 
expression in these processes. 
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7.10  Investigation into the role of NAADP-mediated Ca2+ signalling 
in lysosomal storage diseases 
 
7.10.1 Functional investigation into the role of two-pore channels in endosomal 
membrane fusion in Niemann-Pick disease type C1 
 
A whole-cell endosomal-lysosomal membrane fusion assay in NPC1-mutant 
CHO cells has been previously developed (Lloyd-Evans et al., 2008).  Briefly, cells 
seeded onto coverslips are incubated with the endosomal fusion marker Oregon 
green-labelled avidin and with a lysosomal marker biotin-dextran.  Membrane fusion 
is subsequently monitored via fluorescence microscopy by measuring the increase in 
Oregon green-avidin fluorescence upon binding to biotin-dextran (Lloyd-Evans et al., 
2008). 
Alternatively, in a cell free system, PC12 cells are harvested and washed with 
internalization medium containing dextran conjugated with either Alexa-488 or 
Alexa-594 fluorescent dyes.  Fluorescently labelled dextran is commonly used as a 
probe for endosomes (Lencer et al., 1990).  After internalization of the fluorophore-
labelled dextran cells are homogenised and centrifuged before collecting the 
postnuclear supernatant (PNS).  The Alexa-488 containing PNS and the Alexa-594 
containing PNS are mixed and incubated for a set time.  The reaction is stopped by 
chilling on ice and the fused enzymes are enriched by Nycodenz density gradient 
centrifugation and then adsorbed onto coverslips.  Fluorescence microscopy is then 
used to determine the degree of co-localisation between the two fluorescent dyes thus 
giving an indication of the level of endosomal fusion (Brandhorst et al., 2006). 
Therefore these techniques could be utilised firstly with HA-hTPC2 and His6-
hTPC1 cells to determine the role of NAADP in endosomal-lysosomal membrane 
fusion.  These cells may be incubated with: (1) Ned-19, (2) repeated applications of 
membrane-permeable NAADP-AM (Parkesh et al., 2008), repeated applications of 
NAADP-AM in the presence of Ned-19.  Analysis of the degree of fusion in each of 
these conditions would thus suggest whether or not NAADP is involved in such 
fusion events and moreover, whether NAADP elicits an increase in fusion events via 
a particular TPC subtype. 
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If NAADP-mediated Ca2+ release does promote endosomal-lysosomal fusion, 
then these experiments may be repeated with NPC1-mutant CHO cells to determine 
whether application of NAADP-AM promotes fusion events and, in part, reverses the 
NPC1 phenotype. 
 
7.10.2  Functional investigation into the role of NAADP-mediated Ca2+ release in 
Gaucher disease 
 
In Gaucher disease type II fibroblast cell line (GM07968) Kelly and colleagues 
found that nifedipine, verapamil and diltiazem partially recovered glucocerebroside 
activity (Mu et al., 2008).  Given that Gaucher disease is a lysosome storage disease 
and TPC2 is specifically targeted to lysosomes, TPC2 gating could alter the luminal 
pH by releasing Ca2+ from lysosomes (Morgan et al., 2007).  If VGCC antagonists do 
indeed block TPC2, VGCC antagonists could possible mediate their corrective effects 
by blocking TPC2 and thereby adjusting luminal pH to a range that benefits 
glucocerebrosidase activity. Using the methods outlined in this thesis, this possibility 
could be investigated. 
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Appendix 1: 
 
 
 
Results tables for Chapter 3: 
 
 
 
Total cell 
volume 
(µm3) 
Perinuclear 
region volume 
(µm3) 
Extra-
perinuclear 
region volume 
(µm3) 
Sub-
plasmalemmal 
region volume 
(µm3) 
 2089.31 570.75 616.57 901.99 
 927.2 253.72 225.44 368.13 
 1507.29 453.68 316.91 662.69 
 4206.95 1237.26 751.28 2218.41 
 729.16 192.94 171.92 329.92 
 1879.62 616.13 494.84 768.65 
 1701.72 460.13 715.44 513.17 
 2208.73 554.25 1017.2 637.28 
 1075.34 321.68 215.95 491.53 
 868.45 211.19 236.17 369.82 
 1472.71 438.72 455.17 633.47 
 1366.61 283.73 401.6 641.56 
 741.59 178.63 210.36 285.09 
 1429.76 282.09 458.06 514.44 
 2551.58 1131.17 425.68 958.68 
 1959.04 840.18 318.82 652.62 
 2076.69 758.86 411.12 801.96 
 1688.99 719.56 354.95 569.38 
 1030.88 305.05 274.4 373.02 
 847.31 179.9 168.57 438.5 
 1687.92 350.39 427.51 798.98 
 850.3 204.88 289.56 302.79 
 649.95 191.17 152.61 227.2 
 830.59 197.49 217.92 359.14 
 2300.8 584.03 555.19 1071.32 
 1090.41 309.18 275.59 444.15 
 846.87 266.9 178.52 376.58 
 2073.08 649.4 83.35 540.33 
 2215.08 950.76 590.71 626.81 
 1934.38 948.97 300.32 642.8 
 1557.8 750.38 313.7 443.05 
 1542.94 498.46 387.95 554.32 
 665.34 247.43 89.77 272.12 
 922.2 278.46 187.01 395.83 
 1018.23 329.04 239.9 381.91 
Mean 1501.28 478.47 358.00 587.65 
S.E.M. 122.83 48.68 34.13 59.05 
 
Table 3.1.  Measurements of the volume occupied by the 3 regions of the divided cell for all the 
isolated pulmonary arterial smooth muscle cells analysed 
 
 
 244 
 Volume of 
lysosomal 
labelling 
(µm3) 
Total cell 
volume 
(µm3) 
Density of 
lysosmal 
labelling 
(µm3 per µm3) 
 26.14 2089.31 0.013 
 10.6 927.2 0.011 
 8.68 1507.29 0.006 
 34.78 4206.95 0.008 
 23.59 729.16 0.032 
 34.68 1879.62 0.018 
 28.53 1701.72 0.017 
 31.5 2208.73 0.014 
 31.04 1075.34 0.029 
 34.73 868.45 0.040 
 42.52 1472.71 0.029 
 33.9 1366.61 0.025 
 24.87 741.59 0.034 
 29.73 1429.76 0.021 
 33.15 2551.58 0.013 
 24.46 1959.04 0.012 
 29.13 2076.69 0.014 
 21.28 1688.99 0.013 
 17.72 1030.88 0.017 
 20.62 847.31 0.024 
 36.24 1687.92 0.021 
 20.69 850.3 0.024 
 14.49 649.95 0.022 
 16.36 830.59 0.020 
 31.58 2300.8 0.014 
 29.77 1090.41 0.027 
 22.68 846.87 0.027 
 22.43 2073.08 0.011 
 38.1 2215.08 0.017 
 35.64 1934.38 0.018 
 51.51 1557.8 0.033 
 46.93 1542.94 0.030 
 14.57 665.34 0.022 
 24.53 922.2 0.027 
 22.63 1018.23 0.022 
Mean 27.71 1501.28 0.021 
S.E.M. 1.63 122.83 0.001 
 
Table 3.2.  Measurements of the density of αIgp120 labelling within the whole cell volume of 
isolated pulmonary arterial smooth muscle cells 
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 Volume of 
perinuclear 
lysosomal 
labelling 
(µm3) 
Mean volume 
of individual 
labelling within 
the perinuclear 
region  (µm3) 
Perinuclear 
region volume 
(µm3) 
Density of 
perinuclear 
lysosomal 
labelling 
(µm3 per µm3) 
 8.73 0.42 570.75 0.015 
 3.76 0.58 253.72 0.015 
 3.08 0.55 453.68 0.007 
 15.15 0.33 1237.26 0.012 
 11.12 0.93 192.94 0.058 
 10.04 0.42 616.13 0.016 
 9.55 0.40 460.13 0.021 
 13.86 0.43 554.25 0.025 
 19.88 0.30 321.68 0.062 
 13.3 1.02 211.19 0.063 
 20.79 0.54 438.72 0.047 
 16.05 0.68 283.73 0.057 
 6.59 0.51 178.63 0.037 
 16.57 0.67 282.09 0.059 
 17.12 0.63 1131.17 0.015 
 22.6 1.50 840.18 0.027 
 19.36 0.82 758.86 0.026 
 12.64 0.47 719.56 0.018 
 12.72 0.67 305.05 0.042 
 12.31 0.34 179.9 0.068 
 16.49 0.72 350.39 0.047 
 12.84 0.61 204.88 0.063 
 11.51 0.96 191.17 0.060 
 8.01 0.73 197.49 0.041 
 20.15 0.64 584.03 0.035 
 16.18 0.87 309.18 0.050 
 14.31 0.59 266.9 0.054 
 16.54 0.85 649.4 0.026 
 24.61 1.51 950.76 0.026 
 25.72 0.83 948.97 0.027 
 47.77 1.90 750.38 0.064 
 17.71 1.13 498.46 0.036 
 11.36 0.95 247.43 0.046 
 12.5 1.04 278.46 0.045 
 16.92 1.21 329.04 0.051 
Mean 15.37 0.76 478.47 0.039 
S.E.M. 1.30 0.06 48.68 0.003 
 
Table 3.3.  Measurements of the mean volume of individual αIgp120 labelling and the density of 
αIgp120 labelling within the perinuclear region of isolated pulmonary arterial smooth muscle 
cells 
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 Volume of 
extra-
perinuclear 
lysosomal 
labelling 
(µm3) 
Mean volume 
of individual 
labelling within 
the extra-
perinuclear 
region  (µm3) 
Extra-
perinuclear 
region volume 
(µm3) 
Density of 
extra-
perinuclear 
lysosomal 
labelling 
(µm3 per µm3) 
 7.98 0.43 616.57 0.013 
 0.85 0.22 225.44 0.004 
 2.6 0.21 316.91 0.008 
 9.97 0.30 751.28 0.013 
 8.36 1.19 171.92 0.049 
 9.83 0.41 494.84 0.020 
 2.35 0.90 715.44 0.003 
 6.75 0.29 1017.2 0.007 
 2.7 0.23 215.95 0.013 
 11.66 2.92 236.17 0.049 
 15.34 0.72 455.17 0.034 
 12.56 0.59 401.6 0.031 
 14.21 1.80 210.36 0.068 
 7.36 0.33 458.06 0.016 
 5.28 0.55 425.68 0.012 
 1.09 0.52 318.82 0.003 
 6.16 0.44 411.12 0.015 
 3.91 0.33 354.95 0.011 
 3.28 0.27 274.4 0.012 
 5.24 0.35 168.57 0.031 
 7.65 0.48 427.51 0.018 
 5.17 0.78 289.56 0.018 
 2.35 0.39 152.61 0.015 
 7.05 1.01 217.92 0.032 
 4.27 0.27 555.19 0.008 
 10.8 0.78 275.59 0.039 
 2.87 0.47 178.52 0.016 
 1.73 0.57 83.35 0.002 
 10 1.13 590.71 0.017 
 5.9 0.40 300.32 0.019 
 2.55 0.58 313.7 0.008 
 8.57 0.73 387.95 0.022 
 0.77 0.19 89.77 0.009 
 6.62 0.60 187.01 0.035 
 3.61 0.40 239.9 0.015 
Mean 6.21 0.62 358.00 0.020 
S.E.M. 0.65 0.09 34.13 0.003 
 
Table 3.4.  Measurements of the mean volume of individual αIgp120 labelling and the density of 
αIgp120 labelling within the extra-perinuclear region of isolated pulmonary arterial smooth 
muscle cells 
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Volume of sub-
plasmalemmal 
lysosomal 
labelling 
(µm3) 
Mean volume 
of individual 
labelling within 
the sub-
plasmalemmal 
region  (µm3) 
Sub-
plasmalemmal 
region volume 
(µm3) 
Density of sub-
plasmalemmal 
lysosomal 
labelling 
(µm3 per µm3) 
 9.43 0.31 901.99 0.010 
 2.15 0.21 368.13 0.006 
 3.00 0.22 662.69 0.005 
 7.52 0.27 2218.41 0.003 
 4.11 0.22 329.92 0.012 
 13.19 0.27 768.65 0.017 
 15.46 0.24 513.17 0.030 
 9.09 0.32 637.28 0.014 
 8.28 0.21 491.53 0.017 
 9.77 0.51 369.82 0.026 
 3.72 0.19 633.47 0.006 
 4.33 0.24 641.56 0.007 
 3.94 0.26 285.09 0.014 
 4.75 0.25 514.44 0.009 
 8.47 0.52 958.68 0.009 
 0.77 0.25 652.62 0.001 
 3.30 0.37 801.96 0.004 
 3.26 0.24 569.38 0.006 
 1.53 0.17 373.02 0.004 
 1.99 0.18 438.5 0.005 
 11.08 0.62 798.98 0.014 
 1.36 0.19 302.79 0.004 
 0.63 0.21 227.2 0.003 
 1.15 0.19 359.14 0.003 
 6.10 0.21 1071.32 0.006 
 2.79 0.28 444.15 0.006 
 5.46 0.27 376.58 0.015 
 3.61 0.56 540.33 0.007 
 2.86 0.43 626.81 0.005 
 3.44 0.28 642.8 0.005 
 1.19 0.30 443.05 0.003 
 20.46 0.90 554.32 0.037 
 2.00 0.22 272.12 0.007 
 4.69 0.36 395.83 0.012 
 1.76 0.25 381.91 0.005 
Mean 5.33 0.31 587.65 0.010 
S.E.M. 0.76 0.03 59.05 0.001 
 
Table 3.5.  Measurements of the mean volume of individual αIgp120 labelling and the density of 
αIgp120 labelling within the sub-plasmalemmal region of isolated pulmonary arterial smooth 
muscle cells 
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 % of total 
lysosomal 
labelling 
represented 
by the 
perinuclear 
region 
% of total 
lysosomal 
labelling 
represented 
by the extra-
perinuclear 
region 
% of total 
lysosomal 
labelling 
represented 
by the sub-
plasmalemm
al region 
 
% of whole 
cell volume 
represented 
by the 
perinuclear 
region 
% of whole 
cell volume 
represented 
by the extra-
perinuclear 
region 
 
% of whole 
cell volume 
represented 
by the sub-
plasmalemm
al region 
 33.4 30.5 36.1 27.3 29.5 43.2 
 35.5 8.0 20.3 27.4 24.3 39.7 
 35.5 30.0 34.6 30.1 21.0 44.0 
 43.6 28.7 21.6 29.4 17.9 52.7 
 47.1 35.4 17.4 26.5 23.6 45.2 
 29.0 28.3 38.0 32.8 26.3 40.9 
 33.5 8.2 54.2 27.0 42.0 30.2 
 44.0 21.4 28.9 25.1 46.1 28.9 
 64.0 8.7 26.7 29.9 20.1 45.7 
 38.3 33.6 28.1 24.3 27.2 42.6 
 48.9 36.1 8.7 29.8 30.9 43.0 
 47.3 37.1 12.8 20.8 29.4 46.9 
 26.5 57.1 15.8 24.1 28.4 38.4 
 55.7 24.8 16.0 19.7 32.0 36.0 
 51.6 15.9 25.6 44.3 16.7 37.6 
 92.4 4.5 3.1 42.9 16.3 33.3 
 66.5 21.1 11.3 36.5 19.8 38.6 
 59.4 18.4 15.3 42.6 21.0 33.7 
 71.8 18.5 8.6 29.6 26.6 36.2 
 59.7 25.4 9.7 21.2 19.9 51.8 
 45.5 21.1 30.6 20.8 25.3 47.3 
 62.1 25.0 6.6 24.1 34.1 35.6 
 79.4 16.2 4.3 29.4 23.5 35.0 
 49.0 43.1 7.0 23.8 26.2 43.2 
 63.8 13.5 19.3 25.4 24.1 46.6 
 54.4 36.3 9.4 28.4 25.3 40.7 
 63.1 12.7 24.1 31.5 21.1 44.5 
 73.7 7.7 16.1 31.3 4.0 26.1 
 64.6 26.2 7.5 42.9 26.7 28.3 
 72.2 16.6 9.7 49.1 15.5 33.2 
 92.7 5.0 2.3 48.2 20.1 28.4 
 37.7 18.3 43.6 32.3 25.1 35.9 
 78.0 5.3 13.7 37.2 13.5 40.9 
 51.0 27.0 19.1 30.2 20.3 42.9 
 74.8 16.0 7.8 32.3 23.6 37.5 
Mean 55.6 22.3 18.7 30.8 24.2 39.3 
S.E.M. 2.9 2.0 2.1 1.3 1.3 1.1 
 
Table 3.6.  Measurements of the total αIgp120 labelling and the total cell volume represented by 
each region of sub-divided isolated pulmonary arterial smooth muscle cells 
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 Volume of 
RyR1 labelling 
(µm3) 
Total cell 
volume 
(µm3) 
Density of 
RyR1 labelling 
(µm3 per µm3) 
 47.78 2089.31 0.023 
 19.2 847.29 0.023 
 28.39 1430.7 0.020 
 77.61 4206.95 0.018 
 34.41 729.16 0.047 
 64.48 1879.62 0.034 
 64.22 1701.72 0.038 
 70.07 2208.73 0.032 
 55.83 1075.34 0.052 
 27.49 868.45 0.032 
 38.06 822.47 0.046 
Mean 47.96 1623.61 0.033 
S.E.M. 5.94 305.36 0.004 
 
Table 3.7.  Measurements of the density of RyR1 labelling within the whole cell volume of 
isolated pulmonary arterial smooth muscle cells 
 
 
 
Volume of 
perinuclear 
RyR1 labelling 
(µm3) 
Mean volume 
of individual 
labelling within 
the perinuclear 
region  (µm3) 
Perinuclear 
region volume 
(µm3) 
Density of 
perinuclear 
RyR1 labelling 
(µm3 per µm3) 
 13.54 1.03 570.75 0.024 
 6 0.67 253.72 0.024 
 3.93 0.56 449.64 0.009 
 23.06 0.56 1237.26 0.019 
 13.52 0.65 192.94 0.070 
 26.6 1.34 616.13 0.043 
 7.55 0.93 460.13 0.016 
 31.97 3.61 554.25 0.058 
 23.53 1.05 321.68 0.073 
 8.85 0.49 211.19 0.042 
 15.62 0.58 217.24 0.072 
Mean 15.83 1.04 462.27 0.041 
S.E.M. 2.79 0.27 90.63 0.007 
 
Table 3.8.  Measurements of the mean volume of individual RyR1 labelling and the density of 
RyR1 labelling within the perinuclear region of isolated pulmonary arterial smooth muscle cells 
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Volume of 
extra-
perinuclear 
RyR1 labelling 
(µm3) 
Mean volume 
of individual 
labelling within 
the extra-
perinuclear 
region  (µm3) 
Extra-
perinuclear 
region volume 
(µm3) 
Density of 
extra-
perinuclear 
RyR1 labelling 
(µm3 per µm3) 
 6.52 0.31 616.57 0.011 
 4.45 0.74 225.44 0.020 
 3.87 0.35 312.49 0.012 
 22.52 0.51 751.28 0.030 
 2.87 0.26 171.92 0.017 
 14.03 1.11 494.84 0.028 
 8.13 0.45 715.44 0.011 
 12.64 2.72 1017.2 0.012 
 13.19 0.27 215.95 0.061 
 6.55 0.47 236.17 0.028 
 7.99 0.61 181.18 0.044 
Mean 9.34 0.71 448.95 0.025 
S.E.M. 1.75 0.21 86.98 0.005 
 
Table 3.9.  Measurements of the mean volume of individual RyR1 labelling and the density of 
RyR1 labelling within the extra-perinuclear region of isolated pulmonary arterial smooth muscle 
cells 
 
 
 
Volume of sub-
plasmalemmal 
RyR1 labelling 
(µm3) 
Mean volume 
of individual 
labelling within 
the sub-
plasmalemmal 
region  (µm3) 
Sub-
plasmalemmal 
region volume 
(µm3) 
Density of sub-
plasmalemmal 
RyR1 labelling 
(µm3 per µm3) 
 20.7 0.63 901.99 0.023 
 6.87 0.32 368.13 0.019 
 18.52 0.37 668.57 0.028 
 28.62 0.4 2218.41 0.013 
 14.19 0.43 329.92 0.043 
 16.33 0.48 768.65 0.021 
 36.73 1.27 513.17 0.072 
 16.57 0.33 637.28 0.026 
 14.88 0.55 491.53 0.030 
 11.81 0.59 369.82 0.032 
 12.97 0.46 393.09 0.033 
Mean 18.02 0.53 696.41 0.031 
S.E.M. 2.50 0.08 161.94 0.005 
 
Table 3.10.  Measurements of the mean volume of individual RyR1 labelling and the density of 
RyR1 labelling within the sub-plasmalemmal region of isolated pulmonary arterial smooth 
muscle cells 
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 Volume of 
RyR2 labelling 
(µm3) 
Total cell 
volume 
(µm3) 
Density of 
RyR2 labelling 
(µm3 per µm3) 
 64.61 1472.71 0.044 
 53.54 1366.61 0.039 
 45.39 741.59 0.061 
 58.83 1429.76 0.041 
 44.3 2551.58 0.017 
 36.47 1959.04 0.019 
 36.07 2076.69 0.017 
 52.13 1688.99 0.031 
 24.56 1030.88 0.024 
 35.47 847.31 0.042 
 31.48 1687.92 0.019 
 24.82 850.3 0.029 
 14.42 649.95 0.022 
 44.45 830.59 0.054 
Mean 40.47 1370.28 0.033 
S.E.M. 3.78 154.10 0.004 
 
Table 3.11.  Measurements of the mean volume of individual RyR2 labelling and the density of 
RyR2 labelling within the whole cell volume of isolated pulmonary arterial smooth muscle cells 
 
 
 
Volume of 
perinuclear 
RyR2 labelling 
(µm3) 
Mean volume 
of individual 
labelling within 
the perinuclear 
region  (µm3) 
Perinuclear 
region volume 
(µm3) 
Density of 
perinuclear 
RyR2 labelling 
(µm3 per µm3) 
 15.01 1.23 438.72 0.034 
 10.45 0.49 283.75 0.037 
 21.61 2.30 178.63 0.121 
 12.16 0.64 282.09 0.043 
 5.33 0.40 1131.17 0.005 
 13.14 0.63 840.18 0.016 
 10.98 0.49 758.86 0.014 
 24.05 1.33 719.56 0.033 
 8.58 0.57 305.05 0.028 
 11.54 1.15 179.9 0.064 
 10.38 0.74 350.39 0.030 
 4.44 0.74 204.88 0.022 
 7.63 0.85 191.17 0.040 
 10.71 1.96 197.49 0.054 
Mean 11.86 0.97 432.99 0.039 
S.E.M. 1.46 0.15 81.35 0.008 
 
Table 3.12.  Measurements of the mean volume of individual RyR2 labelling and the density of 
RyR2 labelling within the perinuclear region of isolated pulmonary arterial smooth muscle cells 
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Volume of 
extra-
perinuclear 
RyR2 labelling 
(µm3) 
Mean volume 
of individual 
labelling within 
the extra-
perinuclear 
region  (µm3) 
Extra-
perinuclear 
region volume 
(µm3) 
Density of 
extra-
perinuclear 
RyR2 labelling 
(µm3 per µm3) 
 47.12 2.55 455.17 0.104 
 32.48 1.91 401.6 0.081 
 22.36 4.24 210.36 0.106 
 35.27 1.21 458.06 0.077 
 30.76 2.30 425.68 0.072 
 5.42 0.45 318.82 0.017 
 17.27 0.62 411.12 0.042 
 9.25 0.36 354.95 0.026 
 13.77 0.63 274.4 0.050 
 17.61 2.52 168.57 0.104 
 13.64 0.59 427.51 0.032 
 18.33 1.41 289.56 0.063 
 4.96 0.99 152.61 0.033 
 23.56 2.62 217.92 0.108 
Mean 20.84 1.60 326.17 0.065 
S.E.M. 3.23 0.30 28.91 0.009 
 
Table 3.13.  Measurements of the mean volume of individual RyR2 labelling and the density of 
RyR2 labelling within the extra-perinuclear region of isolated pulmonary arterial smooth muscle 
cells 
 
 
 
Volume of sub-
plasmalemmal 
RyR2 labelling 
(µm3) 
Mean volume 
of individual 
labelling within 
the sub-
plasmalemmal 
region  (µm3) 
Sub-
plasmalemmal 
region volume 
(µm3) 
Density of sub-
plasmalemmal 
RyR2 labelling 
(µm3 per µm3) 
 2.23 0.36 633.47 0.004 
 10.23 0.38 641.56 0.016 
 0.79 0.27 285.09 0.003 
 10.93 0.27 514.44 0.021 
 7.94 0.47 958.68 0.008 
 9.77 0.41 652.62 0.015 
 4.00 0.48 801.96 0.005 
 12.97 0.56 569.38 0.023 
 2.21 0.37 373.02 0.006 
 5.66 0.81 438.5 0.013 
 7.21 0.38 798.98 0.009 
 2.05 0.34 302.79 0.007 
 1.65 0.32 227.2 0.007 
 5.18 1.04 359.14 0.014 
Mean 5.92 0.46 539.77 0.011 
S.E.M. 1.06 0.06 59.03 0.002 
 
Table 3.14.  Measurements of the mean volume of individual RyR2 labelling and the density of 
RyR2 labelling within the sub-plasmalemmal region of isolated pulmonary arterial smooth 
muscle cells 
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 Volume of 
RyR3 labelling 
(µm3) 
Total cell 
volume  
(µm3) 
Density of 
RyR3 labelling 
(µm3 per µm3) 
 66.94 2300.8 0.029 
 37.66 1090.41 0.035 
 29.8 846.87 0.035 
 33.43 2073.08 0.016 
 72.06 2215.08 0.033 
 37.3 1934.38 0.019 
 39.2 1557.8 0.025 
 60.67 1542.94 0.039 
 33.24 665.34 0.050 
 29.61 922.2 0.032 
 28.3 1018.23 0.028 
Mean 42.56 1469.74 0.031 
S.E.M. 4.82 178.93 0.003 
 
Table 3.15.  Measurements of the density of RyR3 labelling within the whole cell volume of 
isolated pulmonary arterial smooth muscle cells 
 
 
 
Volume of 
perinuclear 
RyR3 labelling 
(µm3) 
Mean volume 
of individual 
labelling within 
the perinuclear 
region  (µm3) 
Perinuclear 
region volume 
(µm3) 
Density of 
perinuclear 
RyR3 labelling 
(µm3 per µm3) 
 61.80 4.74 584.03 0.106 
 23.10 1.54 309.18 0.075 
 22.51 2.23 266.9 0.084 
 24.67 1.37 649.4 0.038 
 48.57 1.37 950.76 0.051 
 38.36 3.00 948.97 0.040 
 30.63 1.03 750.38 0.041 
 48.37 3.35 498.46 0.097 
 26.19 2.18 247.43 0.106 
 20.97 2.62 278.46 0.075 
 27.12 3.01 329.04 0.082 
Mean 33.84 2.40 528.46 0.072 
S.E.M. 4.09 0.33 80.95 0.008 
 
Table 3.16.  Measurements of the mean volume of individual RyR3 labelling and the density of 
RyR3 labelling within the perinuclear region of isolated pulmonary arterial smooth muscle cells 
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Volume of 
extra-
perinuclear 
RyR3 labelling 
(µm3) 
Mean volume 
of individual 
labelling within 
the extra-
perinuclear 
region  (µm3) 
Extra-
perinuclear 
region volume 
(µm3) 
Density of 
extra-
perinuclear 
RyR3 labelling 
(µm3 per µm3) 
 1.87 0.38 555.19 0.003 
 10.56 1.29 275.59 0.038 
 6.27 0.35 178.52 0.035 
 1.01 0.51 883.35 0.001 
 18.09 1.99 590.71 0.031 
 1.79 0.45 300.32 0.006 
 4.31 0.75 313.7 0.014 
 2.09 0.58 387.95 0.005 
 2.59 0.52 89.77 0.029 
 8.58 0.86 187.01 0.046 
 0.73 0.24 239.9 0.003 
Mean 5.26 0.72 363.82 0.019 
S.E.M. 1.61 0.15 69.35 0.005 
 
Table 3.17.  Measurements of the mean volume of individual RyR3 labelling and the density of 
RyR3 labelling within the extra-perinuclear region of isolated pulmonary arterial smooth muscle 
cells 
 
 
 
Volume of sub-
plasmalemmal 
RyR3 labelling 
(µm3) 
Mean volume 
of individual 
labelling within 
the sub-
plasmalemmal 
region  (µm3) 
Sub-
plasmalemmal 
region volume 
(µm3) 
Density of sub-
plasmalemmal 
RyR3 labelling 
(µm3 per µm3) 
 2.62 0.19 1071.32 0.002 
 3.6 0.54 444.15 0.008 
 1.02 0.34 376.58 0.003 
 5.53 0.38 540.33 0.010 
 1.35 0.39 626.81 0.002 
 0.78 0.32 642.8 0.001 
 2.92 0.22 443.05 0.007 
 7.27 1.21 554.32 0.013 
 1.09 1.09 272.12 0.004 
 0.62 0.31 395.83 0.002 
 0.45 0.23 381.91 0.001 
Mean 2.48 0.47 522.66 0.005 
S.E.M. 0.67 0.11 64.68 0.001 
 
Table 3.18.  Measurements of the mean volume of individual RyR3 labelling and the density of 
RyR3 labelling within the sub-plasmalemmal region of isolated pulmonary arterial smooth 
muscle cells 
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 Volume of co-
localisation 
(RyR1/lysosomal 
labelling) 
(µm3) 
Total cell 
volume 
(µm3) 
Density of co-
localisation 
(RyR1/lysosomal 
labelling) 
(µm3 per µm3) 
 
 
Pearson 
correlation 
coefficient 
 1.61 2089.31 0.0008 0.12 
 1.02 927.2 0.0011 0.14 
 0.13 1507.29 0.0001 0.05 
 4.61 4206.95 0.0011 0.16 
 3.69 729.16 0.0051 0.13 
 5.85 1879.62 0.0031 0.18 
 9.51 1701.72 0.0056 0.25 
 7.3 2208.73 0.0033 0.20 
 5.17 1075.34 0.0048 0.20 
 4.84 868.45 0.0056 0.18 
Mean 4.37 1719.38 0.0031 0.16 
S.E.M. 0.92 322.87 0.0007 0.02 
 
Table 3.19.  Measurements of the density of co-localisation and correlation between RyR1 and 
αIgp120 labelling within the whole cell volume of isolated pulmonary arterial smooth muscle 
cells 
 
 
 Volume of 
perinuclear co-
localisation 
(RyR1/lysosomal 
labelling) 
(µm3) 
Mean volume 
of individual 
co-localisation 
within the 
perinuclear 
region (µm3) 
Perinuclear 
region volume 
(µm3) 
Density of 
perinuclear co-
localisation 
(RyR1/lysosomal 
labelling)  
(µm3 per µm3) 
 0.57 0.19 570.75 0.0010 
 0.87 0.29 253.72 0.0034 
 0.13 0.13 453.68 0.0003 
 2.41 0.21 1237.26 0.0019 
 2.65 0.44 192.94 0.0137 
 1.42 0.39 616.13 0.0023 
 2.37 0.26 460.13 0.0052 
 4.89 0.40 554.25 0.0088 
 2.99 0.30 321.68 0.0093 
 2.26 0.38 211.19 0.0107 
Mean 2.06 0.30 487.17 0.0057 
S.E.M. 0.44 0.03 96.45 0.0015 
 
Table 3.20.  Measurements of the mean volume of individual areas of co-localisation and the 
density of co-localisation between RyR1 and αIgp120 labelling within the perinuclear region of 
isolated pulmonary arterial smooth muscle cells 
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Volume of extra-
perinuclear co-
localisation 
(RyR1/lysosomal 
labelling) (µm3) 
Mean volume 
of individual 
co-localisation 
within the 
extra-
perinuclear 
region (µm3) 
Extra-
perinuclear 
region volume 
(µm3) 
Density of extra-
perinuclear co-
localisation 
(RyR1/lysosomal 
labelling) 
(µm3 per µm3) 
 0.15 0.14 616.57 0.0002 
 0 0.00 225.44 0.0000 
 0 0.00 316.91 0.0000 
 1.60 0.40 751.28 0.0021 
 0.57 0.29 171.92 0.0033 
 2.94 0.25 494.84 0.0059 
 1.19 0.78 715.44 0.0017 
 0.75 0.32 1017.2 0.0007 
 0.90 0.23 215.95 0.0042 
 2.17 0.31 236.17 0.0092 
Mean 1.03 0.27 476.17 0.0027 
S.E.M. 0.31 0.07 91.40 0.0009 
 
Table 3.21.  Measurements of the mean volume of individual areas of co-localisation and the 
density of co-localisation between RyR1 and αIgp120 labelling within the extra-perinuclear 
region of isolated pulmonary arterial smooth muscle cells 
 
 
 Volume of sub-
plasmalemmal 
co-localisation 
(RyR1/lysosomal 
labelling) 
(µm3) 
Mean volume 
of individual 
co-localisation 
within the sub-
plasmalemmal 
region (µm3) 
Sub-
plasmalemmal 
region volume 
(µm3) 
Density of sub-
plasmalemmal 
co-localisation 
(RyR1/lysosomal 
labelling) 
(µm3 per µm3) 
 0.42 0.15 901.99 0.0005 
 0 0.00 368.13 0.0000 
 0 0.00 662.69 0.0000 
 0.86 0.30 2218.41 0.0004 
 0.47 0.24 329.92 0.0014 
 0.56 0.19 768.65 0.0007 
 0.98 0.33 513.17 0.0019 
 1.34 0.20 637.28 0.0021 
 1.28 0.21 491.53 0.0026 
 0.41 0.41 369.82 0.0011 
Mean 0.63 0.20 726.16 0.0011 
S.E.M. 0.15 0.04 175.88 0.0003 
 
Table 3.22.  Measurements of the mean volume of individual areas of co-localisation and the 
density of co-localisation between RyR1 and αIgp labelling within the sub-plasmalemmal region 
of isolated pulmonary arterial smooth muscle cells 
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 Volume of co-
localisation 
(RyR2/lysosomal 
labelling) 
(µm3) 
Total cell 
volume 
(µm3) 
Density of co-
localisation 
(RyR2/lysosomal 
labelling) 
(µm3 per µm3) 
 
 
Pearson 
correlation 
coefficient 
 7.03 1472.71 0.0048 0.18 
 6.81 1366.61 0.0050 0.24 
 8.52 741.59 0.0115 0.25 
 2.41 1429.76 0.0017 0.14 
 4.13 2551.58 0.0016 0.17 
 3.72 1959.04 0.0019 0.18 
 2.24 2076.69 0.0011 0.09 
 4.65 1688.99 0.0028 0.18 
 4.14 1030.88 0.0040 0.15 
 2.01 847.31 0.0024 0.19 
 3.98 1687.92 0.0024 0.19 
 1.53 850.3 0.0018 0.19 
 1.58 649.95 0.0024 0.19 
 3.09 830.59 0.0037 0.20 
Mean 3.99 1370.28 0.0034 0.18 
S.E.M. 0.58 154.10 0.0007 0.01 
 
Table 3.23.  Measurements of the density of co-localisation and correlation between RyR2 and 
αIgp120 labelling within the whole cell volume of isolated pulmonary arterial smooth muscle 
cells 
 
 
 Volume of 
perinuclear co-
localisation 
(RyR2/lysosomal 
labelling) 
(µm3) 
Mean volume 
of individual 
co-localisation 
within the 
perinuclear 
region (µm3) 
Perinuclear 
region volume 
(µm3) 
Density of 
perinuclear co-
localisation 
(RyR2/lysosomal 
labelling) 
(µm3 per µm3) 
 2.42 0.35 438.72 0.0055 
 1.67 0.34 283.75 0.0059 
 2.82 0.71 178.63 0.0158 
 0.88 0.18 282.09 0.0031 
 0.3 0.15 1131.17 0.0003 
 3.4 0.38 840.18 0.0040 
 1.9 0.35 758.86 0.0025 
 3.92 0.69 719.56 0.0054 
 2.74 0.39 305.05 0.0090 
 1.52 0.27 179.9 0.0085 
 1.92 0.38 350.39 0.0055 
 1.53 0.31 204.88 0.0075 
 1.14 0.38 191.17 0.0060 
 2.22 0.44 197.49 0.0112 
Mean 2.03 0.38 432.99 0.0064 
S.E.M. 0.26 0.04 81.35 0.0010 
 
Table 3.24.  Measurements of the mean volume of individual areas of co-localisation and the 
density of co-localisation between RyR2 and αIgp120 labelling within the perinuclear region of 
isolated pulmonary arterial smooth muscle cells 
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Volume of extra-
perinuclear co-
localisation 
(RyR2/lysosomal 
labelling) 
(µm3) 
Mean volume 
of individual 
co-localisation 
within the 
extra-
perinuclear 
region (µm3) 
Extra-
perinuclear 
region volume 
(µm3) 
Density of extra-
perinuclear co-
localisation 
(RyR2/lysosomal 
labelling) 
(µm3 per µm3) 
 4.47 0.41 455.17 0.0098 
 4.73 0.53 401.6 0.0118 
 5.41 1.80 210.36 0.0257 
 0.85 0.31 458.06 0.0019 
 2.32 0.25 425.68 0.0055 
 0.32 0.32 318.82 0.0010 
 0.34 0.14 411.12 0.0008 
 0.2 0.00 354.95 0.0006 
 1.4 0.28 274.4 0.0051 
 0.49 0.16 168.57 0.0029 
 1.23 0.34 427.51 0.0029 
 0 0.00 289.56 0.0000 
 0.44 0.22 152.61 0.0029 
 0.87 0.17 217.92 0.0040 
Mean 1.65 0.35 326.17 0.0053 
S.E.M. 0.50 0.12 28.91 0.0018 
 
Table 3.25.  Measurements of the mean volume of individual areas of co-localisation and the 
density of co-localisation between RyR2 and αIgp120 labelling within the extra-perinuclear 
region of isolated pulmonary arterial smooth muscle cells 
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 Volume of sub-
plasmalemmal 
co-localisation 
(RyR2/lysosomal 
labelling) 
(µm3) 
Mean volume 
of individual 
co-localisation 
within the sub-
plasmalemmal 
region (µm3) 
Sub-
plasmalemmal 
region volume 
(µm3) 
Density of sub-
plasmalemmal 
co-localisation 
(RyR2/lysosomal 
labelling) 
(µm3 per µm3) 
 0.14 0.14 633.47 0.0002 
 0.41 0.20 641.56 0.0006 
 0.29 0.29 285.09 0.0010 
 0.68 0.15 514.44 0.0013 
 1.51 0.43 958.68 0.0016 
 0 0.00 652.62 0.0000 
 0 0.00 801.96 0.0000 
 0.3 0.25 569.38 0.0005 
 0 0.00 373.02 0.0000 
 0 0.00 438.5 0.0000 
 0.8 0.27 798.98 0.0010 
 0 0.00 302.79 0.0000 
 0 0.00 227.2 0.0000 
 0.00 0.00 359.14 0.0000 
Mean 0.30 0.12 539.77 0.0005 
S.E.M. 0.12 0.04 59.03 0.0002 
 
Table 3.26.  Measurements of the mean volume of individual areas of co-localisation and the 
density of co-localisation between RyR2 and αIgp120 labelling within the sub-plasmalemmal 
region of isolated pulmonary arterial smooth muscle cells 
 
 
 Volume of co-
localisation 
(RyR3/lysosomal 
labelling) 
(µm3) 
Total cell 
volume 
(µm3) 
Density of co-
localisation 
(RyR3/lysosomal 
labelling) 
(µm3 per µm3) 
 
 
Pearson 
correlation 
coefficient 
 8.31 2300.8 0.0036 0.21 
 9.4 1090.41 0.0086 0.27 
 3.76 846.87 0.0044 0.26 
 3.53 2073.08 0.0017 0.27 
 15.21 2215.08 0.0069 0.26 
 12.13 1934.38 0.0063 0.35 
 8.19 1557.8 0.0053 0.33 
 5.16 1542.94 0.0033 0.22 
 5.08 665.34 0.0076 0.21 
 5.02 922.2 0.0054 0.22 
 7.9 1018.23 0.0078 0.27 
Mean 7.61 1469.74 0.0055 0.26 
S.E.M. 1.10 178.93 0.0006 0.01 
 
Table 3.27.  Measurements of the density of co-localisation and correlation between RyR3 and 
αIgp120 labelling within the whole cell volume of isolated pulmonary arterial smooth muscle 
cells 
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 Volume of 
perinuclear co-
localisation 
(RyR3/lysosomal 
labelling) 
(µm3) 
Mean volume 
of individual 
co-localisation 
within the 
perinuclear 
region (µm3) 
Perinuclear 
region volume 
(µm3) 
Density of 
perinuclear co-
localisation 
(RyR3/lysosomal 
labelling) 
(µm3 per µm3) 
 8.31 0.63 584.03 0.0140 
 5.89 1.63 309.18 0.0190 
 3.00 0.43 266.9 0.0110 
 3.53 0.44 649.4 0.005 
 11.44 0.61 950.76 0.0100 
 11.34 0.63 948.97 0.0120 
 8.03 0.46 750.38 0.0110 
 3.28 0.62 498.46 0.0070 
 3.33 0.83 247.43 0.0070 
 3.94 0.66 278.46 0.0141 
 7.75 1.94 329.04 0.0236 
Mean 6.35 0.81 528.46 0.0122 
S.E.M. 0.97 0.15 80.95 0.0016 
 
Table 3.28.  Measurements of the mean volume of individual areas of co-localisation and the 
density of co-localisation between RyR3 and αIgp120 labelling within the perinuclear region of 
isolated pulmonary arterial smooth muscle cells 
 
 
 
Volume of extra-
perinuclear co-
localisation 
(RyR3/lysosomal 
labelling)  
(µm3) 
Mean volume 
of individual 
co-localisation 
within the 
extra-
perinuclear 
region (µm3) 
Extra-
perinuclear 
region volume 
(µm3) 
Density of extra-
perinuclear co-
localisation 
(RyR3/lysosomal 
labelling) 
(µm3 per µm3) 
 0 0.68 555.19 0.0000 
 3.51 0.75 275.59 0.0130 
 0.13 0.35 178.52 0.0007 
 0 0.00 883.35 0.0000 
 3.61 0.68 590.71 0.0060 
 0.24 0.24 300.32 0.0008 
 0.16 0.21 313.7 0.0005 
 1.88 0.30 387.95 0.0050 
 1.32 0.33 89.77 0.0050 
 1.08 0.27 187.01 0.0058 
 0 0.00 239.9 0.0000 
Mean 1.08 0.35 363.82 0.0033 
S.E.M. 0.42 0.08 69.35 0.0012 
 
Table 3.29.  Measurements of the mean volume of individual areas of co-localisation and the 
density of co-localisation between RyR3 and αIgp120 labelling within the extra-perinuclear 
region of isolated pulmonary arterial smooth muscle cells 
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 Volume of sub-
plasmalemmal 
co-localisation 
(RyR3/lysosomal 
labelling) 
(µm3) 
Mean volume 
of individual 
co-localisation 
within the sub-
plasmalemmal 
region (µm3) 
Sub-
plasmalemmal 
region volume 
(µm3) 
Density of sub-
plasmalemmal 
co-localisation 
(RyR3/lysosomal 
labelling) 
(µm3 per µm3) 
 0 0.00 1071.32 0.0000 
 0 0.00 444.15 0.0000 
 0.63 0.11 376.58 0.0017 
 0 0.00 540.33 0.0000 
 0.16 0.16 626.81 0.0002 
 0 0.00 642.8 0.0000 
 0 0.00 443.05 0.0000 
 0 0.00 554.32 0.0000 
 2 0.00 272.12 0.0000 
 0 0.00 395.83 0.0000 
 0.15 0.15 381.91 0.0004 
Mean 0.27 0.04 522.66 0.0002 
S.E.M. 0.18 0.02 64.68 0.00015 
 
Table 3.30.  Measurements of the mean volume of individual areas of co-localisation and the 
density of co-localisation between RyR3 and αIgp120 labelling within the sub-plasmalemmal 
region of isolated pulmonary arterial smooth muscle cells 
 
 
 % of total 
lysosomal 
labelling co-
localised with 
RyR1 labelling  
% of total 
lysosomal 
labelling co-
localised with 
RyR2 labelling  
% of total 
lysosomal 
labelling co-
localised with 
RyR3 labelling  
 6.2 16.5 26.3 
 9.6 20.1 31.6 
 1.5 34.3 16.6 
 13.3 8.1 15.7 
 15.6 12.5 39.9 
 16.9 15.2 34.0 
 33.3 7.7 15.9 
 23.2 21.9 11.0 
 16.7 23.4 34.9 
 13.9 9.7 20.5 
  11.0 34.9 
  7.4  
  10.9  
  18.9  
Mean 15.0 15.5 25.6 
S.E.M. 2.8 2.0 3.0 
 
Table 3.31.  Percentage of the total volume of αIgp120 labelling co-localised with each RyR 
subtype across the entire cell volume of the pulmonary arterial smooth muscle cells studied 
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% of total lysosomal labelling co-
localised with RyR1 labelling 
 
% of total lysosomal labelling co-
localised with RyR2 labelling 
 
% of total lysosomal labelling co-
localised with RyR3 labelling 
 
Peri 
nuclear 
region 
Exxtra-
peri 
nuclear 
region 
Sub-
plasma 
lemmal 
region 
Peri 
nuclear 
region 
Extra-
peri 
nuclear 
region 
Sub-
plasma 
lemmal 
region 
Peri 
nuclear 
region 
Extra-
peri 
nuclear 
region 
Sub-
plasma 
lemmal 
region 
 3.7 2.4 7.9 15.7 72.0 2.6 54.0 0.0 0.0 
 5.6 0.0 0.0 10.8 76.2 7.7 38.2 56.5 0.0 
 0.8 0.0 0.0 18.3 87.1 5.4 19.5 2.1 11.8 
 15.6 25.8 16.1 5.7 13.7 12.8 22.9 0.0 0.0 
 17.2 9.2 8.8 1.9 37.4 28.3 74.3 58.1 3.0 
 9.2 47.3 10.5 22.1 5.2 0.0 73.6 3.9 0.0 
 15.4 19.2 18.4 12.3 5.5 0.0 52.1 2.6 0.0 
 31.8 12.1 25.1 25.5 3.2 5.6 21.3 30.3 0.0 
 19.4 14.5 24.0 17.8 22.5 0.0 21.6 12.4 0.0 
 14.7 34.9 7.7 9.9 7.9 0.0 25.6 17.4 0.0 
    12.5 19.8 15.0 50.3 0.0 2.8 
    9.9 0.0 0.0    
    7.4 7.1 0.0    
    14.4 14.0 0.0    
Mean 13.4 16.5 11.9 13.2 26.5 5.5 41.2 16.7 1.6 
S.E.M 2.8 4.9 2.8 1.7 8.0 2.2 6.3 6.7 1.1 
 
Table 3.32.  Percentage of the total volume of αIgp120 labelling co-localised with each RyR 
subtype within the subdivided regions of the pulmonary arterial smooth muscle cells studied 
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Cells co-labelled for 
RyR1 and αIgp120  
Cells co-labelled for 
RyR2 and αIgp120 
Cells co-labelled for 
RyR3 and αIgp120  
 
Density 
of RyR1 
labelling 
across 
the whole 
cell 
Density 
of 
αIgp120 
labelling 
across 
the whole 
cell 
Density 
of RyR2 
labelling 
across 
the whole 
cell 
Density 
of 
αIgp120 
labelling 
across 
the whole 
cell 
Density 
of RyR3 
labelling 
across 
the whole 
cell 
Density 
of 
αIgp120 
labelling 
across 
the whole 
cell 
 0.0229 0.0125 0.0439 0.0289 0.0291 0.0140 
 0.0227 0.0114 0.0392 0.0248 0.0345 0.0270 
 0.0198 0.0058 0.0612 0.0335 0.0352 0.0270 
 0.0184 0.0083 0.0411 0.0208 0.0161 0.0110 
 0.0472 0.0324 0.0174 0.0130 0.0325 0.0170 
 0.0343 0.0185 0.0186 0.0125 0.0193 0.0180 
 0.0377 0.0168 0.0174 0.0140 0.0252 0.0330 
 0.0317 0.0143 0.0309 0.0126 0.0393 0.0300 
 0.0519 0.0289 0.0238 0.0172 0.0500 0.0219 
 0.0317 0.0400 0.0420 0.0243 0.0321 0.0266 
   0.0187 0.0215 0.0278 0.0222 
   0.0292 0.0243 0.0310  
   0.0222 0.0223 0.0028  
   0.0535 0.0197   
Mean 0.0318 0.0189 0.0328 0.0207 0.0310 0.0225 
S.E.M. 0.0036 0.0035 0.0038 0.0017 0.0028 0.0021 
 
Table 3.33.  Measurements of the density of labelling for αIgp120 and each RyR subtype within 
the whole cell volume of isolated pulmonary arterial smooth muscle cells 
 
 
 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.38 1.18 0.80 212.7 
 0.36 1.58 1.22 340.0 
 0.59 1.07 0.48 80.5 
 0.56 1.03 0.47 83.3 
 0.66 2.26 1.60 243.8 
Mean 0.51 1.42 0.91 192.0 
S.E.M. 0.05 0.21 0.20 45.3 
 
Table 3.34.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the intracellular dialysis of 10 nM NAADP in pulmonary arterial smooth muscle cells 
The resting F340/F380 ratio was determined by the calculating the average F340/F380 ratio taken at 4 time-
points immediately prior to the initiation of the Ca2+ transient.  The peak F340/F380 ratio is the maximum 
F340/F380 ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting 
the peak F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was 
determined by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this 
ratio as a percentage. 
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 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.67 0.98 0.31 46.3 
 0.60 0.81 0.21 34.9 
 0.58 1.00 0.42 71.9 
 0.47 0.70 0.23 48.9 
 0.49 0.79 0.31 62.8 
 0.47 0.69 0.22 46.1 
Mean 0.55 0.83 0.28 51.8 
S.E.M. 0.03 0.05 0.03 5.4 
 
Table 3.35.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the intracellular dialysis of 10 nM NAADP in pulmonary arterial smooth muscle cells pre-
incubated (20 mins) with 30 µM dantrolene 
The resting F340/F380 ratio was determined by the calculating the average F340/F380 ratio taken at 4 time-
points immediately prior to the initiation of the Ca2+ transient.  The peak F340/F380 ratio is the maximum 
F340/F380 ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting 
the peak F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was 
determined by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this 
ratio as a percentage. 
 
 
 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.31 0.69 0.38 122.6 
 0.51 0.94 0.43 84.3 
 0.51 1.10 0.59 114.4 
 0.38 0.58 0.20 52.6 
 0.42 0.63 0.21 50.0 
 0.43 0.63 0.20 46.5 
 0.46 0.79 0.33 71.7 
 0.40 0.62 0.22 55.0 
 0.46 0.79 0.33 71.7 
 0.42 0.66 0.24 57.1 
 0.46 0.73 0.27 58.7 
Mean 0.43 0.74 0.31 71.3 
S.E.M. 0.02 0.05 0.04 7.8 
 
Table 3.36.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the extracellular application of 1 µM ionomycin in pulmonary arterial smooth muscle 
cells 
The resting F340/F380 ratio was determined by the calculating the average F340/F380 ratio taken at 4 time-
points immediately prior to the initiation of the Ca2+ transient.  The peak F340/F380 ratio is the maximum 
F340/F380 ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting 
the peak F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was 
determined by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this 
ratio as a percentage. 
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 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.39 0.66 0.27 69.2 
 0.35 0.72 0.37 105.7 
 0.42 0.69 0.27 64.3 
 0.39 0.67 0.28 71.8 
 0.43 0.63 0.20 46.5 
 0.39 0.65 0.26 66.7 
 0.44 0.65 0.21 47.7 
 0.43 0.86 0.43 100.0 
 0.43 1.17 0.74 172.1 
 0.49 0.84 0.35 71.4 
 0.43 1.10 0.67 155.8 
 0.48 0.71 0.23 47.9 
Mean 0.42 0.78 0.36 84.9 
S.E.M. 0.01 0.05 0.05 12.0 
 
Table 3.37.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the extracellular application of 1 µM ionomycin in pulmonary arterial smooth muscle 
cells pre-incubated (20 mins) with 30 µM dantrolene 
The resting F340/F380 ratio was determined by the calculating the average F340/F380 ratio taken at 4 time-
points immediately prior to the initiation of the Ca2+ transient.  The peak F340/F380 ratio is the maximum 
F340/F380 ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting 
the peak F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was 
determined by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this 
ratio as a percentage. 
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Appendix 2: 
 
 
 
Results tables for Chapter 4: 
 
 
 Volume of 
mCherry-
hTPC2 
labelling 
(µm3) 
Volume of 
LysoTracker 
Green labelling 
(µm3) 
Total cell 
volume 
(µm3) 
Density of 
mCherry-
hTPC2 
labelling 
(µm3 per µm3) 
Density of 
LysoTracker 
Green labelling 
(µm3 per µm3) 
 37.4 36.2 1909.6 0.0196 0.0190 
 19.0 17.5 1610.2 0.0118 0.0109 
 12.6 20.6 1895.2 0.0067 0.0109 
 30.6 36.1 2580.2 0.0119 0.0140 
 26.2 21.2 2850.1 0.0092 0.0074 
 22.3 40.2 2738.1 0.0081 0.0147 
Mean 24.7 28.6 2263.9 0.0112 0.0128 
S.E.M. 3.6 4.0 212.7 0.0019 0.0016 
 
Table 4.1.  Measurements of mCherry-hTPC2 labelling and LysoTracker Green labelling in 
mCherry-hTPC2 cells 
 
 
 Volume of 
colocalisation 
(µm3) 
Total cell 
volume  
(µm3) 
Density of 
colocalisation 
(µm3 per µm3) 
Pearson 
correlation 
coefficient 
 16.8 1909.6 0.0088 0.54 
 4.0 1610.2 0.0025 0.28 
 1.9 1895.2 0.0010 0.15 
 11.6 2580.2 0.0045 0.39 
 4.8 2850.1 0.0017 0.24 
 4.3 2738.1 0.0016 0.20 
Mean 7.2 2263.9 0.0033 0.30 
S.E.M. 2.3 212.7 0.0012 0.06 
 
Table 4.2.  Measurements of the density of co-localisation and correlation between mCherry-
hTPC2 and LysoTracker Green labelling in mCherry-hTPC2 cells 
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 Volume of 
LAMP2 
labelling 
(µm3) 
Volume of HA-
hTPC2 
labelling 
(µm3) 
Total cell 
volume 
(µm3) 
Density of 
LAMP2 
labelling 
(µm3 per µm3) 
Density of HA-
hTPC2 
labelling 
(µm3 per µm3) 
 70.3 103.3 7033.6 0.0100 0.0147 
 38.8 33.4 3072.1 0.0126 0.0109 
 32.8 54.7 2816.7 0.0116 0.0194 
 31.8 29.5 3096.6 0.0103 0.0095 
 22.8 31.9 2510.2 0.0091 0.0127 
 22.5 29.7 3561.9 0.0063 0.0083 
 55.6 65.0 3386.2 0.0164 0.0192 
Mean 39.2 49.6 3639.6 0.0109 0.0135 
S.E.M. 6.7 10.4 580.6 0.0012 0.0017 
 
Table 4.3.  Measurements of LAMP2 labelling and HA-hTPC2 labelling in fixed HA-hTPC2 cells 
 
 
 Volume of 
colocalisation 
(µm3) 
Total cell 
volume 
(µm3) 
Density of 
colocalisation 
(µm3 per µm3) 
Pearson 
correlation 
coefficient 
 49.5 7033.6 0.0070 0.66 
 19.1 3072.1 0.0062 0.62 
 24.7 2816.7 0.0088 0.67 
 16.9 3096.6 0.0055 0.61 
 16.1 2510.2 0.0064 0.67 
 12.7 3561.9 0.0036 0.60 
 35.0 3386.2 0.0103 0.66 
Mean 24.8 3639.6 0.0068 0.64 
S.E.M. 5.0 580.6 0.0008 0.01 
 
Table 4.4.  Measurements of the density of co-localisation and correlation between LAMP2 and 
HA-hTPC2 labelling in fixed HA-hTPC2 cells 
 
 
 
HA-hTPC2 
and LAMP2 
labelling 
GFP-hTPC1 
and LAMP2 
labelling 
GFP-cTPC3 
and LAMP2 
labelling 
GFP-hTPC1 
and 
transferrin 
labelling 
 
GFP-cTPC3 
and M6PR 
labelling 
 0.904 0.441 0.499 0.508 0.508 
 0.899 0.507 0.630 0.549 0.461 
 0.910 0.403 0.527 0.586  
 0.902 0.708 0.616 0.571  
 0.914 0.715 0.478 0.525  
  0.705 0.477 0.587  
  0.602  0.656  
  0.633  0.735  
  0.595    
Mean 0.906 0.590 0.538 0.590 0.485 
S.E.M. 0.003 0.039 0.028 0.026 0.024 
 
Table 4.5.  Measurements of the Pearson product-moment correlation coefficient between each 
TPC subtype and organelle markers in fixed HEK293 cells 
Note, for n = 2 the data are S.E.M. is expressed as a range. 
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 Specific binding 
in wild-type 
HEK293 cells 
(% of wild-type) 
Specific binding 
in HA-hTPC2 
cells (% of wild-
type) 
 144.3 293.0 
 105.0 382.6 
 50.7 338.3 
Mean 100.0 338.0 
S.E.M. 27.1 25.9 
 
Table 4.6  Overall increase in specific binding between wild-type HEK293 cells and HEK293 cells 
stably over-expressing HA-hTPC2 
 
 
Specific binding NAADP (% max) Log ligand 
conc. 
(M) 
1 2 3 4 Mean SEM 
-9.0 122.0 102.3 93.1 82.7 100.0 8.3 
-8.5 90.5 110.3 103.0 86.5 97.6 5.5 
-8.0 63.2 117.2 83.2 70.8 83.6 12.0 
-7.5 95.1 82.4 62.8 63.7 76.0 7.8 
-7.0 53.9 73.9 65.1 69.4 65.6 4.3 
-6.5 57.5 70.6 80.5 50.0 64.6 6.8 
-6.0 37.4 68.0 57.1 50.6 53.3 6.4 
-5.5 16.6 50.0 61.0 48.6 44.0 9.6 
-5.0 16.5 42.6 42.1 35.0 34.0 6.1 
-4.5 -1.2 12.5 21.4 8.7 10.3 4.7 
-4.0 -5.0 6.0 18.5 -8.0 2.9 6.0 
-3.5 -9.4 7.2 23.3 -21.1 0.0 9.7 
-3.0 -14.9 20.1 12.4 33.4 12.7 10.2 
 
Table 4.7.  Competitive inhibition of [32P]NAADP binding by NAADP in HA-hTPC2 cell 
homogenates 
 
 
Specific binding NADP (% max) Log ligand 
conc. 
(M) 
1 2 3 4 Mean SEM 
-9.0 90.3 51.2 140.1 87.7 92.3 18.2 
-8.5 100.8 59.5 116.4 90.5 91.8 12.0 
-8.0 111.8 62.1 123.4 95.1 98.1 13.3 
-7.0 89.0 51.0 152.0 104.2 99.0 20.9 
-6.5 81.0 70.3 125.6 123.2 100.0 14.2 
-6.0 79.3 49.3 139.7 83.9 88.0 18.8 
-5.0 48.2 -2.2 72.4 63.1 45.4 16.6 
-4.5 27.1 -4.2 116.5 58.8 49.6 25.8 
-4.0 34.6 -20.9 81.3 61.3 39.1 22.2 
-3.0 -8.4 -31.9 11.0 29.2 0.0 13.1 
 
Table 4.8.  Competitive inhibition of [32P]NAADP binding by NADP in HA-hTPC2 cell 
homogenates 
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Specific binding NAADP (% max) Specific binding NADP (% max) Log ligand 
conc. 
(M) 
1 2 3 Mean SEM 1 2 3 Mean SEM 
-12 97.1 100.4 95.3 97.6 1.5 96.4 96.6 91.8 94.9 1.6 
-11 97.2 102.8 100.0 100.0 1.6 92.6 98.7 90.8 94.0 2.4 
-10 96.2 99.6 94.8 96.9 1.4 96.6 97.4 95.0 96.3 0.7 
-9 74.2 68.6 75.7 72.8 2.1 94.5 97.5 100.5 97.5 1.7 
-8 58.5 66.0 54.7 59.7 3.3 100.5 99.9 99.6 100.0 0.3 
-7 46.5 45.5 21.4 37.8 8.2 89.7 93.2 88.3 90.4 1.4 
-6 25.3 36.5 41.1 34.3 4.7 58.7 53.4 56.6 56.2 1.5 
-5 8.7 17.6 8.8 11.7 3.0 23.8 21.1 18.4 21.1 1.5 
-4 14.5 5.8 -2.7 5.9 5.0 4.1 9.4 7.2 6.9 1.5 
-3 11.7 0.0 -11.6 0.0 6.7 2.2 1.0 -3.2 0.0 1.6 
 
Table 4.9.  Competitive inhibition of [32P]NAADP binding by NAADP and NADP in mouse liver 
homogenates 
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 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.80 1.14 0.34 43.0 
 1.02 1.95 0.94 92.0 
 0.87 1.96 1.09 125.1 
 0.80 3.16 2.37 297.2 
 0.86 2.95 2.09 244.1 
 1.24 2.28 1.03 83.2 
 1.08 3.08 2.00 185.3 
 1.12 3.50 2.38 212.1 
 0.79 2.37 1.59 201.7 
 0.89 2.82 1.93 216.1 
 0.63 2.75 2.12 334.0 
 0.76 3.39 2.63 346.5 
 0.72 1.59 0.87 121.0 
 0.76 1.89 1.13 149.5 
 0.59 2.13 1.54 263.2 
 0.59 2.23 1.63 274.7 
 0.68 1.52 0.84 123.0 
 0.70 4.72 4.02 576.9 
 0.48 1.54 1.06 220.9 
 0.94 1.95 1.01 108.1 
 0.83 2.43 1.60 192.9 
 0.52 1.49 0.98 189.5 
 0.70 1.30 0.59 84.7 
 0.93 1.73 0.80 85.9 
 0.79 0.99 0.20 24.7 
 0.49 0.55 0.05 11.1 
 0.93 1.02 0.09 9.1 
 0.64 0.90 0.26 40.5 
 0.62 0.79 0.18 28.8 
 1.01 1.08 0.06 6.2 
 0.82 1.05 0.24 29.0 
 0.68 0.73 0.05 8.1 
 0.61 0.78 0.18 29.4 
 0.77 0.93 0.16 21.1 
 0.57 0.72 0.15 25.8 
 0.63 0.88 0.24 38.3 
 0.63 0.77 0.13 21.0 
 0.69 0.83 0.14 20.6 
 0.47 0.52 0.05 10.7 
 0.64 0.79 0.15 23.9 
 0.72 1.60 0.88 121.2 
 0.47 0.56 0.08 17.3 
 0.51 0.73 0.22 42.1 
 1.17 1.42 0.25 21.0 
Mean 0.75 1.67 0.92 120.93 
S.E.M. 0.03 0.15 0.14 18.39 
 
Table 4.10.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the intracellular dialysis of 10 nM NAADP in HA-hTPC2 cells 
The resting F340/F380 ratio was determined by the calculating the average F340/F380 ratio taken at 4 time-
points immediately prior to the initiation of the Ca2+ transient.  When no transient was observed, the 
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resting F340/F380 ratio was determined by calculating the average F340/F380 ratio taken at 4 time-points 
either side of achieving the whole-cell configuration.  The peak F340/F380 ratio is the maximum F340/F380 
ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting the peak 
F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was determined 
by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this ratio as a 
percentage. 
 
 
 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.90 1.09 0.20 22.1 
 0.81 0.86 0.05 6.3 
 0.66 0.67 0.01 1.8 
 0.77 1.01 0.23 30.3 
 0.63 0.84 0.21 34.1 
 0.60 0.70 0.11 17.6 
 0.53 0.65 0.12 23.4 
 0.55 0.56 0.00 0.7 
 0.77 0.97 0.20 26.6 
 0.66 0.74 0.08 12.4 
 0.57 0.58 0.01 1.2 
 0.64 0.77 0.13 19.9 
 0.46 0.53 0.07 16.1 
 0.51 0.65 0.14 28.3 
Mean 0.65 0.76 0.11 17.20 
S.E.M. 0.03 0.05 0.02 3.01 
 
Table 4.11.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the intracellular dialysis of NAADP-free pipette solution in HA-hTPC2 cells 
The resting F340/F380 ratio was determined by calculating the average F340/F380 ratio taken at 4 time-
points either side of achieving the whole-cell configuration.  The peak F340/F380 ratio is the maximum 
F340/F380 ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting 
the peak F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was 
determined by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this 
ratio as a percentage. 
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 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.67 0.55 -0.12 -18.5 
 0.58 0.65 0.07 12.8 
 0.72 0.77 0.05 6.3 
 0.73 0.96 0.23 31.5 
 0.69 0.87 0.18 26.4 
 0.70 0.71 0.02 2.7 
 0.52 0.63 0.11 22.2 
 0.59 0.63 0.04 6.8 
 0.50 0.58 0.08 15.5 
 0.54 0.57 0.03 4.6 
 0.59 0.89 0.30 51.4 
 0.67 0.88 0.20 30.3 
 0.52 0.67 0.15 29.6 
 0.56 0.60 0.05 8.9 
 1.08 0.81 -0.26 -24.4 
Mean 0.64 0.72 0.08 13.7 
S.E.M. 0.04 0.03 0.04 5.0 
 
Table 4.12.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the intracellular dialysis of 10 nM NAADP in wild-type HEK293 cells 
The resting F340/F380 ratio was determined by calculating the average F340/F380 ratio taken at 4 time-
points either side of achieving the whole-cell configuration.  The peak F340/F380 ratio is the maximum 
F340/F380 ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting 
the peak F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was 
determined by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this 
ratio as a percentage. 
 
 
 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.53 0.73 0.20 38.2 
 0.51 0.61 0.09 18.6 
 0.41 0.53 0.12 29.9 
 0.45 0.77 0.32 72.8 
 0.35 0.55 0.19 54.5 
Mean 0.45 0.64 0.19 42.8 
S.E.M. 0.03 0.05 0.04 9.5 
 
Table 4.13.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the intracellular dialysis of 1 µM NAADP in wild-type HEK293 cells 
The resting F340/F380 ratio was determined by the calculating the average F340/F380 ratio taken at 4 time-
points immediately prior to the initiation of the Ca2+ transient.  When no transient was observed, the 
resting F340/F380 ratio was determined by calculating the average F340/F380 ratio taken at 4 time-points 
either side of achieving the whole-cell configuration.  The peak F340/F380 ratio is the maximum F340/F380 
ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting the peak 
F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was determined 
by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this ratio as a 
percentage. 
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 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.40 0.47 0.07 17.0 
 0.56 0.62 0.07 11.9 
 0.44 0.52 0.08 19.3 
 0.42 0.50 0.08 18.9 
Mean 0.45 0.53 0.07 16.8 
S.E.M. 0.03 0.03 0.00 1.7 
 
Table 4.14.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the intracellular dialysis of 100 pM NAADP in HA-hTPC2 cells 
The resting F340/F380 ratio was determined by calculating the average F340/F380 ratio taken at 4 time-
points either side of achieving the whole-cell configuration.  The peak F340/F380 ratio is the maximum 
F340/F380 ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting 
the peak F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was 
determined by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this 
ratio as a percentage. 
 
 
 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.34 1.13 0.79 236.4 
 0.33 1.96 1.63 500.0 
Mean 0.33 1.55 1.21 368.2 
Range 0.00 0.42 0.42 131.8 
 
Table 4.15.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the intracellular dialysis of 1 µM NAADP in HA-hTPC2 cells 
The resting F340/F380 ratio was determined by the calculating the average F340/F380 ratio taken at 4 time-
points immediately prior to the initiation of the Ca2+ transient.  The peak F340/F380 ratio is the maximum 
F340/F380 ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting 
the peak F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was 
determined by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this 
ratio as a percentage. 
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 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.87 4.92 4.05 464.9 
 1.04 2.84 1.80 173.7 
 0.54 2.74 2.20 407.2 
 1.25 4.45 3.20 256.9 
 1.15 3.28 2.13 185.2 
 0.68 0.98 0.30 44.9 
 0.62 0.76 0.13 21.1 
 0.55 0.74 0.19 34.7 
 0.55 0.81 0.26 47.5 
 0.51 0.58 0.07 14.3 
 0.54 0.56 0.03 4.7 
Mean 0.75 2.06 1.31 150.5 
S.E.M. 0.08 0.50 0.43 49.5 
 
Table 4.16.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the intracellular dialysis of 100 µM NAADP in HA-hTPC2 cells 
The resting F340/F380 ratio was determined by the calculating the average F340/F380 ratio taken at 4 time-
points immediately prior to the initiation of the Ca2+ transient.  When no transient was observed, the 
resting F340/F380 ratio was determined by calculating the average F340/F380 ratio taken at 4 time-points 
either side of achieving the whole-cell configuration.  The peak F340/F380 ratio is the maximum F340/F380 
ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting the peak 
F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was determined 
by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this ratio as a 
percentage. 
 
 
 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.57 0.81 0.25 43.4 
 0.59 0.75 0.16 26.9 
 0.55 0.68 0.13 23.9 
 0.52 0.59 0.06 11.8 
 0.62 0.90 0.27 44.2 
 0.50 0.66 0.16 32.3 
 0.60 0.86 0.26 43.7 
 0.52 0.68 0.16 31.4 
 0.58 0.69 0.11 18.7 
 0.47 0.58 0.10 22.2 
Mean 0.55 0.72 0.17 29.8 
S.E.M. 0.02 0.03 0.02 3.6 
 
Table 4.17.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the intracellular dialysis of 1 mM NAADP in HA-hTPC2 cells 
The resting F340/F380 ratio was determined by calculating the average F340/F380 ratio taken at 4 time-
points either side of achieving the whole-cell configuration.  The peak F340/F380 ratio is the maximum 
F340/F380 ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting 
the peak F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was 
determined by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this 
ratio as a percentage. 
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 10 nM NAADP, 
time to 
initiation of 
transient (s) 
1 µM NAADP, 
time to 
initiation of 
transient (s) 
100 µM 
NAADP, time 
to initiation of 
transient (s) 
 70 25 20 
 10 20 25 
 25  20 
 30  10 
 35   
 55   
 30   
 30   
 20   
 35   
 15   
 30   
 20   
 10   
 20   
 15   
 40   
 45   
 25   
 10   
 10   
 40   
Mean 28.18 20.00 18.75 
S.E.M. 3.30 5.0 2.81 
 
Table 4.18.  Record of time taken for the initiation of a Ca2+ transient in HA-hTPC2 cells in 
response to the intracellular dialysis of NAADP 
Intracellular dialysis of either 10 nM, 1 µM or 100 µM NAADP in HA-hTPC2 cells evoked global 
Ca2+ transients.  When a point of initiation of these Ca2+ transients could be clearly determined, the 
delay (seconds) between the formation of the whole-cell configuration to the initiation of the Ca2+ 
transient was recorded.  Note, for n = 2 the S.E.M. is given as the range. 
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 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.58 0.65 0.07 12.8 
 0.65 0.64 0.00 -0.2 
 0.55 0.63 0.08 14.4 
 0.68 0.81 0.13 18.3 
 0.71 0.83 0.13 17.8 
 0.74 1.02 0.29 38.8 
 0.64 0.71 0.08 11.8 
 0.54 0.84 0.30 56.4 
 0.64 0.79 0.15 23.0 
 0.57 0.75 0.18 31.0 
 0.67 1.18 0.51 75.2 
Mean 0.63 0.80 0.17 27.2 
S.E.M. 0.02 0.05 0.04 6.6 
 
Table 4.19.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the intracellular dialysis of 10 nM NAADP in HA-hTPC2 cells pre-incubated (45 mins) 
with 100 nM Bafilomycin A1  
The resting F340/F380 ratio was determined by calculating the average F340/F380 ratio taken at 4 time-
points either side of achieving the whole-cell configuration.  The peak F340/F380 ratio is the maximum 
F340/F380 ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting 
the peak F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was 
determined by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this 
ratio as a percentage. 
 
 
 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.35 0.74 0.40 114.6 
 0.33 0.51 0.18 54.4 
 0.37 0.43 0.06 16.2 
 0.52 0.65 0.14 27.2 
 0.43 0.77 0.35 81.8 
Mean 0.40 0.62 0.23 58.8 
S.E.M. 0.03 0.07 0.06 18.0 
 
Table 4.20.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the intracellular dialysis of 10 nM NAADP in HA-hTPC2 cells pre-incubated (30 mins) 
with 1 µM thapsigargin  
The resting F340/F380 ratio was determined by the calculating the average F340/F380 ratio taken at 4 time-
points immediately prior to the initiation of the Ca2+ transient.  When no transient was observed, the 
resting F340/F380 ratio was determined by calculating the average F340/F380 ratio taken at 4 time-points 
either side of achieving the whole-cell configuration.  The peak F340/F380 ratio is the maximum F340/F380 
ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting the peak 
F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was determined 
by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this ratio as a 
percentage. 
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 Volume of HA-
hTPC2 
labelling 
(µm3) 
Total cell 
volume 
(µm3) 
Density of HA-
hTPC2 
labelling 
(µm3 per µm3) 
 117.1 4056.6 0.029 
 47.8 2155.0 0.022 
 38.0 1039.6 0.037 
 76.3 1209.2 0.063 
Mean 69.8 2115.1 0.038 
S.E.M. 17.7 692.1 0.009 
 
Table 4.21.  Measurements of HA-hTPC2 labelling in fixed HA-hTPC2 cells 
 
 
 Volume of HA-
hTPC2 
labelling 
(µm3) 
Total cell 
volume 
(µm3) 
Density of HA-
hTPC2 
labelling 
(µm3 per µm3) 
 24.7 1618.6 0.015 
 2.2 2606.1 0.001 
 0.0 2149.3 0.000 
 9.8 1296.1 0.008 
 0.0 1323.8 0.000 
 12.0 1833.1 0.007 
Mean 8.1 1804.5 0.005 
S.E.M. 3.9 207.1 0.002 
 
Table 4.22.  Measurements of HA-hTPC2 labelling in fixed HA-hTPC2 cells transfected with 
shRNA against hTPC2 
 
 
 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.68 0.98 0.30 44.3 
 0.94 1.26 0.32 33.9 
 0.66 0.93 0.27 40.9 
 0.93 1.73 0.80 85.9 
 0.61 3.49 2.87 469.5 
 1.01 3.36 2.35 232.7 
Mean 0.80 1.96 1.15 151.2 
S.E.M. 0.07 0.48 0.47 70.6 
 
Table 4.23.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the intracellular dialysis of 10 nM NAADP in HA-hTPC2 cells transfected with scrambled 
shRNA 
The resting F340/F380 ratio was determined by the calculating the average F340/F380 ratio taken at 4 time-
points immediately prior to the initiation of the Ca2+ transient.  When no transient was observed, the 
resting F340/F380 ratio was determined by calculating the average F340/F380 ratio taken at 4 time-points 
either side of achieving the whole-cell configuration.  The peak F340/F380 ratio is the maximum F340/F380 
ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting the peak 
F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was determined 
by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this ratio as a 
percentage. 
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 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.76 0.91 0.15 20.2 
 0.51 0.53 0.02 4.7 
 0.54 0.64 0.10 17.9 
 0.53 0.78 0.25 47.2 
 0.65 0.73 0.08 11.7 
 1.01 0.94 -0.07 -6.9 
 1.15 1.07 -0.08 -6.9 
 0.62 0.92 0.30 48.4 
 0.57 0.62 0.05 8.6 
 0.70 0.68 -0.01 -2.1 
Mean 0.76 0.91 0.15 20.2 
S.E.M. 0.51 0.53 0.02 4.7 
 
Table 4.24.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the intracellular dialysis of 10 nM NAADP in HA-hTPC2 cells transfected with shRNA 
against hTPC2 
The resting F340/F380 ratio was determined by the calculating the average F340/F380 ratio taken at 4 time-
points immediately prior to the initiation of the Ca2+ transient.  When no transient was observed, the 
resting F340/F380 ratio was determined by calculating the average F340/F380 ratio taken at 4 time-points 
either side of achieving the whole-cell configuration.  The peak F340/F380 ratio is the maximum F340/F380 
ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting the peak 
F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was determined 
by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this ratio as a 
percentage. 
 
 
 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 1.03 1.27 0.24 23.4 
 0.74 1.27 0.53 70.8 
 0.61 1.16 0.55 89.5 
 0.47 0.55 0.08 16.5 
 0.92 1.28 0.36 39.3 
Mean 0.75 1.10 0.35 47.9 
S.E.M. 0.10 0.14 0.09 14.0 
 
Table 4.25.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the intracellular dialysis of 10 nM NAADP in His6-hTPC1 cells 
The resting F340/F380 ratio was determined by the calculating the average F340/F380 ratio taken at 4 time-
points immediately prior to the initiation of the Ca2+ transient.  When no transient was observed, the 
resting F340/F380 ratio was determined by calculating the average F340/F380 ratio taken at 4 time-points 
either side of achieving the whole-cell configuration.  The peak F340/F380 ratio is the maximum F340/F380 
ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting the peak 
F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was determined 
by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this ratio as a 
percentage. 
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Appendix 3: 
 
 
 
Results tables for Chapter 5: 
 
 
Typhoon scanner relative fluorescence units 
(x 106 units) 
 
Percentage of radioactivity compared to 
control (%) 
 
Ned-19 
conc. 
(µM) 
1 2 3 Mean S.E.M. 1 2 3 Mean S.E.M. 
0 2.66 2.64 2.77 2.69 0.04 100 100 100 100  
0.1 3.32 2.78 3.08 3.06 0.16 124.9 105.4 111.4 113.9 5.8 
1 3.33 2.71 2.95 3.00 0.18 125.3 102.9 106.5 111.5 6.7 
10 2.89 2.89 2.78 2.85 0.04 109.0 109.5 100.6 106.3 1.3 
100 2.96 2.94 2.39 2.76 0.19 111.4 111.6 86.5 102.9 6.9 
1000 2.44 2.06 2.25 2.25 0.11 91.9 78.1 81.2 83.7 4.1 
 
Table 5.1.  Measurements of the effect of increasing concentrations of Ned-19 on the [32P]NAADP 
radioactivity retained in HA-hTPC2 cell homogenate obtained using a storage phosphor screen 
and scanned using a Typhoon 9400 scanner and analyzed using ImageQuant (GE Healthcare) 
 
 
Scintilation radioactivity count 
(cpm) 
Percentage of radioactivity compared to 
control (%) 
Ned-19 
conc. 
(µM) 1 2 Mean Range 1 2 Mean Range 
0 68247 54704 61476 6771 100.0 100.0 100.0  
0.1 62978 49705 56342 6637 92.3 90.9 91.6 0.7 
1 64940 54713 59826 5114 95.2 100.0 97.6 2.4 
10 59817 53744 56781 3037 87.6 98.2 92.9 5.3 
100 50332 42560 46446 3886 73.7 77.8 75.8 2.0 
1000 3717 2892 3304 413 5.4 5.3 5.4 0.1 
 
Table 5.1.  Measurements of the effect of increasing concentrations of Ned-19 on the [32P]NAADP 
radioactivity retained in sea urchin egg homogenate obtained using Cerenkov scintillation 
counting 
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 Volume of 
mCherry-
hTPC2 
labelling 
(µm3) 
Volume of 
LysoTracker 
Green labelling 
(µm3) 
Total cell 
volume 
(µm3) 
Density of 
mCherry-
hTPC2 
labelling 
(µm3 per µm3) 
Density of 
LysoTracker 
Green labelling 
(µm3 per µm3) 
 37.4 36.2 1909.6 0.0196 0.0190 
 19.0 17.5 1610.2 0.0118 0.0109 
 12.6 20.6 1895.2 0.0067 0.0109 
 30.6 36.1 2580.2 0.0119 0.0140 
 26.2 21.2 2850.1 0.0092 0.0074 
 22.3 40.2 2738.1 0.0081 0.0147 
Mean 24.7 28.6 2263.9 0.0112 0.0128 
S.E.M. 3.6 4.0 212.7 0.0019 0.0016 
 
Table 5.3.  Measurements of mCherry-hTPC2 labelling and LysoTracker Green labelling in 
mCherry-hTPC2 cells 
 
 
 Volume of 
colocalisation 
(µm3) 
Total cell 
volume  
(µm3) 
Density of 
colocalisation 
(µm3 per µm3) 
Pearson 
correlation 
coefficient 
 16.8 1909.6 0.0088 0.54 
 4.0 1610.2 0.0025 0.28 
 1.9 1895.2 0.0010 0.15 
 11.6 2580.2 0.0045 0.39 
 4.8 2850.1 0.0017 0.24 
 4.3 2738.1 0.0016 0.20 
Mean 7.2 2263.9 0.0033 0.30 
S.E.M. 2.3 212.7 0.0012 0.06 
 
Table 5.4.  Measurements of the density of co-localisation and correlation between mCherry-
hTPC2 and LysoTracker Green labelling in mCherry-hTPC2 cells 
 
 
 
Volume of 
mCherry-
hTPC2 
labelling (µm3) 
Volume of Ned-
19 labelling 
(µm3) 
Volume of Co-
localisation 
(µm3) 
Percentage 
mCherry-
hTPC2 
labelling co-
localised (%) 
Percentage 
Ned-19 
labelling co-
localised (%) 
 118.7 72.5 41.2 34.7 56.8 
 73.1 15.4 8.9 12.2 57.8 
 62.7 34.9 10.6 16.9 30.4 
 51.1 40.8 14.9 29.2 36.5 
 25.2 43.9 4.7 18.6 10.7 
 55.0 39.0 17.9 32.6 46.0 
Mean 64.3 41.1 16.4 24.0 39.7 
S.E.M. 12.7 7.5 5.3 3.8 7.3 
 
Table 5.5.  Measurements of mCherry-hTPC2 labelling and Ned-19 labelling in mCherry-hTPC2 
expressing cells 
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Volume of 
LysoTracker 
Red labelling 
(µm3) 
Volume of Ned-
19 labelling 
(µm3) 
Volume of Co-
localisation 
(µm3) 
Percentage 
LysoTracker 
Red labelling 
co-localised 
(%) 
Percentage 
Ned-19 
labelling co-
localised (%) 
 23.8 11.3 6.4 26.7 56.4 
 15.9 15.7 3.9 24.4 24.8 
 10.3 68.6 5.8 55.8 8.4 
 13.8 9.5 4.1 30.1 43.6 
Mean 15.9 26.3 5.0 34.3 33.3 
S.E.M. 2.8 14.2 0.6 7.3 10.5 
 
Table 5.6.  Measurements of LysoTracker Red labelling and Ned-19 labelling in HA-hTPC2 
expressing cells 
 
 
 
Volume of 
LysoTracker 
Red labelling 
(µm3) 
Volume of Ned-
19 labelling 
(µm3) 
Volume of Co-
localisation 
(µm3) 
Percentage 
LysoTracker 
Red labelling 
co-localised 
(%) 
Percentage 
Ned-19 
labelling co-
localised (%) 
 24.4 19.2 4.2 22.0 17.3 
 21.9 80.4 15.7 19.6 72.0 
 5.4 8.0 1.7 21.2 31.7 
 7.5 15.0 2.6 17.4 34.8 
Mean 14.8 30.7 6.1 20.0 39.0 
S.E.M. 4.9 16.7 3.3 1.0 11.7 
 
Table 5.7.  Measurements of LysoTracker Red labelling and Ned-19 labelling in pulmonary 
arterial smooth muscle cells 
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 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.80 1.14 0.34 43.0 
 1.02 1.95 0.94 92.0 
 0.87 1.96 1.09 125.1 
 0.80 3.16 2.37 297.2 
 0.86 2.95 2.09 244.1 
 1.24 2.28 1.03 83.2 
 1.08 3.08 2.00 185.3 
 1.12 3.50 2.38 212.1 
 0.79 2.37 1.59 201.7 
 0.89 2.82 1.93 216.1 
 0.63 2.75 2.12 334.0 
 0.76 3.39 2.63 346.5 
 0.72 1.59 0.87 121.0 
 0.76 1.89 1.13 149.5 
 0.59 2.13 1.54 263.2 
 0.59 2.23 1.63 274.7 
 0.68 1.52 0.84 123.0 
 0.70 4.72 4.02 576.9 
 0.48 1.54 1.06 220.9 
 0.94 1.95 1.01 108.1 
 0.83 2.43 1.60 192.9 
 0.52 1.49 0.98 189.5 
 0.70 1.30 0.59 84.7 
 0.93 1.73 0.80 85.9 
 0.79 0.99 0.20 24.7 
 0.49 0.55 0.05 11.1 
 0.93 1.02 0.09 9.1 
 0.64 0.90 0.26 40.5 
 0.62 0.79 0.18 28.8 
 1.01 1.08 0.06 6.2 
 0.82 1.05 0.24 29.0 
 0.68 0.73 0.05 8.1 
 0.61 0.78 0.18 29.4 
 0.77 0.93 0.16 21.1 
 0.57 0.72 0.15 25.8 
 0.63 0.88 0.24 38.3 
 0.63 0.77 0.13 21.0 
 0.69 0.83 0.14 20.6 
 0.47 0.52 0.05 10.7 
 0.64 0.79 0.15 23.9 
 0.72 1.60 0.88 121.2 
 0.47 0.56 0.08 17.3 
 0.51 0.73 0.22 42.1 
 1.17 1.42 0.25 21.0 
Mean 0.75 1.67 0.92 120.93 
S.E.M. 0.03 0.15 0.14 18.39 
 
Table 5.8.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the intracellular dialysis of 10 nM NAADP in HA-hTPC2 cells 
The resting F340/F380 ratio was determined by the calculating the average F340/F380 ratio taken at 4 time-
points immediately prior to the initiation of the Ca2+ transient.  When no transient was observed, the 
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resting F340/F380 ratio was determined by calculating the average F340/F380 ratio taken at 4 time-points 
either side of achieving the whole-cell configuration.  The peak F340/F380 ratio is the maximum F340/F380 
ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting the peak 
F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was determined 
by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this ratio as a 
percentage. 
 
 
 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.59 0.69 0.09 15.7 
 0.45 0.47 0.02 4.1 
 0.54 0.64 0.10 18.4 
 0.76 0.80 0.04 5.2 
 0.98 1.16 0.17 17.7 
Mean 0.66 0.75 0.08 12.2 
S.E.M. 0.09 0.12 0.03 3.1 
 
Table 5.9.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the intracellular dialysis of 10 nM NAADP in HA-hTPC2 cells pre-incubated (20 minutes) 
with 100 µM Ned-19 
The resting F340/F380 ratio was determined by calculating the average F340/F380 ratio taken at 4 time-
points either side of achieving the whole-cell configuration.  The peak F340/F380 ratio is the maximum 
F340/F380 ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting 
the peak F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was 
determined by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this 
ratio as a percentage. 
 
 
 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.65 4.38 3.73 571.7 
 0.51 2.32 1.81 355.9 
 0.66 1.66 0.99 149.6 
 0.97 2.65 1.68 173.1 
 0.95 2.96 2.01 211.8 
Mean 0.75 2.79 2.04 292.4 
S.E.M. 0.09 0.45 0.45 78.5 
 
Table 5.10.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the extracellular application of 1 mM CCh 
The resting F340/F380 ratio was determined by calculating the average F340/F380 ratio taken at 4 time-
points either side of achieving the whole-cell configuration.  The peak F340/F380 ratio is the maximum 
F340/F380 ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting 
the peak F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was 
determined by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this 
ratio as a percentage. 
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 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.41 2.20 1.79 434.7 
 0.41 2.23 1.82 441.8 
 0.41 3.11 2.70 664.8 
 0.40 3.05 2.64 654.5 
 0.42 2.58 2.16 518.2 
 0.43 2.63 2.20 509.3 
 0.43 2.45 2.02 467.5 
Mean 0.42 2.60 2.19 527.3 
S.E.M. 0.00 0.14 0.14 36.2 
 
Table 5.11.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the extracellular application of 1 mM CCh in HA-hTPC2 cells pre-incubated (20 minutes) 
with 100 µM Ned-19 
The resting F340/F380 ratio was determined by calculating the average F340/F380 ratio taken at 4 time-
points either side of achieving the whole-cell configuration.  The peak F340/F380 ratio is the maximum 
F340/F380 ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting 
the peak F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was 
determined by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this 
ratio as a percentage. 
 
 
 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.38 1.18 0.80 212.7 
 0.36 1.58 1.22 340.0 
 0.59 1.07 0.48 80.5 
 0.56 1.03 0.47 83.3 
 0.66 2.26 1.60 243.8 
Mean 0.51 1.42 0.91 192.0 
S.E.M. 0.05 0.21 0.20 45.3 
 
Table 5.12.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the intracellular dialysis of 10 nM NAADP in pulmonary arterial smooth muscle cells 
The resting F340/F380 ratio was determined by the calculating the average F340/F380 ratio taken at 4 time-
points immediately prior to the initiation of the Ca2+ transient.  The peak F340/F380 ratio is the maximum 
F340/F380 ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting 
the peak F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was 
determined by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this 
ratio as a percentage. 
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 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.32 0.39 0.07 22.1 
 0.34 0.41 0.08 22.6 
 0.35 0.66 0.32 91.6 
 0.37 0.42 0.05 12.7 
Mean 0.34 0.47 0.13 37.2 
S.E.M. 0.01 0.06 0.06 18.3 
 
Table 5.13.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the intracellular dialysis of 10 nM NAADP in pulmonary arterial smooth muscle cells pre-
incubated (20 minutes) with 100 µM Ned-19  
The resting F340/F380 ratio was determined by the calculating the average F340/F380 ratio taken at 4 time-
points immediately prior to the initiation of the Ca2+ transient.  When no transient was observed, the 
resting F340/F380 ratio was determined by calculating the average F340/F380 ratio taken at 4 time-points 
either side of achieving the whole-cell configuration.  The peak F340/F380 ratio is the maximum F340/F380 
ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting the peak 
F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was determined 
by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this ratio as a 
percentage. 
 
 
 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.43 0.76 0.33 77.2 
 0.41 1.19 0.78 190.2 
 0.49 1.26 0.77 157.9 
 0.41 2.62 2.21 540.3 
Mean 0.43 1.46 1.02 241.4 
S.E.M. 0.02 0.40 0.41 102.4 
 
Table 5.14.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the intracellular dialysis of 1 µM IP3 in pulmonary arterial smooth muscle cells pre-
incubated (20 minutes) with 100 µM Ned-19  
The resting F340/F380 ratio was determined by the calculating the average F340/F380 ratio taken at 4 time-
points immediately prior to the initiation of the Ca2+ transient.  When no transient was observed, the 
resting F340/F380 ratio was determined by calculating the average F340/F380 ratio taken at 4 time-points 
either side of achieving the whole-cell configuration.  The peak F340/F380 ratio is the maximum F340/F380 
ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting the peak 
F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was determined 
by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this ratio as a 
percentage. 
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 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.67 2.78 2.11 311.9 
 0.53 2.89 2.36 441.0 
 0.63 2.09 1.46 231.1 
 0.46 1.78 1.32 289.3 
 0.69 1.71 1.02 146.9 
 0.73 2.58 1.85 252.6 
 0.80 2.78 1.98 247.7 
Mean 0.65 2.37 1.73 274.4 
S.E.M. 0.04 0.19 0.18 34.0 
 
Table 5.15.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the extracellular application of 2.5 mM caffeine in pulmonary arterial smooth muscle 
cells 
The resting F340/F380 ratio was determined by the calculating the average F340/F380 ratio taken at 4 time-
points immediately prior to the initiation of the Ca2+ transient.  The peak F340/F380 ratio is the maximum 
F340/F380 ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting 
the peak F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was 
determined by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this 
ratio as a percentage. 
 
 
 Resting 
F340/F380 
Peak 
F340/F380 
Increase in 
F340/F380 
% increase in 
F340/F380 
 0.53 1.10 0.57 107.3 
 0.43 1.56 1.13 260.0 
 0.59 2.23 1.64 280.7 
Mean 0.52 1.63 1.11 216.0 
S.E.M. 0.04 0.33 0.31 54.7 
 
Table 5.16.  Record of the Fura-2 fluorescence ratio measurements taken for each experiment 
during the extracellular application of 2.5 mM caffeine in pulmonary arterial smooth muscle 
cells pre-incubated (20 minutes) with 100 µM Ned-19  
The resting F340/F380 ratio was determined by the calculating the average F340/F380 ratio taken at 4 time-
points immediately prior to the initiation of the Ca2+ transient.  The peak F340/F380 ratio is the maximum 
F340/F380 ratio obtained during the record.  The increase in F340/F380 ratio was determined by subtracting 
the peak F340/F380 ratio from the resting F340/F380 ratio.  The percentage increase in F340/F380 ratio was 
determined by dividing the increase in F340/F380 ratio by the resting F340/F380 ratio, and expressing this 
ratio as a percentage. 
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